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Insulin regulates glucose homeostasis by stimulation of glucose transport into adipose 
and muscle tissues through the regulated trafficking of glucose transporter 4 (GLUT4). 
In response to insulin GLUT4 rapidly translocates from intracellular storage sites to the 
plasma membrane where it facilitates glucose uptake. Significant impairments in 
glucose transport and GLUT4 trafficking are a major hallmark of diabetes mellitus type 
II. Recent advances in light microscopy techniques enabled the study of GLUT4 dynamics 
in the plasma membrane and it was reported that the transporter was clustered in the 
basal state and insulin stimulation resulted in GLUT4 dispersal. 
 
The main aim of this study was to develop a microscopy-based assay to study and 
quantify insulin-stimulated GLUT4 dispersal dynamics in the plasma membrane. Insulin-
stimulated GLUT4 dispersal has only been observed in adipocytes and therefore we have 
chosen this model as a starting point to investigate the molecular mechanisms behind 
GLUT4 clustering and dispersal. We explored a range of cluster analysis methods to find 
the most suitable way to quantify GLUT4 clustering dynamics. Furthermore, this project 
aimed to optimise super resolution imaging in a variety of cell culture models to 
determine whether insulin-stimulated GLUT4 dispersal operates in skeletal and cardiac 
muscle and whether this process is affected by disease.  
 
Using a range of approaches we showed that insulin results in GLUT4 translocation and 
dispersal within the plasma membrane of 3T3-L1 adipocytes. We found that AMPK 
activation attenuated insulin-stimulated glucose uptake in 3T3-L1 adipocytes and also 
GLUT4 dispersal. It was observed that cholesterol depletion resulted in increased 
glucose uptake rates and GLUT4 clustering. Knock down of the membrane-localised 
protein EFR3 that has previously been shown to be involved in glucose uptake resulted 
in disruption of GLUT4 dispersal in adipocytes. We also found that HeLa cells show 
similar insulin-stimulated GLUT4 dispersal as adipocytes and suggest that HeLa cells are 
a suitable experimental model for initial studies of GLUT4 trafficking and dispersal. 
Chronic insulin treatment was observed to induce a state of cellular insulin resistance in 
3T3-L1 adipocytes and resulted in reduced GLUT4 translocation and a more clustered 
GLUT4 configuration for both basal and insulin-stimulated cells. This indicates that 
insulin resistance affects intracellular GLUT4 trafficking pathways as well as the 
organization of the transporter within the plasma membrane in adipocytes. Moreover, 
we found a negative correlation between adipocyte cell area and insulin-stimulated 




We also report that insulin did not stimulate the reorganisation of the transferrin 
receptor in the plasma membrane of HeLa cells suggesting that insulin-stimulated 
GLUT4 dispersal did not originate from endosomal compartments in HeLa cells and that 
this observed effect may be specific for GLUT4. Finally, we observed that insulin did not 
affect GLUT4 distribution in the membrane of a commercially available model of 
skeletal muscle from healthy and diabetic donors. Sortilin is a sorting receptor involved 
in the formation of GLUT4 containing vesicles and levels of this protein were found to 
be reduced in skeletal muscle myotubes derived from a diabetic donor.  
 
Finally, we discovered that insulin stimulated GLUT4 dispersal also operates in stem 
cell-derived cardiomyocytes and have investigated GLUT4 dispersal in a variety of in 
vitro models of cardiac muscle tissue.  
 
Taken together, this thesis has detailed several novel findings regarding the regulation 
of GLUT4 clustering in adipose and muscle tissues. A robust assay to measure GLUT4 
dispersal has been established and molecular mechanisms behind the observed GLUT4 
clustering dynamics have been described in adipocytes. Furthermore GLUT4 clustering 
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Definitions & abbreviations  
2YT    2 Yeast Tryptone 
AP    Adaptor protein 
APS    Adaptor protein with Pleckstrin homology and Src homology 2  
   domains  
AS160    Akt substrate of 160 kDa 
ATP    Adenosine triphosphate 
AVV    Adeno-associated virus 
BMI    Body mass index 
CAP    c-CBL-associated protein 
CHO    Chinese hamster ovary 
CVD   Cardiovascular disease 
DAPI    4′,6-diamidino-20-phenylindole 
DM    Diabetic cardiomyopathy 
DMEM    Dulbecco’s Modified Eagle’s Medium 
DMSO    Dimethyl Sulfoxide 
dSTORM  Direct stochastic reconstruction microscopy 
DTT    Dithiothreitol 
E. coli    Escherichia coli 
EDTA    Ethylenediaminetetraacetic acid  
EGFP    Enhanced Green Fluorescent Protein  
EGTA    Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid  
ER    Endoplasmic Reticulum 
FCS    Foetal Calf Serum 
FFA   Free fatty acid 
GAP    GTPase-Activating Protein  
GCV   GLUT4 containing vesicles 
GFP    Green Fluorescent Protein 
GLUT    Glucose Transporter 
GLUT4   Glucose transporter type IV  
HA    Haemagglutinin 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HF    Heart failure 
IBMX    3-isobutyl-1-methylxanthine  
IF    Immunofluorescence  
iPSC-CM  Induced pluripotent stem cell derived cardiomyocytes 




IRAP    Insulin-Responsive Aminopeptidase 
IRS    Insulin Receptor Substrate 
IRV   Insulin responsive vesicles 
LV   Left ventricle 
MEA    Mercaptoethylamine 
MOI    Multiplicity of infection 
NA    Numerical Aperture  
NCS    Newborn Calf Serum  
PAGE    Polyacrylamide gel electrophoresis 
PBS    Phosphate buffered saline 
PBST    Phosphate buffered saline with Tween 
PCA   Protocatechuic acid  
PCD   Protocatechuic dioxygenase 
PDK1    Phosphoinositide-dependent kinase 1 
PFA    Paraformaldehyde 
PI   Phosphoinositide 
PI3K    Phosphoinositide 3-kinase 
PI4P    Phosphatidylinositol 4-phosphate  
PIK    Phosphoinositide kinase  
PIP3    Phosphatidylinositol 3-phosphate  
PKB    Protein kinase B 
PM   Plasma membrane 
PSF    Point spread function  
ROI    Region of interest 
SD   Standard definition 
SDS   Sodium dodecyl sulphate 
SEM   Standard error of the mean 
SIM    Structured illumination microscopy 
SMLM   Single molecule localization microscopy  
T2DM    Type II diabetes mellitus 
TAE    Tris-acetate EDTA  
TfR    Transferrin receptor  
TGN    Trans-Golgi network 
TIRF   Total internal reflection fluorescence 
TIRFM    Total internal reflection fluorescence microscopy  
VAMP    Vesicle-Associated Membrane Protein 
v/v    Units volume per unit volume 




1. Introduction  
1.1 Glucose homeostasis 
Glucose is the most abundant monosaccharide (simple sugar) with the molecular 
formula C6H12O6 that serves as the primary source of energy for life (Urry et al., 2017). 
It is produced by plants and algae during photosynthesis from carbon dioxide and water 
using the energy supplied by sunlight. Its naturally occurring form is D-glucose and most 
of it is stored in the form of polysaccharides. In humans and animals glucose is 
metabolised by an oxidative process known as glycolysis. Glucose is enzymatically 
broken down to form adenosine triphosphate (ATP) that provides energy for all cellular 
activities (Urry et al., 2017). 
 
Glucose homeostasis is key to survival and long-term health due to the central role of 
glucose as a universal source of energy for cell function (Urry et al., 2017). Circulating 
blood sugar levels are monitored and several mechanisms exist to react to changes and 
maintain levels within narrow limits, 4-6 mM in healthy humans (Urry et al., 2017). 
After a meal glucose is absorbed from the gut and blood glucose levels spike 
considerably. To avoid the effects of chronic hyperglycaemia (high blood sugar) it is 
essential to lower post-prandial blood glucose. Glucose homeostasis is primarily 
achieved by two glucoregulatory hormones of the body with opposing actions (Figure 
1.1). Insulin and glucagon are peptide hormones that are produced by specialised cells 
in the islets of Langerhans of the pancreas (Brelje et al., 1989; Brissova et al., 2005). 
Glucagon is released from α-cells when blood glucose levels are low and is considered 
the body’s main catabolic hormone, raising the concentration of glucose and fatty acids 
in the bloodstream (Urry et al., 2017). Glucagon mainly acts on hepatocytes in the liver 
by binding to the G protein-coupled glucagon receptor in their plasma membrane. In 
response to glucagon hepatocytes convert stored glycogen into glucose through 
glycogenolysis. When glycogen stores are depleted glucagon stimulates the liver and 
kidney to synthesize additional glucose by gluconeogenesis. Furthermore glucagon 
inhibits glycolysis so that glycolytic intermediates can be used for gluconeogenesis (Urry 










In contrast insulin is released from β-cells in response to high blood glucose levels and 
considered the body’s main anabolic hormone. Its main action is to lower blood glucose 
levels by signalling to peripheral tissues to store excess glucose (Levine and Goldstein, 
1958). Insulin binds to the tyrosine kinase insulin receptor (IR) to inhibit hepatic glucose 
production and catalyse glucose uptake by adipose and muscle tissues (Park and 
Johnson, 1955). Glucose is converted to glycogen in liver and muscle tissues and to 
triacylglycerols in adipose tissue which is essential for energy storage.  
 
 
Figure 1.1 Schematic of glucose homeostasis. 
Regulation of blood glucose levels occurs through the release of the two opposing 
peptide hormones glucagon and insulin from the α-cells and β-cells of the pancreatic 
islets respectively. Low blood glucose (hypoglycaemia) triggers the release of glucagon 
into the blood stream. Glucagon binds to its receptor in hepatocytes which activates 
signalling pathways that lead to the breakdown of glycogen into glucose (glycogenolysis) 
and the synthesis of glucose through gluconeogenesis. Insulin is secreted in response to 
increased blood glucose levels (hyperglycaemia). Upon binding to its receptor on muscle 
and adipose cells signalling pathways inducing cellular glucose uptake are triggered. In 







1.2.1 Diabetes is a growing global healthcare burden  
Diabetes mellitus is a lifelong metabolic disorder characterised by high blood glucose 
levels due to relative lack of insulin or insulin resistance (WHO, 2013). In 2014 the WHO 
estimated that 422 million individuals were living with diabetes worldwide (WHO, 2016). 
The global prevalence of diabetes has sharply risen among adults from 4.7% in 1980 to 
8.7% in 2014 with similar rates among women and men (WHO, 2016). It is predicted that 
the incidence of the condition is steadily on the rise. Between 2000 and 2016 a 5% 
increase in premature mortality attributed to diabetes was reported. In 2019 diabetes 
caused 4.2 million deaths worldwide, making it the 7th leading cause of death (IDF, 
2019). Diabetes is prevalent around the globe but it occurs more often in developed 
countries. However, in recent years the greatest increase in rates has been recorded in 
low- and middle-income countries in Africa and Asia (Danaei et al., 2011; Ogurtsova et 
al., 2017). The disease and its complications impose a large economic burden on 
patients and their families, health care systems and national economies through 
medical costs and loss of productivity. The global economic burden of diabetes was 
estimated at 673 billion US dollars in 2015 and is expected to increase significantly in 
the next decades (Bommer et al., 2018; Ogurtsova et al., 2017).  
 
In the UK 4.5 million people are estimated to live with diabetes of which 24,000 are 
predicted to die prematurely (Diabetes UK, 2014). The costs of diabetes to the NHS 
were estimated at 23.7 billion in 2010 with 9.8 billion in direct costs and 13.9 billion in 
indirect costs (Hex et al., 2012). This accounts for approximately 10% of the annual NHS 
budget which is expected to rise to 17% by 2035 (Hex et al., 2012). Mitigation of the 
national and global effects of diabetes is a primary goal as prevalence, deaths and 
health expenditure continue to rise.  
 
1.2.2 Complications  
Complications of diabetes have a dramatic effect on quality of life and can result in 
long-term disability (WHO, 2013). Generally, they can be grouped into acute and 
chronic complications. Diabetic ketoacidosis (DKA) and the hyperglycaemia 
hyperosmolar state (HHS) develop rapidly and are dangerous medical emergencies (IDF, 
2019). DKA is caused by low insulin levels. The liver is stimulated to turn fatty acids to 
ketone as an energy source resulting in the accumulation of ketone bodies in the blood. 
As a consequence the blood’s pH is lowered which can result in hypotension, shock, and 
death if not treated appropriately. HHS is caused by dramatically elevated blood 




blood osmolarity and loss of water leads to dehydration and electrolyte imbalances. 
Hypoglycaemia is naturally rare in diabetic patients but can be caused by a range of 
diabetic treatments. Without urgent medical treatment DKA, HSS and hypoglycaemia 
can result in unconsciousness known as diabetic coma.  
 
Chronic hyperglycaemia is highly toxic for the body and over time leads to serious 
damage of blood vessels and the tissues they supply. Microangiopathy is the damage to 
small blood vessels such as arterioles and capillary beds causing chronic complications 
within target organs. Endothelial cells lining the blood vessels absorb more glucose and 
produce more glycoproteins which leads to thickening and weakening of the vessel 
basement membrane. As a result the small vessels start to leak and slow blood flow. 
Reduced supply of oxygen and nutrients results in severe organ damage. Diabetic 
nephropathy is the chronic loss of kidney function that culminates in kidney failure 
(Haller et al., 2017). Diabetic retinopathy is a medical condition that arises from 
damage to the retina and is the leading cause of blindness in the developed world (Duh 
et al., 2017). The development of microangiopathy correlates closely with neuronal 
dysfunction because neurons and nerves are not sufficiently supplied with blood. The 
loss of function of nerves is known as diabetic neuropathy and affects the whole body 
(Feldman et al., 2019). However, one of the most common pathologies associated with 
diabetes is diabetic foot caused by advanced peripheral nerve dysfunction (Pendsey, 
2010). A combination of dysfunctional motor, autonomic, and sensory components of 
the nervous system result in anatomic foot deformities, skin breakdown, susceptibility 
to infection and ulceration (Pendsey, 2010). The loss of sensation in the affected foot 
causes that patients are unaware of the insult to their feet and the condition 
progressively worsens. As a result treatment is delayed and often only leaves 
amputation as the only remaining option (Pendsey, 2010).  
 
Apart from affecting small vessels hyperglycaemia has a detrimental effect on the large 
vessels of the body. In the Framingham Heart Study a strong positive correlation 
between diabetes and the incidence of cardiovascular disease was established for the 
first time (Kannel and McGee, 1979). Today it is known that diabetic patients have an 
elevated risk of developing a specific form of pre-mature, accelerated atherosclerosis 
(Madonna et al., 2018). Atherosclerosis is characterised by inflammatory remodelling of 
the arterial vascular wall that leads to accumulation of plaques and narrowing of the 
vessel lumen (van Varik et al., 2012). Enlargement of atherosclerotic plaques results in 
either rupture or stenosis. The complete obstruction of blood flow and prevention of 
perfusion of the downstream tissue can lead to myocardial ischaemia in the heart and 




arterial remodelling increases arterial stiffness which promotes pathological 
hemodynamic patterns for instance hypertension which is a strong independent risk 
factor for many cardiovascular diseases. Diabetic macroangiopathy and its complications 
are the number one cause of death in the diabetic patient population.  
 
1.2.3 Causes  
Diabetes mellitus is divided into three main types known as type I, type II and 
gestational. Type I diabetes mellitus is defined by the loss of insulin-producing 
pancreatic β-islet cells resulting in insulin deficiency (WHO, 2013). The majority of 
cases result from an auto-immune response in which a T cell-mediated attack 
culminates in the loss of β-islet cells. Type I accounts for 10% of diabetes mellitus cases 
and it is mostly attributed to genetic factors affecting otherwise healthy individuals 
(Todd et al., 2007; WHO, 2013). In contrast, type II diabetes mellitus (T2DM) is 
characterized by insulin resistance sometimes occurring in combination with relatively 
reduced insulin secretion. Insulin resistance is the inability of the body’s tissues to 
respond adequately to insulin stimuli and decrease blood glucose concentration. T2DM is 
the most common type of diabetes making up 90 % of cases (WHO, 2013). Genetic 
factors have been identified for making people more susceptible to the development of 
T2DM (Florez et al., 2003; Gerich, 1998) but the condition is primarily associated with 
life style factors. The underlying genetic mechanisms are complex, multifaceted and 
still poorly understood but numerous studies reported that lifestyle factors associated 
with weight gain and the development of obesity increase the risk of T2DM. Particularly 
lack of physical activity, a poor diet rich in saturated fatty acids and high glycaemic 
index carbohydrates, stress and smoking are strong environmental risk factors (Dendup 
et al., 2018; Kolb and Martin, 2017; Uusitupa, 2002). Gestational diabetes is a condition 
in which high blood sugar levels are developed during pregnancy and resembles type II 




Treatment strategies for the management of diabetes generally focus on monitoring and 
maintaining blood glucose levels within the appropriate range which can be achieved by 
several means. Injection of insulin is the first line treatment option for type I diabetes 
mellitus (IDF, 2019). T2DM is a more heterogeneous, multifactorial condition and 
treatment consists of a mixture of lifestyle interventions, management of 
cardiovascular risk factors and normalization of blood glucose (Ripsin et al., 2009). 




shown to elicit long-lasting positive effects on disease progression in small subject 
groups (Haw et al., 2017). Nevertheless, the education, implementation and 
sustainability of behaviours needed for ongoing self-management is difficult to establish 
for individual patients in the global context (Franz et al., 2015). The currently available 
pharmacological interventions focus on the treatment of symptoms rather than the 
actual cause (Haw et al., 2017). The global rise in the prevalence of diabetes and 
soaring mortality rates lead to the conclusion that the current treatment options for the 
condition are limited and insufficient. Diabetes research is vital to enhance our 
understanding of the underlying pathophysiology of diabetes and develop novel 
treatment strategies that address the underlying cause.  
 
1.3 Diabetic cardiomyopathy  
1.3.1 Recognition of diabetic cardiomyopathy 
The close link between T2DM and the development of cardiovascular disease (CVD) has 
been long established (Leon and Maddox, 2015). The Framingham Heart Study reported 
that the incidence of heart failure (HF) in T2DM is increased 2.4-fold in men and 5-fold 
in women (Kannel et al., 1974). Moreover, HF clinical outcomes are significantly more 
detrimental for T2DM patients compared to the normal population and HF incidence 
ranges from 19% – 26% (Rydén et al., 2000; Shindler et al., 1996; Thrainsdottir et al., 
2005). It has been found that T2DM has direct adverse effects on the myocardium in the 
absence of other cardiac risk factors such as coronary artery disease, valvular disease, 
hypertension and dyslipidaemia. In 1972 diabetic cardiomyopathy (DCM) was firstly 
described after post-mortem examination of 4 T2DM patients who manifested HF 
without any signs of coronary artery or valvular disease (Rubler et al., 1972). DCM is a 
clinical condition of ventricular dysfunction that is not directly attributable to other 
confounding CVD risk factors. It affects approximately 12% of T2DM patients and its 
prevalence rises in parallel with the global increase in T2DM (Trachanas et al., 2014). 
T2DM leads to different structural and functional modifications in the myocardium 
emerging from metabolic alterations caused by hyperglycaemia, hyperlipidaemia and 
insulin resistance (Lorenzo-Almorós et al., 2017). The functional phenotype of DCM 
manifests itself in stages over time.  
 
1.3.2 Pathophysiology of diabetic cardiomyopathy 
The first clinically asymptomatic stage of DCM is characterised by increased myocardial 
stiffness and fibrosis. During this stage early diastolic filling is reduced, atrial filling is 
increased and left ventricle (LV) end-diastolic pressure is elevated (Westermeier et al., 




LV diastolic dysfunction highlight that this pathology is common in T2DM patients and 
DCM (Boyer et al., 2004; Poulsen et al., 2010; Zahiti et al., 2013). Over time a range of 
adaptive processes occur that result in structural remodelling of the diabetic heart to 
compensate for loss of functional capacity during the initial stage of disease progression 
(Walker et al., 2016). The second stage of DCM is defined by LV hypertrophy, cardiac 
remodelling and advanced diastolic dysfunction. Clinical studies found that diabetics 
had a significantly increased LV wall thickness compared to healthy controls (Devereux 
et al., 2000; Lee et al., 1997; Shang et al., 2016; Walker et al., 2016). The pathological 
LV hypertrophy is associated with an increased cardiomyocyte volume due to collagen 
deposits and activation of mitogen-activated protein kinase (MAPK) and calcium 
signalling pathways resulting in cell death (Bernardo et al., 2010). These molecular 
changes culminate in reduced cardiac contractile capacity (Bernardo et al., 2010). 
During the second stage of DCM clinical symptoms of HF with normal ejection fraction 
develop. Further disease progression leads to systolic dysfunction coexisting with 
diastolic dysfunction and decreased myocardial compliance culminating in HF with 
reduced ejection fraction.  
 
1.3.3 Impaired insulin signalling in diabetic cardiomyopathy 
Studies indicate that abnormal insulin signalling is a key contributor in the development 
of DCM and changes in GLUT4 expression and trafficking precede pathological structural 
and functional changes of the myocardium (Jia et al., 2018). Mice with cardiomyocyte-
restricted deletion of insulin receptors (CIRKO) showed a decrease in cardiac glucose 
uptake and an increase in cardiac reactive oxygen species production and mitochondrial 
dysfunction (Bugger et al., 2012). Insulin receptor substrates function as essential 
signalling intermediates downstream of the activated insulin receptor to regulate cell 
metabolism. Heart-specific double knock out of insulin receptor substrate genes 1 and 2 
in mice resulted in cardiac apoptosis and fibrosis and exhibition of features of HF for 
instance impaired energy metabolism gene expression of the myocardium (Qi et al., 
2013). Moreover in CIRKO mice impaired insulin action was shown to contribute to 
oxidative stress and mitochondrial dysfunction (Boudina et al., 2009). Myocardial 
biopsies from T2DM patients were reported to have reduced insulin signalling and GLUT4 
expression and translocation (Cook et al., 2010). This highlights the importance of 





1.4 Glucose transport 
1.4.1 Glucose transporters 
Glucose transport from the blood stream into cells is mediated by 14 tissue-specific 
members of the glucose transporter (GLUT) family (Mueckler and Thorens, 2013). GLUTs 
are membrane proteins that facilitate transport of glucose and related hexoses across 
cell plasma membranes. GLUT1 was the first facilitative GLUT identified to catalyse 
glucose uptake into erythrocytes in 1985 (Mueckler et al., 1985). The molecular cloning 
of GLUT1 subsequently led to the identification of homologue genes and discovery of 
four more facilitative GLUTs (GLUT2-5) (Joost and Thorens, 2001). Only in recent years 
more GLUT-like sequence fragments were identified in homology searches of gene 
databases from various genome projects. With this strategy seven new members of the 
GLUT family were identified sharing significant similarity with GLUT1 (Joost and 
Thorens, 2001). GLUTs are encoded by the SLC2 genes and composed of approximately 
500 amino acids and can be divided into three classes based on sequence similarities 
(Deng and Yan, 2016). All members of the GLUT family contain 12 membrane-spanning 
α-helices with intracellular N- and C-termini, seven conserved glycine residues, two 
conserved tryptophan residues and two conserved tyrosine residues (refer to figure 1.2 
for GLUT structural features). Class I facilitative GLUTs are glucose-specific GLUTs 
represented by GLUT1-4 and GLUT14 with specific glutamine residues on helix 5 and 
STSIF-motifs in loop 7. Class II comprises the fructose-specific GLUT5 and the related 
GLUTs 7, 9 and 11 with a characteristic lack of tryptophan in helix 10. Class III are the 
structurally atypical GLUT6, 8, 10, 12, 13 characterised by a shorter extracellular loop 1 
lacking a glycosylation site (Mueckler and Thorens, 2013). One or more GLUTs are 
present in all cells of the body and although structurally very similar GLUT isoforms 
differ in tissue and cellular distribution, substrate specificity and transport kinetics 
(Kahn, 1992). Class I GLUTs are most well-characterised whereas the functions of GLUTs 
in class II and III are not clearly defined at present. The first comprehensively studied 
GLUT was GLUT1 which is highly abundant in erythrocytes and the blood-brain barrier 
(Kasahara and Hinkle, 1977; Mueckler et al., 1985). GLUT3 is a high-affinity isoform and 
referred to as the “neuronal GLUT” and also highly expressed in brain tissue. The brain 
is dependent on a continuous and constant supply of its main energy substrate glucose 
and therefore the GLUTs in the brain are mainly located in the abluminal membranes of 
brain cells (Duelli and Kuschinsky, 2001). GLUT2 is the major GLUT expressed in 
hepatocytes and able to catalyse bidirectional flow of glucose in fed and fasting states 
(Thorens and Mueckler, 2010). GLUT2 is a low-affinity isoform that facilitates glucose 
uptake for glycolysis and glycogenesis and glucose release during gluconeogenesis. 




into adipose tissue, skeletal and cardiac muscle (Bell et al., 1993). GLUTs catalyse 
glucose transport through an ATP-independent, facilitative diffusion mechanism. Crystal 
structures for GLUT1, 3 and 5 have only become available recently and suggest that 
GLUTs transport glucose down its concentration gradient according to a model of 
alternate conformation (Holman, 2020). It is predicted that the membrane spanning 
domains are built from replicated trimer substructures that move relative to each 
other. GLUTs expose a substrate binding site toward the outside of the cell and 
substrate binding results in a conformational change that closes the cleft towards the 
external side and alternately opens a cleft to the internal side of the membrane to 
release the substrate on the other side (Holman, 2020). Glucose transporters in the 
heart specifically are discussed separately in section 5.1.1. Since its discovery GLUT4 
(James et al., 1988) has been the subject of numerous investigations and received more 
attention than any other membrane transport protein (Thorens and Mueckler, 2010). 
GLUT4 plays a key role in glucose homeostasis and its dysregulation in several prevalent 
insulin-resistant disease states makes it an important study target that will also be 
addressed in this thesis.  
 
1.4.2 Glucose transporter 4 
In the early 1980s pioneering work in the Cushman (Cushman and Wardzala, 1980), Kono 
(Suzuki and Kono, 1980) and Jenrenaud (Wardzala and Jeanrenaud, 1981) laboratories 
revealed that insulin causes translocation of glucose transport units from an 
intracellular storage site to the PM in adipocytes (Thorens and Mueckler, 2010). In 1988 
the production of a monoclonal antibody (mAb 1F8) against a GLUT residing in 
microsomes of primary adipocytes enabled the identification of a unique, insulin-
regulatable GLUT isoform known as GLUT4 today (James et al., 1988). In resting cells no 
protein was detectable through immunoblotting in the plasma membrane fraction of the 
adipocytes but upon insulin stimulation an increase in cell surface labelling was evident. 
This experiment provided the first evidence for the existence of GLUT4 translocating 
from an intracellular location to the cell surface in response to insulin (James et al., 
1988). The SLC2A4 gene encoding GLUT4 was cloned (Birnbaum, 1989; James et al., 
1989) and mapped (Bell et al., 1989) in the following year. It shares ~65% sequence 
identity with the SLC2A1 gene encoding GLUT1 referred to as HepG2 GLUT at the time 
(Bell et al., 1989). Structurally GLUT4 shares basic similarities with other GLUTs 
(Mueckler and Thorens, 2013). However, GLUT4 has some unique differences in the 
amino acid arrangement of its primary sequence (Figure 1.2) supporting its specific 
functions and playing a role in the kinetics of endo- and exocytosis (Huang and Czech, 
2007). Genetically engineered mouse models with enhanced or ablated GLUT4 




The homozygous fully GLUT4-deficient knock-out mouse displays a range of 
compensatory mechanisms ensuring its survival and is therefore less informative (Katz 
et al., 1995). Heterozygous GLUT4+/- mice with decreased GLUT4 expression in adipose 
and muscle tissues have increased levels of blood glucose and insulin, reduced muscle 
glucose uptake, hypertension, and diabetic pathologies comparable to human patients 
in their heart and liver (Stenbit et al., 1997). Overexpression of GLUT4 in heterozygous 
GLUT4+/- mice prevents the development of insulin insensitivity and the diabetic 
phenotype showing that GLUT4 is a key player in glucose homeostasis (Tsao et al., 
1999). Transgenic mice overexpressing GLUT4 selectively in either adipocytes (Shepherd 
et al., 1993) or muscle cells (Tsao et al., 1996) showed enhanced in vivo glucose 
tolerance and basal and insulin-stimulated glucose transport. Selective GLUT4 depletion 
in both adipose (Abel et al., 2001) and muscle tissues (Zisman et al., 2000) results in 
insulin resistance and glucose intolerance. Targeted GLUT4 gene disruption in specific 
tissues using cre-lox recombination in mice was found to strongly affect other tissues 
metabolically which is surprising especially regarding adipocytes that only account for a 
small fraction of body glucose disposal (Abel et al., 2001; Zisman et al., 2000).  
 
 
Figure 1.2 Glucose transporter 4 structural features. 
The affinity of GLUT4 for insulin is strongly linked to its unique sequences found in the 
H2N and C-termini. GLUT4 shares basic structural similarities with other members of the 
GLUT family but its H2N contains a F5QQI motif that interacts with adaptor proteins 
important for endocytosis. The C-terminal end contains a double leucine and an acidic 
TELEY motif that regulate the intracellular distribution of GLUT4 (adapted from (Huang 




1.4.3 GLUT4 intracellular trafficking overview 
In the following, a nomenclature will be defined to discuss GLUT4 intracellular 
trafficking appropriately. In the absence of insulin, GLUT4 populates tubules and 
vesicles throughout the cell. Multiple names are used in the field of GLUT4 traffic to 
identify/define intracellular GLUT4-containing vesicles. For clarity, the names used in 
this thesis and the meaning I ascribe to them are given below: 
 
GSC All intracellular vesicles and tubules that contain GLUT4 – hence the GLUT4 
Storage Compartment – this includes GLUT4 in endosomes, the trans-Golgi network and 
the compartment targeted by CHC22 in humans.  IRVs are regarded as a separate 
compartment. The GSC is likely comprised of multiple sub-compartments (Kandror and 
Pilch 2011; Bogan 2012; Kioumourtzoglou et al. 2015). 
 
IRV  Insulin-Responsive Vesicles: That population of vesicles derived from the GSC 
that respond acutely to insulin by mobilisation to the cell surface. IRV are formed from 
donor membranes that are likely a sub-domain of the trans-Golgi network and/or 
recycling endosomes. The general view is that these vesicles are depleted of endosome 
or Golgi markers. 
 
In this thesis, I will use IRV to represent any GLUT4-containing vesicle that approaches 
the PM in response to insulin. ‘GLUT4 containing vesicle’ will be used when the nature 
of the GLUT4-containing structure is ambiguous or ill-defined. 
 
Vesicle exocytosis is vital for the delivery of intracellular material to the extracellular 
space and governed by signalling pathways that regulate and coordinate proteins 
associated with the vesicle trafficking machinery (Leto and Saltiel, 2012). Several 
membrane proteins are known to cycle between the membrane and intracellular loci 
known as the endosomal cycle (Rea and James, 1997). Selective retrieval of GLUT4 from 
the PM occurs either through clathrin-mediated endocytosis or other pathways that 
proceed independently of clathrin in adipose and muscle tissues (Doherty and McMahon, 
2009). Clathrin-independent endocytotic pathways require specialised lipid domains 
such as cholesterol with or without participation of caveolin (Antonescu et al., 2008, 
2009). Kinetic and morphological analysis of GLUT4 sequence mutants have largely 
contributed to the understanding of GLUT4 endocytosis and sorting (Rea and James, 
1997). GLUT4 contains a unique N-terminal phenylalanine residue in addition to 
dileucine and acidic motifs in its COOH terminus (Figure 1.2). It was shown that the 
dileucine motif L489 / L490 present in the GLUT4 C-terminus is critical for GLUT4 sorting 




dileucine motif with alanine substitutions did not inhibit GLUT4 internalisation but 
slowed basal GLUT4 intracellular retention after insulin withdrawal indicating that 
L489/L490 is not the only endocytosis motif (Blot and McGraw, 2008). The C-terminus 
acidic cluster TELEYLGP motif (498-505) is important for the sequestration of GLUT4 
from endosomal compartments to specialised vesicles that can fuse with the PM (Blot 
and McGraw, 2008). Replacing 12 amino acids in the GLUT4 C-terminus with the same 
sequence found in human GLUT3 creates chimeras that remain stuck in the endosomal 
cycle (Shewan et al., 2000). The F5QQI sequence plays a critical role in GLUT4 
sequestration from endosomes and ablation of the sequence results in inhibition of 
GLUT4 recycling after insulin stimulation and the targeting of GLUT4 to late 
endosomes/lysosomes where it is degraded (Palacios et al., 2001). GLUT4 molecules are 
stable proteins with a half-life of 48 hours and will undergo multiple rounds of recycling 
before being degraded (Sargeant and Pâquet, 1993). Complex interactions between 
numerous proteins regulate the subcellular localization of GLUT4 and its translocation 
to the plasma membrane in response to insulin stimulation, a process known as GLUT4 
trafficking (Leto and Saltiel, 2012). In contrast to other GLUT family members, GLUT4 is 
not always present in the PM. In the basal state the majority of GLUT4 is sequestered in 
intracellular tubulo-vesicular structures. The investigation of the intracellular 
distribution of GLUT4 in rat adipose tissue with immunolocalization and electron 
microscopy revealed that 99 % of GLUT4 was located in small vesicles near the 
trans-Golgi reticulum and tubulo-vesicular structures in the cytoplasm whereas only 
1 % of total GLUT4 were located in the PM under basal conditions (Slot et al., 
1991a). Insulin stimulation resulted in an increase of total GLUT4 in the PM to 40 %. 
A later study confirmed the existence of a population of small vesicles in the neuro-
endocrine cell line PC12 transfected with rat GLUT4 (Herman et al., 1994). It was 
found that GLUT4-containing vesicles did not colocalise with the transferrin 
receptor (TfR), a marker of recycling endosomes, indicating the presence of a 
distinct class of intracellular GLUT4 storage vesicles beyond the endosomal system 
(Herman et al., 1994). Another study using subcellular fractionation of 3T3-L1 
adipocytes reported that 40 % of GLUT4-positive vesicles colocalised with TfR 
whereas 60 % of GLUT4-positive vesicles were TfR-negative confirming the existence 
of a specialized intracellular compartment involved in GLUT4 trafficking 
(Livingstone et al., 1996). In 1997 the compartment was referred to as GLUT4 
storage compartment and the GLUT4-positive, TfR-negative vesicles named GLUT4 
storage vesicles (Rea and James, 1997); the latter are now more usually referred to 
as IRVs (see above). Biochemically, several proteins have been identified as markers 




associated membrane protein 2 (VAMP2) and insulin-regulated aminopeptidase 
(IRAP) have been reported to colocalise with insulin-responsive GLUT4-containing 
vesicles (Martin et al., 1996; Subtil et al., 2000). Furthermore sortilin-1, low-density 
lipoprotein receptor-related protein 1 and the tethering protein TUG have been 
reported to localise with GLUT4 in the GSC (Jedrychowski et al., 2010; Shi and 
Kandror, 2005; Yu et al., 2007). It was proposed that 40-50 % of GLUT4 is retained in 
the endosomal cycle whereas 50-60 % is distributed in the trans-Golgi network and 
IRVs (Martin et al., 1996; Zeigerer et al., 2002). The current model of GLUT4 
trafficking is that GLUT4 is distributed between the two intracellular pools that are 
in dynamic communication with one another (Zeigerer et al., 2002). The simplified 
fundamental concept of GLUT4 trafficking depicted in figure 1.3 is that GLUT4 is 
internalised into a general endosomal system from which it can enter a specific 
cycle where it is targeted to the trans-Golgi network to be sorted into insulin-
responsive IRVs that translocate to the PM upon insulin stimulation. 
 
Figure 1.3 Schematic of intracellular GLUT4 trafficking. 
GLUT4 is sequestered intracellularly in the GLUT4 storage compartment (GSC) which 
includes cycle-1 and cycle-2. GLUT4 is sorted into insulin responsive vesicles (IRV) which 
translocate to the plasma membrane upon insulin stimulation. After endocytosis GLUT4 
enters the endosomal pathway (cycle 1). During cycle 1 GLUT4 can either be returned 
to the PM, targeted to lysosomes to be degraded or sequestered into IRV via the trans-
Golgi network. The static retention model describes a specialised sorting cycle (cycle 2) 
in which GLUT4 continuously cycles through the trans-Golgi network and recycling 




1.4.4 GLUT4 trafficking in muscle tissues 
Similarly to adipocytes GLUT4 is mostly retained within intracellular GSC and excluded 
from the cell surface in resting skeletal muscle fibres. In rat muscle it was observed 
that 23 % of GLUT4 was present in large structures for instance multivesicular 
endosomes located in the trans-Golgi network and 77 % was associated with small 
tubulovesicular structures (Ploug et al., 1998). Several studies investigating skeletal 
muscle in living mice employing novel confocal imaging techniques have demonstrated 
that insulin as well as contractions induce GLUT4 translocation to the plasma membrane 
proper known as sarcolemma and its extensions known as t-tubular membranes 
(Lauritzen et al., 2006, 2008, 2010). Quantitative analysis of imaging data revealed that 
insulin stimulation increased GLUT4 labelling 7-fold and contraction 9-fold in the 
sarcolemma of rat muscle fibres. The two stimuli combined resulted in a 14-fold 
increase in GLUT4 labelling indicative of an additive effect (Ploug et al., 1998). 
Furthermore, insulin stimulation increased GLUT4 labelling 15-fold and contraction 20-
fold in the t-tubules of the muscle fibres with both stimuli resulting in a 30-fold 
increase (Ploug et al., 1998). Due to the additive nature of insulin- and contraction-
induced glucose transport it was proposed that two different pools of GLUT4 exist in 
skeletal muscle in rodents that are recruited by distinct mechanisms. These processes 
are more difficult to demonstrate in human subjects due to technical and ethical 
constraints. Nevertheless several studies showed that both insulin and contraction 
stimulate recruitment of GLUT4 to the plasma membrane and increase glucose transport 
in human skeletal muscle (Goodyear et al., 1996; Gumà et al., 1995; Kennedy et al., 
1999). Skeletal muscle glucose transport is further described in section 6.1.1. 
 
The transport of glucose across the sarcolemma is facilitated by GLUT4 in fully 
differentiated cardiomyocytes similarly to adipose and skeletal muscle tissues (Slot et 
al., 1991b). In the resting state GLUT4 is located in intracellular tubulovesicular 
structures that comprise at least two distinct populations (Fischer et al., 1997). The 
first pool contains predominantly GLUT4 and low levels of GLUT1 and secretory carrier 
membrane proteins (SCAMPs) whereas the second pool is enriched with GLUT1 and 
SCAMPs and contains less GLUT4. In isolated rat cardiac myocytes insulin treatment 
resulted in GLUT4 depletion from both pools and GLUT1 and SCAMPs depletion from the 
second pool (Fischer et al., 1997). Insulin withdrawal was observed to result in re-entry 
of GLUT1 and GLUT4 to the specific pools they translocated from. Glucose transporters 





1.4.5 GLUT4 endocytosis 
The protein clathrin plays a fundamental role in endocytosis and the formation of 
coated vesicles in the cytoplasm for intracellular trafficking (Pearse, 1976). In the basal 
state GLUT4 was reported to be present on clathrin-coated vesicles from the PM and the 
trans-Golgi network indicating that clathrin also plays a role in intracellular GLUT4 
retention (Robinson et al., 1992). Another study observed that GLUT4 colocalised with 
clathrin lattices and appeared to be continually retrieved from the PM through the 
clathrin pathway in the basal state (Chakrabarti et al., 1994). Insulin treatment 
decreased the concentration of GLUT4 in PM-derived clathrin coated vesicles 
specifically by 60%. It was hypothesised that insulin has a direct effect on GLUT4 
endocytosis via the described mechanism (Chakrabarti et al., 1994). Later it was found 
that GLUT4 retention occurs via two different pathways dependent on either cholesterol 
or clathrin adaptor protein complex-2 (AP-2) (Blot and McGraw, 2006). In the basal state 
80% of GLUT4 was observed to be internalised by a cholesterol-dependent mechanism 
independent of AP-2. Insulin stimulation was observed to inhibit the cholesterol-
dependent pathway and shift GLUT4 internalization towards an AP-2-dependent 
pathway in adipocytes (Blot and McGraw, 2006). 
 
However, comparison of the time courses of tracer-tagged GLUT4 redistribution under 
basal and insulin-stimulated conditions in 3T3-L1 adipocytes revealed that endocytosis 
rate constants were only 30% slower following insulin stimulation (Yang and Holman, 
1993). Moreover, it was found that insulin increased GLUT4 exocytosis rate constants 
significantly indicating that insulin stimulation had a minimal effect on GLUT4 
endocytosis compared to substantial effects on exocytosis (Yang and Holman, 1993).  
 
1.5 Insulin signalling 
After a meal the β-cells of the pancreas sense the sudden increase in blood glucose 
levels and release insulin. Binding of insulin to the membrane-bound insulin receptor 
(IR) initiates a complex intracellular signalling cascade that culminates in translocation 
of GLUT4 to the PM within minutes (Figure 1.4). Insulin binds to the two IR α-subunits 
resulting in auto-phosphorylation of the two internal-facing IR β-subunits activating the 
receptor intrinsic tyrosine kinase activity (Lee and Pilch, 1994). Following activation of 
the IR tyrosine kinase binding sites for several protein signalling partners containing Src-
homology 2 (SH2) and phosphotyrosine-binding domains become available (De Meyts, 
2000). Various intracellular signalling cascades are coordinated by either insulin 
receptor substrates (IRS) or adapter protein with a pleckstrin homology and an SH2 




mitogenic effects in several tissues. Insulin signalling in cardiac tissues is described in 
section 6.1.2 specifically. 
 
1.5.1 Mitogen-activated protein (MAP) kinase signalling pathway 
The mitogen-activated protein (MAP) kinase signalling pathway mediates the mitogenic 
actions of insulin resulting in cellular proliferation and gene transcription (Boucher et 
al., 2014). After ligand binding Shc proteins are recruited and phosphorylated. This 
results in phosphorylation of Grb2 and binding of son-of-sevenless (SOS) proteins. The 
membrane-bound Ras is switched from its GDP-bound form to its active GTP-bound form 
by SOS resulting in interaction with Raf. Raf stimulates MEK1 and 2 leading to activation 
of the MAP kinases ERK1 and 2. Phosphorylated ERK controls cell proliferation, 
differentiation, gene expression and cytoskeletal reorganisation (Boucher et al., 2014).  
 
1.5.2 Insulin receptor substrate (IRS) signalling pathway 
The best studied insulin signal transduction pathway is coordinated by the IRS-1, -2, -3 
and -4 proteins that mediate varying pathways resulting in the metabolic actions of 
insulin (Figure 2.4). IRS-1 and -2 are most abundant in insulin sensitive tissues and the 
key mediators. In adipose and muscle tissues the activated IR tyrosine kinase 
phosphorylates IRS-1 resulting in the recruitment of phosphatidylinositol-3-kinase (PI3K) 
(Backer et al., 1992). Experimental inhibition of either IRS-1 or PI3K results in an 
impairment of insulin-stimulated glucose transport in adipocytes suggesting that these 
proteins are key intermediates of insulin signalling (Clarke et al., 1994; Quon et al., 
1994). PI3K promotes the formation of the lipid second messenger phosphatidylinositol 
(3,4,5) trisphosphate (PIP3) from phosphatidylinositol (4,5)bisphosphate (PIP2) at the 
inner leaflet of the PM. PIP3 recruits phosphoinositide dependant kinase 1 (PDK1) and 
protein kinase B (Akt) to the cell surface where Akt is activated by phosphorylation 
(Kohn et al., 1996). Akt activation results in activation of numerous downstream targets 
regulating lipid and glycogen synthesis, gluconeogenesis, and glucose transport (Boucher 
et al., 2014). In this thesis the main focus will be put on insulin’s actions on regulating 
glucose transport. Pharmacological Akt activation in 3T3-L1 adipocytes engineered to 
express a rapidly drug-inducible Akt2 system showed that Akt2 activation alone results 
in a GLUT4 translocation response comparable to insulin stimulation (Ng et al., 2008). 
Therefore, Akt2 is regarded as another key intermediate in the IRS insulin signalling 
pathway governing glucose transport. Akt activation leads to phosphorylation of its main 
target Akt substrate of 160 kDa (AS160). AS160 contains a GTPase-activating protein 
(GAP) domain that inhibits GTP loading and activation of downstream effectors. In 




the relief of AS160 inhibition of GAP activity and allows GTP loading of Rab10. This 
process activates the Rab10 protein and culminates in IRV translocation to and fusion 
with the PM (Sano et al., 2007). IRV fusion with the PM is driven by SNARE proteins 
which are present as monomers on incoming and target cell membranes. The v-SNARE 
protein VAMP2 assembles irreversibly with the two t-SNARE proteins syntaxin4 and 
SNAP23 situated on the target membrane and fusion of the proximate lipid bilayers is 
established through thermodynamic melting (Bryant and Gould, 2011).  
 
Figure 1.4 Schematic of the insulin signalling cascade culminating in GLUT4 
translocation to the plasma membrane. 
Insulin binds to its receptor which results in autophosphorylation leading to activation of 
the IRS and APS signalling pathways. IRS recruits PI3K which promotes formation of PIP3 
at the PM. In response PDK1 and Akt are recruited to the cell surface and activated. 
AS160 is phosphorylated which results in the relief of AS160 inhibition of GAP activity 
and allows GTP loading of Rab10. This activates the Rab10 protein and culminates in 
GLUT4 translocation. The APS signalling branch is less well characterised but activation 
results in recruitment of TC10-GTP, which binds to CIP4 aiding GLUT4 translocation. 
 
 
1.5.3 Adaptor protein with pleckstrin homology and Src homology 
domains (APS) signalling pathway 
Several studies proposed that the APS interacts with the IR kinase and that this 
signalling branch contributes to GLUT4 translocation in 3T3-L1 adipocytes (Isakoff et al., 
1995; Wiese et al., 1995). However, the APS signalling branch is less well characterised 
than the previously described IRS branch (Figure 2.4). Studies suggest that APS 
activation recruits c-CBL associated protein (CAP) which associates with c-Cbl in 3T3-L1 
adipocytes and Chinese hamster ovary (CHO) cells to allow for c-Cbl tyrosine 
phosphorylation (Ahmed and Pillay, 2003; Ahmed et al., 2000; Liu et al., 2002; Wakioka 
et al., 1999). The CAP/Cbl complex recruits the guanine nucleotide exchange factor 




in the exchange of GDP for GTP in the small effector G protein TC10. The activated 
TC10 binds to Cdc42-interacting protein 4 (CIP4) aiding GLUT4 translocation 
independently of the PI3-kinase pathway (Liu et al., 2002, 2003). Many studies 
investigate insulin signalling and GLUT4 translocation in adipocytes but currently less is 
known about cardiac and skeletal muscle tissues. 
 
1.5.4 Insulin signalling in muscle tissues 
As previously discussed insulin signalling can be transduced along different metabolic 
pathways containing several points of regulation and signal divergence. Further 
complexity is added by the expression of multiple tissue-specific isoforms of insulin 
signalling substrates and protein kinases (Taniguchi et al., 2006). The insulin signalling 
cascade resulting in GLUT4 translocation in muscle tissues is only fragmentarily 
understood. In skeletal muscle the small GTPases Rab8 and Rab14 have been identified 
to be activated instead of Rab10 downstream of AS160 (Ishikura et al., 2007; Sun et al., 
2010). Furthermore, the Rab GTPase activating protein TBC1D4 has been described as a 
key component of the insulin signalling axis whereas its TBC1D1 paralog has been 
identified to contribute to contraction-induced GLUT4 translocation in skeletal muscle 
(Taylor et al., 2008). SNARE proteins are responsible for docking with and fusion to the 
PM and in skeletal muscle the actin skeleton has been identified to significantly 
contribute to insulin-stimulated GLUT4 translocation (Chiu et al., 2011; JeBailey et al., 
2004; Ueda et al., 2010). The Rho family GTPase Rac1 has been proposed to play a 
critical role in insulin-stimulated GLUT4 translocation in skeletal muscle (Ueda et al., 
2010). Ectopic expression of activated Rac1 in combination with insulin stimulation 
caused GLUT4 translocation in mice whereas insulin-dependent GLUT4 translocation was 
significantly decreased in Rac1-knockout mice (Ueda et al., 2010). In general it is 
assumed that contractions stimulate GLUT4 translocation through molecular pathways 
distinct from insulin stimulation. Nevertheless, in their distal parts the insulin- and 
contraction-induced molecular pathways converge involving a number of similar 
signalling molecules.  
 
As is the case in adipose and skeletal muscle tissue, the binding of insulin to its receptor 
induces autophosphorylation and increases tyrosine kinase activity for IRS proteins in 
cardiac muscle. In the heart IRS1 and IRS2 are the most abundant isoforms and required 
to activate PI3K to catalyse the generation of PIP3 (Riehle and Abel, 2016). In isolated 
cardiomyocytes it has been observed that Akt2 is required for insulin-stimulated glucose 
uptake independent of Akt1 (DeBosch et al., 2006a). Therefore in the heart Akt2 
mediates the metabolic effects of insulin whereas Akt1 governs somatic growth of 




and inactivates its GTPase-activating function and thereby enables the activation of Rab 
proteins. In skeletal muscle a protein from the same family, TBC1D1, plays a similar role 
but does not seem to be expressed in cardiomyocytes (Montessuit and Lerch, 2013). The 
specific Rab proteins involved in cardiac insulin signalling need to be investigated 
further. Only Rab11 has been consistently reported to contribute to insulin-stimulated 
GLUT4 translocation in the myocardium (Kessler et al., 2000; Uhlig et al., 2005). Rab4a 
may also participate in GLUT4 vesicle trafficking (Dransfeld et al., 2000).  
 
1.5.5 Insulin signalling defects in T2DM 
A major hallmark of T2DM is significantly reduced insulin-mediated glucose transport 
into fat and muscle tissues (Dutka et al., 2006; Hu et al., 2018b; Szablewski, 2017). This 
impairment is associated with a range of molecular defects at one or several levels of 
the insulin signalling cascade. The first step of the insulin signalling cascade is IR 
autophosphorylation leading to activation of its intrinsic tyrosine kinase activity. In 
insulin-resistant rodent models it was observed that insulin-induced phosphorylation of 
the IR beta subunit was significantly decreased compared to controls (Kadowaki et al., 
1984; Le Marchand-Brustel et al., 1985). However in skeletal muscle samples of diabetic 
human subjects only modest impairments of IR autophosphorylation were reported 
(Maegawa et al., 1991; Nolan et al., 1994). In adipocytes from human diabetic subjects 
decreased numbers of IR and IR binding were reported (Kolterman et al., 1981; Sinha et 
al., 1987) alongside a significant decrease in insulin-induced tyrosine kinase activity 
(Freidenberg et al., 1987; Sinha et al., 1987). Taken together these studies show that 
alterations of insulin receptor functionality contribute to the development of T2DM but 
significant differences exist between tissues. Phosphorylation of IRS proteins provides 
docking sites for SH2 domain containing molecules and activates PI3K which mediates 
the further transmission of the insulin signal. Numerous independent studies have 
reported that IRS1 tyrosine phosphorylation is diminished on several sites in skeletal 
muscle and adipocytes from T2DM patients (Björnholm et al., 1997; Bouzakri et al., 
2003; Danielsson et al., 2005; Goodyear et al., 1995; Krook et al., 2000). The role of 
insulin-induced PI3K activation resulting in formation of PIP3 at the PM has been 
extensively investigated in vitro and alterations of PI3K in the context of T2DM are only 
fragmentarily understood in vivo (Fröjdö et al., 2009). Some groups reported impaired 
activation of PI3K in human diabetic subjects but paradoxically unaltered Akt activation 
downstream (Beeson et al., 2003; Kim et al., 1999, 2003). Furthermore, the impairment 
of insulin-induced activation of Akt in the development of T2DM in skeletal muscle is 
currently debated. Some studies reported reduced Akt phosphorylation in T2DM patients 
(Cozzone et al., 2008; Meyer et al., 2002) whereas other studies observed no 




The reports regarding impaired activation of Akt in adipocytes from T2DM patients are 
more consistent (Carvalho et al., 2000; Rondinone et al., 1999). Reduced insulin-
stimulated phosphorylation of Akt was reported in these cells in combination with 
reduced glucose uptake (Carvalho et al., 2000; Rondinone et al., 1999). However, it is 
important to note that how modest changes in signalling translate to impaired insulin 
action has been questioned (Tan et al., 2015). In addition to impaired insulin signalling, 
defects in GLUT4 trafficking have been suggested to contribute to the progression of 
T2DM and are described in section 6.1.2. There is emerging evidence that insulin action 
influences GLUT4 dynamics in the PM and dysregulation of this newly described process 
might be another impairment contributing to the development of insulin resistance.  
 
1.6 GLUT4 in the plasma membrane 
Since the discovery of the GLUT4 protein in 1988 GLUT4 signalling pathways have been 
extensively studied (Klip et al., 2019). Biochemical approaches have revealed that 
insulin stimulates a complex signalling cascade culminating in GLUT4 translocation from 
intracellular storage vesicles to the PM where the channel becomes available for glucose 
uptake (Birnbaum, 1989; James et al., 1988). Relatively little is known about GLUT4 
dynamics within the PM itself. The discovery of green fluorescent protein (GFP) and the 
ability to use it as a marker for protein localization fundamentally altered the scope of 
which questions could be addressed by cell biologists (Tsien, 1998). In 1994 GFP was 
successfully expressed in E. coli and only two years later GFP-tagged GLUT4 was used to 
visualise the dynamics of insulin-stimulated GLUT4 translocation in living CHO cells 
(Dobson et al., 1996). Shortly after the same group managed to express GLUT4-GFP in 
3T3-L1 adipocytes and observed GLUT4 translocation in response to insulin for the first 
time (Powell et al., 1999). Two years later another group inserted an additional 
hemagglutinin (HA) tag into the first exofacial loop of the GLUT4-GFP fusion protein and 
expressed it in rat adipocytes (Dawson et al., 2001). This was the first time that 
intracellular GLUT4 could be distinguished from GLUT4 that fused with the PM using 
confocal microscopy (Dawson et al., 2001). These studies laid the foundation for all 
future studies using microscopy to investigate GLUT4 dynamics and HA-GLUT4-GFP has 
become the most prevalent genetically modified variant of GLUT4 used to study all 
aspects of GLUT4 dynamics over time. The development of light microscopy and recent 
emergence of novel high-resolution live cell microscopy techniques facilitated the study 
of GLUT4 regulation and behaviour in close proximity to the PM. The key studies in this 





1.6.1 Total internal fluorescence microscopy reveals plasma 
membrane GLUT4 dynamics 
Total internal reflection fluorescence (TIRF) microscopy has been a valuable tool in the 
study of PM GLUT4 dynamics (Jiang et al., 2008; Li et al., 2004; Lizunov et al., 2005, 
2013a; Stenkula et al., 2010). TIRF microscopy is an elegant method that allows the 
selective visualisation of fluorescent proteins within a thin optical section of the 
biological sample (Ambrose, 1956). In general, refraction of light when it encounters 
the interface between two media with different refractive indexes (RI) leads to the 
confinement of a proportion of the light to the higher RI medium. A laser beam that 
passes through a medium and hits this interface is either refracted upon entering the 
second medium or reflected at this interface (Figure 1.5). This physical phenomenon is 
dependent on the incident angle of the laser beam and the specific RI of the two media. 
 
Figure 1.5 The physical basis of epifluorescence and TIRF microscopy. 
Schematic showing the cover-slip-sample interface (Mattheyses et al., 2010). (A) During 
epifluorescence illumination the laser beam travels directly through the cover-slip-
sample interface and as a consequence excites all fluorophores indicated by the green 
colour. (B) During TIRF illumination the laser beam enters the sample from the right at 
an incidence angle that is larger than the critical angle and is reflected off the cover-
slip–sample interface on the left side. An evanescent field is generated on the opposite 
side of the interface penetrating the sample <200nm. Only fluorophores within this 





At oblique angles greater than what is known as the ‘critical angle’ the light beam is 
totally reflected in a transparent solid substance with high RI for instance a cover slip 
(Axelrod, 1981). This generates a highly restricted electromagnetic field called the 
‘evanescent wave’ that propagates in parallel to the liquid-solid interface. The intensity 
of the evanescent wave decays exponentially with perpendicular distance and thus 
extends only 200-300 nanometres into the sample to excite fluorophores in close 
proximity (Axelrod, 1981).  
 
The first study taking advantage of TIRF microscopy allowed investigation of the three-
dimensional mobility of single GLUT4 containing vesicles labelled with EGFP-fused 
GLUT4 in live 3T3-L1 adipocytes (Li et al., 2004). The exponential decay of the 
evanescent wave in the TIRF microscope was used to study GLUT4 containing vesicles  
that approach the PM as these presented with increased fluorescence intensity the 
closer they moved towards the interface. This property was used to track the vertical 
movement of GLUT4 containing vesicles specifically (Li et al., 2004). Most GCV moved 
repeatedly up and down in the TIRF-zone indicating that these GLUT4 containing 
vesicles were not docked to the PM. Moreover, it was observed that GLUT4 containing 
vesicles moved as if restricted within a cage within a 160 nm radius laterally suggesting 
the presence of an intracellular tethering matrix (Li et al., 2004). How these GLUT4 
containing vesicles relate to IRVs or the GSC is not certain, reflecting the difficulty in 
resolving the GSC into distinct vesicle types. 
 
Without insulin similar behaviour of GLUT4 containing vesicles rapidly moving along 
the PM has been observed by applying time-lapse TIRFM to primary rat adipocytes 
(Lizunov et al., 2005). Under basal conditions GLUT4 containing vesicles were 
described to move along predefined trajectories along the entire PM periodically 
stopping and loosely tethering to the PM indicating presence of a microtubule 
network. Insulin stimulation resulted in a drastic reduction of GLUT4 containing 
vesicles movement indicating immobilization of these vesicles at the PM (Lizunov et 
al., 2005). TIRFM has enhanced our understanding of how GLUT4 containing vesicles 
interact with the PM and enabled detection of single GLUT4 containing vesicles and 
quantification of tethering and fusion in 3T3-L1 (Jiang et al., 2008; Li et al., 2004) 





1.6.2 The effect of insulin action on plasma membrane GLUT4 
dynamics 
As previously described insulin stimulation resulted in tethering of mobile GLUT4 
containing vesicles to the PM (Lizunov et al., 2005). In the basal state the spatial 
distribution of GLUT4 containing vesicles near the plasma membrane was reported to be 
uniform whereas insulin stimulation resulted in targeting of GLUT4 containing vesicles 
to specific regions of the PM in rat adipocytes. This result could indicate either 
tethering of GLUT4 containing vesicles in these areas prior to fusion as hypothesised in 
the study (Lizunov et al., 2005) or the movement of GLUT4 containing vesicles into 
relatively static PM regions. In the PM of primary mouse adipocytes clathrin which is 
fundamental for exocytosis has been found to be localised in large immobile patches 
(Bellve et al., 2006). In adipocytes dual-colour TIRFM revealed that insulin stimulation 
resulted in colocalization of GLUT4 and clathrin (Huang et al., 2007). In the basal state 
colocalization was observed to a smaller extent indicating that insulin promotes 
accumulation of GLUT4 in clathrin-coated regions of the PM (Huang et al., 2007). In 
contrast to this finding, a more recent study distinguishing between intracellular and PM 
GLUT4 reported that surface-exposed HA-GLUT4 only colocalised with ~10% in basal and 
insulin-stimulated adipocytes (Stenkula et al., 2010). The majority of GLUT4 colocalized 
with clathrin was found in intracellular compartments and clathrin was hypothesised to 
be important for GLUT4 endocytosis from existing clusters (Stenkula et al., 2010).  
 
Reversible GLUT4 containing vesicles docking, priming and fusion are the key steps 
occurring at the PM but it remains unclear which steps are directly regulated by insulin 
action (Bai et al., 2007). Time-lapse images of 3T3-L1 adipocytes expressing EGFP-
GLUT4 were acquired in TIRF mode and thousands of fusion events were analysed with a 
novel computational method to address how insulin signalling affects what presumably 
reflect IRV trafficking pathways (Bai et al., 2007). EGFP-GLUT4 approaching the PM 
were characterised by an increase in fluorescence intensity and appearance of a 
fluorescent spot. Docking events were characterised by the mentioned fluorescent spot 
remaining static in the field of view for a defined time period and fusion of IRV was 
characterised by dispersion of the fluorescence signal post docking. A decrease of 
fluorescence after docking indicated vesicle undocking without fusion (Bai et al., 2007). 
Detailed quantitative kinetic analysis revealed that insulin stimulation resulted in an 8-
fold increase in fusion rate and a 2-fold increase in docking rate. The mean dwell time 
defined as the period of time the IRV remained in the docked state decreased by 30%. 
The PI3K inhibitor wortmannin was reported to decrease the docking rate significantly 




the first time that insulin regulates IRV fusion whereas docking is regulated by PI3K and 
its downstream effector AS160 (Bai et al., 2007). 
 
pH-dependent GFP variants known as pHluorins have become valuable tools for the non-
invasive tracking of cell surface proteins during exocytosis and endocytosis (Ashby et 
al., 2004). IRAP co-localises with GLUT4 and can be labelled with pHluorin on its luminal 
c-terminus. Prior to fusion pHluorin is located in the acidic lumen of the IRV where it is 
non-fluorescent at a pH < 6.0. Once the IRV fuse with the plasma membrane pHluorin 
will be exposed to the extracellular medium where it is fluorescent at a pH of 7.4 and 
provides a high contrast signal for identification of fusion events (Chen and Lippincott-
Schwartz, 2015). Tagging GLUT4 containing vesicles with pHluorin is an elegant way to 
visualise fusion events without ambiguity. The development of a novel dual-coloured 
probe to monitor GLUT4 translocation as well as prefusion behaviour of GLUT4 
containing vesicles advanced the elucidation of the underlying molecular processes even 
further (Jiang et al., 2008). In this study IRAP was not only tagged with pHluorin on its 
luminal end but also with the red fluorescence protein Tdimer2 on its cytosolic end 
(Jiang et al., 2008). The pH-insensitive Tdimer2 is visible at all times in the red channel 
and used to monitor pre-fusion behaviour. The combination of both dyes allowed 
reliable quantification of docking, priming and fusion events in living 3T3-L1 cells based 
simply on an abrupt fluorescence increase. For the first time the fusion rate constant of 
single adipocytes was estimated and a 40-fold insulin-stimulated increase in GLUT4 
fusion events was reported. A dysfunctional mutant of the RabGAP AS160, known as 
AS160-4P, inhibited IRV docking but not fusion suggesting that AS160 is essential for IRV 
docking and probably not involved in processes downstream of IRV docking. 
Furthermore, a mode of fusion similar to the ‘kiss-and-run’ mode of fusion observed in 
synaptic vesicles has been observed for IRV that preserved the integrity of vesicles and 
permitted fast local vesicle internalisation (Jiang et al., 2008). These studies confirmed 
that GLUT4 molecules are distributed non-homogenously within the PM but it remains 
unclear how insulin regulates spatial dynamics of GLUT4 organization in the PM.  
 
By labelling GLUT4 containing vesicles of 3T3-L1 adipocytes with VAMP2-pHluorin 
another study also reported ‘kiss-and-run’ events and GLUT4 containing vesicles fusing 
with the PM briefly before being endocytosed again (Xu et al., 2011). The first study 
reported that in the basal state 15% of fusion events were ‘kiss-and-run’ (Jiang et al., 
2008) whereas the second study observed almost 40% (Xu et al., 2011). Insulin 
stimulation resulted in a significant decrease in observed ‘kiss-and-run’ fusion events to 
5% total (Xu et al., 2011). Insulin stimulation resulted in fusion pore expansion but 




a direct impact on IRV fusion pores. To summarise, in adipocytes GLUT4 containing 
vesicles/IRVs approach the PM where they dock and a fusion pore opens up (Figure 1.6). 
The fusion pore can either close and the vesicle undock in the ‘kiss and run’ mode or 
the vesicle can fuse entirely with the PM. The first event is more common during the 
basal state whereas in the insulin-stimulated state the latter event it more common 
resulting in GLUT4 dispersal in the PM (Figure 1.6).  
 
Impaired tethering and fusion of GLUT4 containing vesicles has been associated with 
T2DM (Lizunov et al., 2013b). Adipocytes isolated from human subjects with varying BMI 
and peripheral insulin sensitivity were transfected with fluorescently labelled GLUT4 
and imaged using TIRFM (Lizunov et al., 2013b). Under basal conditions there was no 
observed difference in GLUT4 containing vesicles trafficking to and fusion with the PM 
and total PM GLUT4 levels of cells derived from different donors. This finding indicates 
that basal GLUT4 trafficking mechanisms were not affected by obesity or insulin 
resistance. However, insulin-stimulated GLUT4 trafficking was significantly impaired in 
states of insulin resistance. Insulin stimulation in cells derived from healthy subjects 
increased GLUT4 containing vesicles tethering and fusion 3-fold and this resulted in an 
increase in total cell-surface GLUT4. With decreasing levels of donor insulin sensitivity 
GLUT4 containing vesicles tethering and fusion decreased accompanied by a decrease in 
total PM GLUT4 (Lizunov et al., 2013b).  
 
Recently, a new line of investigation has emerged that suggests that insulin does not 
only affect intracellular GLUT4 trafficking but the distribution of the transporter in the 
PM itself after the fusion event (Stenkula et al., 2010). A study combining multi-colour 
TIRF and wide field microscopy investigated GLUT4 organization and its relationship 
with insulin-regulated GSC recycling in rat adipocytes transfected with HA-GLUT4-GFP 
(Stenkula et al., 2010). It was observed that two distinctive populations of GLUT4 
molecules exist in the PM: relatively stationary clusters and freely diffusible monomers. 
In the basal state most GLUT4 molecules within the TIRF zone appeared as stationary 
clusters with the amounts of GLUT4 molecules localized in clusters and being dispersed 
being roughly equal. Insulin stimulation resulted in a 4-fold increase in the amount of 
dispersed monomers and a 2.5-fold increase in the number of clusters (Stenkula et al., 
2010). The total amount of GLUT4 translocated to the PM upon insulin-stimulation 
corresponded to the increase in insulin-stimulated glucose uptake and therefore 
indicates that both GLUT4 populations were functional glucose transporters. Moreover, 
two distinct types of GLUT4-vesicle exocytosis were identified: fusion-with-release 
events dispersed GLUT4 within the PM whereas fusion-with-retention events (previously 




the basal state 95% of events observed were fusion-with-retention and insulin led to a 
60-fold increase in fusion-with-release events within 2-3 min (Stenkula et al., 2010).  
This study identifies GLUT4 dispersal in the PM as a potential key aspect of insulin 
action. However, this aspect of insulin action lacks mechanistic detail. Currently it is 




Figure 1.6 Schematic summary of the key events of GCV docking, priming and fusion 
occuring at the plasma membrane identified by imaging experiments. 
In the basal state GCV either approach the plasma membrane and dock without fusion 
or dock with opening of a fusion pore before retreating in a kiss-and-run like fashion. 
This process was recently described as fusion with retention and ensures that the 
majority of GLUT4 remains sequestered intracellularly in the absence of insulin. Insulin 
stimulation triggers an increase of GCV delivery to the PM. GCV fully fuse and disperse 
GLUT4 across the entirity of the PM. Insulin stimulation results in a shift from fusion 
with retention to fusion with dispersal (Stenkula et al., 2010). 
 
1.7 Aims and hypothesis  
Since the discovery of the insulin-responsive GLUT4 in 1988 numerous mechanistic 
studies have laid the foundations for our understanding of how insulin regulates glucose 
uptake in muscle and fat (Klip et al., 2019). Various effects of insulin action on GLUT4 
trafficking have been identified over the years and dysfunction has been associated 
strongly with the development of T2DM. Currently there is no cure for T2DM and 
prevalence is globally on the rise. In recent years it has been reported that insulin does 
not only regulate GLUT4 translocation from intracellular stores but also affects the 
distribution of GLUT4 in the PM (Stenkula et al., 2010). In the basal state GLUT4 
appears in clusters whereas insulin was reported to disperse GLUT4 in adipocytes 
(Figure 1.7). In the basal state fusion with retention was found to result in the creation 
of de novo GLUT4 clusters at the PM. Internalisation of GLUT4 is hypothesised to be 




events and dispersal of GLUT4 monomers (Stenkula et al., 2010). This observation 
resulted in the development of a novel kinetic model of GLUT4 trafficking in which 
clustered and monomeric GLUT4 co-exist and insulin regulates the amount of GLUT4 in 
each of these distinct pools (Figure 1.7). The underlying mechanisms of GLUT4 dispersal 
remain unresolved but are of great therapeutic interest.  
 
 
Figure 1.7 Kinetic model of insulin-regulated recycling and spatial distribution of 
GLUT4 in the plasma membrane of adipocytes. 
Schematic model of insulin-regulated GLUT4 recycling among GLUT4 storage vesicles, 
endosomes, and GLUT4 monomers and clusters found in the plasma membrane of 3T3-L1 
adipocytes. GLUT4 molecules are assumed to be cycling among four quasi-
compartments. In the basal state clusters play a key role in regulation of the recycling 
of GLUT4 between the PM and intracellular pools as endocytosis is restricted to clusters. 
Insulin stimulation releases GLUT4 monomers diffusely into the PM (adapted from 
(Stenkula et al., 2010)). 
 
The key aim of this project was to develop a microscopy-based assay to study and 
quantify insulin-stimulated GLUT4 dispersal dynamics in the PM. Super resolution 
microscopy is a relatively young field that provides the opportunity to visualise 
individual GLUT4 molecules and quantify their spatial relationships. Insulin-stimulated 
GLUT4 dispersal has only been observed in adipocytes and therefore we have chosen 
this model as a starting point for our investigation. Firstly, we aimed to optimise super 
resolution imaging in our lab and hypothesised that insulin stimulation would shift 
GLUT4 distribution in the PM from a clustered to a more dispersed state in line with the 




resolution imaging is rapidly evolving and persistently engages cell biologists with new 
challenges. One of these challenges is the generation of big data sets and interpretation 
of results. Here, we also aimed to explore a range of cluster analysis methods to find 
the most suitable way to quantify GLUT4 clustering and dispersal dynamics in response 
to various stimuli (Chapter 1). Moreover, we investigated the underlying molecular 
mechanisms of this dispersal in adipocytes, in particular the role of AMPK, cholesterol 
and EFR3 (Chapter 2).  
 
Patients suffering from T2DM commonly develop DCM that culminates in heart failure. 
The link between T2DM and CVD has long been established but relatively little is known 
about the underlying molecular mechanisms of DCM and treatment options are limited. 
One of the biggest challenges of cardiovascular science is the identification of 
appropriate in vitro models. Thus, we aimed to optimise super resolution imaging in a 
variety of cardiac cell culture models to research whether insulin-stimulated GLUT4 
dispersal exists in the myocardium. This is the first investigation of GLUT4 spatial 
patterning at the single molecule level in cardiac tissues and will provide new insights 
into the spatial organisation of GLUT4 in the PM of cardiac muscle (Chapter 3).  
 
Next we aimed to investigate different aspects of GLUT4 trafficking and dispersal in 
health and disease (an introduction to GLUT4 trafficking in diabetes will be provided in 
Chapter 4). We aimed to characterise how insulin resistance affects GLUT4 dispersal in 
adipocytes. We hypothesised that chronic insulin treatment would result in a state of 
cellular insulin resistance and attenuation of insulin-stimulated GLUT4 dispersal could 
be the underlying cause (Chapter 4). Furthermore, we aimed to investigate whether the 
observed mechanism of PM dispersal is specific to GLUT4. Therefore, we performed 
experiments to investigate the spatial patterning of TfR on the cell surface (Chapter 4). 
 
Finally, we aimed to characterise GLUT4 dispersal in a cell culture model of human 
skeletal muscle for the first time (Chapter 4). We also aimed to investigate the 
expression of several proteins involved in the GLUT4 trafficking cascade to gain insights 









2. Materials and Methods 
2.1 Materials 
2.1.1 Commercially derived cells 
Identity Origin 
3T3-L1 fibroblasts  
P/N: CL-173 
American Tissue Culture Collection, 
Manassas, Virginia, USA 
HeLa  
P/N: CCL-2 
American Tissue Culture Collection, 
Manassas, Virginia, USA 
HEK 293FT  
P/N: CRL-1573 
American Tissue Culture Collection, 
















FujiFilm Cellular Dynamics International (CDI), 
Wisconsin, USA 
5-alpha Competent E.coli 
P/N: C2987I 
Thermo Fisher Scientific, UK 
Stbl3 competent E. coli 
P/N: C737303 
Thermo Fisher Scientific, UK 
  
















2.1.2 Primary cells  
Identity Origin 
New Zealand White Rabbits Male, 2.5-3.2 kg, approximately 20 weeks old, in 
collaboration with the Godfrey Smith 
Laboratory,                                                      
University of Glasgow 
Wistar rat neonates Male, 1-2 days old, gifted by George Baillie 
Laboratory, University of Glasgow 
C57BL/6 mice Male, 12 weeks old, Biological Procedures Unit,                      
University of Strathclyde 
  










Lentiviral plasmid containing the gene sequence 
for GLUT4 tagged with green fluorescent protein 
and hemagglutinin; generated by Silke Morris in 
house (Morris et al., 2020) 
pEGFP-N1-Flag-TfR-GFP Plasmid for cloning and expression of FLAG-GFP 
tagged transferrin receptor, generated and 
gifted by Jennifer Lippincott-Schwartz 
Laboratory, USA (Patterson and Lippincott-
Schwartz, 2002) 
pCDH-CMV-MCS-EF1-TfR-GFP Generated in this project, described in section 
6.2.2 
  











2.1.4 General materials and reagents 
This list summarises key materials used in this project with corresponding suppliers and 
product numbers (P/N) in all cases possible.  
 
Axiogenesis, NCardia, Leiden, The Netherlands 
Cor.4U® Culture medium for maintenance containing FBS (P/N: Ax-MHC250) 
Cor.4U® BMCC serum free medium (P/N: Ax-M-BMCC250) 
 
BioRad Labatories Ltd, Hemel Hemstead, Hampshire, UK 
Precision Plus Protein™ All Blue Standards (P/N: 1610373)  
 
Cellular Dynamics International, Wisconsin, USA 
iCell Cardiomyocytes2 Maintenance Medium (P/N: CMM-100-120-001) 
iCell Cardiomyocytes2 Plating Medium (P/N: CMM-100-110-001) 
 
Corning Incorporated, Maine, USA 
6 well polystyrene TC-treated cell culture plate (P/N: 3516) 
12 well polystyrene TC-treated cell culture plate (P/N: 3513) 
24 well TC-treated cell culture plate (P/N: 3524) 
75cm2 Polystyrene Cell Culture Flask (P/N: 430641U) 
96 well clear flat bottom polystyrene TC-treated microplates (P/N: 3596) 
 
Electron Microscopy Sciences, Hatfield, PA, USA 
CoverWell™ Modular Hybridization System (P/N: 70327-05) 
 
Fisher Scientific UK Ltd., Loughborough, Leicestershire, UK 
2-[4-(2-hydroxyethyl)-1-piperazine] ethanesuphonic acid (HEPES) 
Bovine Serum Albumin (P/N: BP9702-100) 
D-Glucose anhydrous (P/N: G/0500/53) 
Ethanol (P/N: 10680993) 
Glycerol (P/N: G/0650/17) 
Glycine (P/N: 10061073) 
Immu-Mount (P/N: 10662815) 
Pierce™ Micro BCA™ Protein Assay Kit (P/N: 23225) 
RPMI Media 1640 (P/N: 21875091) 






Formedium, Norfolk, UK 
Agar (P/N: AGA02) 
Tryptone (P/N: TRP02) 
Yeast Extract Powder (P/N: YEA02) 
 
Gibco by Life Technologies, ThermoFisher Scientific, Paisley, UK 
Dulbecco’s Modified Eagle Medium (1x) 0 g/L D-Glucose (P/N: 11966025) 
Dulbecco’s Modified Eagle Medium (1x) 1 g/L D-Glucose (P/N: 11885084) 
Dulbecco’s Modified Eagle Medium (1x) 4.5 g/L D-Glucose (P/N: 41965039) 
Dulbecco’s Phosphate Buffered Saline (1x) (P/N: 14190094) 
Dulbecco’s Phosphate Buffered Saline, calcium, magnesium (P/N: 14040141) 
Fetal Bovine Serum (FBS) (P/N: 10500064) 
Horse Serum, heat inactivated, New Zealand origin (P/N: 16050130) 
L-Glutamine 200mM (100x) (P/N: 25030024) 
Lipofectamine® 2000 transfection reagent (P/N: 11668019) 
Medium 199, Earle's Salts (P/N: 11150059) 
MEM Non-Essential Amino Acids Solution (100X) (P/N: 11140-050) 
Newborn Calf Serum (P/N: 16010159) 
OPTI-MEM (1X) Reduced Serum Medium (P/N: 31985062) 
Penicillin-Streptomycin (Pen-Strep) (10,000U/mL) (P/N: 15140122) 
0.05% Trypsin-EDTA (P/N: 25300054) 
 
Lonza Bioscience, Basel, Switzerland  
SkGMTM-2 Skeletal Muscle Cell Growth Medium-2 BulletKitTM (P/N: CC-3245) 
ReagentPackTM Subculture Reagents: Trypsin/EDTA, trypsin neutralizing solution, and 
HEPES buffered saline solution (P/N: CC-5034) 
 
Marienfeld Laboratory Glassware, Lauda-Koenigshoefen, Germany  
Coverglass, high precision (1.5H), diameter - 24mm (P/N: 0117640) 
 
Melford Laboratories Ltd., Chelsworth, Ipswich, UK 
Dithiothreitol (DTT) (P/N: MB1015) 
 
Merck, Darmstadt, Germany 







New England Biolabs, Massachusetts, USA 
CutSmart Buffer 10x (P/N: B7204S) 
KasI restriction enzyme (P/N: R0544S) 
NheI restriction enzyme (P/N: R0131S) 
NotI restriction enzyme (P/N: R0189S) 
SOC Outgrowth Medium (P/N: B9020S) 
T4 DNA Ligase (P/N: M0202S) 
10X T4 DNA Ligase Reaction Buffer (P/N: B0202S) 
 
Pall Life Sciences, Portsmouth, UK 
BioTrace NT Nitrocellulose Transfer Membrane 0.2μm pore thickness (P/N: 66485) 
 
Perkin Elmer, Massachusetts, USA 
Deoxy-D-glucose, 2-[1,2-3H (N)] (P/N: NET328A001MC) 
Ultima Gold Liquid Scintillation Counting Cocktail (P/N: 6013326) 
 
Promega, Wisconsin, USA 
Blue/Orange DNA Loading Dye, 6X (P/N: G1881) 
FuGENE HD Transfection Reagent (P/N: E2311) 
1kb DNA ladder (P/N: G5711) 
Wizard Plus SV Minipreps DNA Purification Systems (P/N: A1330) 
 
Qiagen, Hilden, Germany 
Nuclease-Free water (P/N: 129115) 
QIAfilter Plasmid Midi and Maxi Kits 
 
Roche Diagnostic Ltd., Burgess Hill, UK 
Complete™ Protease Inhibitor Cocktail Tablets (P/N: 11697498001) 
 
Sartorius, Gottingen, Germany 
Minisart 0.2 um pore size syringe filter (P/N: 16534K) 
 
Severn Biotech Ltd., Worcestershire, UK 








Sigma-Aldrich Ltd., Gillingham, Dorset, UK 
Ampicillin Sodium Salt (P/N: A0166) 
Bromophenol Blue (P/N: B0126) 
(±)-Carnitine hydrochloride (P/N: C9500) 
Creatine (P/N: C0780) 
Cysteamine (MEA) (P/N: M9768) 
Cytochalasin B from Drechslera dematioidea (P/N: C6762) 
2-Deoxy-D-glucose (P/N: D8375) 
Dexamethasone (P/N: D4902) 
Dimethyl suphoxide (DMSO) (P/N:  D2650) 
Dulbecco’s Phosphate Buffered Saline (DPBS) with MgCl2 and CaCl2 (P/N: D8662) 
Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 (P/N: 51445C) 
Ethylenediaminetetracetic acid (EDTA) (P/N: E6758) 
Ethidium Bromide Solution (P/N: E1510) 
Fibronectin from bovine plasma (P/N: F1141) 
Gelatine from cold water fish skin (P/N: G7041) 
Goat serum (P/N: G9023) 
HEPES (P/N: H3375) 
Insulin from porcine pancreas (P/N: I5523) 
3-isobutylmethylxanthine (IMBX) 
Isopropanol (P/N: I9516) 
Laminin from Engelbreth-Holm-Swarm murine sarcoma basement membrane (P/N: 
L2020) 
Magnesium sulphate (MgSO4) (P/N: M3409) 
Methyl-β-cyclodextrin (P/N: C4555) 
N,N,N’,N’-Tetramethylethylenediamine (TEMED) (P/N: T9281) 
Palmitic acid (P/N: P0500) 
Paraformaldehyde powder (P/N: 158127) 
Ponceau S (P/N: P3504) 
Protease from Streptomyces griseus, Type XIV (P/N: P5147) 
Taurine (P/N: 86329) 
3,3’,5-Triiodo-L-thyronine sodium salt (P/N: T6397) 
Triton X-100 (P/N: T9284) 
Troglitazone (P/N: T2573) 
Trypan Blue Solution (0.4%) (P/N: T8154) 
TWEEN 20 (P/N: P7949) 





ViraQuest Inc. Iowa, USA 
HA-GLUT4-GFP Adeno virus 
HA-GLUT4-GFP Adeno associated virus 
 
VWR International Ltd., Lutterworth, Leicestershire, UK 
Glacial Acetic Acid (P/N: 36289.AE) 
Calcium chloride (CaCl2) (P/N: 190464K) 
di-Sodium hydrogen phosphate anhydrous (Na2HPO4) (P/N: 102494C) 
Ethanol absolute (P/N: 20821.330) 
Magnesium chloride hexahydrate (P/N: 25108.260) 
Potassium chloride (KCl) (P/N: 26764.260) 
Sodium chloride (NaCl) (P/N: 27810.295) 
Sodium dodecyl sulphate (SDS) (P/N: 442444H) 
 
Worthington Biochemical Corporation, Lakewood, NJ, USA 
Collagenase from Clostridium histolyticum, Type 1 (P/N: CLS-1) 
 

























2x Laemmli Sample Buffer (LSB)   100mM Tris, HCl pH 6.8, 4% (w/v) SDS, 20%  
      (v/v) glycerol, 0.2% (w/v) bromophenol  
      blue, 100 mM DTT  
 
2YT      1.5% (w/v) Tryptone, 1% (w/v) Yeast Extract 
      0.5% (w/v) NaCl, (Autoclaved prior to use) 
 
ADS buffer      120 mM NaCl, 20 mM HEPES, 1 mM Na2PO4, 5 
      mM glucose, 5.4 mM KCl, 1.8 mM MgSO4, pH 
      7.4 
 
Basic Krebs Solution    130 mM NaCl, 5 mM HEPES, 4.5 mM KCl, 0.4 
      mM NaH2PO4, 3.5 mM MgCl2, 10 mM  
      glucose, 140 μM CaCl2, pH 7.4 
 
Calcium solutions Basic Krebs solution supplemented with 
either 100 µM, 200 µM, 500 µM, 1 mM or 
1.8 mM CaCl2 
 
Immunofluorescence buffer   0.2 % (w/v) Fish skin gelatin 0.1 % (v/v) goat 
      serum in PBS 
    
Krebs–Ringer–Phosphate (KRP) Buffer 136 mM NaCl, 5 mM sodium phosphate buffer 
      (NaH2PO4–Na2HPO4·7H2O, pH 7.4), 4.7  
      mM KCl, 1 mM MgSO4, 1 mM CaCl2, pH 7.4  
 
LB Broth      1% (w/v) Tryptone, 0.5% (w/v) Yeast Extract 
      1% (w/v) NaCl (autoclaved prior to use)  
 
PBS       140mM NaCl 3mM KCl, 1.5mM KH2HPO4, 
      8mM Na2HPO4, pH 7.4 
 
PBS-T       140mM NaCl 3mM KCl, 1.5mM KH2HPO4, 
      8mM Na2HPO4, 0.1% (v/v) Tween-20 
 




Ponceau S      0.2% (w/v) Ponceau S, 1% (v/v) acetic acid 
 
Quenching buffer     50 mM NH4Cl in PBS 
 
RIPA Buffer      50mM Tris, HCl pH8, 150mM NaCl, 2mM 
      MgCl2, 1% Triton X-100, 0.5% sodium 
      deoxycholate (w/v), 0.1% (w/v) SDS, 1mM 
      DTT, 1x Protease Inhibitor Cocktail Tablet 
 
SDS-PAGE running buffer    25mM Tris, 190mM glycine, 0.1% (w/v) SDS 
 
SDS-PAGE transfer buffer    25 mM Tris-HCl, 192 mM glycine, 20% (v/v)  
      ethanol 
 
STORM imaging buffer   PBS, 50mM MEA, pH 8 
 
TAE buffer     40 mM Tris, 1 mM EDTA, pH 7.4 
 
TBS      20 mM Tris-HCl, 137 mM NaCl, pH 7.5 
 
TBS-T       20 mM Tris-HCl, 137 mM NaCl, pH 7.5,  

















2.1.6 Primary Antibodies and Nanobodies  
Antigen Working dilution Description Source 
Acetyl-CoA 
Carboxylase 
1:2000 in 3% 
BSA in TBS-T 
Rabbit, monoclonal Cell Signalling 
(P/N: 3676)  
CHC17 1:1000 in 3% 
BSA in TBS-T 
Mouse, monoclonal R&D systems  
(P/N: AF6784) 
CLTCL1 / CHC22 1:1000 in 3% 
BSA in TBS-T 
Rabbit, monoclonal LifeSpan 
BioSciences  
(P/N: C803540) 
Desmin 1:1000 in 5% 
BSA/2 % goat 
serum in PBS 
Rabbit, polyclonal AbCam 
(P/N: 15200) 
GAPDH 1:80,000 in 1% 
milk in PBS-T 
Mouse, monoclonal Ambion 
(P/N: 4300) 
GFP 1:10 in 5% BSA/2 % 
goat serum in PBS 
Camelid nanobody 





GFP 1:1000 in 3% 





GLUT1 1:1000 in 1% 







1:2000 in 5% 





GLUT8 1:1000 in 1% 





GLUT12 1:1000 in 1% 





HA tag 1:125 in 5 % BSA/2 
% goat serum in 
PBS 
Mouse, monoclonal Invitrogen (P/N: 
26183-A647) 
HA tag 1:200 in 5 % BSA in 
PBS 
Mouse, monoclonal BioLegend 
(P/N: 901503) 
Pan Akt 1:2000 in 3% 
BSA in TBS-T 





1:2000 in 3% 
BSA in TBS-T 
Rabbit, monoclonal Cell Signalling 
(P/N: 11818) 
Phospho-Akt 1:1000 in 3% 
BSA in TBS-T 
Rabbit, monoclonal Cell Signalling 
(P/N: 4058) 
Rab10 1:1000 in 3% 
BSA in PBS-T 
Rabbit, monoclonal Cell Signalling 
(P/N: 4262) 
Rab14 1:1000 in 3% 
BSA in PBS-T 
Rabbit, monoclonal AbCam 
(P/N: 40938) 
Sortilin 1:1000 in 3% 
BSA in PBS-T 
Rabbit, monoclonal Cell Signalling 
(P/N: 20681) 
    





2.1.7 Secondary Antibodies and Nanobodies  









(P/N: 925 68023) 
Mouse IgG  
(Western blotting) 
1:5000-10,000, in 
1% milk in PBS-T 
IRDye 680LT 
Donkey anti 
Mouse IgG  
LI-COR Biosciences 
(P/N: 925 68070) 
Mouse IgG  
(Western blotting)  
1:5000-10,000, in 
1% milk in PBS-T 
IRDye 800CW  
Donkey anti  
Mouse IgG 
LI-COR Biosciences 





3% BSA/2 % goat 
serum in PBS 
Goat anti-Mouse IgG, 
Secondary Antibody, 





1:10 in 3% BSA/2 
% goat serum in 
PBS 
Camelid nanobody 







    


















2.2 Cell Culture Methods  
2.2.1 3T3-L1 fibroblast growth and maintenance 
Wild-type 3T3-L1 murine fibroblasts and cells expressing HA-GLUT4-GFP previously 
generated in the laboratory were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% (v/v) Newborn Calf Serum (NCS) at 37°C under 10% CO2. Cells 
were fed every second day. Cells were passaged and frozen down as described (Laidlaw, 
2018). 
2.2.2 3T3-L1 adipocyte differentiation 
Differentiation into mature adipocytes was initiated 2 days post confluence and lasted 
for 8 days. Day 0 medium consisted of DMEM supplemented with 10% (v/v) Fetal Calf 
Serum (FCS), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 1 μM insulin, 0.25 μM 
dexamethasone, and 1nM troglitazone. 3 days after differentiation media was changed 
to Day 3 medium containing DMEM supplemented with 10% (v/v) FCS, 1μM insulin and 
1nM troglitazone. On day 6 media was replaced with Day 6 medium containing DMEM 
supplemented with 10% (v/v) FCS. Cells were fully differentiated after Day 8 and used 
from 9-12 days post differentiation. Media was changed every second day after day 6 
with DMEM supplemented with 10% (v/v) FCS. 
2.2.3 HEK 293 and HeLa cell growth and maintenance  
Wild-type HEK 293 and HeLa cells and HeLa cells expressing HA-GLUT4-GFP that were 
previously generated in the laboratory were cultured in DMEM supplemented with 10% 
(v/v) FCS and 1% (v/v) glutamine at 37°C under 5% CO2. Media was changed every other 
day until cells were ready for passage or use. 
2.2.4 iPSC-CM growth and maintenance 
2.2.4.1 Plating of Axiogenesis iPSC-CM 
Cryopreserved induced pluripotent stem cell derived cardiomyocytes (iPSC-CM) were 
sourced commercially from Axiogenesis and transferred to liquid nitrogen for storage 
upon receipt. Approximately 3 h before plating 25mm diameter glass coverslips were 
placed into 6-well tissue culture plates and coated with 500 μL fibronectin diluted 1:100 
in PBS supplemented with MgCl2 and CaCl2 that resulted in a final concentration of 2 
μg/cm2. Moreover, Cor.4U® Culture Media was transferred to a 50 mL tube and pre-
warmed to 37°C. Cor.4U® iPSC-CM were removed from liquid nitrogen storage and 
transferred directly to a 37°C water bath for 1-2 min. The vial was transferred into the 
laminar flow cabinet once the frozen cell suspension detached from the bottom and 
only a small ice clump was visible. The cells were carefully transferred to the pre-




tube was constantly and gently agitated by hand. Subsequently, 10 μl of the cell 
suspension was mixed with the same amount of 0.4 % trypan blue and applied to a 
Neubauer haematocytometer to count viable and dead cells. The percentage of total 
cell viability was determined; typically >80% of cells were viable. Plating density ranged 
from 100,000 – 200,000 living cells per well. 12 h post seeding a media change was 
conducted to remove dead cells and DMSO. The media was replaced every other day.  
2.2.4.2 Plating of CDI iPSC-CM 
iCell iPSC-CM were obtained from CDI and stored in liquid nitrogen upon receipt. Prior 
to plating dishes were coated with fibronectin as described above. For plating cells a 
vial was removed from liquid nitrogen storage and placed into a 37°C water bath for 3 
min. The contents of the vile were transferred into an empty sterile 50 mL falcon tube 
and the vile was rinsed with CDI plating medium which was then added dropwise to the 
cells. An additional 3 mL of plating medium was added afterwards to reach a final 
volume of 5 mL of cell suspension. A live cell count was performed using a 
haematocytometer as described in the previous section. CDI iPSC-CM were plated at a 
density of 200,000 cells per well for imaging experiments. Finally, plating medium was 
replaced with pre-warmed (37°C) CDI maintenance medium approximately 4 h post-
plating. 
2.2.4.3 Maintenance of Axiogenesis and iCell CDI iPSC-CM 
Both Axiogenesis and iCell CDI iPSC-CM were kept in a sterile humidified incubator 
at 37°C and 5% CO2 and maintenance media was replaced every 24 h. Typically cells 
were cultured 7 (+/- 1) days post plating for both imaging experiments and obtaining 
protein lysates. Cells were allowed to recover from cryopreservation and only used once 
they presented with a stable contractile phenotype. Cells were transfected with Ad-HA-
GLUT4-GFP 3-4 days after plating and used for experiments once expression of 
fluorescent protein was visible under a microscope 48-72 h later.  
2.2.5 Primary rabbit cardiomyocyte isolation 
Septal cardiomyocytes were isolated from adult male New Zealand white rabbits (2-
2.5kg) by standard enzymatic dissociation (Kettlewell et al., 2009). Animals were 
anaesthetised by administration of an intravenous injection of sodium pentobarbital 
(100mg/kg) containing 1.000 IU of heparin. The heart was excised in accordance with 
the United Kingdom Animals (Scientific Procedures) Act 1986 and conformed to the 
Guide for the Care and use of Laboratory Animals (NIH publication no. 85-23, revised 
1985). The aorta was rapidly cannulated and perfused retrogradely in a Langendorff 
system at a perfusion rate of 25 ml min−1 (37°C) with Krebs solution. The solution was 




mg ml−1 type XIV protease for 15 min. Finally, perfusion was changed to a 1% bovine 
serum albumin 0.075 mM Ca2+ Krebs solution. The digested septum was removed from 
the cannula, cut into small pieces and agitated in 0.125 mM Ca2+ solution for 1 h. 
Subsequently, the cardiomyocytes were re-suspended in a series of Krebs solution 
containing (mM) 0.25, 0.5 and 1 Ca2+. 
2.2.6 Primary rabbit cardiomyocyte maintenance 
Cardiomyocytes were cultured in Medium 199 (M199) supplemented with 1% penicillin/ 
streptomycin (v/v), 1mM glutamine, 5mM carnitine, 5mM creatine and 5mM taurine. 
Media was changed every other day.  
2.2.7 Neonatal rat cardiomyocyte isolation 
Neonatal rat cardiomyocytes were isolated from 1-2 day old Sprague-Dawley rats by 
standard enzymatic dissociation. Animals were anaesthetised by administration of an 
intraperitoneal injection of Euthatal. Hearts were excised in accordance with the 
United Kingdom Animals (Scientific Procedures) Act 1986 and placed directly into a 5 cm 
dish containing ice-cold ADS buffer. Atrial and aortic tissue was removed by dissection 
and the hearts were squeezed gently to remove residual ventricular blood and 
transferred to a new 5 cm dish with fresh ice-cold ADS buffer. Hearts were cut up into 
1mm3 sized pieces before being transferred into a 50 mL tube. The heart tissue was left 
to settle and the supernatant ADS buffer was aspirated. Collagenase buffer consisting of 
0.03% (w/v) collagenase and 0.06% (w/v) pancreatin was added and the tissue was 
incubated in a shaking water bath at 37°C for 5 min. During the first step of the serial 
enzymatic digestions pericardial collagen was removed. Afterwards the collagenase 
buffer was replaced with fresh buffer and the heart tissue subjected to 20 min 
digestions 4-5 times. The heart tissue was allowed to settle after each digestion and the 
supernatant was removed and added to a sterile 15 mL tube containing 500 µL NCS to 
terminate the digestion. Tubes were centrifuged at 1500 x g or 5 min and pellets were 
resuspended in 2 mL NCS. Tubes were kept at 37°C until subsequent digestions were 
completed. After the last digestion cells were pooled and centrifuged at 1500 x g for 5 
min and then resuspended in Day 1 medium (M1) containing 80% (v/v) DMEM and 20% 
(v/v) M199 supplemented with 10% (v/v) horse serum, 5% (v/v) NCS, 1% (v/v) L-
glutamine and 1% (v/v) penicillin/streptomycin. At this stage, the cells were a mixed 
culture comprised mainly of fibroblasts and neonatal rat cardiomyocytes. To purify 
remove fibroblasts, a pre-plating step was carried out. 10 mL of the cell suspension 
were plate per 10 cm culture dish and incubated for 2 h at 37°C. Fibroblasts adhere to 
the culture dish whereas neonatal rat cardiomyocytes do not and thus remain in 
suspension. The suspension containing the neonatal rat cardiomyocytes was removed 




all cardiomyocytes. Cells were centrifuged at 1250 rpm for 5 min and resuspended in 
fresh M1. Cells were seeded at a density of 400,000 cells per well of a 6 well plate 
containing cleaned coverslips that were previously coated with 1 µg/cm2 laminin. Cells 
were incubated at 37°C with 5% CO2. 
2.2.8 Neonatal rat cardiomyocyte maintenance 
After 24 h of culture in M1, neonatal rat cardiomyocytes were washed twice with ADS 
M1 was replaced with Day 2 medium (M2) containing 80% (v/v) DMEM and 20% (v/v) 
M199 supplemented with 5% (v/v) horse serum, 0.5% (v/v) NCS, 1% (v/v) L-glutamine 
and 1% (v/v) penicillin/ streptomycin. Before virus infection, the cells were left in the 
incubator for at least two h. The cells were incubated at 37°C with 5% CO2 and the 
medium changed every other day. 
2.2.9 Human skeletal muscle myoblast growth and maintenance 
Cryopreserved human skeletal muscle myoblasts (HSMMs) were from Lonza Bioscience 
(Switzerland). Two batches from either a healthy (HSMM) or a diseased (D-HSMM) donor 
were used. Closely matches samples of age, weight etc were not available. HSMM were 
obtained from a healthy Caucasian female, age 19 years, weight 70 kg and smoking (Lot 
#0000629287). D-HSMM were obtained from a T2DM Caucasian female, age 85 years, 
weight 66 kg and non-smoker (Lot #00002192060). The following data were also supplied 
by the manufacturer and matched for both cell types: no history of heart disease or 
hypertension, cell passage 2, cell count 700,000, ATP quantity 25 and doubling time 20 
h. Myoblasts were maintained in SkGMTM-2 Basal Medium with SkGMTM-2 SingleQuotsTM 
supplements containing human epidermal growth factor, dexamethasone, l-glutamine, 
foetal bovine serum, and gentamicin/amphotericin-B at 37°C in 5% CO2 atmosphere. A 
reagent pack containing trypsin-EDTA solution, HEPES-buffered saline and trypsin-
neutralizing solution was also obtained from the manufacturer. Cells were passaged at 
50-70 % confluence to avoid spontaneous myotube formation. Cells were seeded at 
3,500 cells/cm2 for maintenance and at 10,000 cells/cm2 one day before initiation of 
differentiation for experiments. Myoblast cells were differentiated by switching the 
medium to DMEM:F12 supplemented with 2% horse serum. Growth and differentiation 
media were changed every other day. HSMMs were grown for 5 days before preparing 






2.3 Super resolution microscopy methods 
2.3.1 Coverslip preparation 
High performance (⌀ 24mm; thickness 1.5mm) glass coverslips were placed into a Wash-
N-Dry coverslip rack and sequentially submerged in 0.1M NaOH and 0.1% (v/v) Decon-90 
for two min in each solution with constant sonication in a sonicating water bath. 
Coverslips were washed by submerging them into 1L of deionised water 3 times. 
Coverslips were submerged in 100% ethanol and 100% acetone for 2 min with constant 
sonication in a sonicating water bath and the washing step was repeated. Coverslips 
were placed into 100% ethanol and transferred to the laminar flow hood. Lab tissue was 
soaked in ethanol and coverslips were placed on top and were left to dry under UV light 
for at least 30 min. Once all coverslips were washed and the tissue was dry each 
coverslip was removed individually with tweezers and placed into a 6 well plate. The 6 
well plates including the coverslips were sealed with cling film and stored at 4°C until 
use.  
2.3.2 Seeding cells onto coverslips 
Coverslips were cleaned as described previously and removed from 4°C storage 30 min 
prior to cell seeding to adjust to room temperature. Cells were added as described in 
the passaging methods for each individual cell type. HeLa cells were seeded and 3T3-L1 
fibroblasts differentiated on the glass coverslips without any previous coating steps. 
Primary rabbit cardiomyocytes and neonatal rat cardiomyocytes were seeded onto 
coverslips coated with laminin (1 μg/cm2). Laminin was slowly thawed on ice and 
suspended to the desired concentration in PBS. Glass coverslips were covered with 
coating solution and incubated for three h at 37°C. The coating solution was removed 
and primary rabbit cardiomyocytes (~100,000 cells/well) and neonatal rat 
cardiomyocytes (~300,000 cells/well) were seeded directly. iPSC-CM were seeded onto 
coverslips coated with fibronectin (2 μg/cm2). Fibronectin was suspended in DPBS with 
Ca2+ and Mg2+ and coverslips were covered in coating solution for two h at 37°C. The 
coating solution was removed and iPSC-CM (~200,000 cells/well) were seeded as 
described before.  
2.3.3 Infection of cells with HA-GLUT4-GFP adeno virus 
Viral gene transfer was the preferred method for expressing the HA-GLUT4-GFP 
construct in the cell models for this study. HeLa and 3T3-L1 cell lines stably expressing 
HA-GLUT4-GFP were previously generated in the laboratory (Morris et al., 2020). 
Primary rabbit cardiomyocytes and neonatal rat cardiomyocytes were seeded onto glass 
coverslips as described (section 2.3.2). Primary rabbit cardiomyocytes were infected 




(MOI) of 100 in cell culture media 4 h after seeding. Virus containing media was 
removed after 24 h and replaced with fresh culture media. The cells were incubated for 
another 24 h to give the protein 48 h overall to be expressed. Neonatal rat 
cardiomyocytes were infected with HA-GLUT4-GFP adeno virus at 40MOI in cell culture 
medium 24 h after isolation. Media was removed after 24 h and replaced with fresh 
culture media. The cells were incubated for another 24 h. CDI iPSC-CM were infected 
with HA-GLUT4-GFP adeno virus at 50MOI and HSMM were infected with virus at 500MOI. 
Transfection was assessed before fixation by checking the GFP signal through an 
epifluorescence microscope.  
2.3.4 Infection of cells with HA-GLUT4-GFP adeno-associated virus  
Axiogenesis iPSC-CM were seeded onto glass coverslips as previously described. 12 h 
after plating and removal of the freezing media cells were infected with 150MOI of HA-
GLUT4-GFP adeno-associated virus (AVV) in serum-free Opti-MEM. The Opti-MEM 
containing the AVV was removed and replaced with fresh culture media after 24 h. Cells 
were left to express the HA-GLUT4-GFP protein for another 72 h. Transfection was 
assessed before fixation by checking the GFP signal through an epifluorescence 
microscope. 
2.3.5 Fixation of cells on coverslips 
Cells were serum-starved for 2 h prior to fixation. Cells were placed on ice to stop all 
reactions and washed with ice cold PBS 3 times. Coverslips were fixed with 4% (w/v) 
paraformaldehyde (PFA) in PBS overnight at 4°C. The samples were quenched with 
50mM NH4Cl in PBS for 10 min at room temperature and washed with PBS. Samples were 
stored at 4°C and stained prior to imaging experiments.  
2.3.6 Immunofluorescence staining  
2.3.6.1 Anti-HA conjugated antibody stain 
Samples were incubated in blocking solution containing 2% (w/v) BSA with 5% (v/v) goat 
serum in PBS for 30 min. Afterwards cells were incubated with a conjugated anti-HA 
antibody coupled to Alexa Fluor 647 at a concentration of 8 mg/mL (1:125 dilution) in 
blocking solution for 1 h in the dark. Samples were then washed with PBS for 10 min 3 
times on an orbital shaker. Cells were stored at 4°C no longer than a week before 
imaging.  
2.3.6.2 Anti-GFP nanobody stain 
Samples were stained with FluoTag®-Q anti-GFP nanobody according to manufacturer’s 
instructions. Samples were permeabilised and blocked with immunofluorescence (IF) 




for 15 min on an orbital shaker. Samples were treated with 0.5µM FluoTag®-Q anti-GFP 
nanobody (1:10 dilution) coupled to Alexa Fluor 647 in IF buffer for 1h. Samples were 
then washed with PBS for 10 min 3 times on an orbital shaker. Cells were stored at 4°C 
no longer than a week before imaging. 
2.3.6.3 Anti-HA primary antibody with secondary nanobody stain 
Samples were blocked with 10% (v/v) goat serum in PBS for 30 min. Samples were 
incubated in primary mouse anti-HA antibody at a concentration of 8 mg/mL (1:125 
dilution) in 10% (v/v) goat serum in PBS for 1 h. Samples were washed with PBS 3 times 
before treatment with 0.5µM FluoTag®-X2 anti-Mouse nanobody (1:10 dilution) coupled 
to Alexa Fluor 647 in 10% (v/v) goat serum in PBS for 1h. Samples were then washed 
with PBS for 10 min 3 times on an orbital shaker. Cells were stored at 4°C no longer 
than a week before imaging. 
2.3.7 Microscope setup 
The dSTORM image sequences were acquired on a Zeiss Elyra PS. 1 system with ZEN 
Black software. The commercial system comes with all components necessary for SMLM 
image acquisition with a resolution of 20-30 nm in the x/y and 50-80 nm in the z-axis. 
Optical systems alignment is a prerequisite for accurate localization of molecules at 
nanometre precision. Firstly, the objective phase plate needs to be aligned with the 
condenser annulus of the microscope. To achieve this bright-field illumination was 
switched on and an objective removed to place a clear glass slide into the 
transillumination pathway. Another glass slide was placed into the sample holder on the 
microscope stage. The “stage alignment” tool was selected in the software window and 
displayed the objective rear focal plane with the misaligned objective phase plate and 
condenser annulus light cones. The X- and Y-bolts on the stage enabled the adjustment 
of the position of the condenser annulus light cone with respect to the fixed objective 
phase plate. When the two annuli were centred, the ideal illumination of the specimen 
was ensured. Secondly, chromatic shifts between different colour channels were 
corrected with the “Channel alignment” tool. The 100x 1.46 alpha Plan-Apochromat DIC 
M27 Elyra objective was selected and a fluorescent bead sample placed on the stage 
and the eye piece used to focus on it. A bead calibration file was created in the 
acquisitions tab which includes a z-stack of images with the activation of the 405 
(50mW), 488 (200mW), 561 (200mW) and 642 (150mW) HR Diodes. Next the channel 
alignment transformation table was obtained in the processing tab of the software. The 
“channel alignment” tool was selected and the previously obtained bead calibration file 
chosen as input image. Running the “channel alignment” tool resulted in all colour 




2.3.8 Image acquisition 
Coverwell modular hybridisation chambers were glued onto glass slides. Cold dSTORM 
imaging buffer containing 50mM mercaptoethylamine (MEA) in PBS (pH=8) was pipetted 
into the chamber and coverslips with the fixed and stained samples were vacuum-sealed 
onto the chambers to avoid oxygen entry. The dSTORM imaging buffer was stored on ice 
during the imaging session in case it was needed at a later stage. The dSTORM image 
sequences were acquired in TIRF configuration using a 100x 1.46 oil-immersion alpha 
Plan-Apochromat DIC M27 Elyra TIRF objective with a BP 420 - 480/BP 495 - 550/LP 650 
emission and MBS 405/488/642 excitation multi-band filter set. Samples were 
illuminated with 647 nm laser light at 100% (150mW). Images were recorded on an 
Andor iXon 897 EMCCD camera using a centred 256 × 256 pixel region at 30 ms per frame 
for 10,000 frames and an electron multiplier gain of 200 and pre-amplifier gain profile 
3. 
2.3.9 Image reconstruction  
The dSTORM data were processed using the freely available Image J plugin 
ThunderSTORM (Ovesný et al., 2014). ThunderSTORM is a comprehensive platform for 
analysis of SMLM data including several different localisation methods and processing 
tools. The image reconstruction parameters chosen are lined out in the following: pre-
detection wavelet filter (B-spline, scale 2, order 3), initial detection by local maximum 
with 8-connected neighbourhoods (radius 1, threshold at two standard deviations of the 
F1 wavelet), and sub-pixel localisation by integrated Gaussian point-spread function 
(PSF) and maximum likelihood estimator with a fitting radius of 3 pixels. The first pass 
detected localisations were filtered according to the following criteria: an intensity 
range of 300 - 5000 photons, a sigma range of 50 - 250, and a localisation uncertainty of 
less than 25 nm. Subsequently, the filtered data set was corrected for sample drift using 
cross-correlation of images from 5 bins at a magnification of 5. Repeated localisations, 
such as can occur from dye re-blinking, were reduced by merging points which re-
appeared within 20 nm and 1 frame of each other. 
2.3.10 GLUT4 localization density 
Localization density of GLUT4 molecules in the PM was determined using the Image J 
plugin LocFileVisualizer_v1.1 (van de Linde, 2019). Briefly, csv files previously 
generated using ThunderSTORM were opened and the Image J polygon selection tool was 
used to draw around the outline of each cell. Area and mean intensity grey value were 
measured for each individual cell. Graphpad prism was used to prepare a list containing 
all cells and their mean intensity values were normalised against the corresponding cell 




2.3.11 GLUT4 cluster analysis  
GLUT4 cluster analysis was carried out using several approaches which are described in 
detail in the introduction to Chapter 1 of this thesis (see section 3.1.6).  
2.3.11.1 SR Tesseler 
Ripley’s K function analysis was carried out using SR Tesseler software (Levet et al., 
2015). The software version 1 and its dependencies and external libraries were 
downloaded from Github (https://github.com/flevet/SR-Tesseler). Ripley’s K function 
analysis was carried out according to the SR Tesseler manual (section 3.1.6.1). In brief, 
csv files were imported into the SR Tesseler interface and minimum, maximum and step 
radius chosen before the K function was automatically calculated. Furthermore, Voronoï 
diagrams were calculated on the GLUT4 localization data using SR Tesseler. The density 
factor was set to 2 and objects were created automatically by the software based on 
the Voronoï diagrams. Object (cluster) information was exported as an excel file.  
2.3.11.2 Bayesian cluster analysis 
For Bayesian GLUT4 cluster analysis R (https://cran.r-project.org/) and RStudio 
(https://www.rstudio.com/) were installed (Griffié et al., 2016). Additionally the two R 
libraries “splancs” and “igraph” were installed using the R Studio interface. Firstly, 
experimental data sets were appropriately formatted for analysis, working directories 
created and regions of interest defined. Folders were created for each cell and the files 
provided for the analysis placed into these folders (formatting.R, get_histograms.m, 
run.R, internal.R, postprocessing.R, simulate.R, formatting_params.txt, 
sim_params.txt, Coord.txt and config.txt files). Four regions of interest were chosen for 
each cell that were 3 μm x 3 μm in size. Secondly, the code for cluster analysis provided 
as a download was run in R Studio (processing 45 min per ROI). Lastly, a postprocessing 
step was carried out to generate cluster descriptors for each ROI. Theories of the 
Bayesian approach for cluster analysis can be found in section 3.1.6.2. 
2.3.11.3 Cluster analysis with machine learning 
Python scripts for cluster analysis with machine learning was obtained from Gitlab 
(https://gitlab.com/quokka79/caml). Firstly, a provided script was used to create a 
JSON file that contained all important information about the data set (Williamson et al., 
2020). In the following the Data Preparation script was run that measured all distances 
between individual GLUT4 molecule localizations (see section 3.1.6.3). In the next step 
the data points and distances are evaluated with a previously generated model. In this 
project the previously generated model KRIRK0 was used. Furthermore, David 
Williamson who is the author of the software also prepared a specific model trained on 




2.3.11.4 Density-based spatial clustering of applications with noise 
Python scripts for the hierarchical density-based spatial clustering of applications with 
noise algorithm were downloaded from Github (https://github.com/scikit-learn-
contrib/hdbscan). A script was written in collaboration with Marie Cutiongco that 
applied the HDBSCAN algorithm automatically to GLUT4 localizations using the Python 
integrated development environment Spider. Clusters were determined for whole cells 
and ROIs of 8 μm x 8 μm size. A detailed description of how the algorithm operates can 
be found in section 3.1.6.5. 
2.3.11.5 Spatial statistics 
The complete spatstat package version 1.64-1 was downloaded from the comprehensive 
R archive network website (https://cran.rproject.org/web/packages/spatstat/ 
index.html). Spatial statistics analysis of GLUT4 localization data was carried out in 
collaboration with Marie Cutiongco and based on the book published by the software 
authors (Baddeley et al., 2016). Refer to section 3.1.6.6 for a detailed account of the 
calculations that were carried out in this project.  
2.4 Glucose uptake assay 
2.4.1 3T3-L1 adipocyte glucose uptake assay  
3T3-L1 fibroblasts were differentiated into mature adipocytes in 12 well plates as 
previously described. Cells were rendered quiescent for 2 h in serum-free medium and 
then washed twice with pre-warmed Krebs–Ringer–Phosphate (KRP) buffer containing 
136 mM NaCl, 20 mM, 5 mM sodium phosphate buffer (NaH2PO4–Na2HPO4·7H2O, pH 7.4), 
4.7 mM KCl, 1 mM MgSO4, 1 mM CaCl2). All glucose uptake experiments were performed 
with 3 technical replicates per group. The buffer was removed and the cells were 
incubated with or without 100nM insulin in KRP buffer at 37°C for 30 min. Subsequently, 
an aliquot of [3H]-2-deoxy-d-glucose in KRP buffer was added (0.25 uCi/well; 50μM final 
concentration) and incubated at 37 °C for 10 min. Half of the samples were incubated 
with 10 M of cytochalasin B (CB), a mycotoxin which inhibits facilitative glucose uptake 
in the cells and serves as a measure for background in this assay. After that, the cells 
were rinsed carefully with ice-cold PBS 3 times, air dried and lysed with 1% (v/v) Triton 
100x (1mL/well). The radioactivity in the sample was measured using liquid scintillation 
counting.  
2.4.2 Primary cardiomyocyte glucose uptake assay  
Primary rabbit cardiomyocytes were plated in 96-well plates and on experiment day the 
plate was transferred to a hotplate at 37°C and washed with pre-warmed KRP buffer 




30 min with all combinations of 100 μL KRP +/- 40 μM CB +/- 860 nM insulin, in 
triplicate, as previously described (section 2.4.1). 100 μL of 10μCi/ml of [3H]-2-deoxy-
d-glucose in KRP buffer supplemented with 100μM 2-deoxy-d-glucose was added and 
cells were incubated at 37°C for 30 min. Termination of the procedure was initiated by 
pipetting off the solution and washing the wells with ice-cold PBS once. Cells were lysed 
and suspended in scintillation fluid as previously described and radioactivity was 
measured.  
2.4.3 Interpretation of glucose uptake assay results 
At minimum 3 replicates were obtained from each glucose uptake experiment for 4 
experimental conditions. Firstly. The raw data were plotted and visually inspected for 
outliers and abnormalities. In the rare event that a data point would be lower than its 
associated CB value exclusion of the data point was justified as this is a strong indicator 
of measurement error. The mean CB values for +/- insulin conditions was calculated and 
subsequently these values were subtracted from each data point for the corresponding 
condition. These background corrected data are reported in all of the figures included 
in this project. Final graphs were plotted and statistical comparisons made between 
conditions using GraphPad Prism. 
2.5 Protein assays 
2.5.1 Production of protein lysates 
Rabbit cardiomyocytes were left to sediment in a tube for 20 min. The supernatant was 
removed and the tube was placed on ice. RIPA buffer was applied to the cells and 
samples were homogenised using a tissue grinder and left to incubate on ice for 20 min. 
The grinding was repeated twice and the samples centrifuged at 12470 x g at 4°C for 5 
min to separate the insoluble material from the lysate. Lysates were stored at -20°C 
until required. For cells on plasticware, cells were washed 3 times with cold PBS and 
placed on ice. Protein was extracted by applying Laemmli Sample Buffer on ice for 20 
min. Samples were centrifuged at 12470 x g at 4°C for 5 min and stored at -20°C until 
used. 
2.5.2 Bicinchoninic acid assay 
When appropriate a bicinchoninic acid assay (BCA) assay was performed for the 
colorimetric detection and quantitation of protein concentration. Protein standards 
with bovine serum albumin (BSA) concentrations between 25 – 2,000 µg/mL were 
prepared and 25 µL of each standard and the experimental sample were mixed with 200 
µL working reagent supplied by the manufacturer. Further dilutions were prepared of 
protein standards and experimental samples diluted 1:1 in distilled water to make sure 




pipetted into a microplate in duplicate and incubated at 37°C for 30 min. A microplate 
reader was used to measure the absorbance at 562 nm. 
2.5.3 Western immunoblotting  
Polyacrylamide resolving gels were cast manually in the laboratory using Biorad mini-
Protean III equipment. The final percentage of acrylamide was determined by the size 
of the protein but was usually at 10 %. Protein samples were thawed and boiled at 95°C 
for 5 min or heated to 65°C for 10 min when probing for GLUT4. BioRad Precision Plus 
Protein Standards All Blue Markers was used as molecular weight ladder. Samples were 
usually electrophoresed at 100V for approximately 2 h and subsequently transferred 
onto Nitrocellulose membrane. Membranes were stained with Ponceau solution to check 
correct transfer of proteins prior to immunolabelling. Nitrocellulose membranes were 
blocked in 5% (w/v) BSA or milk powder in PBS-T for 30 min at room temperature, then 
incubated with primary antibody at 4°C overnight. The next day membranes were 
washed in PBS-T three times for ~5 min before incubation with appropriate secondary 
antibodies at room temperature for 1 h. After washing, the blots were visualised with a 
LI-COR Odyssey-SA. 
2.5.4 Densitometry 
Scanning of nitrocellulose membranes was performed with a resolution of 100 μm and 
high quality composite images of 2 channels of excitation/emission were obtained. 
Images were imported into Image Studio Lite software (Version 5.2) provided by LI-COR. 
In the analysis window a box was drawn around each protein band of interest and the 
automatically background corrected mean pixel intensity was measured. Mean pixel 
intensities of proteins of interest were normalised against GAPDH protein intensities to 
adjust values for the amounts of protein that were loaded.  
2.6 Molecular methods 
2.6.1 Amplification of plasmid DNA 
Several plasmids had to be amplified in volume during this project for subsequent aims 
and a general description of this process is provided in this section. All steps were 
performed in semi-sterile conditions on a bench top under a flame using sterile 
equipment. Plasmid DNA was transformed into Stbl 3 or 5-alpha E. Coli cells. 1 µL of 
plasmid DNA was incubated with 50 μL of competent cells in an Eppendorff tube on ice 
for 30 min. The cells were heat shocked at 42°C for 45 s and placed on ice for another 2 
min. In the following 300 μL of SOC medium was added and the mixture was shaken in a 
37°C incubator for 45 min. Cells were plated on antibiotic selection agar plates and 
incubated overnight at 37ºC. Additionally, untransformed E. Coli cells were plated on an 




marker (positive control) for each experiment. Success of the transformation protocol 
was assessed the following day by observation of bacterial growth on appropriate plates 
only. A single colony was scraped off the plate using a P20 sterile pipette tip and placed 
into a tube containing 5 mL 2YT medium. The culture was placed into a shaker at 37ºC 
during the day (~ 8 h). The small culture was then transferred into a big flask containing 
100 mL 2YT medium which was rigorously shaken at 37ºC overnight (~ 16 h). The 
following day a commercially obtained Maxi Prep kit was used to extract the plasmid 
DNA from the cells. A NanoDrop spectrophometer was used to determine the 
concentration of the new DNA preparation.  
2.6.2 Transfection of mammalian cells with plasmid DNA 
HeLa cells were plated in 6-well plates for imaging experiments and preparation of 
protein lysates. At 50-70 % confluency cells were transfected with the transfection 
reagent Lipofectamine 2000 and plasmid DNA. As indicated in figure legends several 
concentrations of Lipofectamine 2000 and DNA were used for optimisation during this 
project. Usually 8 μL Lipofectamine 2000 plus 2.5 μg DNA in 500 μL Opti-MEM were 
prepared for each well of a 6-well plate. 8 μL Lipofectamine 2000 and 2.5 μg DNA were 
added to 250 μL Opti-MEM respectively and incubated for 5 min. Thereafter, the two 
solutions were mixed thoroughly and incubated for 20 min before application to the well 
plate containing the HeLa cells. Opti-MEM containing either Lipofectamine 2000 or 
plasmid DNA were prepared to serve as controls for each experiment. Cells were 
incubated at 37°C and 5% CO2 with the reagents for 4 h and then medium was switched 
back to normal maintenance medium. Cells were used for experiments exactly 48 h post 
transfection.  
2.6.3 Generation of a novel TfR-GFP lentiviral plasmid  
To generate a plasmid suitable for the development of a lentivirus the TfR-GFP gene 
sequence had to be subcloned from the pEGFP-N1-Flag-TfR-GFP plasmid into the pCDH 
backbone of the pCDH-CMV-MCS-EF1-HA-GLUT4-GFP plasmid. This was achieved using a 
NotI/NheI double digest of both the original TfR-GFP plasmid and the pCDH backbone. 
After purification and ligation using standard procedures, single putative positive 
colonies were amplified and DNA purificated using commercial mini-prep plasmid kits 
according to the manufacturer’s instructions. The DNA was digested with the same 
restriction enzymes to confirm that the backbone (pCDH) and insert (TfR-GFP) were of 
the correct molecular size. Once this was achieved the newly generated plasmid was 
transformed into Stbl 3 E. Coli and amplified in volume for future use. 
2.7 Confocal microscopy  
Cells were seeded onto ⌀ 12mm and 24mm coverslips and fixed when 70-80 % confluent 




samples were washed with PBS 3 times. After fixation quenching buffer was applied for 
10 min and immunofluorescence buffer was used for blocking for a minimum of 30 min. 
Cells were stained with primary and secondary antibodies specified in table 2.4 and 2.5. 
Coverslips were mounted onto clean glass slides using Immu-Mount non-fluorescent anti-
fading medium and left to dry overnight. Samples were imaged using a 40x or 63x 
objective lens on a Zeiss LSM 800. Images were processed using Image J. 
2.8 Flowcytometry  
2.8.1 GLUT4 translocation assay set up for HeLa cells 
Flow cytometry is a powerful multiparameter laser-based technology for assaying GLUT4 
translocation in a high throughput fashion. Firstly, this technique was optimised in HeLa 
cells as they are a highly homogenous cell population. Wild-type and unstained HeLa 
cells stably expressing HA-GLUT4-GFP were used as experimental controls. Detection 
thresholds for HeLa cells were set at 150,000 SSC-A (side scatter area) and 250,000 FSC-
A (forward scatter area). Log intensities of scattered light and fluorescence (FITC, 488 
nm excitation/515-545 nm emission; APC, 635 nm excitation/650-670 nm emission) 
were collected for 20,000-30,000 cells from the control samples. HeLa cells in culture 
contain healthy cells and some cellular debris. Data collection thresholds were set 
based on FSC and SSC profiles to omit small light scattering debris and machine noise 
from the analysis. A first elliptical gate was set to identify the HeLa cell population. 
Fluorescence detector gains were set so that background autofluorescence in 
noninfected cells was collected in the first log decade of the detector range. A second 
elliptical gate was drawn to separate cells expressing the HA-GLUT4-GFP (GFP-positive) 
construct from cells that did not express the construct (GFP-negative).  
2.8.2 Preparation of HA-GLUT4-GFP HeLa cells for FACS analysis 
HA-GLUT4-GFP HeLa cells were seeded into 6 well plates (~300,000 cells/well) 24 h pre-
analysis. On the experiment day cells were serum-starved for two h and half of the HA-
GLUT4-GFP HeLa cell samples were stimulated with 1 μM insulin for 40 min at 37°C. The 
plates were then placed on ice where all subsequent steps were performed with use of 
ice-cold solutions. Surface GLUT4 was stained for using the HA-tag. Cells were 
incubated with labelling medium containing primary anti-HA antibody at a 
concentration of 1:200 in DMEM with 10% (v/v) FCS for one h. Cells were washed 3 times 
with PBS and incubated in labelling medium containing 1:300 secondary antibody 
conjugated with AlexaFluor® 647 for one h. Cells were washed with PBS and gently 
dissociated with collagenase type I (2 mg/ml (w/v)) in PBS supplemented with 0.5mM 
EDTA and 10% (v/v) FCS at 37°C for 10 min. Samples were diluted in PBS and gently 




LSR II flow cytometer. Events of 50,000 cells were collected for each experimental 
condition.  
2.8.3 GLUT4 translocation assay set up for adipocytes 
Subsequently, this GLUT4 translocation assay was optimised in 3T3-L1 adipocytes. 
Mature adipocytes were differentiated from 3T3-L1 fibroblasts and therefore presented 
as a more heterogeneous cell population in culture. Differentiated 3T3-L1 adipocytes in 
culture contain fully differentiated adipocytes, nondifferentiated fibroblasts and 
necrotic cells that died during differentiation. Wild-type and unstained HA-GLUT4-GFP 
adipocytes were used as experimental controls. Detection thresholds for 3T3-L1 cells 
were set at 250,000 SSC-A (side scatter area) and 250,000 FSC-A (forward scatter area). 
Log intensities of scattered light and fluorescence (FITC, 488 nm excitation/515-545 nm 
emission; APC, 635 nm excitation/650-670 nm emission) were collected for 20,000-
30,000 cells from the control samples. For the analysis of adipocytes an elliptical gate 
was applied to the FSC and SSC resulting in analysis of only adipocytes and exclusion of 
any residual fibroblasts and cellular debris. 3T3-L1 adipocytes expressing the HA-GLUT4-
GFP construct were separated from cells that did not express the construct using a 
threshold gate in SSC and FITC.  
2.8.4 Preparation of HA-GLUT4-GFP adipocytes for FACS analysis 
HA-GLUT4-GFP 3T3 L1 fibroblasts were seeded into 12 well plates and differentiation 
into mature adipocytes was initiated 10 days prior to the experiment as previously 
described. On the experiment day cells were serum-starved for two h and half of the 
HA-GLUT4-GFP 3T3 L1 adipocyte samples were stimulated with 100 nM insulin for 40 min 
at 37°C. The plates were then placed on ice where all subsequent steps were performed 
with use of ice-cold solutions. Surface GLUT4 was stained for using the HA-tag. Cells 
were incubated with labelling medium containing primary anti-HA antibody at a 
concentration of 1:200 in DMEM with 10% (v/v) FCS for one h. Cells were washed 3 times 
with PBS and incubated in labelling medium containing 1:300 secondary antibody 
conjugated with AlexaFluor® 647 for one h. Cells were washed with PBS and gently 
dissociated with collagenase type I (2 mg/ml (w/v)) in PBS supplemented with 0.5mM 
EDTA and 10% (v/v) FCS at 37°C for 10 min. Samples were diluted in PBS and gently 
filtered through a 100 μm cell strainer to remove clumps of cells and analysed on a BD™ 
LSR II flow cytometer. Events of 50,000 selectively gated GFP-positive HA-GLUT4-GFP 
3T3 L1 adipocytes were collected for each experimental condition.  
2.8.5 Analysis of flowcytometry data 
The flow cytometric data were analysed using Flowjo v8 software (BD, USA). Briefly, for 
both fibroblasts and adipocytes FITC mean fluorescence was determined for GFP-




staining FITC fluorescence values for GFP-negative cells were subtracted from FITC 
fluorescence values of GFP-positive cells. Mean values were determined for APC and 
FITC fluorescence and the HA/GLUT4 ratio calculated by dividing the fluorescence 
intensity of the APC (HA signal, GLUT4 located in the PM) by the fluorescence intensity 
of the FITC (GFP signal, total intracellular GLUT4). The HA/GLUT4 ratio was expressed 
as fold change between conditions. 
2.9 Statistical analysis 
Throughout this project, GraphPad Prism (version 7) was used for the appropriate 
statistical analysis of experimental data. Most frequently an unpaired t-test or one-way 
ANOVA was deemed appropriate and the level of significance was set at p<0.05. Full 

























3. Stochastic optical reconstruction microscopy for 
the assessment of GLUT4 dispersal  
3.1 Introduction 
3.1.1 The diffraction limit of light 
The optical resolution of an imaging system is defined as the ability to resolve detail 
within the sample and depends on the minimum distance at which two points can be 
distinguished as individuals (Nollmann and Georgieva, 2015). Throughout history 
resolving power has been enhanced to a certain extent by careful design of lenses and 
optics. Nevertheless, any optical microscope has a finite resolution rooted in the 
fundamental physical laws governing light diffraction referred to as the ‘diffraction 
limit’. Fluorophores are point sources of light that emit photons diffracted by the 
optical components of the imaging system and appear as regularly spaced rings known 
as Airy disks at the detector unit (Figure 3.1). The point spread function (PSF) is the 
three-dimensional representation of the Airy disk in the image plane and is unique for 
each imaging system (Nollmann and Georgieva, 2015). The numerical aperture (NA) of 
the objective defines its performance and is dependent on the amount of photons that 
can be collected and the refractive index of the immersion medium. Fluorescence 
microscopy objectives typically have an NA ranging between 0.2 to 0.95 for air 
objectives and 0.85 to 1.4 for oil objectives. The physicist Ernst Abbe was the first to 
empirically define the resolution of an optical microscope (Abbe, 1873) as 
𝑑 = λ/2𝑁𝐴 
The smallest resolvable distance d between two PSFs is the wavelength of the observed 
light λ divided by two times the NA of the objective. The visible spectrum of light 
ranges from 400 to 750 nm and a typical oil immersion objective has an NA of 1.4 
resulting in a maximum resolution of 200-300 nm for a standard microscope (Figure 3.1). 
Many subcellular structures and processes remain elusive due to the diffraction limit 
and novel imaging techniques are required to enhance the limit of resolution and so 





Figure 3.1 Principle of resolution. 
Monochromatic light passed through a small circular aperture results in the appearance 
of circular intensity profiles known as Airy discs. Plotting the signal intensity of this 
point source of light on a graph it appears as peaks. The Rayleigh criterion is defined as 
the smallest possible separation between two light sources that can be resolved into 
separate objects. Adapted from (Thorley et al., 2014). 
 
3.1.2 Super resolution microscopy 
In the 1990s Eric Betzig, Stefan Hell and William Moerner came up with different ideas 
on how to circumvent the physical barriers of the diffraction limit (Betzig et al., 1991; 
Dickson et al., 1997; Hell and Wichmann, 1994). This was the beginning of the field of 
super resolution microscopy resulting in the award of the Nobel Prize in Chemistry in 
2014 (Thorley et al., 2014). The term super resolution microscopy encompasses several 
techniques that can be divided in two major groups known as deterministic and 
stochastic super-resolution. The work described in this thesis employs a stochastic 
super-resolution approach. 
 
Stochastic super resolution microscopy techniques take advantage of the chemical 
complexity and temporal behaviour of fluorophores which can be used to make closely 
situated fluorophores emit light at separate times. These techniques include all single 
molecule localization microscopy (SMLM) methods such as photo-activated localization 
microscopy (PALM) (Betzig et al., 2006; Hess et al., 2006) and stochastic optical 
reconstruction microscopy (STORM) (Heilemann et al., 2008; Rust et al., 2006). SMLM 




advantage of our ability to localize these single molecules with nanometre precision 
resulting in the reconstruction of a final super-resolved image.  
 
3.1.3 Stochastic optical reconstruction microscopy 
Stochastic optical reconstruction microscopy has become one of the most widely used 
super resolution techniques for single molecule imaging (Rust et al., 2006). Subcellular 
structures can be selectively stained with fluorescent molecules which are either linked 
to an antibody as in immunolabelling or fused genetically to a target of interest. As in 
standard fluorescence microscopy a set of photons is collected from a molecule and 
becomes visible as a diffraction-limited PSF in the image plane of the microscope. The 
centre of this PSFs can be determined by fitting the observed emission profile to a 
geometrical Gaussian function in two dimensions (Figure 3.2). In this scenario the 
resolution is only limited by the precision with which the centre of a molecule can be 
localized and the overall number of localizations. The localization precision ∆𝑥 can be 
approximated by  
∆𝑥 =   𝜎/√𝑛 
with σ being the standard deviation of the PSF and n being the number of photons 
collected. The more photons can be collected from a molecule the lower is the error in 
localizing the centre of this molecule.  
Nevertheless, localization precision does not automatically translate to high resolution. 
Most structures and organelles in biological samples are densely populated with 
fluorophores with several fluorescent molecules sharing the same volume of diffraction-
limited space making single-molecule localization virtually impossible. SMLM methods 
take advantage of the possibility to switch fluorophores between a light and a dark 
state. A relatively sparse subset of fluorophores within a densely labelled sample is 
randomly switched on at an image frame. Subsequently signals of several subsets of 
activated fluorophores are collected over a series of imaging cycles and the molecule 
centres are localized with nanometre precision (Figure 3.2). The final result is a table of 
coordinates containing an accumulation of each individual molecule localization and a 
final image can be reconstructed from these coordinates with a resolution of up to 20 
nm (Rust et al., 2006). The discovery that conventional commercially available 
fluorophores can be reversibly photo-switched without the presence of an activator dye 
has revolutionised the field of STORM (Heilemann et al., 2008). The simplified method 
using single-dye switching is called direct STORM (dSTORM) and is currently the method 






Figure 3.2 Principle of stochastic optical reconstruction microscopy. 
A high density of fluorophores results in overlap of individual intensity profiles and 
limited resolution due to the Abbe diffraction limit. Selective activation of isolated 
fluorophores over a number of frames achieves temporal separation of the signals. 
Spatial separation is obtained by localization of molecules by fitting Gaussian curves 
onto the individual intensity profiles from each frame and a super resolved image with 
single molecule coordinates is reconstructed. Adapted from (Heilemann et al., 2008). 
 
 
Photo-switches are all fluorescent molecules that can be switched between a light and a 
dark state by external means (Heilemann et al., 2008). Photoactivatable fluorophores 
transition from a dark to a light state in an irreversible manner. These molecules are 
activated, read-out and subsequently bleached and cannot be reactivated. PALM 
generally uses genetic fusion constructs to exogenously express photoactivatable 
fluorescent protein within biological samples. Photoactivation and photobleaching limit 
the fluorescence lifetime in this setup and continuous emission of the fluorophore 
between these states is desirable during image acquisition (Heilemann et al., 2008). In 
contrast, dSTORM makes use of antibodies tagged with organic dyes that can be 
reversibly switched from a fluorescent to a non-fluorescent state. Cycling between the 
light and dark states is enabled by electron transfer. High energy light of a short 
wavelength will excite a fluorescent molecule and promote an orbital electron within 




the excited singlet state S1. After several nanoseconds the electron will relax back to 
the ground state and the stored energy will be released as an emitted photon 
(Heilemann et al., 2008). This emitted fluorescent light has a longer wavelength than 
the absorbed light and the difference between the excitation and emission energy is 
termed the Stokes shift. Excitation of an electron to a higher energy state can be 
accompanied by a change of spin state of the electron which is then called intersystem 
crossing to the excited triplet state T1. When the electron has changed its spin state it 
cannot quickly relax back to its ground state because the re-emission involves quantum-
mechanically complex energy state transitions and therefore phosphorescence is the 
delayed emission of absorbed radiations. To stabilise fluorescence emission during SMLM 
and generate long-lasting off-states before reactivating a fluorescent molecule the 
triplet state and therefore phosphorescence need to be quenched (Heilemann et al., 
2008). Adding reducing agents with thiol groups for instance MEA have been shown to 
successfully quench the triplet state and thus retain the electron in the dark state 
(Olivier et al., 2013). Molecular oxygen can oxidise the fluorescent molecule so it can 
return to its ground state. This molecular mechanism can be induced for several cycles 
and this is how efficient photo-switching is achieved in SMLM techniques. The optimal 
photo-switching rate, at which the activated subset of fluorophores in each frame are 
further apart than the diffraction limit can be determined by varying the laser intensity, 
thiol, and oxygen concentration (Olivier et al., 2013). 
 
dSTORM is widely used among the state-of-the-art super resolution microscopy 
techniques as it offers many advantages. The use of a wide range commercially 
available standard fluorescent probes which can be used to label virtually any structure 
have hugely increased the popularity of dSTORM in recent years (Heilemann et al., 
2008). Furthermore, the experimental setup only requires a standard confocal 
microscope with sufficiently powerful lasers which is readily available in most 
laboratories around the world. Sample preparation is time-efficient, inexpensive and 
easy to execute without specialist training. DSTORM also offers one of the best 
resolutions down to ~20 nm which makes it more powerful in resolving molecular details 
compared to deterministic super resolution microscopy methods.  
 
3.1.4 Sample preparation 
Increased resolution gives rise to various new technical issues that must be addressed in 
order to obtain faithful and high quality super resolution images (Leyton Puig et al., 
2016). Both sample preparation and appropriate imaging conditions are key to 
successful SMLM experiments. Sample preparation starts with fixation of the structure 




cellular structures differently and buffers can also impact on fixation. 
Paraformaldehyde (PFA) and glutaraldehyde (GA) are crosslinking fixatives and usually 
preferred to ethanol, methanol and acids (Leyton Puig et al., 2016). Both PFA and GA 
bind amino groups preserving the location of structures within the cell. The 4 % PFA 
solution has been the standard fixative for immunostaining of fluorescence microscopy 
samples for many decades (Richter et al., 2018). PFA does not change the tertiary 
structure of target proteins and their epitopes remain available for antibody binding. 
Nevertheless, studies have reported various problems with PFA fixation, including 
morphological changes, loss of epitopes, mis-localization of target proteins and slow 
and incomplete fixation (Melan, 1994; Schnell et al., 2012; Tanaka et al., 2010). GA 
alleviates these problems by crosslinking proteins more strongly (Smith and Reese, 
1980). However, GA introduces free aldehyde groups into the fixed sample leading to 
alterations in tertiary protein structure. This makes epitopes unrecognizable for 
antibodies and interferes negatively with immunostaining. Mixtures of PFA and GA result 
in efficient fixation with reduction of the lateral mobility of molecules but can reduce 
the efficiency of immunostaining by blocking antibody access to epitopes (Tanaka et al., 
2010). Therefore, it is crucial to find a balance between strong fixation with accurate 
morphology preservation and good quality immunostaining with reliable antibody 
binding. Fixation artefacts may be negligible in conventional microscopy but need to be 
taken into consideration to avoid drawing the wrong conclusions about biological 
processes from SMLM data.  
 
Antibody staining of endogenous GLUT4 protein has been unsuccessful in the 
visualisation of GLUT4 dynamics historically (personal communication). However, the 
availability of fluorescent tags revolutionised GLUT4 research and enabled visualisation 
of GLUT4 and quantification of GLUT4 translocation. The reporter construct HA-GLUT4-
GFP is most widely distributed in the GLUT4 research community and its extensive use 
resulted in reliable characterisation (Figure 3.3). HA-GLUT4-GFP was found to display 
comparable translocation, localisation and recycling kinetics to endogenous GLUT4 
(Dawson et al., 2001; Zeigerer et al., 2002). It was reported that only GFP-labelling of 
the GLUT4 C-terminus resulted in trafficking dynamics resembling endogenous GLUT4 
and placement of the GFP-tag in different molecular locations resulted in undesirable 






Figure 3.3 Schematic of the HA-GLUT4-GFP construct. 
Cells expressing the HA-GLUT4-GFP construct are valuable for the quantification of 
GLUT4 translocation. Human GLUT4 protein is tagged with a hemagglutinin (HA)-tag on 
its first exofacial loop and a green fluorescent protein (GFP)-tag fused to its C-terminus. 
The GFP-fluorescence is directly proportional to the total amount of GLUT4 expressed. 
When GLUT4 fuses with the PM the HA-tag becomes exposed at the surface and binding 
of a fluorescently labelled antibody to the HA-tag in nonpermeabilized cells is 
proportional to the amount of GLUT4 that translocated to the PM. 
 
In theory resolution of super resolution microscopy techniques can reach molecular 
scale. However, resolution is often limited by sample specific factors for instance the 
size of the fluorescent label (Huang et al., 2009). At high resolution common antibodies 
significantly limit how well the image reflects the actual structure by increasing the 
apparent size of visualised structures. Binding of primary and secondary antibody 
complexes was reported to increase the diameter of microtubules from 25 nm to about 
60 nm using STORM imaging (Bates et al., 2007). Reducing the distance between the dye 
and fluorescent label, known as linkage error, can be achieved by genetic fusion of 
organic dye molecules to target proteins (Popp et al., 2007). However, genetic 
engineering and overexpression is time consuming and not appropriate for all 
experiments and therefore the use of labelled nanobodies as nanoscale detection tools 
has emerged recently (Beghein and Gettemans, 2017). Conventional heterotetrameric 
immunoglobulin-γ (IgG) antibodies are composed of two identical heavy (H)-chain and 
two identical light (L)-chain polypeptides (Padlan, 1994). The H-chain comprises four 
domains whereas the L-chain folds into two domains. In 1993 Hamers-Casterman and 
colleagues observed that in addition to conventional IgG antibodies camelids possess 
special H chain-only antibodies devoid of L-chains and lacking the first constant domain 




H-chain antibodies contain a single variable N-terminal domain (VHH) with dimensions in 
the nanometer range (Ingram et al., 2018; Muyldermans, 2013). Nanobodies are 
engineered from H-chain antibodies and contain only the single monomeric VHH 
(Harmsen and De Haard, 2007). They have a molecular weight of 12-15 kDa and are 
much smaller than common antibodies (150-160 kDa) but have similar binding affinities 
and improved solubility (Beghein and Gettemans, 2017). Nanobodies can be equipped 
with a single strongly fluorescent organic dye molecule and significantly reduce 
fluorescent label linkage error by delivering fluorophores into close proximity of target 
proteins (Beghein and Gettemans, 2017). Moreover, their small size allows for binding of 
hidden intracellular epitopes. Recently several studies have reported the successful use 
of anti-GFP nanobodies that target genetically encoded green fluorescent fusion 
proteins for super resolution imaging applications (Chamma et al., 2016; Platonova et 
al., 2015; Ries et al., 2012). High affinity nanobodies have become commercially 
available, are cost-efficient and allow quantitative labelling because every nanobody 
can be linked to a single fluorescent molecule (Rothbauer et al., 2006). Nanobodies 
should always be explored as an alternative to conventional antibodies to avoid linkage 
error and localization bias in super resolution experiments.  
 
3.1.5 Cluster analysis 
Cluster analysis consists of several methods that can be used to classify a set of objects 
into a group or cluster that share similar properties compared to other sets of objects 
within a sample (Everitt et al., 2011). It can be achieved by a number of algorithms that 
vary in how clusters are detected and what is identified as a cluster. Clustering in 
biological samples can be regarded as a multi-objective optimization problem because 
the appropriate clustering algorithm and parameter settings depend on the specific 
sample and intended use of results (Everitt et al., 2011). Data pre-processing steps and 
model parameters such as distance function, density threshold or number of expected 
clusters often need to be modified and adjusted to each individual data set until the 
desired cluster segmentation can be achieved (Levet et al., 2015; Williamson et al., 
2020).  
 
The first aim of my research is to quantify GLUT4 clustering and statistically analyse the 
spatial point pattern generated during dSTORM experiments. To this end, several 
methods of cluster analysis were evaluated in this study and are described in this 
chapter. Information on GLUT4 clusters obtained through the use of each individual 
method was compared to information available from the literature (Gao et al., 2017; 





3.1.5.1 Ripley’s K function and its derivatives 
In 1976 the British statistician Brian Ripley developed a function to analyse the 
occurrence of point patterns over a given area of interest (Ripley, 1976). Ripley’s K 
function enables researchers to investigate whether points of interest appear dispersed, 
clustered or randomly distributed within a sample. The K function is described as 
𝐾(𝑟) = 1/𝑛  (∑ 𝑁
𝑛
𝑖=1
_𝑝𝑖  (𝑟))/𝐴 
with n being the number of points, 𝑁_𝑝𝑖 being the number of points within a distance r 
and A being the area (Kiskowski et al., 2009). Ripley’s K function is usually calculated at 
multiple distances to see how the point pattern distributions change with scale (Figure 
3.4). Concentric circles are drawn around each point and the number of neighbours 
enclosed is counted and plotted against the radius resulting in a graph giving 
information about the spatial point distribution (Kiskowski et al., 2009).  
 
Figure 3.4 Schematic of the analysis of spatial point patterns with Ripley’s L 
function. 
The normalized Ripley’s K function L(r) is a spatial analysis method used to describe 
whether spatial point patterns in a given area of interest appear to be uniform 
(complete spatial randomness=CSR), clustered or dispersed. In this graphic L(r) 
represents the counts of the number of neighbouring trees found within a given distance 
r of each individual tree. This number is compared to the number of trees that were 
expected to be found if all trees were distributed based on CSR (blue line). If the 
number of trees is bigger than that for CSR the distribution is clustered (green line) and 
if the number of trees is smaller the distribution is dispersed (red line). Adapted from 




The variance stabilised L function is usually used in data analysis and defined as 
𝐿(𝑟) = √(𝐾(𝑟)/𝜋) 
If the points of interest within a sample are randomly distributed the L function is a 
straight line (Kiskowski et al., 2009). If the points are more clustered the obtained L 
value plotted against r will be bigger than expected and when the points are more 
dispersed the L value will be smaller than expected. Ripley’s K and L functions are the 
gold standard of spatial descriptive statistics and used to detect deviations from spatial 
homogeneities in many fields of biology. Furthermore, this analysis method is easy to 
carry out with freeware software packages and the least time consuming (Baddeley and 
Turner, 2005; Levet et al., 2015; Rubin-Delanchy et al., 2015).  
 
3.1.5.2 Bayesian cluster analysis 
In 2015 Dylan Owen developed a new specialist model-based Bayesian approach to 
analyse pointillist SMLM data sets (Rubin-Delanchy et al., 2015). SMLM raw data consist 
of a list of the x and y coordinates of all localised fluorophores that also contains an 
associated, estimated localization precision value for each of the points. Based on 
Ripley’s K function the Bayesian cluster analysis evaluates molecular cluster assignment 
taking into account the localization precision for each localised molecule. Several 
cluster proposals are generated for the SMLM data points with variable spatial scales 
and thresholds and the model that approximates the spatial distribution of the data best 
is selected (Rubin-Delanchy et al., 2015). The Bayesian cluster analysis has been 
especially developed for analysis of SMLM data. It is more accurate and eliminates many 
of the shortcomings of Riley’s K function such as occurrence of edge effects and user-
selected parameters that require some pre-existing information of the sample to be 
correct. However, the generation of thousands of cluster proposals is very time-
consuming and requires more computing power and space for data storage.  
 
3.1.5.3 Cluster analysis with machine learning 
In 2018 a supervised machine-learning approach to cluster analysis was developed to 
convert SMLM point pattern data into a meaningful description of clustering (Williamson 
et al., 2020). Machine learning is a method of data analysis that provides computer 
systems with the ability to learn to perform specific tasks without being explicitly 
programmed (James et al., 2013). In supervised machine learning a function is learnt by 
mapping labelled input training data to desired output values (Figure 3.5). A supervised 
training algorithm analyses artificially simulated SMLM pointillist input data sets for 




function that can be used for mapping new real SMLM data sets (Williamson et al., 
2020). The generated model firstly classifies point coordinates as clustered or non-
clustered (Figure 3.5). In the next step this information is used to partition points into 
spatially similar cluster shapes (Williamson et al., 2020). This approach has the benefit 
of combining fast analysis with high precision and moreover it requires minimal 
parameter input and pre-existing information about the sample of interest.  
 
Figure 3.5 Cluster analysis with machine learning.  
CAML uses raw data with spatial molecule coordinates of STORM experiments (black 
dots). Distances are measured from each point in the data set to its neighbouring 
points. The pattern of the distance values changes from points in dense regions 
(clusters) to points within a fields of randomly distributed points. Nearby-neighbour 
distances and distance-differences are used to classify as either clustered (yellow dots) 
or non-clustered (blue dots). The yellow clustered points are then assigned to spatially 
similar clusters around which a cluster shape is fitted (cluster partitioning). The model 
can be compared to the training data to determine the accuracy of the process (ground 
truth). Adapted from (Williamson et al., 2020). 
 
3.1.5.4 Tesselation 
In mathematics, Voronoï tessellation is the subdivision of space into numerous polygonal 
regions centred around a given set of objects in terms of Euclidian distance (Ju et al., 
2011). In the simplest case, the objects are a finite amount of points in a plane called 
seeds. The polygonal regions provide detailed information about the neighbourhood 
surrounding the points. The Voronoï diagram can be built from single molecule 
coordinates and thus applied for cluster analysis of dSTORM data (Levet et al., 2015). 
Voronoï polygons are centred on individual localizations and their edges are equidistant 
from the two nearest seeds and perpendicular bisectors computed between them. Each 
polygon region is influenced by its corresponding seed, and characteristics such as 
polygon area or shape can be used to describe the molecular organization of the seeds 
(Levet et al., 2015). Regions with low molecular density are composed of large seeds 
whereas regions with higher molecular density are comprised of smaller and denser 
polygons. This is followed by the computing of an object segmentation process that 
selects polygons with parameters of interest in defined thresholds. Selected polygons 




became available that allowed for automatic segmentation of biological data based on 
Voronoï tessellation (Levet et al., 2015). The software is time and cost efficient and 
user-friendly and was explored for the quantification of GLUT4 organization in the PM. 
 
3.1.5.5 Density-based spatial clustering of applications with noise  
The density-based spatial clustering of applications with noise (DBSCAN) has become 
one of the most common data clustering algorithms since its development in 1996 (Xu, 
1996). Density-based clustering defines clusters as areas of higher density compared to 
the remainder of the data points (Figure 3.6). DBSCAN relies on a specific cluster model 
called "density-reachability" (Xu, 1996). Given a set of points it connects points with 
many nearby neighbours within certain distance thresholds. DBSCAN requires two 
parameters: the minimum amount of points needed to form a dense region (minPts) and 
epsilon (ε) determining the radius of a neighbourhood with respect to some point. Only 
points that satisfy a global density criterion are classified as clusters and clusters consist 
of these density-connected core points plus border points that lie within these points' 
range (Xu, 1996). 
 
Figure 3.6 Schematic of density-based spatial clustering of applications with noise. 
DBSCAN divides datasets into n dimensions and forms n dimensional shapes around each 
point in the dataset and counts how many points fall within that shape. For this 
schematic minPts=4. The green points A are core points that contain at least 4 points 
(including the point itself) in their radius Ɛ. DBSCAN counts this shape as a single cluster 
because each point is reachable from one another. The blue points B and C are border 
points because they lie within Ɛ of core points. They are classed to belong to the cluster 
too. The red point N is an outlier because it is not a core point or directly reachable.  
 
DBSCAN can identify arbitrary cluster shapes, requires minimum a priori parameter 
input and can be applied to big data sets and is therefore the most cited clustering 
algorithm in the scientific literature. Several extensions have been proposed over the 
years including hierarchical algorithm versions (Ankerst et al., 1999; Campello et al., 




parameters of fixed size which makes their application less suited to complex data. 
Parametric models are fast and their results easily interpreted but they are constrained 
to a specific form and frequently the algorithms have a poor fit and do not match the 
underlying processes. HDBSCAN is a nonparametric algorithm that runs in Python and 
uses a density-based approach to find clusters making few implicit assumptions. 
HDBSCAN is an extension that performs DBSCAN over a range of ε values which allows to 
find clusters of varying densities and is more robust to parameter selection (Campello et 
al., 2015). We explored HDBSCAN as a method to evaluate GLUT4 clustering dynamics.  
 
3.1.5.6 Spatial statistics 
Spatstat is a package for analysing spatial point pattern data in the R programming 
language (Baddeley et al., 2016). The spatstat package supports a range of activities for 
instance exploratory data analysis, creation, manipulation and plotting of point 
patterns, parametric model fitting and simulation of point process models (Baddeley 
and Turner, 2005). Spatstat features a generic algorithm for fitting point process models 
to point pattern data. One of its biggest advantages is that the package can manage 
realistic data sets that are often inhomogeneous, contain sampling regions of arbitrary 
shape and additional covariate data (Baddeley and Turner, 2005). A big variety of 
empirical statistics are implemented in the spatstat package and can be generated and 
displayed. Ripley’s K and L functions, the empty space function F, the nearest 
neighbour distance function G, pair correlation function g, and the J-function which 
expresses the combined estimates of the F and G functions (Baddeley et al., 2016).  
 
Edge effects in spatial point pattern data are generated by choosing a defined sampling 
region which creates a bias by only studying points that fall into the specific region 
without knowing what occurs outside of the frame. There are several methods for 
correction of edge effects but the details of the techniques and their relative merits are 
not within the scope of this study. Spatstat automatically performs an edge correction 
and the developers state that the particular choice of edge correction technique is not 
critical (Baddeley et al., 2016). The summary functions generated by spatstat assume 
that a point process is stationary. In our experiment GLUT4 is sequestered 
intracellularly during the basal state and insulin stimulation results in translocation of 
the transporter to the PM leading to an increase in the total number of GLUT4. The 
‘inhomogeneous’ versions of the summary functions have been proposed for the analysis 
of point pattern that are subject to special conditions with non-stationary underlying 
point processes, for instance when the intensity is gradually varying across the sampling 




the summary functions because GLUT4 clustering does not follow homogeneous 
patterns. 
 
3.1.6 Hypothesis and Research Aims 
The aim of this chapter was to find a reliable assay to study GLUT4 organization in the 
PM for application to several cell culture model systems. Using dSTORM to circumvent 
the resolution limit we hoped to be able to visualise individual GLUT4 molecules and 
quantify their spatial relationships in the PM as previously reported in the literature. 
Firstly, we aimed to establish dSTORM in our laboratory and optimised experimental 
procedures for instance sample preparation and imaging setup to achieve visualization 
of GLUT4 clusters comparable to the existing literature (Gao et al., 2017; Lizunov et 
al., 2013a; Stenkula et al., 2010). Secondly, we explored a wide range of cluster 
analysis methods to find the most suitable way to evaluate the molecular organization 
of GLUT4 and quantify clustering and dispersal dynamics in response to various stimuli 
using a single dataset to facilitate comparisons. We qualitatively assessed each 
computational cluster analysis method using the following predefined parameters: ease 
of use, requirement of a priori parameter input, time consumption, ease of 



















3.2.1 The effects of sample preparation on super resolution image 
quality 
One of the aims of this study was the visualization of GLUT4 at the single molecule level 
in 3T3-L1 adipocytes expressing HA-GLUT4-GFP. GLUT4 organization was investigated in 
this cell line previously (Gao et al., 2017) and thus it served as a control to optimise 
experimental protocols and obtain super resolution images of a comparable standard in 
this project. We explored a variety of protocols to establish dSTORM imaging in our 
laboratory. High-precision coverslips with an exceptionally accurate thickness (170 ± 5 
µm) were rinsed in 100 % ethanol and exposed to 30 min UV-light for sterilization prior 
to cell culture. Our first experiments had considerable background noise and imaging 
artefacts (data not shown) which were minimised by cleaning of coverslips by sonication 
in Decon 90™ Liquid Detergent, sodium hydroxide, ethanol and acetone. Furthermore, 
coverslips were exposed to 30 min of UV-light irradiation to eliminate autofluorescence 
originating from the coverslips themselves. 
 
For staining we explored two commercially available anti-GFP VHH / nanobodies from 
Chromotek and Nanotag. For dSTORM experiments organic dyes with high photon yields, 
low on-off duty cycles and a large number of switching cycles are desirable. The 
Chromotek anti-GFP nanobody was coupled to Atto 647N which belongs to a new 
generation of fluorescent labels in the red spectral region (λex 644 nm; λem 667 nm) 
with strong absorption, excellent quantum yield (0.65), high photostability and good 
solubility. We observed that the nanobody co-localized well with the GFP signal in the 
HA-GLUT4-GFP 3T3-L1 adipocytes at a concentration of 1:800 (Appendices Figure 8.1). 
The presence of dissolved oxygen is known to suppress blinking and fluorescent dyes. 
The solution to this problem is the addition of enzymatic oxygen-scavenging systems and 
chemicals that improve dye blinking. To make the Atto 647N dye photoswitch 
effectively during dSTORM experiments we used a buffer with the PCD/PCA oxygen 
scavenging system and COT, BME and MEA as reducing agents. We varied concentrations 
of the individual components until bright blinks were observed during dSTORM image 
acquisitions. Imaging buffers had to be prepared freshly before each imaging 
experiment which was very time consuming. Reconstructions calculated with the Image 
J plugin ThunderSTORM always showed a high amount of background noise and imaging 
artefacts so that the individual cells were not recognisable (Figure 3.7). We concluded 
that the use of Atto 647N in combination with an oxygen-scavenging buffer system did 
not yield satisfactory results for the visualization of individual GLUT4 molecules in 3T3-




More recently nanobodies coupled to different fluorescent dyes have become 
commercially available. The Nanotag anti-GFP nanobody was coupled to Alexa Fluor 647 
which proved to match all imaging criteria very well and has become the most used 
dSTORM dye during the past years. Alexa Fluor 647 is three times brighter than Atto 
647N and this much brighter fluorescence signal results in improved single molecule 
localization. Another advantage is that the Chromotek nanobodies are randomly 
labelled with Atto 647N molecules and the Nanotag nanobodies have directly labelled 
sites with a choice of either 2 or 4 dye molecules per nanobody. At a concentration of 
1:50 the nanobody co-localized well with the GFP signal but dSTORM imaging 
experiments required a dilution of 1:10 to yield satisfactory results (Appendices Figure 
8.1). Figure 3.7 shows that the Nanotag anti-GFP nanobody diluted 1:10 resulted in 
reconstructions of 3T3-L1 cells with recognisable cell outlines. However, the images still 
had background noise and some imaging artefacts. The biggest advantage of using 
nanobodies is the less than 2 nm epitope-label displacement which reduces the linkage 
error significantly. However, the use of nanobodies resulted in lower quality 
reconstructions and GLUT4 molecule localization. This might be due to the fact that 
nanobodies bind to GFP and there are no nanobodies available that bind to the HA-tag. 
For the use of nanobodies samples always had to be subjected to permeabilization so 
that the GFP-tag is exposed. Staining for the GFP-tag will result in staining of GLUT4 in 
the PM and also in the vicinity of the PM, such as in vesicles undergoing endocytosis, or 
vesicles adjacent to but not yet fused with the PM. Only staining for the HA-tag in intact 
cells will result in targeting only GLUT4 molecules that have fused with the PM. 
Therefore, we decided to use a conjugated anti-HA antibody coupled to Alexa Fluor 
647. 
 
Next, we investigated the impact of fixation on super resolution microscopy results. We 
used 4 % PFA to fix our samples prior to experiments and also PFA supplemented with 
different concentrations of GA (Figure 3.8). Ripley’s L function analysis of dSTORM 
images of cells fixed with PFA or PFA+GA yielded similar results. Therefore, applying GA 
as a supplement for stronger morphology preservation did not interfere with our 
imaging results. However, the manufacturer of the antibody that we finally decided to 
use for our imaging experiments advise against GA and therefore all samples were fixed 










Figure 3.7 TIRF and STORM images of surface GLUT4-GFP in basal and insulin-
stimulated 3T3-L1 adipocytes stained with anti-GFP nanobodies. 
HA-GLUT4-GFP 3T3-L1 cells were serum-starved for 2 h prior and stimulated with 100 
nM insulin for 20 min or left untreated. Cells were fixed and stained with two anti-GFP 
nanobodies (Chromotek/Nanotag as labelled) and images acquired on a Zeiss Elyra PS.1 
(described in section 2.3). Reconstructions were calculated using ThunderSTORM. TIRF 
images (left) and scatterplots (right) of basal and insulin-stimulated 3T3-L1 adipocytes 
showing localizations of single GLUT4-GFP molecules. Scale bars 20 μm. This experiment 




















Figure 3.8 Ripley's L function analysis of the effect of fixation on GLUT4 molecule 
distribution in the PM of 3T3-L1 adipocytes. 
Representative plot of Ripley’s L function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were fixed with 4 % PFA 
or 4 % PFA supplemented with GA and stained for surface HA and dSTORM images 
acquired. GLUT4 molecule coordinates were obtained using ThunderSTORM and 
subjected to Ripley’s L-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 400 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are means. The experiment was performed once for 4 % PFA (N=10 cells) and 4 % 
PFA + GA (N=10 cells) conditions. p = 0.0047 determined by two-tailed Student’s t test. 
 
3.2.2 Automated computing of Ripley’s K function analysis for the 
study of GLUT4 clustering  
We next aimed to investigate a range of cluster analysis methods for super resolution 
microscopy data and chose one representative 3T3-L1 adipocyte imaging data set to 
perform each method on (basal=8 cells; insulin=9 cells) to facilitate comparison. The 
first step of image analysis for SMLM was to localize each recorded emission of the 
individual GLUT4 single molecules and generate an output file that contains the 
complete x/y coordinates of millions of molecule localizations (van de Linde, 2019). 
There is a wide range of open source software available for localization and image 
reconstruction and we chose the Image J plug in ThunderSTORM for automated 
processing, analysis and visualization of our imaging data (Ovesný et al., 2014). 
ThunderSTORM is freely available and was chosen because it is heavily discussed in the 
community and cited in the literature as comprehensive and accurate. The imaging set 




quality image reconstructions. This allowed careful evaluation of the results returned 
for each analysis method.  
 
SR Tesseler is a framework for precise and automatic quantification of protein 
organization (Levet et al., 2015). The software is freely available and has a graphical 
user interface giving instant visual feedback of analysis results. SR Tesseler contains an 
algorithm for the automatic calculation of Ripley’s L function. The experimentally 
obtained distribution of GLUT4 molecules is compared to a reference spatially uniform 
distribution. If for a given radius (r) the average number of localizations is bigger than 
the reference distribution the molecules are clustered (Levet et al., 2015). The 
software computes the value of r whilst maximising L(r) and the minimum radius, step 
radius and maximum radius can be manipulated by the user (Figure 3.9). Figure 3.9 
shows the results obtained by Ripley’s L function analysis with SR Tesseler for basal and 
insulin-stimulated HA-GLUT4-GFP 3T3-L1 adipocytes stained with an anti-HA antibody. 
The graph shows that GLUT4 is more clustered in the basal condition and the molecules 
dispersed following insulin stimulation. This analysis method is very fast and allows to 
detect changes in GLUT4 clustering dynamics efficiently. 
 
Figure 3.9 Ripley's L function analysis of GLUT4 clustering in basal and insulin-
stimulated 3T3-L1 adipocytes. 
Representative plot of Ripley’s L function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are means. The experiment was performed once for basal (N=10 cells) and insulin-
stimulated (N=12 cells) conditions. p < 0.0001 determined by two-tailed Student’s t 
test. 















However, the algorithm is very simplistic and lacks accuracy. Some limitations are that 
the experimental localizations are compared to a general reference distribution and 
inhomogeneous cluster distributions and background noise are confounding variables. 
 
3.2.3 Bayesian cluster analysis 
We investigated Bayesian cluster analysis as a method to quantify GLUT4 clusters in 
basal 3T3-L1 adipocytes and dispersal of the transporter in response to insulin. Four 
3 x 3 μm sized ROIs were chosen from each cell and the percentage of molecules in 
clusters, the number of clusters per ROI, the mean number of molecules per cluster, 
and the mean radius of clusters was determined for basal and insulin-stimulated cells. 
The individual data values of the obtained results were widely spread and frequency 
distribution bar graphs were prepared to give an overview of the distinct values (Figures 
3.9). The majority of the ROIs chosen for basal cells showed that 50 % of molecules 
were found in clusters and fewer ROIs showed 30, 40, 60 or 70 % of molecules that were 
clustered (Figure 3.10 A). The majority of ROIs chosen from insulin-stimulated cells 
showed that 40 % of molecules were found in clusters and many of the other analysed 
ROIs showed 20 – 30 % of molecules in clusters indicating that GLUT4 molecules were 
less clustered and more dispersed after insulin-stimulation. In insulin-stimulated 3T3-L1 
adipocytes the frequency distribution for the number of clusters per ROI was observed 
to shift towards the right indicating that more ROIs contained fewer clusters compared 
to basal cells (Figure 3.10 B). The average number of molecules per cluster was reduced 
after insulin stimulation suggesting that GLUT4 clusters decreased in size (Figure 3.10 
C). This result was supported by the analysis of the mean cluster radius which was also 
reduced after insulin stimulation (Figure 3.10 D). Some ROIs showed clusters with very 
large radii after insulin stimulation which might be analysis artefacts and may represent 
dispersing clusters that appear larger because they are less compact. Descriptive 
statistics of the Bayesian cluster analysis frequency distribution are summarized in table 
3.11. The Bayesian cluster analysis approach yielded results that enable quantification 
of insulin-stimulated GLUT4 dispersal in the PM of 3T3-L1 adipocytes as reported in the 
literature. A major drawback of this approach is that the analysis is slow and uses 
considerable computer time to process the data. We have also performed Bayesian 





Figure 3.10 Bayesian Cluster Analysis of GLUT4 molecules in the PM of basal and 
insulin stimulated 3T3-L1 adipocytes. 
GLUT4 molecule coordinates were subjected to Bayesian cluster analysis. Basal cells: 
black, n = 8; Insulin stimulated: white, n = 9. 4 ROIs of 3x3 µm size per cell were 
analysed. Bar graphs shown are frequency distributions. (A) Percentage of molecules in 
clusters. (B) Number of clusters per ROI. (C) Mean number of molecules per cluster. (D) 




































Mean  32.58 31.3 52.82 44.73 20.56 21.26 29.70 31.65 
STD 12.46 10.39 11.67 13.80 7.64 8.23 7.81 12.23 
SEM 2.54 2.00 2.38 2.65 1.59 1.68 1.59 2.36 
Low 
CI  
27.31 27.18 47.89 39.27 17.25 17.78 26.40 26.81 
Upper 
CI 
37.84 35.41 57.75 50.19 23.86 24.74 33.00 36.49 
 
Table 3.11 Summary of descriptive statistics for the Bayesian cluster analysis 
frequency distribution tables. 
GLUT4 molecule coordinates were subjected to Bayesian cluster analysis. Basal cells n = 
8; Insulin stimulated n = 9. 4 ROIs of 3x3 µm size per cell were analysed. This table is a 
summary of the frequency distribution bar graphs depicted in figure 3.10. (A) 
Percentage of molecules in clusters. (B) Number of clusters per ROI. (C) Mean number of 
molecules per cluster. (D) Mean radius of clusters. STD=Standard deviation, 
SEM=Standard error of the mean, Low CI=lower 95% confidence interval, Upper Ci= 
upper 95% confidence interval. 
 
3.2.4 Cluster analysis with machine learning 
Cluster analysis with machine learning (CAML) is a novel method of converting point 
pattern data into meaningful descriptions of clustering (Williamson et al., 2020). Keras 
is an open-source machine-learning framework for Python that was used to construct 
machine learning model configurations consisting of several layers defining the work 
flow and scripts used at different stages (Williamson et al., 2020). Firstly, we used a 
configured and trained model from the developers of CAML called KRIRK0. Training data 
were generated by a cell simulator and contained a broad range of different clustering 
scenarios with differences in overall point density, point density within each cluster, 
proportion of clustering and a maximum distance from a cluster seed (Williamson et al., 
2020). KRIRK0 was trained using 500,000 points with an even mix of clustered and non-
clustered values and completely spatially random data before validation against 100,000 
different values. Performance was evaluated using novel simulated data and points 
were labelled accurately as clusters or non-clustered in 90 % of cases. Furthermore, we 
configured and trained a personally-specified model for GLUT4 clustering with the 
developers David Williamson and Dylan Owen (Kings College, London) named Q3VHAP. 
Q3VHAP was trained with input data from basal and insulin-stimulated cells labelled as 
clustered and non-clustered. We analysed our 3T3-L1 adipocyte data set with both 
models. A plot of the cluster area (nm2) against points per cluster density distributions 
of the populations of basal and insulin-stimulated cells is shown in Figure 3.12. Most of 




cells when evaluated by KRIRK0 (Figure 3.12 A). Q3VHAP analysis of the same data 
shows a different spread of the values (Figure 3.12 B). Values for cluster area and points 
per cluster are widely spread out for both basal and insulin-stimulated cells.  
 
Figure 3.12 Cluster analysis with machine learning (CAML) to quantify GLUT4 
clustering in 3T3-L1 adipocytes. 
Cells were stimulated with 100 nM insulin for 20 min or left untreated before fixation 
and staining for surface HA. DSTORM images were acquired (see section 2.3) and 
reconstructions calculated using ThunderSTORM. Cluster analysis was performed with 
CAML. Representative plots of area of, and points contained by, individual clusters 
detected in HA-GLUT4-GFP 3T3-L1 which were either unstimulated (black circles) or 
stimulated with 100 nM insulin for 20 min (grey circles). (A) Cluster metrics from CAML 






Figure 3.13 Cluster analysis with machine learning (CAML) to quantify GLUT4 
clustering in 3T3-L1 adipocytes. 
Cells were stimulated with 100 nM insulin for 20 min or left untreated before fixation 
and staining for surface HA. DSTORM images were acquired (see section 3.4) and 
reconstructions calculated using ThunderSTORM. Cluster analysis was performed with 
CAML. Representative plots of (A) cluster area (nm2) and (B) clusters per μm2 evaluated 
by two different CAML model configurations KRIRKO and Q3VHAP. p< 0.0001 (****); 





Cluster area was significantly reduced and clusters per μm2 were increased after insulin-
stimulation compared to basal cells evaluated by KRIRK0 (Figure 3.13). When analysing 
the dataset with Q3VHAP cluster area increased after insulin stimulation clusters per 
μm2 decreased (Figure 3.13).  
 
3.2.5 Tesselation 
Apart from containing a feature for the automatic calculation of Ripley’s L function the 
SR Tesseler software is able to construct Voronoï diagrams from molecule localizations 
(Levet et al., 2015). Voronoï diagrams are useful for segmentation of dSTORM 
localizations and cluster analysis. For the construction of the Voronoï diagram and the 
following object segmentation the user needs to define parameters for instance density 
factors, minimum and maximum cluster area/number of localizations (Figure 3.14).  
 
Figure 3.14 Creation of a Voronoï diagram followed by object segmentation with SR 
Tesseler for GLUT4 cluster analysis. 
Cells were stimulated with 100 nM insulin for 20 min or left untreated before fixation 
and staining for surface HA. DSTORM images were acquired (see section 2.3) and 
reconstructions calculated using ThunderSTORM. GLUT4 coordinates were imported into 
SR Tessler software. (A) Image of the imported GLUT4 coordinates of an insulin-
stimulated 3T3-L1 cell in the graphical SR Tesseler user interface. (B) GLUT4 
coordinates after an inbuilt filtering step. (C) Voronoï diagram created on the 
localizations of the cell shown in (A). (D) Magnification of the Voronoï diagram showing 
individual seeds surrounded by polygons. (E) Bigger magnification of polygons shown in 
(D). Dark orange colour depicts dense region with a cluster defined by neighbouring 





The advantage of this method is that the algorithm can create a Voronoï diagram of 
hundreds of thousands of localizations in a few seconds on a standard computer (Levet 
et al., 2015). Thus, clusters can be rapidly identified and further spatial point pattern 
analysis carried out quickly to quantify relationships between the identified clusters. 
This is discussed in 3.2.7 below. 
 
3.2.6 Hierarchical density-based spatial clustering of applications 
with noise 
Real world data sets often contain clusters of different sizes, with arbitrary shapes, 
with different densities, background noise and outliers. HDBSCAN identifies regions of 
the data that are denser than the surrounding space and considers these regions to be 
clusters with a higher probability. A cluster hierarchy is established on the probabilities 
of the underlying distributions resulting in robust identification of clusters of all shapes 
and sizes (Campello et al., 2013, 2015). The user can manipulate two variables known 
as minimum cluster size and minimum samples. Minimum cluster size describes the 
smallest size grouping that should be considered to form a cluster. The simplest 
explanation for what the parameter minimum samples describes is a measure of how 
conservative the clustering should be. The larger the value of minimum samples the 
more points will be considered to be noise and clusters will only be identified in 
progressively more dense areas. We explored HDBSCAN as a method to identify clusters 
of GLUT4 in dSTORM images of 3T3-L1 adipocytes. Firstly, we tried several parameters 
and observed how clustering changes in response (Appendices section 8.3). We chose 
minimum cluster size 5 and minimum samples 30 to get a good visualization of GLUT4 
clustering in basal and insulin-stimulated 3T3-L1 adipocytes (Figure 3.15). In basal cells 
HDBSCAN identified several GLUT4 clusters and also dispersed GLUT4 molecules (Figure 
3.15 A-C). After insulin-stimulation it can be observed that more GLUT4 clusters are 
visible in the PM and the presence of dispersed GLUT4 molecules is much higher (Figure 
3.15 D-F). This result is in line with the current literature stating that about 50 % of 
GLUT4 molecules are clustered in the basal state and insulin stimulation induces an 
increase in GLUT4 clusters in the PM. Furthermore, insulin stimulation leads to the 
presence of significantly more GLUT4 monomers in the PM of 3T3-L1 adipocytes as seen 
in Figure 3.15 F. To quantify clusters identified through HDBSCAN further spatial point 





Figure 3.15 Hierarchical density-based spatial clustering of applications with noise 
analysis of basal and insulin-stimulated 3T3-L1 adipocytes.  
Cells were stimulated with 100 nM insulin for 20 min or left untreated before fixation 
and staining for surface HA. DSTORM images were acquired (see section 3.4) and 
reconstructions calculated using ThunderSTORM. 6 ROI of 8μm x 8μm were selected in 
Image J for each cell. GLUT4 molecule coordinates were processed using an HDBSCAN 
script written in house with Marie Cutiongco in Python. (A) GLUT4 molecule coordinates 
of a basal 3T3-L1 adipocyte. Image scale 51.2 μm. The red square highlights a 
representative ROI. (B) Coloured clusters identified in the chosen ROI of (A) by HDBSCAN 
min_cluster_size=5, min_samples=30. (C) Coloured clusters and grey non-clustered 
GLUT4 molecules in the ROI of (A). (D) GLUT4 molecule coordinates of an insulin-
stimulated cell. Image scale 51.2 μm. (E) Colourful clusters identified in the chosen ROI 
of (D) by HDBSCAN. (F) Coloured clusters and grey non-clustered GLUT4 molecules in 
the ROI of (D).  
 
3.2.7 Statistical analysis of spatial point pattern data in R 
The spatstat package in R offers a number of options to statistically analyse spatial 
point pattern data. Here we explored some of them to quantify GLUT4 molecule 
distribution in the PM. The spatial analysis can be carried out using the raw localization 
data obtained from ThunderSTORM. However, localizations are numerous and some cells 
contain more than 1,000,000 localized GLUT4 molecules which limits time efficiency 
and requires considerable computational power. Therefore we also performed the 
analysis on previously identified clusters through the methods of tessellation and 
HDBSCAN. These two techniques already segment the data into clustered and non-




used to investigate spatial relationships time-efficiently with less computing power. 
Furthermore, ROI can be chosen to further reduce the data set.  
 
Spatstat was used to compute an estimate for the edge-corrected inhomogeneous 
Ripley’s L-function (Figure 3.16). It can be observed that the inhomogeneous L-function 
peaks at higher values for basal cells indicating a clustered distribution compared to 
insulin-stimulated cells. The same analysis was performed on ROI with conflicting 
results (Appendices 8.4). 
 
Figure 3.16 Ripley's inhomogeneous L function of GLUT4 molecule clustering in 3T3-
L1 adipocytes using spatstat in R. 
Representative plot of Ripley’s inhomogeneous L function analysis of the clustering 
abilities of GLUT4 molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were 
left untreated before fixation (panel A) or stimulated with 100 nM insulin for 20 min 
(panel B) then stained for surface HA. DSTORM images were acquired (see section 3.4) 
and reconstructions calculated using ThunderSTORM. GLUT4 coordinates were subjected 
to Ripley’s inhomogeneous L function analysis using spatstat. The presented data are 
means (solid black lines). The grey shading indicates the global upper and lower 
envelopes which stand for the most extreme deviation from the theoretical L function 
at any distance r. The function is displayed as centred (red line). The experiment was 
performed for basal (N=8 cells) and insulin-stimulated (N=9 cells) conditions.  
 
The edge-corrected inhomogeneous L-function generated with spatstat looks different 
than the one we received from the automatic analysis with SR Tesseler (Figure 3.9). The 




previously reported in the literature (Gao et al., 2017) and therefore this function 
describes GLUT4 clustering dynamics more accurately. 
 
3.3 Discussion 
3.3.1 Is my super resolution image a high-precision representation 
of the spatial organization of GLUT4 within the plasma membrane? 
Super resolution microscopy has been one of the most significant developments in the 
life sciences over the last decades. The pace of innovation and accomplishment of this 
relatively young field has been very fast with novel methods for sample preparation, an 
innovative and breath-taking range of fluorescent labels, exciting new instruments and 
techniques for post-acquisition image analysis (Davis, 2009). However, many super 
resolution techniques rely on procedures that can result in the production of imaging 
artefacts leading to misinterpretation of biological information. One of the key 
questions always remains whether the experiments have been performed in such a way 
that the image reconstructions reflect underlying morphology and molecule locations 
accurately. Data quality assessment frequently relies on subjective comparison to prior 
published results or benchmarking against electron microscopy images. 
 
One recent study quantitatively characterized the switching properties of 26 organic 
dyes and their impact on super resolution image quality (Dempsey et al., 2011). The two 
properties that are crucial to image quality are the amount of photons detected per 
switching event and its duty cycle which is the time a fluorophore is in the on state 
(Huang et al., 2010). Localization precision depends on the number of detected photons 
and therefore dyes with a high photon yield are desired. The maximum number of 
fluorophores that can be localized in an imaging area is inversely proportional to the 
duty cycle and therefore a low duty cycle is beneficial. Fluorescent dyes with high 
photon yield and low duty cycle result in high localization precision and molecule 
density and were used to successfully resolve an example structure (a nanoscopic ring-
like object) (Dempsey et al., 2011). Experiments performed with dyes with low photon 
yields and/or high duty cycles obscured the ring-like structure. One central outcome of 
the study was that Alexa dyes were more suitable for dSTORM imaging than Atto dyes 
and that Alexa Fluor 647 requires thiol for photo switching (Dempsey et al., 2011). This 
result is in line with the results obtained in our study. We observed that we were unable 
to resolve the molecular distribution of GLUT4 using an anti-GFP nanobody coupled to 
Atto 647N. However, we were successful in obtaining high quality images with Alexa 
Fluor 647 as a label that closely resembled the super-resolved images of GLUT4 




In 2015 a study examined how different methods of sample preparation for SMLM affect 
clustering of the well-known mitochondrial import receptor subunit Tom20 (Whelan and 
Bell, 2015). It was reported that variations in fixative and antibody concentration alter 
the apparent clustering of Tom20 significantly. Fixation with a mixture of PFA and GA 
resulted in a lower degree of Tom20 clustering than previously reported. Staining with 
higher concentrations of primary and secondary antibody resulted in significantly 
enlarged clusters of Tom20 (Whelan and Bell, 2015). Another study investigated 
appropriate fixation and staining conditions using the transmembrane lymphatic vessel 
endothelial hyaluronan receptor 1 (LYVE-1) and CD44 as an example (Stanly et al., 
2016). Even in resolution-limited confocal images it was apparent that different 
methods of fixation and immunostaining resulted in  artefactual clustering of receptors 
in lymphatic endothelial cells. In this study use of PFA alone resulted in incomplete 
fixation and additional treatment with 0.2 % GA introduced reduction of mobility of the 
LYVE-1 (Stanly et al., 2016). Furthermore, using super-resolved STED imaging it was 
observed that fixation with PFA alone resulted in larger LYVE-1 cluster sizes. 
Immunostaining with a primary anti-LYVE-1 antibody and a secondary fluorescently 
tagged antibody resulted in a more punctate, clustered distribution of LYVE-1 indicative 
of antibody and not receptor clustering (Stanly et al., 2016). In our study fixation and 
staining procedures were optimised to reduce clustering image artefacts. Results from 
previous studies were taken into account and different mixtures of PFA and GA 
investigated for fixation of cells. Ultimately 4 % PFA had to be used for fixation in our 
study because we observed limitations in antibody binding. We also investigated 
antibodies and nanobodies for staining of GLUT4. The first anti-GFP nanobody coupled 
to Atto 647N did not have a high quantum yield or low duty cycle and therefore was not 
able to resolve the underlying distribution of GLUT4. Another anti-GFP nanobody 
coupled to Alexa Fluor 647 produced more high-quality images but we were unable to 
detect whether GLUT4 molecules had fused with the plasma membrane. GFP is not 
indicative of GLUT4 within the plasma membrane and no nanobodies are available for 
HA-staining. Therefore, we used a conjugated anti-HA Alexa Fluor 647 antibody for all 
future experiments.   
 
3.3.2 Image analysis is key to single molecule localization 
STORM provides sub-diffraction spatial high-resolution images and progress of the 
technique has been accompanied by the continuous and innovative development of 
image processing tools. In the last decade a large set of different data analysis tools and 
packages has become available (Sage et al., 2019; van de Linde, 2019). Packages are 
available in various programming languages for instance Python, Matlab, C, Java and IDL 




independent and open-source image analysis software that allowed users to write their 
own macros to automate image processing steps or plugins to add new functionality 
(Schneider et al., 2012). Image J has a well organised graphical user interface and has 
become very popular with hundreds of downloadable plugins being available today.  
 
In 2010 QuickPALM was the first available Image J plugin for single molecule localization 
(Henriques et al., 2010). The software detected the centroids of diffraction limited 
spots and was able to process image stacks in real time. Four years later ThunderSTORM 
was published with a variety of features (Ovesný et al., 2014). ThunderSTORM has many 
options for image filters and Gaussian fitting routines. The graphical user interface 
contains explanations on each of the settings making it the most comprehensive plugin 
(van de Linde, 2019). Furthermore, we studied PeakFit for localization of GLUT4 
molecules which is part of the GDSC SMLM Image J plugin. Both ThunderSTORM and 
PeakFit performed very well in single molecule localization (Sage et al., 2019). Haar 
wavelet kernel (HAWK) processing is also available as a plugin in Image J (Marsh et al., 
2018). HAWK is a preprocessing method for avoiding artefacts from high spot densities. 
The plugin separates fluorophores prior to localization and generates an image stack 
with increased frames with a lower density of emitters (Marsh et al., 2018). NanoJ-
SQUIRREL is an image J-based analytical tool that has recently become available for the 
minimisation of super-resolution optical imaging artefacts (Culley et al., 2018). It 
compares diffraction-limited images and super resolution reconstructions and generates 
a quality score and quantitative map of super resolution defects. Researchers can 
obtain feedback on the quality of their super resolution images and optimise imaging 
parameters accordingly. The plug-in has been used in our study and parameters have 
been adjusted until quality scores were satisfactory (data not shown). 
 
3.3.3 Ripley’s K function and its derivatives for GLUT4 cluster 
analysis   
Cluster analysis is the next step following single molecule localisation to understand the 
underlying spatial relationships of GLUT4 molecules. Cluster analysis is a multi-objective 
optimization problem and requires that many considerations have to be taken into 
account. In 2010 a study revealed that insulin stimulates GLUT4 dispersal within the PM 
of adipocytes for the first time using diffraction-limited TIRF microscopy (Stenkula et 
al., 2010). More recently GLUT4 dispersal was observed using dSTORM imaging and 
Ripley’s K function for quantification of GLUT4 clusters (Gao et al., 2017). Ripley’s K 
function has been employed in many fields including geography, economics and 




protein clusters in the PM using SMLM. A study evaluated the accuracy of determining 
cluster size by Ripley’s K function analysis in SMLM (Ruan et al., 2019). A modelled 
SMLM image was created with simulated clusters of 50 nm size. The average radius of 
clusters was calculated from the image using the point of maximum aggregation of L(r) 
which equalled 63 nm. Thus the error was determined to be 25 %. It was concluded that 
Ripley’s K function analysis may predict the cluster radius within a factor of 1.3 of 
actual radius but it was found to be essential to estimate the cluster radius by averaging 
data of at least ten cells (Ruan et al., 2019). Furthermore choosing small ROIs improved 
the accurate estimation of the cluster radius. In the following epidermal growth factor 
receptor (EGFR) clusters were successfully assessed in COS7 cells and cluster properties 
characterised with error normalization (Ruan et al., 2019).  
 
Here we used an automated calculation of Ripley’s K function with the open source 
software SR Tesseler (Figure 3.9). In the scientific community many laboratory groups 
seem to develop their own tools for the calculation of Ripley’s K function and its 
derivatives. One paper studied the spatial organization of endoplasmic reticulum–
plasma membrane (ER–PM) junctions in HeLa cells using PALM and SR Tesseler Ripley’s K 
function analysis (Hsieh et al., 2017). The radius of maximal aggregation derived from 
Ripley’s K function analysis was determined to estimate junctional size and the results 
were comparable to values obtained previously through electron microscopy (EM). 
Furthermore SR Tesseler was used to create Voronoï diagrams and segment ER–PM 
junctions. Morphological analysis of Voronoï diagrams resulted in values with equivalent 
diameter comparable to EM for junctional size (Hsieh et al., 2017). To further verify the 
results the group applied DBSCAN analysis to characterise ER–PM junctions and obtained 
similar results for the size of morphological features of the junctions after careful 
parameter selection (Hsieh et al., 2017). It was concluded that Ripley’s K function 
analysis and object segmentation through tessellation with SR Tesseler made 
comparable estimations about the size of ER–PM junctions. Another study investigated 
the intracellular Ca2+ channels called inositol 1,4,5-trisphosphate receptors (IP3Rs) in 
the ER-PM in HeLa cells using dSTORM (Thillaiappan et al., 2017). Voronoï tessellation 
was successfully applied to study the distribution of EGFP-IP3R1s in endogenous 
clusters. SR Tesseler has also been applied to the study of plant plasma membrane 
protein dynamics (Gronnier et al., 2017) and G-protein-coupled receptors in pancreatic 
cancer cells (Jorand et al., 2016). The software developers validated their method on 
live neurons expressing GluA1-mEOS2, integrin-β3−mEOS2 expressed in fibroblasts and 
tubulin−Alexa Fluor 647 in COS7 cells (Levet et al., 2015). SR Tesseler has been 
frequently cited in the literature and was the fastest approach we tested. The analysis 




particularly suitable for quick optimisation of experimental protocols. Ripley’s K 
function analysis has a strong theoretical underpinning, but it does not generate key 
cluster descriptors for instance number of molecules per cluster or the number of 
clusters.  
 
3.3.4 Machine learning for GLUT4 cluster analysis  
Both the Bayesian cluster analysis approach and CAML were developed in the laboratory 
of Dylan Owen (Rubin-Delanchy et al., 2015; Williamson et al., 2020). The Bayesian 
cluster analysis proposes numerous cluster configurations and scores them against a 
generative model, which assumes Gaussian clusters overlaid on a spatially random 
background. In the following each point is scrambled by its localization precision (Rubin-
Delanchy et al., 2015). The package generates interesting cluster descriptors such as 
the number of clusters, cluster radii and the percentage of molecules in clusters. These 
new Bayesian approaches were validated using simulated data sets and experimental 
data investigating T-cell synapses (Griffié et al., 2017, 2018). The accuracy of the 
Bayesian approach was very high and output results including key cluster descriptors 
were a great advantage. The biggest disadvantage of this method was that it was the 
most time-consuming taking 1-2 days for generating cluster proposals for four 3 x 3 μm 
sized ROIs from one cell (Figure 3.10.1/2). The approach was declared suitable for 
analysis of final datasets but the length of the analysis was not realistic for optimisation 
of experimental protocols.  
 
That is the reason why the same group explored a different approach of cluster analysis 
for SMLM datasets using a machine learning algorithm (Williamson et al., 2020). 
Recently machine learning applications have become very popular in the field of biology 
and been used for classification of cellular images, genome analysis and drug discovery. 
A supervised machine-learning approach was developed to analyse large-scale datasets 
with inhomogeneities in clustering in a fast and accurate manner. CAML was 
downloaded with different models that were trained on a variety of simulated clustering 
data and then used to classify GLUT4 molecules into clustered or not clustered 
(Williamson et al., 2020). Cluster area, shape, and point-density were calculated using 
this method (Figure 3.12 and 13). The model has been designed carefully and performed 
cluster analysis with great accuracy shown through validation on simulated datasets and 
experimental datasets from T-cell synapses. Furthermore the approach has been 
compared to the Bayesian approach and performed with equal accuracy but much 
improved computation speed (Williamson et al., 2020). The code runs in Python and in 
principle the instructions and user interface are comprehensive. However, the code 




environment on a Windows computer was not realistic for researchers without an 
extensive background in programming. A visit had to be arranged so that the developer 
of the machine learning approach installed the package on our Windows machines. Once 
the right dependencies were installed the analysis was carried out easily. The output 
contained numerous data files with tables which makes it difficult to summarise and 
interpret the obtained results. Our analysis showed that depending on the model that 
was used clustering was increased in basal or insulin-stimulated cells (Figure 3.12 and 
13). We used a previously generated model and one that was personally trained that led 
to contradictory results. The previously generated model was generic and unable to 
identify GLUT4 clusters whereas the personally trained model performed better in 
identifying GLUT4 clusters in adipocytes specifically. CAML is advantageous because it 
does not need any parameter input prior to analysis. However, the machine learning 
approach only works if the model is trained appropriately and validated on datasets 
similar to the experimental ones. 
 
In contrast to supervised machine learning algorithms unsupervised machine learning 
algorithms can classify data correctly based on finding some commonality in their 
features that can be used to predict classes of new data without training. HDBSCAN can 
classify clusters of different sizes, with arbitrary shapes, with different densities, 
background noise and outliers. After careful parameter selection HDSCAN produced 
striking visual representations of GLUT4 clusters in basal and insulin-stimulated cells 
(Figure 3.15). However, spatial analysis of previously identified HDBSCAN clusters 
yielded conflicting results. Parameter selection was very difficult for GLUT4 clusters 
because they have great inhomogeneity and different descriptions of GLUT4 clustering 
were found in the literature (Gao et al., 2017; Lizunov et al., 2013a; Stenkula et al., 
2010).  
 
3.3.5 Spatial point pattern analysis with Spatstat in R 
The spatstat package in the R language provides the broadest range of capabilities for 
analysis of spatial point pattern data. The package comes with extensive documentation 
focused on researcher’s practical needs explaining statistical principles, practicalities 
and helping with scientific interpretations of the results (Baddeley and Turner, 2005; 
Baddeley et al., 2016). This analysis was the most extensive performed as part of this 
chapter and was carried out in collaboration with Marie Cutiongco (University of 
Glasgow). Methods for spatial correlation such as the K and L function and of spacing 
such as the G, F and J function were used to quantify GLUT4 clustering dynamics (see 
Appendices). We performed spatial analysis on GLUT4 localizations, GLUT4 localizations 




HDBSCAN and previously identified clusters by HDBSCAN with ROI (see Appendices). 
Spatial analysis on GLUT4 localizations themselves yielded an estimate of L(r) (Figure 
3.16) which was increased for basal cells indicative of GLUT4 clustering that was 
comparable to the results found in the literature (Gao et al., 2017) used as baseline 
validation in this study. This analysis was edge corrected and accounted for 
inhomogeneity in intensity caused by increased GLUT4 translocation in insulin-
stimulated samples. Raw GLUT4 localizations were not confounded by pre-processing 
and definition of arbitrary clustering parameters. Both tessellation and HDBSCAN 
required parameter input prior to cluster analysis and these were selected by trial and 
error. However, a disadvantage of performing spatial statistics on raw localizations is 
that it is majorly time-consuming. Identifying clusters before spatial analysis greatly 
reduces datasets and thus computation times. Spatstat also offers the option to perform 
a variety of hypothesis tests and simulation envelops. Normally spatial statistics 
summary functions are compared to an arbitrary Poisson process to determine whether 
data are clusters, random or dispersed. Simulation envelopes can be generated to assess 
the goodness-of-fit of a point process model to a particular set of point pattern data 
(Baddeley et al., 2016). We tried to perform Monte Carlo simulations to model the 
probability of different outcomes of L(r) and K(r). Unfortunately, the university has a 
traditional IT structure and no infrastructure to perform analysis of big data. As we 
performed our simulations they continuously crashed, and we were not able to obtain 
results with our small analysis computing clusters.  
 
Table 3.16 gives an overview of all methods that were explored for GLUT4 cluster 
analysis in this chapter. Each method has its inherent advantages and disadvantages. We 
have carefully considered our experimental design and extensively optimised protocols 
to be able to investigate GLUT4 dispersal in the following chapters in a range of model 
cells. Here we compared visual representations of GLUT4 clustering with information 
available from the existing literature and successfully generated super-resolved images 
of GLUT4 clustering dynamics in adipocytes. Furthermore we have ruled out fixation 
artefacts and antibody linkage error to visualise GLUT4 clusters at molecular scale. A 
wide range of image processing methods has been applied for super resolution imaging 
and was qualitatively assessed using predefined parameters. Each cluster analysis 
approach yielded different information on spatial GLUT4 clustering dynamics. The most 
time-consuming methods Bayesian cluster analysis and cluster analysis with machine 
learning have provided detailed descriptors of GLUT4 clustering. However it is 
important to take into consideration that use of dSTORM as a method (fixation and use 
of antibodies) introduces problems for direct quantification of protein clusters 
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Table 3.16 Summary of approaches for cluster analysis of GLUT4 dispersal. 
This table provides an overview of all analysis methods explored in this chapter to 









We reached the conclusion that automated Ripley’s K function analysis is a valuable tool 
to summarise spatial dependence over a range of distances and indicates changes in 
GLUT4 clustering dynamics. It has been the fastest approach we tested and hence will 
be used for future analysis throughout this thesis. In this chapter we have come to 
appreciate its limitations and these will be kept in mind for future experiments. The 
most accurate methods for cluster analysis were also the most time-consuming. These 





























4. Plasma membrane GLUT4 dispersal in adipocytes 
4.1 Introduction 
4.1.1. Insulin-stimulated GLUT4 dispersal in adipocytes  
Recently, experimental evidence has emerged that as well as stimulating GLUT4 
translocation, insulin also affects the distribution of GLUT4 in the PM itself. Diffraction-
limited TIRFM has been used to observe that in the basal state a majority of GLUT4 
molecules appears in relatively stationary clusters whereas insulin stimulation promotes 
dispersal of the transporter into freely diffusible monomers in primary adipocytes 
(Stenkula et al., 2010).  
 
The emergence of super resolution microscopy techniques (Betzig et al., 2006; Hess et 
al., 2006; Rust et al., 2006) followed by their application by cell biologists paved the 
way to obtain structural and dynamic information on length scales of vesicle trafficking 
and understand the relationship between the functional state of GLUT4 and its mobility 
in the PM. A follow-up study by the same group aimed to investigate GLUT4 cluster 
retention and the molecular dynamics guiding GLUT4 exchange in the PM and how these 
processes are affected by the presence of insulin (Lizunov et al., 2013a). Isolated 
adipocytes were transfected with a newly developed photo switchable HA-GLUT4-EOS 
probe that undergoes a shift from green to red fluorescence when illuminated with UV 
irradiation. Controlling UV exposure allowed activation of a small subset of expressed 
HA-GLUT4-EOS and to monitor vesicular movements within the PM through TIRFM. The 
results suggest that insulin had three effects that contributed to the shift of GLUT4 
molecules within the PM from a clustered to a more dispersed state. Firstly it was found 
that insulin shifted the fraction of dispersed GLUT4 upon delivery, secondly insulin 
increased the dissociation of GLUT4 monomers from clusters and lastly insulin decreased 
the rate of GLUT4 endocytosis (Lizunov et al., 2013a). It was proposed that GLUT4 
confinement in clusters is a novel kinetic mechanism of how insulin regulates glucose 
homeostasis. 
 
Most recently, STORM was used to reveal the insulin-resistance-regulated reorganization 
of GLUT4 on the PM at the single molecule level (Gao et al., 2017). 3T3-L1 adipocytes 
stably expressing HA-GLUT4-GFP stained with an anti-HA antibody were imaged to 
analyse the spatial patterning of GLUT4 within the PM and how this is influenced by 
insulin resistance. Results showed that PM GLUT4 distribution was non-homogenous and 
that GLUT4 molecules formed clusters or monomers in normal 3T3-L1 adipocytes and in 




analysis revealed that GLUT4 molecules were less clustered after insulin stimulation 
(Gao et al., 2017). Insulin resistance in 3T3-L1 adipocytes increased GLUT4 clustering 
and insulin stimulation only led to small changes in clustering due to the reduced insulin 
sensitivity of the cells.  
 
4.1.2 The effects of AMPK activation on adipocyte GLUT4 
trafficking and dispersal 
The enzyme 5’ adenosine monophosphate-activated protein kinase (AMPK) is highly 
evolutionarily conserved from yeast to humans and plays a vital role in cellular energy 
homeostasis. AMPK can sense cellular energy levels and its activation largely results in 
increased glucose and fatty acid uptake and oxidation (Winder and Hardie, 1999). The 
enzyme is a heterotrimeric protein complex that consists of an α, a β, and a γ subunit 
with specific roles (Hardie et al., 1998). AMPK is able to sense shifts in the adenosine 
monophosphate (AMP): adenosine triphosphate (ATP) ratio through its γ subunit that 
contains four Cystathionine beta synthase (CBS) domains. These four CBS domains form 
two Bateman domains that act as binding sites for AMP. Once an AMP nucleotide binds 
to a Batman domain the binding affinity of the second Bateman domain increases. The 
binding of AMP to both Bateman domains of the γ subunit induces a conformational 
change resulting in the exposure of the catalytic domain located on the α subunit. AMPK 
becomes activated when phosphorylation occurs in this catalytic domain at the 
threonine-172 residue by an upstream AMPK kinase (Hawley et al., 1996). AMPK 
influences numerous metabolic processes and has been described to serve as a 
metabolic master switch (Winder and Hardie, 1999). 
Numerous studies observed an increase in glucose uptake in response to insulin and 
contraction in skeletal muscle (Barnard and Youngren, 1992; Goodyear and Kahn, 1998; 
Hayashi et al., 1997). Both insulin-stimulated and contraction-induced glucose uptake 
are regulated by GLUT4 translocation from intracellular stores to the PM and the 
transverse tubules but use different signalling mechanisms and probably involve distinct 
GLUT4 intracellular pools (Richter and Hargreaves, 2013). AMPK is thought to be 
involved in contraction-stimulated glucose transport (Richter and Hargreaves, 2013). 
 
5’-aminoimidazole-4-carboxamide ribonucleotide (AICAR) is a nucleoside that is taken 
up and accumulated inside the cell where it is converted to the monophosphorylated 
form ZMP (Figure 4.1). ZMP acts as an AMP analogue and directly activates AMPK by 
binding to the AMPKγ subunit resulting in activation of the complex as previously 
described (Kim et al., 2016). ZMP does not influence the intracellular AMP:ATP ratio or 




potency for the γ subunit compared to AMP resulting in requirement of high effective 
concentrations (Gruzman et al., 2009). As an AMP analog AICAR/ZMP activates other 
AMP-dependent enzymes for instance fructose-1,6-bisphosphatase, 6-phosphofructo-2-
kinase and glycogen phosphorylase that may result in off-target effects (Gruzman et al., 
2009). In animal models of diabetes and diabetic patients AICAR treatment was reported 
to exhibit several antidiabetic effects (Kim et al., 2016). Other highly specific AMPK 
activators include A-769662 and compound 911. However these compounds have a 
molecular mechanism of AMPK activation that is not fully elucidated (Gruzman et al., 
2009). AMPK activation via AICAR mimics contraction signalling in skeletal muscle 
experimental systems and has a dual effect to stimulate glucose transport and increase 
fatty acid oxidation (Merrill et al., 1997). It was hypothesised that AMPK activation 
following the increasing energy demands of contracting muscles increases availability of 
fatty acids and glucose (Merrill et al., 1997). Ongoing studies within the field provided 
further evidence that AICAR stimulates glucose uptake into skeletal muscle in the 
absence of insulin and that this effect is additive with insulin stimulation (Hayashi et 
al., 1998). Moreover it was established that skeletal muscle glucose uptake stimulated 
by AICAR is caused directly by translocation of GLUT4 to the PM (Kurth-Kraczek et al., 
1999).  
 
Figure 4.1 Depiction of the chemical structure of 5-Aminoimidazole-4-carboxamide 
ribonucleotide (AICAR) and its mechanism of action. 
AICAR is taken up into cells by adenosine transporters and phosphorylated by adenosine 
kinase to AICAR monophosphate (ZMP). ZMP is an AMP-mimetic that binds to site 3 on 






The role of the AMPK cascade and effects of AICAR on adipocyte glucose uptake 
remained undefined for numerous years. A study conducted in 2000 was the first to 
report that AICAR stimulates AMPK activity in a time- and dose-dependent manner in 
3T3-L1 adipocytes and increased glucose transport by 2-fold (Salt et al., 2000). 
Surprisingly it was reported that AICAR reduced insulin-stimulated glucose transport and 
also inhibited insulin-stimulated GLUT4 translocation. In contrast to skeletal muscle in 
which AMPK activation stimulates glucose uptake to provide ATP as a fuel in adipocytes 
AMPK activation inhibits insulin-stimulated glucose uptake to conserve ATP in scenarios 
of cellular stress (Salt et al., 2000). The observation that AMPK activation has different 
effects on glucose uptake in skeletal muscle and adipose tissues led to the hypothesis 
that the mode of AMPK activation must involve different signalling pathways or 
modulation of the same pathway. One of the aims of this chapter is to ascertain 
whether AMPK activation modulates the dispersal GLUT4 translocation within the PM. 
 
4.1.3 The effects of cholesterol depletion on adipocyte GLUT4 
trafficking and dispersal 
Cholesterol is a type of lipid that is a vital structural component of all cell membranes 
and required for membrane formation and maintenance. Cholesterol composes 
invaginated caveolae and clathrin-coated pits that play roles in endocytosis and thus 
cholesterol itself functions in intracellular transport and cell signalling (Hailstones et 
al., 1998). Investigations of the function of cholesterol in endocytosis frequently use 
methyl-β-cyclodextrin to deplete the PM from cholesterol and observe the resulting 
effect (Hailstones et al., 1998; Parpal et al., 2001; Shapira et al., 2018). Using 
immunogold electron microscopy and immunofluorescence microscopy it was observed 
that insulin receptors are localised in cholesterol-rich regions of the PM in isolated rat 
adipocytes (Gustavsson et al., 1999). Cholesterol removal with cholesterol oxidase or β-
cyclodextrin was observed to attenuate insulin receptor signalling and replenishment 
with exogenous cholesterol reversed the effect of the observed insulin signalling 
attenuation in adipocytes (Gustavsson et al., 1999). Furthermore, cholesterol depletion 
with β-cyclodextrin was observed to decrease insulin-stimulated glucose transport in 
3T3-L1 and isolated rat adipocytes (Parpal et al., 2001). It was shown that cholesterol 
depletion had neither an effect on the access to or affinity of insulin for its receptor nor 
the autophosphorylation of the receptor itself. But it was observed that cholesterol 
depletion inhibited tyrosine phosphorylation of insulin receptor substrate-1 and protein 
kinase B and therefore affected downstream targets of insulin signalling (Parpal et al., 
2001); similar results were reported by others (Nystrom et al., 1999). Confocal 




independent rise in the amount of GLUT4 within the PM of 3T3-L1 adipocytes 
(Shigematsu et al., 2003). Cholesterol replenishment reversed the observed effect. It 
was reported that GLUT4 endocytosis was impaired and that the rise in surface GLUT4 
was due to decreased GLUT4 endocytosis (Shigematsu et al., 2003). Taken together 
these findings suggest that there is a relationship between cholesterol, insulin signalling 
and GLUT4 translocation and further studies are needed for characterisation.  
 
4.1.4 EFR3 and its potential role in GLUT4 clustering 
The EFR3 membrane protein is conserved from yeast to mammals and a genetic screen 
of the Saccharomyces cerevisiae yeast strain has shown that the protein potentially 
plays a role in regulation of GLUT4 within the PM (Wieczorke et al., 2003). In 
Saccharomyces cerevisiae EFR3 has been found to bind to YPPI and form a complex that 
is required to recruit Stt4 to the PM to form phosphoinositide kinase (PIK) clusters (Baird 
et al., 2008; Wu et al., 2014). Specifically EFR3 is thought to be the membrane-
anchoring component that associates with the PM through palmitoylation of its N-
terminus (Baird et al., 2008; Wu et al., 2014). The mammalian homologue Stt4 is 
phosphatidylinositol 4-kinase type III α (PI4KIIIα) which functions in the metabolic 
conversion of PIP2 (Nakatsu et al., 2012). Phosphatidylinositols are glycerphospholipids 
that are phosphorylated at different sites and play numerous fundamental roles in 
several signalling pathways in the trans-Golgi network, endosomes, and the PM 
(Falkenburger et al., 2010). PI3K is found in late endosomes and plays a role in insulin 
signalling and PI4K is found in the trans-Golgi network and GSC where it catalyses the 
formation of PI4P and generates PI4P pools in the PM (Tan and Brill, 2014). 
 
Previous work in our laboratory has found that overexpression of EFR3 results in 
increased GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes and that siRNA 
targeting EFR3 inhibited insulin-stimulated glucose transport by ~80% (Laidlaw, 2018). 
Inhibition of PI4KIIIα with phenylarsine oxide or knockdown of PI4KIIIa with siRNA was 
found to inhibit glucose uptake indicating that the observed effect of EFR3 
overexpression is consistent with effects via PI4KIIIα (Laidlaw, 2018). Because PI4K is PM 
associated, it was hypothesised that insulin signalling has an effect on the EFR3 
machinery by activating PI4KIIIα in adipocytes. We hypothesise that activation of 
PI4KIIIα phosphorylates PI in the PM and PI4P is formed and as a result GLUT4 clusters 
are dispersed within the PM. This process prevents GLUT4 from being endocytosed and 
thus increases glucose uptake. To further test this hypothesis electroporation was used 
to knock down EFR3 in 3T3-L1 adipocytes (Laidlaw, 2018; Morris, 2020). STORM imaging 
experiments and Ripley’s K-function cluster analysis with SR Tesseler showed that 




adipocytes (Morris, 2020). The previously chosen analysis method using SR Tesseler is 
easy and fast but to publish these findings we have re-analysed the existing EFR3 knock 
out STORM imaging data with the thorough but time-consuming spatial point pattern 
analysis tool spatstat (described in sections 3.1.4.6 and 3.2.7). 
 
4.1.5 HeLa cells as a tool to investigate GLUT4 trafficking  
Because of difficulties associated with over-expression of genes in primary cells it has 
proven challenging to study GLUT4 trafficking in vivo and in human tissues (Bryant and 
Gould, 2020). A prevalent view in the field is that insulin-stimulated GLUT4 
translocation is a property that is highly specific to adipose and muscle tissues and that 
the larger an observed insulin response in a model system the more physiologically 
relevant it is (Bryant and Gould, 2020). Studies conducted in primary rat adipocytes and 
the murine 3T3-L1 cell line report 10 to 30-fold increases in GLUT4 translocation and 
glucose uptake in response to insulin stimulation which represents a huge magnitude of 
change (Satoh et al., 1993; Yang et al., 1996). The argument that the larger the insulin 
response of an experimental model the more physiologically relevant it is may be 
flawed and does not necessarily correlate with our current knowledge of human glucose 
metabolism (Bryant and Gould, 2020). Studies using human adipocytes and muscles 
frequently report insulin-stimulated changes in GLUT4 translocation of 2 to 3-fold much 
smaller effects compared to rodent adipocytes (Kashiwagi et al., 1983; Kozka et al., 
1995).  
 
Heterologous expression of GLUT4 can be achieved in a range of model cell systems. 
Studies of GLUT4 trafficking in Saccharomyces cerevisiae revealed that this model 
organism shares several common features of GLUT4 trafficking with adipose and muscle 
tissues (Kasahara and Kasahara, 1997; Shewan et al., 2013; Wieczorke et al., 2003). 
GLUT4 is sequestered intracellularly in yeast and can be mobilised to the surface in 
response to an environmental cue (Shewan et al., 2013). Furthermore the same 
molecular machinery regulating GLUT4 trafficking exists in yeast and other eukaryotic 
cells indicating that the proteins regulating GLUT4 developed before the evolution of 
GLUT4 itself. Fibroblasts, HeLa and CHO cells were reported to translocate GLUT4 to 
the PM in response to insulin stimulation further supporting that GLUT4 trafficking is not 
limited to insulin-responsive tissues in the classical sense (Haga et al., 2011; Lampson et 
al., 2000).   
 
Recently a study characterised GLUT4 trafficking in HeLa cells expressing an HA-GLUT4-
GFP construct compared to 3T3-L1 adipocytes (Morris et al., 2020). This study was 




translocation of HA-GLUT4-GFP in both cell types with similar kinetics and with 
activation of a similar trafficking machinery. However the observed GLUT4 translocation 
effect was in order of 2 to 3-fold and thus significantly smaller than the effect observed 
in adipocytes of magnitude 10 to 20-fold  (Morris et al., 2020). The machinery and 
capacity of HeLa cells to traffic GLUT4 is not equally as developed as in adipose tissues 
but their response seems more similar to the response observed in human tissues. On 
this basis, we propose that HeLa cells are a valid, experimentally tractable human 
model system (Bryant and Gould, 2020) to further our understanding of GLUT4 
trafficking and PM dispersal. 
 
4.1.6 Hypothesis and research aims 
The aim of this chapter was to investigate and quantify surface GLUT4 spatial 
patterning at the single molecule level in adipocytes using dSTORM. We aimed to 
optimise dSTORM imaging in our lab and hypothesised that insulin stimulation would 
shift GLUT4 distribution in the PM from a clustered to a more dispersed state in line 
with the current literature.  
 
Subsequently we aimed to investigate some of the underlying molecular mechanisms of 
the process in particular the relationship between AMPK activation and GLUT4 
clustering. We hypothesised that AMPK activation attenuates insulin-stimulated glucose 
transport by attenuating insulin-stimulated GLUT4 dispersal.  
We sought to ascertain whether cholesterol depletion using methyl-β-cyclodextrin 
modulated GLUT4 dispersal in the PM.  
Finally, given the similarities between GLUT4 trafficking in adipocytes and HeLa cells, 
we aimed to investigate GLUT4 dispersal in response to insulin stimulation in HeLa cells 










4.2 Results  
4.2.1 Insulin regulates GLUT4 dispersal on the plasma membrane 
of adipocytes 
As a starting point for our study we assessed GLUT4 protein expression and insulin 
sensitivity of differentiated 3T3-L1 adipocytes from our lab by western immunoblotting 
(Figure 4.2). 3T3-L1 cells demonstrated a high endogenous expression of GLUT4 protein 
seen in figure 4.2 A. They also showed insulin-stimulated phosphorylation of Akt as 




Figure 4.2 Endogenous GLUT4 protein expression and insulin sensitivity in 3T3-L1 
adipocytes.  
3T3-L1 adipocytes were differentiated as previously described and protein expression 
was assessed by western immunoblotting. (A) 10 μl and 20 μl of sample were loaded. 
Blots were incubated with anti–GLUT4 or anti-GAPDH (as a loading control) as labelled. 
(B) Cells were treated with or without 100 nM insulin for 20 min as indicated. Blots were 
incubated with anti-Akt or anti-phospho Akt (p-Akt). Blots were visualised with a LI-COR 
Odyssey-SA system; data from a typical experiment is shown. 
 
We investigated glucose uptake in 3T3-L1 adipocytes using 3H labelled 2-deoxyglucose to 
find the optimal conditions for insulin stimulation in this cell type (Figure 4.3). The 
glucose analog 2-deoxyglucose is taken up into the cells where it is phosphorylated and 
cannot be metabolised further. The compound gets trapped in the cells and a 
scintillation counter is used to measure radioactivity which directly corresponds to the 
amount of 2-deoxyglucose taken up by the cells. 3T3-L1 adipocytes were left untreated 
or stimulated with 100 nM insulin for 5, 10 and 20 min and significant increases in 
glucose uptake were observed for all durations of insulin stimulation (p>0.0001; as 
determined by one-way ANOVA). As has been previously reported, insulin stimulated 
deoxyglucose transport ~10-fold, and was maximal 20 min after insulin addition; this 
was therefore chosen as duration of stimulation for all future experiments. In another 
experiment the dose-dependence of insulin stimulated deoxyglucose transport was 
examined in 3T3-L1 adipocytes (Figure 4.3 B). Based on this, 100 nM insulin was chosen 





Figure 4.3 Insulin-stimulated deoxyglucose uptake in 3T3-L1 adipocytes.  
2-deoxyglucose uptake was measured as described (section 2.4.1). 3T3-L1 adipocytes 
were incubated in serum-free medium for 2 h prior to experiments. Cells were washed 
with KRP and treated (A) for a range of time points with 100 nM insulin or (B) with a 
range of insulin concentrations for 20 min followed by a 5 min uptake of 2-deoxyglucose 
at 37°C. Basal glucose uptake rates were typically of the order of 600 counts per 
min/well. The data displayed represent fold changes of insulin stimulation from one 
experiment conducted in triplicate. Data from a representative experiments is shown. 
p<0.0001 indicated by *; determined by one-way ANOVA. 
 
 
Imaging experiments were performed on 3T3-L1 cells stably expressing an HA-GLUT4-
GFP construct previously generated in the lab. Representative confocal images of HA-
GLUT4-GFP adipocytes in figure 4.4 show that unstimulated cells had a strong GLUT4-
GFP signal visible inside the cells (green arrows). HA-staining at the PM was elevated in 
insulin-stimulated adipocytes indicated by a strong ring formation around the majority 
of cells (blue arrows). Furthermore GLUT4-GFP was localised to the PM in insulin-
stimulated 3T3-L1 cells and co-localised with the HA-stain (yellow arrows) which is 
representative of the majority of GLUT4 molecules having translocated from 






Figure 4.4 Confocal images of HA-GLUT4-GFP expressing 3T3-L1 adipocytes. 
Representative confocal images of 3T3-L1 adipocytes expressing HA-GLUT4-GFP (see 
section 2.7). The upper panel shows non-stimulated (basal) cells and the lower panel 
shows cells stimulated with 100 nM insulin for 20 min. Images on the right show GLUT4-
GFP and images on the left show HA-tag GLUT4 staining. Displayed are grayscale images 
with inverted LUTs. Scale bars=30 μm. Data are representative of many experiments of 
this type performed by multiple users in the Gould lab over 5 years. 
 
 
To observe the molecular distribution and quantify the spatial patterning of GLUT4 
within the PM with nanometre precision HA-staining was carried out in HA-GLUT4-GFP 
3T3-L1 adipocytes and dSTORM images acquired. For the acquisition of dSTORM images 
adipocytes were screened in TIRF mode (Figure 4.5 A and D) and only cells that were big 
and rounded and adipocyte-like were chosen and fibroblast-like phenotypes were 
avoided. The vast majority of cells exhibited adipocyte-like morphology and contained 
lipid droplets (seen in figure 4.4). Representative TIRF images show selectively excited 
diffraction-limited GLUT4-GFP in close proximity to the plasma membrane with 
elimination of background fluorescence originating from out of focus GLUT4-GFP (Figure 
4.5 A and D). Reconstructed dSTORM images of HA-GLUT4-GFP adipocytes show clearly 
visible single GLUT4 molecules as well as clusters withing the PM (Figure 4.5 B and E). 




of the reconstructed images as seen in figure 4.5 for a (C) basal and (F) insulin-
stimulated cell show that the density of GLUT4 molecules and clusters at the cell 
surface was increased in insulin-stimulated adipocytes. 
 
 
Figure 4.5 TIRF and STORM images of surface GLUT4 in basal and insulin-stimulated 
3T3-L1 adipocytes. 
HA-GLUT4-GFP 3T3-L1 cells were incubated in serum-free medium for 2 h prior to the 
experiment and stimulated with 100 nM insulin for 20 min or left untreated. Cells were 
fixed and stained for surface HA and dSTORM images acquired on a Zeiss Elyra PS. 1 
(described in section 2.3). Reconstructions of raw images were calculated using the 
ImageJ plugin ThunderSTORM. (A) Representative TIRF image of a basal 3T3-L1 
adipocyte. (B) Representative scatterplot of a basal cell showing localisations of single 
GLUT4 molecules. (C) Magnified section of image B. (D) Representative TIRF image of an 
insulin-stimulated cell. (E) Representative scatterplot of an insulin-stimulated cell 
showing localisations of single GLUT4 molecules. (F) Magnified section of image D. Scale 
bars 10 μm (A, B, D, E) and 1 μm (C and F). This experiment was repeated 5 times with 
similar results.  
 
Ripley’s K-function analysis was carried out to quantify changes in GLUT4 dispersal in 
the PM of basal and insulin-stimulated adipocytes. Ripley’s L-function is normalised 
against the radius and plotting values from randomly distributed points results in an 
expected straight line L(r). If the observed L(r) is bigger than the expected L(r) it 
indicates that the points in the sample are more clustered and if the observed L(r) is 
smaller than the expected L(r) it indicates that the points in the sample are more 
dispersed. Figure 4.6 shows the averaged L(r) functions for basal and insulin-stimulated 
cells from three independently performed experiments. The observed L(r) peaked at 




insulin-stimulated cells with a significant difference (section 2.3.10). This indicates that 
GLUT4 on the plasma membrane was less clustered in response to insulin-stimulation. 















Figure 4.6 Ripley's K-function analysis of GLUT4 clustering in basal and insulin-
stimulated 3T3-L1 adipocytes. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were serum-starved for 
2 h prior to the experiment and stimulated with 100 nM insulin for 20 min or left 
untreated. Cells were fixed and stained for surface HA and dSTORM images acquired. 
GLUT4 molecule coordinates were obtained using ThunderSTORM and the obtained 
localization data was subjected to Ripley’s K-function analysis using SR Tesseler with 
the minimum radius 10 nm, step radius 10 nm, and maximum radius 400 nm. L(r)-r (y-
axis) represents the clustering ability and r (x-axis) represents the radial scales of 
clustering. The presented data are mean ± SD. The experiment was performed 
independently 3 times for basal (N=19 cells) and insulin-stimulated (N=20 cells) 
conditions. p < 0.0001 determined by two-tailed Student’s t-test. 
 
 
4.2.2 AMPK activation regulates insulin-stimulated GLUT4 
dispersal 
AMPK is activated pharmacologically by AICAR which accumulates inside cells as its 
monophosphorylated form ZMP. Activated AMPK is known to phosphorylate and 
inactivate acetyl-CoA carboxylase (ACC). In our study we firstly confirmed this effect by 
determining phosphorylation of ACC by western immunoblotting (Figure 4.7). Total ACC 
protein and phosphorylated ACC (pACC) protein expression were examined. pACC levels 
increased in cells treated with 2 mM AICAR or a combination of 2 mM AICAR and 100 nM 
insulin. These results mirror an increased accumulation of ZMP and AMPK activity 




phosphorylated and total Akt in response to 100 nM insulin stimulation and 2mM AICAR 
treatment. There was no phosphorylated Akt protein detected in basal samples. AICAR 
stimulation modestly elevated pAkt levels whereas insulin induced a strong pAkt signal, 
as expected. These data are similar to that reported by others in the field (Salt et al., 
2000).  
 
Figure 4.7 AICAR and Insulin sensitivity in 3T3-L1 adipocytes. 
3T3-L1 adipocytes were serum-starved for 2 h prior to experiments and left untreated 
(‘Basal’) or treated with 2mM AICAR for 1 h (‘AICAR’), insulin for 20 min (‘Insulin’) or 
both (“AICAR + Ins’). Cells were lysed and equal amounts of protein lysates were 
separated on SDS-PAGE and immunoblotted using the antibodies indicated on the right 
of the figure (see section 2.6 for details). Data from a typical experiment is shown. 
 
 
We assessed the effect of AMPK activation on basal and insulin-stimulated glucose 
transport in 3T3-L1 adipocytes using 3H labelled 2-deoxyglucose. Salt et al (2000) 
incubated cells with 500 μmol/l AICAR and/or 10 nmol/l insulin for 1 h. Here we tested 
several concentrations and durations of AICAR stimulation (data not shown) and 
concluded that 2mM AICAR and 100 nM insulin stimulation for 1 h were most 
appropriate. A significant 6-fold increase in deoxyglucose uptake was observed following 
insulin stimulation with 100 nM for 1 h (Figure 4.8) compared to untreated adipocytes. 
Treatment of 3T3-L1 adipocytes with 2 mM AICAR for 1 h increased deoxyglucose uptake 
by 1.7-fold. These results suggest that AMPK activation itself had a modest effect on 
basal levels of glucose uptake in adipocytes, consistent with published data (Salt et al., 
2000). AICAR treatment reduced insulin-stimulated glucose uptake by about 15% (Figure 
4.8). This result indicates that there is a trend of AMPK activation attenuating insulin-






Figure 4.8 AICAR- and insulin-stimulated glucose uptake in 3T3-L1 adipocytes.  
Glucose uptake was measured using 3H labelled 2-deoxyglucose as outlined (section 
2.4.1). 3T3-L1 adipocytes were incubated in serum-free medium for 2 h prior to 
experiments, washed with KRP and left untreated or were treated with 2 mM AICAR for 
1h or 100 nM insulin for 1 h or both. This was followed by a 5 min uptake of 2-
deoxyglucose at 37°C. Basal glucose uptake rates were typically of the order of 1500 
counts per min/well. The data displayed represent fold changes of insulin stimulation 
from one experiment conducted in triplicate. Data from a representative experiment is 
shown. p<0.0001 indicated by *; determined by one-way ANOVA.  
 
Flow cytometry has emerged as a powerful technology for assaying GLUT4 translocation 
in a high throughput fashion. We analysed HA-GLUT4-GFP 3T3-L1 adipocytes treated 
with 100 nM insulin and 2 mM AICAR or both by flowcytometry to quantify effects on 
GLUT4 translocation in thousands of cells. Mature adipocytes were differentiated from 
3T3-L1 fibroblasts and presented as a heterogeneous mixed population of cells 
containing residual fibroblasts, cellular debris and adipocytes of various sizes. In 
flowcytometry cells are suspended in a clear saline solution and funnelled to produce a 
single cell stream past a set of laser light sources. Light scatter is detected by two 
detectors. The parameter forward scatter is measured along the path of the laser 
whereas side scatter is detected at a ninety degree angle relative to the laser. Forward 
scatter allows for the discrimination of cells by size due to light diffraction around the 
cell. Side scatter gives information about the granularity of cells because intracellular 
structures cause the light to refract or reflect resulting in differences in signal. 
Selective forward versus side scatter gating was applied to identify adipocytes in the 
sample based on their size and granularity and to exclude any residual fibroblasts and 
cellular debris (Figure 4.9 A and B). Wild type 3T3-L1 adipocytes are auto-fluorescent in 
the GFP-channel and HA-GLUT4-GFP 3T3-L1 adipocytes do not express the GFP-positive 
construct in equal amounts and therefore GFP-fluorescence threshold gates were set to 
control for these confounding variables (Figure 4.9 C and D). The gates were set so that 




population (Figure 4.9 C). With these gates in place 54.1 % of unstained HA-GLUT4-GFP 
3T3-L1 adipocytes were identified as GFP-positive population (Figure 4.9 D). HA-GLUT4-
GFP 3T3-L1 adipocytes contain more GFP-positive cells than identified here but for this 
study the choice was made to carefully exclude auto-fluorescent and very dim cells 
from the analysis.  
 
Figure 4.9 Selective gating for quantification of insulin-stimulated GLUT4 
translocation to the plasma membrane by flow cytometry in 3T3-L1 adipocytes. 
Wild type and HA-GLUT4-GFP 3T3-L1 fibroblasts and adipocytes were washed and 
collagenase-digested and subsequently acquired on a BD LSR II™ and analysed using 
FlowJo® software as described (section 2.8). The collected light emissions are displayed 
as dual-colour fluorescence density plots. (A) SSC (side scatter) versus FSC (forward 
scatter) plot with a gate around 3T3-L1 fibroblasts and cellular debris. (B) SSC versus 
FSC plot with a gate around 3T3-L1 adipocytes. (C) Wild type adipocytes previously 
gated in B were subjected to another GFP-fluorescence threshold gate and identified as 
GFP-negative population. (D) HA-GLUT4-GFP 3T3-L1 adipocytes previously gated in B 
were subjected to another GFP-fluorescence threshold gate and identified as GFP-
positive population. 30,000 cells per condition. Data from a typical experiment is 
shown. 
 
In the following sample analysis 50,000 GFP-positive HA-GLUT4-GFP 3T3-L1 adipocytes 
were included for each condition and the experiment was performed two times 
independently. Adipocytes were left untreated, stimulated with 2 mM AICAR for 1 h or 




translocation using flowcytometry (Figure 4.10). In the basal state 5.39 % of HA-GLUT4-
GFP adipocytes were GFP-positive and stained for surface HA-GLUT4 (Figure 4.10 C). 
Insulin stimulation lead to an 8-fold increase in surface HA-GLUT4 with an increase in 
fluorescence in 43.3 % of adipocytes (Figure 4.10 D). Treatment with 2 mM AICAR for 1 h 
resulted in a 1.4-fold change in GLUT4 translocation (Figure 4.10 E). Stimulation with 2 
mM AICAR and insulin simultaneously resulted in a 9.4-fold increase in HA-epitope 
staining which is representative of GLUT4 translocation to the PM. These results 
indicate that AMPK activation slightly increases GLUT4 translocation from intracellular 
stores by itself and that AMPK activation attenuates insulin-stimulated GLUT4 
translocation in 3T3-L1 adipocytes. These data are consistent with our own assays of 
deoxyglucose transport (Figure 4.8) and with (Salt et al., 2000). 
 
Having established that our reagents and cells recapitulated published data on the 
effects of AICAR, we investigated the effect of AMPK activation on GLUT4 clustering in 
the PM of 3T3-L1 adipocytes (Figure 4.11). We performed Ripley’s K-function analysis to 
investigate the effect of AMPK activation on the spatial patterning of membrane GLUT4 
and data from two experiments are presented in figure 4.11. As previously reported the 
observed L(r) peaked at significantly higher clustering values for GLUT4 on the PM of 
untreated adipocytes. There was no difference between untreated cells and cells 
treated only with 2 mM AICAR for 1 h and the L(r) function followed a similar curve 
progression. Thus, AICAR treatment alone did not appear to modulate GLUT4 clustering. 
Our results indicate that insulin stimulation led to a more dispersed distribution of 
GLUT4 within the PM of adipocytes as previously observed. We also report for the first 
time that AMPK activation attenuated insulin-stimulated GLUT4 dispersal in 3T3-L1 














Figure 4.10 Quantitative measurement of insulin-stimulated GLUT4 translocation to 
the plasma membrane by flow cytometry in 3T3-L1 adipocytes. 
3T3-L1 adipocytes were serum-starved 2 h prior to experiments and left untreated or 
stimulated with 2 mM AICAR for 1h or 100 nM insulin for 40 min or both. Cells were 
stained with anti-HA and in low serum medium on ice. Cells were washed and 
collagenase-digested and 50,000 events per condition acquired on a BD LSR II™ and 
analysed using FlowJo® software. The collected light emissions are displayed as 
histograms and density plots. (A) Quantification of HA/GFP fluorescence ratio (mean 
+SD; N=2). (B) Single parameter histogram showing number of cells as percentage of the 
whole population (y-axis) and fluorescence intensity of the HA-epitope stain. (C-F) Two-
parameter dual colour fluorescence density plots displaying total GLUT4-GFP 
fluorescence vs HA-stain fluorescence for (C) untreated, (D) insulin-stimulated, (E) 
AICAR treated and (F) AICAR- and insulin-treated 3T3-L1 adipocytes. p=0.0108 indicated 






Figure 4.11 Ripley's K-function analysis of the effect of AMPK activation on GLUT4 
clustering in basal and insulin-stimulated 3T3-L1 adipocytes. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were serum-starved for 
2 h prior and stimulated with 100 nM insulin for 20 min, 2 mM AICAR for 1 h or both or 
left untreated. Cells were fixed and stained for surface HA and dSTORM images 
acquired. GLUT4 molecule coordinates were obtained using ThunderSTORM and 
subjected to Ripley’s K-function analysis using SR Tesseler with minimum radius 10 nm, 
step radius 10 nm, and maximum radius 400 nm. L(r)-r (y-axis) represents the clustering 
ability and r (x-axis) represents the radial scales of clustering. The presented data are 
mean ± SD. The experiment was performed independently 3 times for basal (N=24 cells), 
insulin-stimulated (N=26 cells), AICAR-treated (N=26 cells) and AICAR- and insulin-
treated (N=30 cells) conditions. p <0.0001; determined by one-way ANOVA. 
 
4.2.3 Cholesterol depletion enhances basal GLUT4 clustering 
Studies have identified relationships between lipid rafts, caveolae, cholesterol, insulin 
signalling and GLUT4 translocation (Gustavsson et al., 1996, 1999; Nystrom et al., 1999; 
Parpal et al., 2001; Parton et al., 2002; Ros-Baro et al., 2001; Shigematsu et al., 2003; 
Yamamoto et al., 1998). We investigated whether GLUT4 clustering was associated with 
lipid rafts. We used methyl-β-cyclodextrin (MβCD) treatment which removes cholesterol 
from cultured cells and disrupts lipid rafts (Kabouridis et al., 2000). Firstly, we assessed 
whether MβCD treatment had an effect on insulin stimulation in 3T3-L1 adipocytes by 
assay of pAKT levels (Figure 4.12). Insulin stimulation led to a significant 47-fold 
increase in Akt phosphorylation (Figure 4.12 B) compared to untreated cells. Cells 
treated with 5 mM MβCD alone showed a 3.4-fold increase in pAkt signal. Furthermore, 
MβCD treatment resulted in a significant decrease of insulin-stimulated Akt 
phosphorylation by 50 %.  















Figure 4.12 Effect of cholesterol depletion on insulin sensitivity in 3T3-L1 
adipocytes.  
3T3-L1 adipocytes were serum starved for 2 h and treated with 100 nM insulin for 20 
min or 5 mM MβCD for 1 h or both or left untreated. (A) Equal amounts of protein were 
immunoblotted with antibodies indicated at the right of the figure. (B) Quantification of 
the immunoblot displayed in panel (A) performed via densitometry, expressed as the 
ratio of phosphorylated to total Akt. Data of a representative experiment is shown. 
p<0.05 indicated by *; determined by one-way ANOVA.  
 
Next we examined the effect of cholesterol depletion on glucose transport in 3T3-L1 
adipocytes (Figure 4.13). Insulin stimulation with 100 nM for 20 min led to a significant 
10-fold increase in glucose uptake in three independent experiments. Treatment of 
cells with 5 mM MβCD alone for 1 h also resulted in a significant 7-fold increase in 
glucose uptake compared to baseline levels (Figure 4.13). MβCD treatment leading to 
the depletion of cholesterol within the PM had a strong effect on basal glucose uptake 
in 3T3-L1 adipocytes. 
 
We investigated the effect of cholesterol depletion on spatial GLUT4 patterning on the 
surface of adipocytes. Data from two independent experiments are shown in figure 
4.14. As previously observed insulin stimulation for 20 min with 100 nM shifted the L(r) 
function towards smaller clustering values indicating that GLUT4 molecules in the 
sample were more dispersed. Treatment with 5 mM MβCD for 1 h resulted in a more 
curved L(r) compared to basal cells indicating a higher degree of GLUT4 clustering in 









Figure 4.13 MβCD- and insulin-stimulated deoxyglucose uptake in 3T3-L1 
adipocytes. 
Deoxyglucose uptake was measured in 3T3-L1 adipocytes incubated in serum-free 
medium for 2 h. Cells were washed and  treated with 5 mM MβCD for 1 h or 100 nM 
insulin for 20 min or both or left untreated followed by a 5 min uptake of 2-
deoxyglucose at 37°C. Basal glucose uptake rates were of the order of 1000 counts per 
min/well. Data displayed represent fold changes from basal values from three 
experiments conducted in triplicate. p<0.0001 indicated by *; determined by one-way 
ANOVA. 
 
Figure 4.14 Ripley's K-function analysis of the effect of cholesterol depletion on 
GLUT4 clustering in basal 3T3-L1 adipocytes. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were serum-starved for 
2 h and stimulated with 100 nM insulin for 20 min or 5 mM MβCD for 1 h or left 
untreated. Cells were fixed and stained for surface HA and dSTORM images acquired. 
GLUT4 molecule coordinates were obtained and subjected to Ripley’s K-function 
analysis using SR Tesseler with minimum radius 10 nm, step radius 10 nm, and maximum 
radius 200 nm. L(r)-r (y-axis) represents the clustering ability and r (x-axis) represents 
the radial scales of clustering. The presented data are mean ± SD. The experiment was 
performed independently 2 times for basal (N=18 cells), insulin-stimulated (N=16 cells) 
and MβCD-treated (N=18 cells) conditions. p <0.0001; as determined by one-way ANOVA.  

















4.2.4 EFR3 regulates insulin-stimulated GLUT4 dispersal 
To assess the effect of EFR3 on insulin-stimulated GLUT4 dispersal in 3T3-L1 adipocytes 
electroporation was used to knock down the protein with 50 % efficiency and STORM 
imaging experiments were performed by Silke Morris (Morris, 2020). Previously, it was 
observed that protein levels of other GSC components were not affected by the 
electroporation procedure (Morris, 2020). Here existing imaging data were filtered 
(described in section 2.3.9) and Ripley’s L-function analysis was carried out using the 
spatstat package in R with help of Marie Cutiongco (described in sections 2.3.11 and 
3.1.4.6) to allow a more rigorous analysis of this dataset. During the analysis data were 
corrected for inhomogeneity of GLUT4 levels in the PM following insulin stimulation and 
edge corrections applied (see section 3.2.7). Figure 4.15 A shows that GLUT4 molecules 
appeared clustered in control basal cells and insulin stimulation shifted GLUT4 
distribution to become more dispersed. EFR3 knock down did not affect GLUT4 
clustering in the basal state but it was found that EFR3 knock down significantly 
attenuated insulin-stimulated GLUT4 dispersal in 3T3-L1 adipocytes (figure 4.15 B/C). 
This result is in line with the previously reported effect of EFR3 knock out on insulin-







Figure 4.15 Ripley’s inhomogeneous L function analysis of GLUT4 molecule 
clustering in EFR3 knock down basal and insulin-stimulated 3T3-L1 adipocytes using 
spatstat.  
In HA-GLUT4-GFP 3T3-L1 cells EFR3 knock down was carried out as previously described 
(Morris, 2020). After 72h cells were serum-starved for 2h and stimulated with 100 nM 
insulin for 20min or left untreated. Surface HA-staining was performed and dSTORM 
images acquired and molecule coordinates obtained. Data subjected to analysis using 
spatstat described in 3.4.11. Representative graphs of Ripley’s L-function for (A) control 
basal (N=40) and insulin-stimulated (N=35) cells. (B) EFR3 knock down basal (N=35)  and 
insulin-stimulated (N=31) cells. (C) All experimental groups. The presented data are 
means; grey shading indicates the most extreme deviation from the theoretical L 
function at any distance r; the function is displayed as centred (red line). 
 
4.2.5 Insulin regulates GLUT4 dispersal in HeLa cells 
Recently it has been shown that HeLa cells have comparable kinetics and orthologous 
GLUT4 trafficking mechanisms compared to 3T3-L1 adipocytes and offer a useful, 
human model system. HeLa cells traffic GLUT4 to the PM in response to insulin but the 
observed effect is much smaller compared to 3T3-L1 adipocytes. We used 
flowcytometry to quantify GLUT4 translocation in HeLa cells in a high throughput 
fashion. HeLa cells are highly homogenous in size but selective threshold gates were 




GFP-negative wild type cells (Figure 4.16). Figure 4.16 B shows 79% of unstained HA-
GLUT4-GFP HeLa cells were identified as GFP-positive.  
 
Figure 4.16 Selective gating for quantification of insulin-stimulated GLUT4 
translocation to the plasma membrane by flow cytometry in HeLa cells. 
Wild type and HA-GLUT4-GFP HeLa cells were washed and collagenase-digested and 
subsequently acquired on a BD LSR II™ and analyzed using FlowJo® software. The 
collected light emissions are displayed as dual-colour fluorescence density plots. (A) 
Wild type HeLa cells were subjected to a GFP-fluorescence threshold gate and 
identified as GFP-negative population. (B) HA-GLUT4-GFP HeLa cells were subjected to 
a GFP-fluorescence threshold gate and identified as GFP-positive population. N=1; 
30,000 cells per condition.  
 
 
In the following sample analysis 50,000 GFP-positive HA-GLUT4-GFP HeLa cells were 
included for each condition (Figure 4.17). A 1.3-fold increase in insulin-stimulated 
GLUT4 translocation was observed in HeLa cells (Figure 4.17 A). The shift in surface HA-
epitope staining fluorescence intensity is most apparent in the fluorescence intensity 
histogram (Figure 4.17 B). The dual-colour fluorescence density plots show that there is 
a significant increase in surface HA-positive cells between the basal (Figure 4.17 C) and 
insulin-stimulated (Figure 4.17 D) conditions. This indicates that intracellular GLUT4 
translocated to the PM where the HA-tag was exposed and stained. It should be noted 
that others have observed 2 to 3-fold increases in magnitude of translocation in this cell 
type (Morris et al., 2020), but we did not attempt to optimise the assay parameters 






Figure 4.17 Quantitative measurement of insulin-stimulated GLUT4 translocation to 
the plasma membrane by flow cytometry in HeLa cells. 
HeLa cells were incubated in serum-free medium 2 h prior to experiments. Cells were 
left untreated or stimulated with 1 μM insulin for 20 min. Cells were stained with 
primary mouse anti-HA (1:200) and secondary anti-mouse Alexa-Fluor 647 (1:300) 
antibodies on ice. HeLa cells were washed and collagenase-digested and subsequently 
50,000 events per condition acquired on a BD LSR II™ and analyzed using FlowJo® 
software. The collected light emissions are displayed as histograms and density plots. 
(A) Quantification of HA/GFP fluorescence ratio (mean+SD; N=2). (B) Single parameter 
histogram showing the number of cells as percentage of the whole population (y-axis) 
and the fluorescence intensity of the AF647 channel corresponding to the staining for 
the HA-epitope. Red=unstained, blue=basal and orange=insulin-stimulated cells. (C-D) 
Two-parameter dual colour fluorescence density plots displaying total GLUT4-GFP 
fluorescence vs AF647 fluorescence for (C) untreated and (D) insulin-stimulated HeLa 
cells. p=0.0377 indicated by *; determined by unpaired Student’s t-test.  
 
Having observed an insulin effect on translocation, we investigated GLUT4 dispersal in 
response to insulin stimulation. Representative TIRF images show selectively excited 
diffraction-limited GLUT4-GFP in close proximity to the plasma membrane with 
elimination of background fluorescence originating from out of focus GLUT4-GFP (Figure 
4.18 A and D). Reconstructed dSTORM images of HA-GLUT4-GFP HeLa cells show clearly 
visible single GLUT4 molecules (Figure 4.18 B and E). Magnifications of the 




cell show that there are more GLUT4 molecules visible in response to insulin 
stimulation. This result confirms GLUT4 translocating to the PM at the single molecule 
level in HeLa cells similarly to 3T3-L1 adipocytes.  
 
 
Figure 4.18 TIRF and STORM images of surface GLUT4 in basal and insulin-stimulated 
HeLa cells. 
HeLa cells expressing HA-GLUT4-GFP were incubated in serum-free medium for 2 h prior 
to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. Cells 
were fixed and stained for surface HA and dSTORM images acquired on a Zeiss Elyra PS. 
1 (described section 2.3). Reconstructions of raw images were calculated using the 
ImageJ plugin ThunderSTORM. (A) Representative TIRF image of GLUT4-GFP in a basal 
HeLa cell (B) Representative scatterplot of a basal cell showing localisations of single 
GLUT4 molecules. (C) Magnified section of image A. (D) Representative TIRF image of a 
insulin-stimulated HeLa cell. (E) Representative scatterplot of an insulin-stimulated cell 
showing localisations of single GLUT4 molecules. (F) Magnified section of image E. Scale 
bars 10 μm (A, B, D, E) and 1 μm (C and F). This experiment was repeated twice with 
similar results. 
 
We performed Ripley’s K-function analysis of dSTORM images of untreated and insulin-
stimulated HeLa cells. Data from two independent experiments are shown in figure 
4.19. Insulin stimulation for 20 min significantly shifted the L(r) function towards 
smaller clustering values indicating that GLUT4 molecules in the sample were more 
dispersed (p=0.0028; determined by two-tailed Student’s t-test). Therefore insulin 
stimulation altered surface GLUT4 distribution significantly towards a more dispersed 
distribution. This is the first demonstration of GLUT4 dispersal in a cell type other than 
adipocytes; while compared to 3T3-L1 adipocytes the effect was of a much smaller 




dispersal is a replicable observation in other cell types, and adds weight to the idea that 
HeLa cells are a useful model system for the study of GLUT4 translocation (Bryant and 
Gould, 2020; Morris et al., 2020). 



















Figure 4.19 Ripley's K-function analysis of GLUT4 clustering in basal and insulin-
stimulated HeLa cells. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP HeLa cells. Cells were serum-starved for 2 h prior 
to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. Cells 
were fixed and stained for surface HA and dSTORM images acquired. GLUT4 molecule 
coordinates were obtained using ThunderSTORM and the obtained localization data was 
subjected to Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 200 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are mean ± SD (N=2). The experiment was performed independently 2 times for 
basal (N=16 cells) and insulin-stimulated (N=16 cells) conditions. p = 0.0028; determined 
















4.3.1 GLUT4 clustering in adipocytes 
The spatial and temporal organization of plasma membrane GLUT4 has been identified 
to play a key role in the regulation of cell metabolism (Stenkula et al., 2010). In 2010 it 
has been reported that insulin induces a burst of exocytosis that disperses GLUT4 
directly within the PM. Some glucose transporter family members for instance GLUT1 
are known to appear as oligomeric structures that influence their transport function 
(Zottola et al., 1995). However, GLUT4 has been thought to function as a monomer but 
an inhomogeneous distribution in the PM has been repeatedly observed (Gustavsson et 
al., 1996; Parton et al., 2002). Previous imaging studies have reported a punctate 
staining of GLUT4 (Lauritzen et al., 2008; Li et al., 2004; Lizunov et al., 2005). Stenkula 
et al were the first to identify the presence of GLUT4 clusters and monomers in the PM 
and quantify the relative amounts of GLUT4 in each state and how this was affected by 
insulin-stimulation in adipocytes (Stenkula et al., 2010). It was reported that clustered 
GLUT4 is internalised via recruitment of clathrin and clusters represent the molecular 
organization that functions as intermediate centre between GLUT4 delivery and 
reinternalization depending on insulin (Stenkula et al., 2010). Current kinetic models of 
GLUT4 trafficking propose a tightly regulated system of GLUT4 cycling between storage 
vesicles, intracellular compartments and the PM (Klip et al., 2019). Insulin has been 
reported to influence GLUT4 trafficking by interacting with several components of this 
system. It has been reported that insulin affects sorting and formation of storage 
compartments (Kandror and Pilch, 1994; Shi and Kandror, 2005), trafficking of GLUT4 
towards the PM (Huang et al., 2007), intracellular untethering and PM tethering (Bai et 
al., 2007; Bogan et al., 2003), GLUT4 fusion and inhibition of endocytosis (Blot and 
McGraw, 2008). Insulin affects a large number of processes and now evidence is 
accumulating that one of the key actions of insulin is to regulate GLUT4 distribution 
within the PM (Gao et al., 2017; Lizunov et al., 2013a; Stenkula et al., 2010). As a 
consequence a new kinetic model containing 4 quasi-compartments has been proposed 
for GLUT4 cycling in adipocytes (Figure 1.7).  
 
According to this model GLUT4 cycles between storage vesicles, endosomes and GLUT4 
monomers and clusters within the PM (Stenkula et al., 2010). In this study we were able 
to quantify GLUT4 clustering and insulin-stimulated dispersal with the use of dSTORM 
(Figure 4.6) in line with the current literature. This then provided us with a mechanism 





4.3.2 Does regulation of clustering underpin observed effects of 
AMPK activation on glucose transport? 
The molecular mechanisms of GLUT4 clustering have not been fully elucidated and in 
this study we investigated the effect of AMPK activation via stimulation with AICAR on 
GLUT4 clustering in 3T3-L1 adipocytes. Previous studies have shown that AICAR 
significantly attenuated insulin-stimulated glucose uptake and GLUT4 translocation. 
Based on these results we hypothesised that AMPK activation would affect insulin-
stimulated GLUT4 dispersal within the PM. Here we report that AMPK activation had no 
effect on basal GLUT4 clustering but attenuated insulin-stimulated GLUT4 dispersal and 
shifted the molecular distribution of GLUT4 towards a more clustered state using super 
resolution microscopy (Figure 4.11). It has been suggested that AMPK is activated in 
response to cellular stress in adipocytes and inhibits the effects of insulin to conserve 
ATP levels (Salt et al., 2000). GLUT4 clusters have been described to function as hubs 
between GLUT4 exocytosis and endocytosis and the main site for GLUT4 internalization. 
In line with these two hypotheses it seems plausible that AMPK activation affects insulin 
signalling within the PM through preventing insulin-stimulated GLUT4 dispersal.  
 
4.3.3 Cholesterol depletion and GLUT4 dispersal 
Several studies have reported that cholesterol depletion increased the amount of PM 
GLUT4 and enhanced insulin-sensitivity, resembling the effect of AMPK activation in 
adipocytes (Chen et al., 2006; Liu et al., 2004; Pattar et al., 2006). Treatment of 3T3-
L1 adipocytes with MβCD to deplete membrane cholesterol increased GLUT4 
incorporation into the PM. This increase in plasma membrane GLUT4 in response to 
cholesterol depletion has been attributed to the inhibition of GLUT4 endocytosis (Ros-
Baro et al., 2001; Shigematsu et al., 2003). It has been reported that 1 h of MβCD (2-20 
mM) treatment of 3T3-L1 adipocytes resulted in a concentration-dependent decrease in 
the abundance of cholesterol (Parpal et al., 2001). Moreover, increased concentrations 
of MβCD were observed to inhibit insulin-stimulated glucose uptake especially at MβCD 
concentrations of 10 mM and above (Parpal et al., 2001). These results indicate that the 
extent of insulin stimulation on glucose transport was correlated to the abundance of 
cholesterol in the PM. In our study we incubated 3T3-L1 adipocytes in 5 mM MβCD for 1 
h and reported a 7-fold increase in basal glucose transport in line with these findings 
(Figure 4.13).  
 
The relationship of membrane cholesterol and GLUT4 clustering and dispersal is less 
well elucidated. Previously clathrin-coated pits and caveolae have been associated with 




localisation and interaction of clathrin and GLUT4 revealed that 25 % of clathrin and 
total amount of GLUT4-GFP were co-localized in the basal state and this increased to 
30-40 % after insulin stimulation in 3T3-L1 adipocytes (Stenkula et al., 2010). However 
only 8 % of clathrin was found to be co-localized with surface-exposed HA-GLUT4 in the 
basal state and 11 % after insulin-stimulation. This difference between the total and 
surface-exposed GLUT4 co-localization with clathrin makes an accumulation of GLUT4 in 
clathrin-coated pits unlikely. Therefore GLUT4 clustering was not associated with 
accumulation in caveolar structures in primary rat adipocytes (Stenkula et al., 2010). 
Another study used dSTORM to study the association between maintenance of GLUT4 
clusters and lipid rafts (Gao et al., 2017). The F5QQI motif on the N-terminal of GLUT4 
has been associated with maintenance of GLUT4 clusters and was mutated to block the 
association between PM GLUT4 clusters and clathrin-coated pits. It was observed that 
the F5QQI motif mutation of GLUT4 promoted a more clustered distribution of GLUT4 
under basal and insulin-stimulated conditions by itself. 3T3-L1 adipocytes with a F5QQI 
motif mutation were treated with 10 mM MβCD for 15 min to disrupt lipid rafts and an 
increase in GLUT4 density and dispersal of F5QQI-GLUT4 was observed under basal 
conditions (Gao et al., 2017). Previous studies have found that GLUT4 clustering was not 
associated with clathrin regulation (Lizunov et al., 2013a; Stenkula et al., 2010) and 
thus it was speculated that the F5QQI motif GLUT4 mutation increased amounts of 
plasma membrane GLUT4 via protein-protein interactions (Gao et al., 2017). There is 
evidence that cholesterol depletion and disruption of lipid rafts did not disrupt GLUT4 
clustering (Lizunov et al., 2013a) whereas this study found that cholesterol depletion 
dispersed F5QQI -GLUT4 indicating a role for lipid rafts in GLUT4 clustering (Gao et al., 
2017).  
 
Our finding that cholesterol depletion resulted in increased basal glucose transport 
seems to contradict our finding that cholesterol depletion enhanced GLUT4 clustering. 
If GLUT4 clustering functionally diminishes glucose transport in adipocytes the more 
clustered GLUT4 configuration following cholesterol depletion should result in reduced 
glucose transport rates. However, the functional role of GLUT4 clustering could be 
linked to insulin action specifically and here the effect of cholesterol depletion on 
insulin-stimulated glucose transport and trafficking was not investigated. Basal glucose 
transport is maintained by GLUT isoform 1 (Calderhead et al., 1990). Another possibility 
is that in the presence of cholesterol GLUT4 clusters are readily endocytosed. 
Cholesterol depletion could interfere with this process resulting in increased glucose 
transport rates. Further studies are needed to elucidate the underlying mechanisms of 
the effects of cholesterol depletion on glucose transport and PM GLUT4 clustering. 




distribution is ongoing. Different methodologies of imaging and data analysis and 
incubation with different concentrations of MβCD can explain contradictions in findings 
and more studies are needed to establish the relationship between GLUT4 regulation 
and lipid rafts. 
 
4.3.4 The role of EFR3 in insulin-stimulated GLUT4 dispersal 
Previous work in our laboratory has characterised and discussed the role of EFR3 in 
insulin-stimulated GLUT4 trafficking (Laidlaw, 2018; Morris, 2020). Two homologues 
have been identified namely EFR3a and EFR3b (Bojjireddy et al., 2015) and it was found 
that adipocytes predominantly express EFR3a (Laidlaw, 2018). EFR3 was found to be 
localised to the PM in 3T3-L1 adipocytes and insulin stimulation had no effect on the 
distribution of the protein. This indicates that EFR3 plays a role in the dynamics of PM 
GLUT4 specifically (Laidlaw, 2018; Morris, 2020). Overexpression of EFR3 resulted in 
increased GLUT4 translocation and glucose uptake in response to insulin and 
overexpression of a dominant negative mutant inhibited the described effects (Laidlaw, 
2018). Knock down of EFR3 resulted in significantly diminished insulin-stimulated 
glucose transport (Laidlaw, 2018). Knock down of EFR3 did not affect expression levels 
of other proteins participating in the GLUT4 trafficking machinery indicating that EFR3 
acts independently. Insulin-stimulated GLUT4 dispersal was attenuated by EFR3 knock 
down indicating that EFR3 plays a significant role in GLUT4 clustering (Morris, 2020). As 
previously discussed EFR3 knock down also resulted in attenuating of insulin-stimulated 
glucose uptake and linking these results together this is an indirect indication that 
GLUT4 clustering controls insulin sensitivity in adipocytes. When GLUT4 is clustered in 
the basal state the ability of GLUT4 to transport glucose into the cell is diminished. This 
could be due to the conformation of GLUT4 clusters or the distribution of clusters itself 
in the PM and further experiments are necessary to link GLUT4 dispersal and glucose 
uptake responses directly (Morris, 2020).  
 
In this study we reanalysed existing STORM raw data of control and EFR3 knock out 
conditions in basal and insulin-stimulated 3T3-L1 adipocytes. Previously, GLUT4 cluster 
analysis was performed with automated Ripley’s K-function analysis using SR Tesseler 
(Morris, 2020). Advantages and disadvantages and why this method has been chosen for 
GLUT4 cluster analysis in this study have been described in detail in chapter 1. Spatial 
point pattern analysis with spatstat was used to reanalyse previously generated data 
sets for means of publication and L(r)-r curves generated using spatstat were 
comparable to those generated with SR Tesseler (Morris, 2020). In the context of this 




has most importantly validated the use of Ripley’s K-function analysis with SR Tesseler 
for other imaging data sets.  
 
4.3.5 HeLa cells as a model system 
The HeLa cell line has been derived from cervical cancer cells and is durable, highly 
prolific, easily genetically manipulated, cheap to obtain, of human origin and has led to 
significant scientific research advances since its discovery (Masters, 2002). Recently, 
the cells have been compared to 3T3-L1 adipocytes and it was reported that they have 
comparable kinetics and orthologous GLUT4 trafficking mechanisms (Morris et al., 
2020). In this study we reported that GLUT4 translocated to the PM and dispersed within 
the PM in HeLa cells in response to insulin. The observed response was quantitatively 
less pronounced than the one observed in 3T3-L1 adipocytes. Much of our current 
knowledge of GLUT4 trafficking has been established by the interpretation of data from 
a variety of model systems. In the 1960s and 1970s primary rat adipocytes were the 
model of choice until the murine 3T3-L1 cell culture line was developed in 1975 (Green 
and Kehinde, 1975; Green and Meuth, 1974). Both cell types are derived from rodents 
and show large insulin-induced increases in glucose transport and GLUT4 translocation 
(Satoh et al., 1993; Yang et al., 1996). A study comparing rat to human adipose tissue 
revealed that there were no differences in basal glucose transport between species. 
However, the maximal rate of insulin-stimulated glucose transport was found to be 15-
fold lower in human adipose cells compared to rat adipocytes (Kozka et al., 1995). 
Photo-labelling GLUT4 revealed that 50 % of total GLUT4 molecules translocated to the 
surface in both rat and human adipocytes in response to insulin stimulation. But it was 
found that there is a lower overall abundance of surface GLUT4 in human adipocytes. 
Moreover a higher proportion of total GLUT4 of about 25 % was present in the PM of 
human adipocytes in the basal state compared to 2 % in rat adipocytes (Kozka et al., 
1995). It was hypothesised that differences in insulin response between human and 
rodent tissues are related to differences in metabolic demands (Kozka et al., 1995). 
Human adipocytes are bigger in size and can fulfil their basic metabolic needs with a 
smaller available residual intracellular GLUT4 reserve pool. Modest 2 to 3-fold increases 
in glucose transport are sufficient in human tissues (Bryant and Gould, 2020). There is a 
high degree of genetic and physiologic similarities between humans and rodents but 
species-specific differences in pathways and networks exist and can have profound 
effects on overall functionality of metabolism (Blais et al., 2017). A large number of 
rodent animal models have been developed to study T2DM over the last thirty years and 
numerous studies elucidated T2DM pathogenesis and treatment options in rodents 
(Chandrasekera and Pippin, 2014). There are still huge gaps in our understanding of 




translation of research results between rodent models and human patients. It has been 
pointed out that species-specific differences exist between rodents and humans at many 
levels of glucose regulation reaching from gene/protein expression over cellular 
signalling mechanisms up to the tissue and organ level (Chandrasekera and Pippin, 
2014). Viewed in this context the magnitude of insulin responses in rodent tissues 
appears to be a species-specific adaptation that should not determine the validity of 
models to study glucose metabolism, GLUT4 trafficking and dispersal. HeLa cells have 
much smaller insulin responses and were dismissed as lacking the GLUT4 trafficking 
machinery in previous years (Bryant and Gould, 2020). This study has reported that 
HeLa cells respond appropriately to insulin as a stimulus. Insulin did not only stimulate 
GLUT4 translocation but also controlled GLUT4 distribution within the PM following 
GLUT4 fusion. We argue that HeLa cells provide a valuable model organism to study 
GLUT4 dynamics that further the elucidation of mechanisms that operate in human 
adipose tissues.  
 
Most research of how insulin regulates GLUT4 distribution within the plasma membrane 
has been carried out in adipocytes to this date. In the next chapter we aim to 




















5. Plasma membrane GLUT4 dispersal in 
cardiomyocytes 
5.1 Introduction 
5.1.1 Glucose transporters in the healthy heart 
The heart beats 100,000 times per day to supply the body with oxygen and nutrients and 
remove waste products. It needs a continuous energy supply to maintain its contractile 
function and has adapted to utilise a variety of metabolic substrates (Shao and Tian, 
2015; Szablewski, 2017). Substrate utilization is tightly controlled and changed in 
response to substrate availability. Free fatty acids are the major metabolic substrate 
for the healthy adult heart to generate ATP (Saddik et al., 1993). Glucose generates 25-
30 % of myocardial ATP at rest (Bing et al., 1953). During anoxic conditions the heart 
switches substrate preference from fatty acid to glucose (Shao and Tian, 2015; 
Szablewski, 2017). The rate-limiting step of glucose utilization in cardiac muscle is 
glucose uptake which is mediated by glucose transporters (GLUT) (Chanda et al., 2016). 
The main GLUT isoforms expressed in the healthy human heart are GLUT1 and GLUT4. 
Both transporters are differentially expressed during development. GLUT1 is the 
predominant GLUT in the embryonic and early neonatal heart and is located in the 
sarcolemma during basal conditions. After birth GLUT1 is downregulated rapidly and 
GLUT4 is upregulated and becomes the main isoform expressed in the new-born and 
adult heart (Santalucía et al., 1992). GLUT4 is located in intracellular membrane 
compartments and translocated to the plasma membrane and T-tubules of 
cardiomyocytes in response to insulin, catecholamines, increased workload and 
ischaemia (Egert et al., 1997, 1999; Wheeler et al., 1994). Overall expression of GLUT1 
and GLUT4 and their relative distribution determine the rate of glucose transport in the 
heart. GLUT1 expression in the adult heart is regulated by chronic-hypoxia and long-
term fasting (Kraegen et al., 1993; Malhotra and Brosius, 1999; Sivitz et al., 1992). 
Similarly GLUT4 expression in the adult heart is influenced by various stimuli such as 
insulin depletion, fatty acids and hormones (Fischer et al., 1996; Gosteli-Peter et al., 
1996; Sivitz et al., 1992; Vettor et al., 2002). Changes of expression of these two 
isoforms have been observed during various pathophysiological states.  
While insulin (and contraction)-mediated GLUT4 translocation in cardiomyocytes is well-
established, currently there is no information available regarding the role of insulin 





5.1.2 Insulin-independent stimuli of GLUT4 trafficking in the heart 
In cardiac muscle insulin is not the only trigger that induces GLUT4 translocation. 
Ischaemia and exercise also stimulate GLUT4 translocation and increase glucose 
transport in the myocardium. Studies demonstrate that the underlying mechanisms are 
distinct from insulin-stimulated glucose transport and activation of AMPK was identified 
to mediate the effects (Coven et al., 2003; Egert et al., 1997; Kudo et al., 1995). 
Exercise was also observed to stimulate GLUT4 translocation by increasing AMPK activity 
(Coven et al., 2003). Transgenic mice with cardiac AMPK inactivation showed impaired 
GLUT4 translocation, reduced glucose uptake following ischemia and higher 
susceptibility to ischemic injury (Russell et al., 1999). Increased workload is associated 
with increased glucose transport and GLUT4 translocation and the mechanisms are 
incompletely understood. Recently AMPK activation was suggested to mediate this 
effect but additional mechanisms likely exist (Abel, 2004). 
 
5.1.3 Challenges of investigating GLUT4 trafficking in cardiac 
tissue models 
Glucose metabolism, insulin signalling and GLUT4 trafficking have been thoroughly 
investigated in adipose tissues over the past decades (Klip et al., 2019). Adipose tissue 
is a loose connective tissue located beneath the skin and around internal organs that is 
easily collected through biopsies. The development of the 3T3-L1 adipocyte cell line as 
an advantageous in vitro model has even furthered research into this particular tissue 
type (Green and Kehinde, 1975; Green and Meuth, 1974). More than 120 years ago it 
was discovered that contraction stimulates glucose uptake in skeletal muscle tissue but 
the mechanisms are still not fully elucidated today (Richter and Hargreaves, 2013). 
Skeletal muscle consists of thousands of long, large, multinucleated muscle fibres with 
complex membrane architecture and specialised compartments enabling voluntary 
movement. This tissue complexity and the existence of a variety of insulin-independent 
GLUT4 signalling pathways have been technically challenging to investigate. 
Cardiovascular research is particularly challenging because obtaining human 
cardiomyocytes is highly invasive and dangerous for patients and there is no appropriate 
in vitro model to study human adult cardiac cell biology (Parameswaran et al., 2013). In 
the heart, cells are arranged as a three-dimensional anisotropic tissue, embedded in a 
network of extracellular matrix and exposed to an abundance of biochemical, 
mechanical, electrical and other types of stimuli (Zuppinger, 2019). Cardiomyocytes 
repeatedly contract and undergo cyclic deformation, show rapid calcium transients and 
electrical signals or experience shear stress from blood flow (Zuppinger, 2019). It is 




human heart in the laboratory environment (Mathur et al., 2016). However there is a 
vast availability of experimental models for the study of cardiovascular function and 
disease with inherent advantages and disadvantages and appreciation of these will help 
to choose the most appropriate model system for a particular question under 
investigation (Hearse and Sutherland, 2000). 
In vitro models have the advantage that total body and systemic influences are removed 
and experiments are performed in comparative isolation providing the ability to 
manipulate a single mechanism at a time (Fearon et al., 2013). The first step in the 
development of a functional cardiac in vitro model is the identification of the optimal 
source of cardiomyocytes (Mathur et al., 2016). A straightforward model to study 
changes at the cellular level is the use fully differentiated cells directly isolated from 
living tissue. For more than a century animal models, explanted hearts and later 
isolated primary cardiomyocytes have been used to study cardiac cell physiology and 
electrophysiology and have increased our knowledge tremendously (Zuppinger, 2019).  
 
Neonatal cardiomyocytes have long been used in cardiac research. These 
cardiomyocytes isolated from neonatal mice and rats profit from an easy and cheap 
isolation procedure. Furthermore the cells are not sensitive to reintroduction into a 
calcium-containing medium after dissociation which is associated with an increased cell 
yield. Neonatal cells are spontaneously beating and readily transfectable. The isolation 
of rat neonatal cardiomyocytes has some advantages over that of mouse cells for 
instance higher cell yields, better transfection efficiencies and the ability for prolonged 
maintenance in culture (Ehler et al., 2013; Parameswaran et al., 2013). Investigations 
of insulin signalling and GLUT4 trafficking have been carried out in neonatal rat 
ventricular myocytes previously (Czubryt et al., 2010; Heim et al., 2020; Mangmool et 
al., 2016; Montessuit et al., 2004, 2006; Morishima et al., 2018). Neonatal rat 
ventricular myocytes respond appropriately to insulin stimuli and were therefore chosen 
as a starting point to investigate insulin-regulated GLUT4 dispersal in cardiac tissues. 
Many studies investigated neonatal and adult cardiomyocytes in combination. Adult 
cardiomyocytes are more difficult and costly to isolate, are sensitive to calcium 
gradients and have low cell yields and are difficult to genetically manipulate (Louch et 
al., 2011). Nevertheless, they represent the most accurate model for the study of adult 
cardiac physiology (Parameswaran et al., 2013) and therefore they have been included 
as a model in this investigation.  
 
It is known that variation exists between cardiomyocytes derived from different species 
(Jayasinghe et al., 2012). Insulin-regulated GLUT4 dispersal has never been investigated 




cardiomyopathy and therefore it is of vital importance to further the knowledge of the 
actions of insulin on cardiac tissues and changes occurring in disease. This is the aim of 
this investigation. There is no adequate cardiac cell culture model and therefore it is 
important to approach the investigation from several angles and include a variety of 
cardiac in vitro models to slowly elucidate GLUT4 dispersal cardiac tissues. Recently, 
there has been a shift in cardiac research towards the use of human-derived cell culture 
models.  
 
5.1.4 Disease modelling in human induced pluripotent stem cells 
In 2006 the ground-breaking discovery that mature cells can be reprogrammed to be 
pluripotent changed the scientific world (Takahashi and Yamanaka, 2006). In the 
following years iPSC have been generated from a variety of tissues and a number of 
different strategies have been explored to reprogram cells (Feng et al., 2009; Stadtfeld 
and Hochedlinger, 2009; Stadtfeld et al., 2008a). Use of iPSC as a clinical tool in 
regenerative medicine has proven challenging due to inefficient reprogramming, lack of 
consistency, spontaneous mutagenesis and existence of an epigenetic memory 
(Brambrink et al., 2008; Stadtfeld et al., 2008b; Takahashi and Yamanaka, 2013). These 
challenges need to be overcome for iPSC to reach their full translational potential. 
Meanwhile iPSC revolutionised biological research and provide an unlimited supply of 
human tissues for modelling and investigating diseases and high-throughput screening 
for drug discovery and toxicity in vitro (Bragança et al., 2019). The iPSC technology is 
increasingly used in various areas of cardiovascular research and iPSC-derived 
cardiomyocytes (iPSC-CM) can be reliably generated by manipulation of developmental 
signalling pathways required for heart development (Burridge et al., 2012, 2014; Zwi et 
al., 2009). IPSC-CM are spontaneously beating, arranged as isotropic tissue, exhibit 
cardiac specific transcription factor/gene/protein expression, demonstrate immature 
striated patterns, stable pacemaker activity and synchronized action potential 
propagation (Zwi et al., 2009). Current studies using iPSC-CM have largely focused on 
investigation of and drug screening for genetic cardiovascular disorders for instance long 
QT syndrome (Itzhaki et al., 2011; Josowitz et al., 2011; Matsa et al., 2011; Moretti et 
al., 2010).  
 
Human iPSC-CM also represent an appealing cell source for modelling of DCM (Granéli et 
al., 2019). In 2014 iPSC-CM were used to develop the first environmentally and 
genetically driven in vitro models of the condition (Drawnel et al., 2014). Cells were 
cultured in a diabetogenic environment to induce features found in DCM and exposed to 
high insulin in the absence of glucose to force them to utilise fatty acids as carbon 




mediators of diabetes were used to mimic the condition of glucose excess despite 
reliance on fatty acid metabolism found in DCM. Cells presented with hypertrophy, loss 
of sarcomeric integrity, altered calcium transients, intracellular lipid accumulation, 
oxidative stress and changes in gene expression indicative of diabetic 
cardiomyopathic phenotype in vitro (Drawnel et al., 2014). Furthermore, dermal 
fibroblasts from different DCM patients were retrovirally reprogrammed to pluripotency 
and differentiated into iPSC-CM. The patient-derived iPSC-CM presented with a similar 
disease phenotype as the cells exposed to a diabetogenic environment (Drawnel et al., 
2014) and were used in a screen to identify potentially protective drugs. Such studies 
emphasise the utility of IPSC-CM, and their value in the investigation of DCM. Therefore, 
we have chosen iPSC-CM as a model to investigate GLUT4 dispersal in cardiomyocytes of 
human origin. 
 
5.1.5 Hypothesis and research aims 
The aim of this chapter was to investigate and quantify surface GLUT4 spatial 
patterning at the single molecule level in cardiac tissues using dSTORM. One of the 
biggest challenges of cardiovascular science is the identification of appropriate in vitro 
models. Here, we aimed to optimise dSTORM imaging in a variety of cardiac cell culture 
models to research whether insulin stimulation would shift GLUT4 distribution in the PM 
from a clustered to a more dispersed state as observed in adipocytes. We used neonatal 
rat ventricular myocytes as starting point for our investigation because their isolation 
and culture has several advantages. We then moved on to the use of adult rabbit 
cardiomyocytes to investigate insulin-stimulated GLUT4 dispersal in cardiac tissues 
because their electrophysiology is closely related to that of the human heart. Finally, 

















5.2.1 Insulin does not regulate GLUT4 dispersal in neonatal rat 
ventricular myocytes 
A commercial adenovirus was commissioned to express the HA-GLUT4-GFP construct in a 
variety of cardiac cell culture systems. The construct used for adenovirus generation 
was similar to that expressed in 3T3-L1 adipocytes and has been previously described 
(see section 4.2.1). HeLa cells were infected with the HA-GLUT4-GFP adenovirus (Ad-
HA-GLUT4-GFP) at varying concentrations and GLUT4 protein expression was assessed by 
western immunoblotting to verify the efficacy of the virus (Figure 5.1). There was no 
exogenous GLUT4 protein present in control samples but protein was detected in all 
HeLa cell samples transduced with Ad-HA-GLUT4-GFP at varying concentrations.  
 
Figure 5.1 GLUT4 protein expression in HeLa cells infected with a commercial HA-
GLUT4-GFP adenovirus.  
HeLa cells were left untreated (control) or transduced with viral medium containing Ad-
HA-GLUT4-GFP at a multiplicity of infection (MOI) of 5, 10 or 25 as labelled (see section 
2.3.3. Cells were lysed as outlined (in section 2.6) and 10 μl and 20 μl of each sample 
were loaded (this equates to 30 and 60 % lysate from a 12-well plate). Blots were 
incubated with anti–GLUT4 or anti-GAPDH (as a loading control) as labelled. Blots were 
visualised with a LI-COR Odyssey-SA system; data from a typical experiment is shown. 
HA-GLUT4-GFP is a characteristic ‘smear’ as a consequence of heterogeneous 
glycosylation at around 70 kDa. 
 
 
Neonatal rat ventricular myocytes (NRVM) are one of the most well-established models 
for in vitro cardiac research and permit the study of many morphological, biochemical 
and electrophysiological characteristics of the heart. We chose this model to investigate 
spatial plasma membrane GLUT4 distribution due to its numerous advantages such as 
availability, cost-efficiency, ease of gene transfer and ease of isolation and culture. As 
a starting point we assessed GLUT4 protein expression and insulin sensitivity of isolated 
NRVM by western immunoblotting (Figure 5.2). NRVM lacked expression of GLUT4 
protein which was expected given their early developmental stage. NRVM exhibited 





Figure 5.2 Endogenous GLUT4 protein expression and insulin sensitivity in neonatal 
rat ventricular myocytes.  
Neonatal rat ventricular myocytes (NRVM) were isolated as previously described (see 
3.3.9) and protein expression was assessed by western immunoblotting. (A) 10 μl of 
NRVM sample were loaded (this equates to 25 % lysate from a 6-well plate) next to an 
equal amount of lysate from 3T3-L1 adipocytes as a control. Blots were incubated with 
anti–GLUT4 or anti-GAPDH (as a loading control) as labelled. (B) Cells were treated with 
or without 1 μM insulin for 20 min as indicated and 20 μl of NRVM sample were loaded 
(this equates to 50 % lysate from a 6-well plate). Blots were incubated with anti-Akt or 
anti-phospho Akt (pAkt). Blots were visualised with a LI-COR Odyssey-SA system; data 
from a typical experiment is shown. 
 
 
NRVM were infected with Ad-HA-GLUT4-GFP to perform imaging experiments. The 
expression of GFP-tagged GLUT4 protein following adenoviral transduction was 
confirmed by epifluorescence microscopy 48 h post-transduction prior to each imaging 
experiment. A high number of NRVM expressing GFP was observed and this was 
indicative of a satisfactory transduction efficiency (data not shown). NRVM transduced 
with Ad-HA-GLUT4-GFP were beating rhythmically indicating high cell viability and 
maintenance of functional properties post-transduction. To observe the molecular 
distribution and quantify the spatial patterning of GLUT4 within the PM HA-staining was 
carried out and dSTORM images acquired. For the acquisition of dSTORM images NRVM 
were screened in TIRF mode (Figure 5.3 A and D) and only cells that were brightly 
fluorescent were chosen and dim cells were avoided. Representative TIRF images show 
selectively excited diffraction-limited GLUT4-GFP in close proximity to the plasma 
membrane with elimination of background fluorescence originating from out of focus 
GLUT4-GFP (Figure 5.3 A and D). Reconstructed dSTORM images show clearly visible 
single GLUT4 molecules as well as clusters withing the PM (Figure 5.3 B and E). The 
black dots in the cell reconstructions (Figure 5.3 B and E) are density artefacts that may 
have originated from laminin-coating of glass coverslips to ensure adherence of NRVM. 
Magnifications of reconstructed images for (C) basal and (F) insulin-stimulated cells are 






Figure 5.3 TIRF and STORM images of surface GLUT4 in basal and insulin-stimulated 
neonatal rat ventricular myocytes. 
NRVM transduced with Ad-HA-GLUT4-GFP were incubated in serum-free medium for 2 h 
prior to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. 
Cells were fixed and stained for surface HA and dSTORM images acquired on a Zeiss 
Elyra PS.1 (see section 2.3). Reconstructions of raw images were calculated using the 
ImageJ plugin ThunderSTORM. (A) Representative TIRF image of a NRVM. (B) 
Representative scatterplot of a basal cell showing localisations of single GLUT4 
molecules. (C) Magnified section of image B. (D) Representative TIRF image of an 
insulin-stimulated cell. (E) Representative scatterplot of an insulin-stimulated cell 
showing localisations of single GLUT4 molecules. (F) Magnified section of image D. Scale 
bars = 10 μm (A, B, D, E) and 1 μm (C and F). This experiment was repeated 3 times 
with similar results.  
 
 
Insulin stimulates GLUT4 translocation in several tissues (Bryant and Gould, 2020) and 
we investigated whether this applies to NRVM by determination of GLUT4 localisation 
density in the plasma membrane per μm2 (Figure 5.4). The localisation density of GLUT4 
molecules significantly increased by 35 % from 347 localisations per μm2 in the basal 
state to 517 per μm2 after insulin stimulation. This shows that more GLUT4 molecules 
were present in the plasma membrane of NRVM following insulin stimulation. Therefore, 
insulin-stimulated GLUT4 translocation occurs in NRVM but the observed effect is 





Figure 5.4 Localisation density in basal and insulin-stimulated neonatal rat 
ventricular myocytes determined by dSTORM imaging. 
NRVM transduced with Ad-HA-GLUT4-GFP were incubated in serum-free medium for 2 h 
prior to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. 
Cells were fixed and stained for surface HA and dSTORM images acquired on a Zeiss 
Elyra PS.1 (described in section 2.3). Reconstructions of raw images were calculated 
using the ImageJ plugin ThunderSTORM. Localisation density was determined using the 
ImageJ plugin LocFileVisualizer (see section 2.3.10). Basal: 347 ± 175 (n = 24), Insulin: 




Ripley’s L-function analysis was carried out to quantify changes in GLUT4 dispersal in 
the PM of basal and insulin-stimulated NRVM (previously described in 4.2.1). Figure 5.5 
shows the averaged L(r) functions for basal and insulin-stimulated cells from three 
independently performed experiments. The observed L(r) peaked at similar clustering 
values for GLUT4 on the PM of untreated and insulin-stimulated cells. This indicates 
that there was no significant difference in GLUT4 clustering on the plasma membrane in 





Figure 5.5 Ripley's L-function analysis of GLUT4 clustering in basal and insulin-
stimulated neonatal rat ventricular myocytes. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP NRVM. Cells were serum-starved for 2 h prior to 
the experiment and stimulated with 1 μM insulin for 20 min or left untreated. Cells were 
fixed and stained for surface HA and dSTORM images acquired. GLUT4 molecule 
coordinates were obtained using ThunderSTORM and the obtained localization data was 
subjected to Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 200 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are mean ± SD. The experiment was performed independently 3 times for basal 
(N=24 cells) and insulin-stimulated (N=26 cells) conditions. p >0.99; determined by one-
way ANOVA. 
 
NRVM are in the postnatal developmental stage and still have the ability to grow, divide 
and differentiate providing many advantages for long-term cell culture applications. 
However, NRVM have unique features and differ from adult fully differentiated 
cardiomyocytes. GLUT4 expression and trafficking change greatly throughout 
development and therefore NRVM may not be the most advantageous model to study 
insulin-stimulated GLUT4 dispersal. In the following we used cardiomyocytes isolated 
from rabbits to further our knowledge of GLUT4 trafficking in a physiologically relevant 
system of the adult myocardium. 
 

















5.2.2 Primary cardiomyocytes are a challenging model for the 
investigation of GLUT4 dispersal in cardiac tissues 
We assessed GLUT4 protein expression of freshly isolated cardiomyocytes by western 
immunoblotting (Figure 5.6). Rabbit cardiomyocytes expressed GLUT4 protein after 
isolation but GLUT4 protein was less abundant than in adipocytes.    
 
 
Figure 5.6 Endogenous GLUT4 protein expression of isolated rabbit cardiomyocytes. 
Rabbit cardiomyocytes were isolated as previously described (see 3.3.7) and protein 
expression was assessed by western immunoblotting. (A) Different amounts of 
cardiomyocyte samples were loaded as labelled (10 μl of sample equate to 25 % from a 
12-well plate). Equal amounts of lysate from 3T3-L1 adipocytes were loaded as a 
control. Blots were incubated with anti–GLUT4 or anti-GAPDH (as a loading control) as 
labelled. Blots were visualised with a LI-COR Odyssey-SA system; data from a typical 




Cardiomyocytes in the whole heart are strongly connected by intercalated discs and 
extracellular matrix and form a functional syncytium. Dissociation and maintenance in 
culture as single cells results in dedifferentiation associated physiological changes. 
Therefore, we assessed changes in GLUT4 protein expression in cultured cardiomyocytes 
over time by western immunoblotting (Figure 5.7). We observed that GAPDH protein 
expression decreased by around 40 % at 48 h in culture indicating a decline in cell 
survival. Furthermore, GLUT4 protein expression, normalised against GAPDH levels, 
decreased by about 50 % over a similar period (Figure 5.7 B). It appears that GLUT4 
protein expression is relatively stable during the first 24 h post-isolation, then decreases 









Figure 5.7 Changes in endogenous GLUT4 protein expression of isolated rabbit 
cardiomyocytes over time. 
Rabbit cardiomyocytes were isolated as previously described (see 3.3.7) and protein 
expression was assessed by western immunoblotting. (A) Cardiomyocytes were plated in 
culture medium and protein expression assessed at 12h, 24h, 36h and 48h as labelled. 
20 μl of lysate were loaded (this equates to 50 % of sample from a 12-well plate). Blots 
were incubated with anti–GLUT4 or anti-GAPDH (as a loading control) as labelled. (B) 
Quantification of the immunoblot displayed in panel (A) performed via densitometry, 
expressed as fold change of basal GLUT4 signal normalized against GAPDH. p<0.0001 
indicated by *; determined by one-way ANOVA. Blots were visualised with a LI-COR 
Odyssey-SA system; data from a typical experiment is shown.   
 
 
The previous experiment showed a reduction in cell viability over time. Cardiomyocytes 
had to be kept in culture for at least 48 h post-isolation to be able to express the GFP-
tagged GLUT4 construct via adenoviral transduction. Therefore, we assessed the insulin 
sensitivity of adult cardiomyocytes over time to ensure the cells remained responsive 
for the time needed to transduce them with Ad-HA-GLUT4-GFP (Figure 5.8). The cells 
showed insulin-stimulated phosphorylation of Akt and this response was preserved up to 
48 h post-isolation (Figure 5.8 A). However, the experiment was replicated many times 
and in several batches of cardiomyocytes a loss of insulin-stimulated phosphorylation of 







Figure 5.8 Changes of insulin sensitivity in rabbit cardiomyocytes over time.  
Rabbit cardiomyocytes were isolated as previously described (see 3.3.7) and protein 
expression was assessed by Western immunoblotting. Cells were stimulated with 1 μM 
insulin for 20 min or left untreated and 20 μl of sample were loaded (this equates to 50 
% lysate from a 12-well plate). (A) Protein expression assessed at 0, 24 and 48 h post-
isolation. Blots were incubated with anti-phospho Akt or anti-GAPDH (as a loading 
control) as labelled. (B) Similar experiment performed on a different batch of isolated 
cardiomyocytes at 12, 24, 36 and 48 h post-isolation. Blots were visualised with a LI-COR 
Odyssey-SA system; data from two typical experiments is shown. 
 
 
GAPDH protein expression was observed to decline similarly which might be due to 
reduced cell viability (Figure 5.8 B). We also observed that cardiomyocytes did not 
attach well to surfaces (data not shown). Next, we investigated the use of different 
substrates for efficient cardiomyocyte attachment. Several substrates were used to 
attach cardiomyocytes to glass coverslips (Figure 5.9). Poly-D-lysine provided the best 
overall cell attachment and was superior to other reagents examined and consequently 






Figure 5.9 Optimisation of substrates used in primary cardiomyocyte culture to 
attach cells to glass coverslips. 
Rabbit cardiomyocytes were isolated as previously described (see 3.3.7). Glass 
coverslips were cleaned and (A) left uncoated or coated with (B) 2% gelatin, (C) 
Collagen type I, (D) poly-D-lysine 50mg/mL, (E) poly-D-lysine 100mg/ml. Phase contrast 
images of fixed cells were acquired on an EVOS FL Auto imaging system 48 h after 
seeding the cardiomyocytes onto the substrates. Data from one typical experiment is 
shown. Scale bars = 250 μm. 
 
Having established reasonable cell adherence, we then investigated glucose uptake in 
isolated rabbit cardiomyocytes using 3H labelled 2-deoxyglucose as a means to establish 
the validity of this model system (Figure 5.10). Rabbit cardiomyocytes were left 
untreated or stimulated with 1 μM insulin for 20 min and a significant 2-fold increase in 
glucose uptake was observed.  
 
Figure 5.10 Insulin-stimulated deoxyglucose uptake in rabbit cardiomyocytes. 
2-deoxyglucose uptake was measured as described (section 2.5.2). Cardiomyocytes were 
washed with KRP and treated with or without 1 μM insulin for 20 min followed by a 30 
min uptake of 2-deoxyglucose at 37°C. Basal glucose uptake rates were typically of the 
order of 1,600 counts per min/well. The data displayed represent fold changes of insulin 
stimulation from one representative experiment. The experiment was performed three 




After optimisation of primary cardiomyocyte culture conditions, we transduced cells 
with Ad-HA-GLUT4-GFP to perform imaging experiments. Epifluorescence microscopy 
images of HA-GLUT4-GFP cardiomyocytes showed that the rod-shaped cardiomyocytes 
had rounded edges and sarcomeres appeared disorganized (Figure 5.11 A). These 
changes are commonly observed during primary cardiomyocyte culture. Imaging the 
cells in TIRF-mode revealed that cardiomyocytes attached only partly to the glass 
coverslips and that the membrane does not sit flat on the glass (Figure 5.11 B). This 




Figure 5.11 Epifluorescence and TIRF images of HA-GLUT4-GFP cardiomyocytes. 
Isolated cardiomyocytes were transduced with Ad-HA-GLUT4-GFP and fixed and images 
acquired on a Zeiss Elyra PS.1 (see section 2.3). (A) Representative epifluorescence 
image of cardiomyocyte showing GLUT4-GFP. (B) Representative TIRF image of the same 
cardiomyocyte showing only GLUT4-GFP in close proximity to the glass coverslip. Scale 
bars 10 μm.  
 
 
A wide range of substrates was examined to attach cardiomyocytes more effectively to 
the glass coverslips to perform successful super resolution imaging (data not shown). 
But the rod-shaped cardiomyocytes were observed mostly floating above the glass 
coverslips which only exposed a small part of their membrane for imaging experiments 
(Figure 5.12 A). Another obstacle was that primary cardiomyocyte cultures contained a 
high number of apoptotic cells and the cellular debris interfered with HA-staining and 
produced imaging artefacts (Figure 5.12 B). Even those cells that attached partly to the 
coverslips and were successfully imaged in TIRF mode did not lead to the production of 
clean reconstructions of GLUT4 localisations. Numerous imaging experiments were 







Figure 5.12 TIRF and dSTORM images of HA-GLUT4-GFP cardiomyocytes. 
Isolated cardiomyocytes were transduced with Ad-HA-GLUT4-GFP. Cells were fixed and 
stained for surface HA and images acquired on a Zeiss Elyra PS.1 (see section 2.3). (A) 
Representative TIRF image of a cardiomyocyte. (B) Representative scatterplot of the 
same cell showing localisations of single GLUT4 molecules. Scale bars 10 μm.  
 
 
5.2.3 Insulin regulates GLUT4 dispersal in human induced 
pluripotent stem cell-derived cardiomyocytes (NCardia) 
We commercially obtained induced pluripotent stem cell-derived cardiomyocytes (iPSC-
CM) from Axiogenesis (this company has recently merged with Pluriomics to form 
NCardia) and FUJIFILM Cellular Dynamics International (CDI) and performed western 
immunoblotting to assess GLUT4 protein expression and insulin sensitivity (Figure 5.13 
and 5.14). These experiments were carried out and published by Peter Bowman, a 
member of our lab (Bowman et al., 2019), and not repeated by myself due to the high 
cost associated with these cells. Relative to primary rodent cardiomyocytes both iPSC-
CM obtained from NCardia and CDI were found to express low levels of endogenous 
GLUT4 (Figure 5.13).  
 
Figure 5.13 Endogenous GLUT4 protein expression of induced pluripotent stem cell-
derived cardiomyocytes from two commercial sources. 
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) were obtained from 
two sources and protein expression was assessed by western immunoblotting. Two times 
20 μl of sample generated from NCardia and CDI iPSC-CM was loaded next to one sample 
of primary mouse cardiomyocytes (5 μg total protein). Note that 20 μl iPSC-CM 
corresponds to lysate generated from approximately 20,000 cells. Blots were incubated 
with anti–GLUT4 or anti-GAPDH (as a loading control) as labelled. Blots were visualised 
with a LI-COR Odyssey-SA system; data from a typical experiment is shown that was 




In iPSC-CM the insulin signalling intermediate Akt was expressed and capable of 
exhibiting insulin-stimulated phosphorylation (Figure 5.14). In NCardia iPSC-CM insulin-
stimulated phosphorylation of Akt was hard to detect because a very strong basal 
phosphorylation of Akt was observed (Figure 5.14 A). CDI iPSC-CM showed a more 
pronounced increase in Akt phosphorylation in response to insulin stimulation with a 
lower basal Akt phosphorylation (Figure 5.14 B). 
 
Figure 5.14 Insulin sensitivity of induced pluripotent stem cell-derived 
cardiomyocytes from two commercial sources. 
IPSC-CM were commercially obtained and protein expression assessed by western 
immunoblotting. Cells were serum starved 3 h prior to the experiment and stimulated 
with 860 nM insulin for 30 min or left untreated and 20 μl of sample were loaded. (A) 
Protein expression of NCardia iPSC-CM from 2 technical replicates of basal and insulin 
stimulated lysates from 1 biological sample. Blots were incubated with anti-phospho Akt 
or anti-Akt as labelled. (B) Similar experiment for CDI iPSC-CM including 3 replicate 
samples for each condition within one experimental day. Blots were visualised with a LI-
COR Odyssey-SA system; data from a typical experiment is shown, carried out 
independently three times (N=3). 
 
 
In the following we transduced NCardia iPSC-CM with Ad-HA-GLUT4-GFP to investigate 
the spatial patterning of GLUT4 within the PM. HA-staining was carried out and dSTORM 
images acquired. As previously described NCardia iPSC-CM were screened in TIRF mode 
to selectively excite GLUT4-GFP in close proximity to the PM (Figure 5.15 A and D). 
Reconstructed dSTORM images of HA-GLUT4-GFP iPSC-CM show clearly visible single 
GLUT4 molecules as well as clusters withing the PM (Figure 5.15 B and E). Magnifications 
of these images seen in figure 5.15 for a (C) basal and (F) insulin-stimulated cell show 





Figure 5.15 TIRF and STORM images of surface GLUT4 in basal and insulin-stimulated 
induced pluripotent stem cell-derived cardiomyocytes obtained from NCardia. 
NCardia iPSC-CM transduced with Ad-HA-GLUT4-GFP were incubated in serum-free 
medium for 2 h prior to the experiment and stimulated with 1 μM insulin for 20 min or 
left untreated. Cells were fixed and stained for surface HA and dSTORM images acquired 
on a Zeiss Elyra PS.1 (see section 2.3). Reconstructions of raw images were calculated 
using the ImageJ plugin ThunderSTORM. (A) Representative TIRF image of a cell. (B) 
Representative scatterplot of a basal cell showing localisations of single GLUT4 
molecules. (C) Magnified section of image B. (D) Representative TIRF image of an 
insulin-stimulated iPSC-CM. (E) Representative scatterplot of an insulin-stimulated cell 
showing localisations of single GLUT4 molecules. (F) Magnified section of image D. Scale 
bars 10 μm (A, B, D, E) and 1 μm (C and F). This experiment was repeated 2 times with 
similar results.  
 
 
We investigated whether insulin stimulates GLUT4 translocation in NCardia iPSC-CM by 
determination of GLUT4 localisation density in the plasma membrane per μm2 (Figure 
5.16). The localisation density of GLUT4 molecules significantly increased by 70 % in 





Figure 5.16 Localisation density in basal and insulin-stimulated induced pluripotent 
stem cell derived cardiomyocytes determined by dSTORM imaging. 
IPSC-CM transduced with Ad-HA-GLUT4-GFP were incubated in serum-free medium for 2 
h prior to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. 
Cells were fixed and stained for surface HA and dSTORM images acquired on a Zeiss 
Elyra PS.1 (described in section 2.3). Reconstructions of raw images were calculated 
using the ImageJ plugin ThunderSTORM. Localisation density was determined using the 
ImageJ plugin LocFileVisualizer (see 2.3.10). Basal: 1142 ± 131 (n = 23), Insulin: 1918 ± 




Ripley’s L-function analysis was carried out to quantify changes in GLUT4 dispersal in 
the PM of basal and insulin-stimulated NCardia iPSC-CM. Figure 5.17 shows the averaged 
L(r) functions for basal and insulin-stimulated cells from two independently performed 
experiments. The observed L(r) peaked at higher clustering values for GLUT4 on the PM 
of untreated iPSC-CM compared to insulin-stimulated cells with a significant difference 
(section 2.3.10). This indicates that GLUT4 on the plasma membrane was less clustered 
in response to insulin-stimulation. To our knowledge this was the first time that insulin-





Figure 5.17 Ripley's L-function analysis of GLUT4 clustering in basal and insulin-
stimulated induced pluripotent stem cell-derived cardiomyocytes from NCardia. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP iPSC-CM. Cells were serum-starved for 2 h prior 
to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. Cells 
were fixed and stained for surface HA and dSTORM images acquired. GLUT4 molecule 
coordinates were obtained using ThunderSTORM and the obtained localization data was 
subjected to Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 200 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are mean ± SD. The experiment was performed independently 2 times for basal 
(N=24 cells) and insulin-stimulated (N=20 cells) conditions. p<0.0001; determined by 
one-way ANOVA of all cells combined from N=2. 
 
 
After the performance of these two independent experiments NCardia announced that 
they detected embryonic markers in their batches of iPSC-CM making the origin of the 
cells questionable (personal communication). The cells were no longer commercially 
available for an indefinite amount of time until quality control measures of iPSC 
production were met again by the company. Our previous experiments showed 
differences in GLUT4 protein expression and insulin sensitivity between NCardia and CDI 
iPSC-CM. We continued our investigation of GLUT4 dispersal in cardiac tissues using CDI 
iPSC-CM and repeated the super resolution microscopy experiments previously carried 
out in NCardia iPSC-CM.  
 

















5.2.4 Differences in insulin-stimulated GLUT4 dispersal exist in 
human induced pluripotent stem cell-derived cardiomyocytes 
depending on their source 
CDI iPSC-CM transduced with Ad-HA-GLUT4-GFP exhibited a less strong expression of 
GFP hinting at a lower transduction efficiency compared to cells obtained from NCardia 
(Figure 5.18). Furthermore, it was observed that CDI iPSC-CM are morphologically 
different from NCardia iPSC-CM. CDI cells (Figure 5.18) were generally smaller 
compared to NCardia cells (Figure 5.15). Screening the cells in TIRF mode it became 
obvious that NCardia cells are bigger and spread out more evenly on the glass coverslips 
so that their complete membrane comes in close contact with the coverslip (Figure 
5.15). However, CDI iPSC-CM seemed smaller and more rounded and formed adhesions 
to the coverslips only on their outer edges (Figure 5.18). Reconstructions of dSTORM 
images show GLUT4 molecules in the plasma membrane (Figure 5.18 B and D) and 
magnifications of these images show no difference in GLUT4 clustering or molecule 
density in (C) basal and (F) insulin-stimulated CDI iPSC-CM. 
 
Figure 5.18 TIRF and STORM images of surface GLUT4 in basal and insulin-stimulated 
induced pluripotent stem cell derived cardiomyocytes. 
IPSC-CM transduced with Ad-HA-GLUT4-GFP were serum starved for 2 h and stimulated 
with 1 μM insulin for 20 min or left untreated. Cells were fixed and stained for surface 
HA and dSTORM images acquired (see section 2.3). Reconstructions were calculated 
using ThunderSTORM. (A) Representative TIRF image of a basal cell (B) Scatterplot of a 
basal cell showing localisations of single GLUT4 molecules. (C) Magnified section of 
image B. (D) Representative TIRF image of an insulin-stimulated iPSC-CM. (E) 
Scatterplot of an insulin-stimulated cell showing localisations of single GLUT4 
molecules. (F) Magnified section of image D. Scale bars = 10 μm (A, B, D, E) and 1 μm (C 




We investigated whether insulin stimulates GLUT4 translocation in CDI iPSC-CM as 
previously described (Figure 5.19). The localisation density of GLUT4 molecules 
significantly increased by 40 % in response to insulin stimulation indicating occurrence 
of GLUT4 translocation in iPSC-CM. GLUT4 localisation density per μm2 in basal and 
insulin-stimulated CDI cells was 75 % less compared to cells obtained from NCardia 
(Figure 5.16).  
 
Figure 5.19 Localisation density in basal and insulin-stimulated induced pluripotent 
stem cell derived cardiomyocytes determined by dSTORM imaging. 
IPSC-CM transduced with Ad-HA-GLUT4-GFP were incubated in serum-free medium for 2 
h prior to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. 
Cells were fixed and stained for surface HA and dSTORM images acquired on a Zeiss 
Elyra PS.1 (described in section 2.3). Reconstructions of raw images were calculated 
using the ImageJ plugin ThunderSTORM. Localisation density was determined using the 
ImageJ plugin LocFileVisualizer (see 3.4.10). Basal: 321 ± 176 (n = 12), Insulin: 541 ± 270 
(n = 8). Mean ± SD. p = 0.0394; determined by unpaired two-tailed Student’s t-test. 
 
Again we used Ripley’s L-function analysis to quantify changes in GLUT4 dispersal in CDI 
iPSC-CM. The experiment was carried out several times but in most cases the 
transduction was ineffective and the fluorescence signal was too low to quantify 
molecular GLUT4 dynamics. Figure 5.20 shows the averaged L(r) functions for basal and 
insulin-stimulated cells from one successful experiment. The observed L(r) peaked at 
similar clustering values for GLUT4 on the PM of untreated and insulin-stimulated cells 
indicating no difference in GLUT4 clustering on the plasma membrane in response to 






















Figure 5.20 Ripley's L-function analysis of GLUT4 clustering in basal and insulin-
stimulated induced pluripotent stem cell-derived cardiomyocytes from CDI. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP iPSC-CM. Cells were serum-starved for 2 h prior 
to the experiment and stimulated with 1 μM insulin for 20 min or left untreated. Cells 
were fixed and stained for surface HA and dSTORM images acquired. GLUT4 molecule 
coordinates were obtained using ThunderSTORM and the obtained localization data was 
subjected to Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 200 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are mean ± SD. The experiment was performed once for basal (N=12 cells) and 

















5.3.1 GLUT4 clustering in neonatal ventricular cardiomyocytes 
Following the discovery that insulin regulates plasma membrane distribution of GLUT4 
in adipocytes the aim of this study was to investigate whether a similar mechanism 
exists in cardiac tissues. We used neonatal rat ventricular cardiomyocytes (NRVM) as a 
model system because it has several advantages above the culture of primary 
cardiomyocytes. Several studies have investigated glucose metabolism in these cells and 
reported an increase in glucose transport and GLUT4 translocation in response to insulin 
stimulation (Austin and Langley-Evans, 2011; Contreras-Ferrat et al., 2010; Florian et 
al., 2010; Guan et al., 2008; Heim et al., 2020; Malhotra and Brosius, 1999; Morisco et 
al., 2005; Pentassuglia et al., 2016). Neuregulin-1β is a cell adhesion molecule critically 
involved in cardiac development that improves cardiac performance under a range of 
pathological conditions. Several studies have investigated the effect of neuregulin-1β in 
NRVM and reported that it enhanced glucose uptake in NRVM via Akt phosphorylation in 
a similar magnitude as insulin stimulation (Heim et al., 2020; Pentassuglia et al., 2016). 
Pharmacological interventions have shown that neuregulin-1β and insulin-induced 
glucose uptake require PI3K and Akt and both increase phosphorylation of the Akt 
downstream target AS160. Interestingly, neuregulin-1β and insulin treatment had an 
additive effect on Akt phosphorylation but not on AS160 phosphorylation in NRVM (Heim 
et al., 2020). Several other stimuli have been identified to stimulate glucose uptake and 
GLUT4 translocation in NRVM. One study reported that azide-induced hypoxia and the 
AMPK activator AICAR increased glucose uptake and GLUT4 translocation in NRVM and 
that AICAR stimulation had an additive effect on insulin action (Guan et al., 2008). 
Treatment with the AMPK inhibitor Ara A was reported to lead to a decrease in AICAR- 
and azide-stimulated glucose uptake but had no effect on basal and insulin-stimulated 
glucose uptake. These studies indicate that glucose uptake in NRVM is mechanistically 
similar to insulin action and AMPK activation (Guan et al., 2008). 
 
In our study we found that isolated NRVM lacked expression of GLUT4 protein but 
exhibited a strong insulin-stimulated phosphorylation of Akt. In the literature, weak 
expression of GLUT4 protein has been frequently reported in NRVM (Czubryt et al., 
2010; Mangmool et al., 2016; Montessuit et al., 2006). Although several interventions 
have been reported to increase GLUT4 content in NRVM (Czubryt et al., 2010; Mangmool 
et al., 2016; Montessuit et al., 2006), we virally expressed human GLUT4 in NRVM to 
study whether insulin affected plasma membrane GLUT4 distribution. Insulin stimulation 
did not result in GLUT4 dispersal previously observed in adipocytes in this model of 




Since the first isolation of NRVM in 1963 these cells have been invaluable for in vitro 
cardiac cell biology (Harary and Farley, 1963). The immature phenotype of NRVM 
presents the biggest disadvantage of working with these cells and is similarly the source 
of their many advantages (Peter et al., 2016). In rodents and humans the growing heart 
undergoes considerable structural and functional changes at the cardiomyocyte level 
(Karbassi et al., 2020). Growth of the prenatal heart predominantly occurs through 
hyperplasia and NRVM still exhibit this proliferative potential. In rodents 
cardiomyocytes undergo mitotic quiescence in the first week of postnatal life and after 
this further growth of the heart occurs by increasing cardiomyocyte size. Mature 
cardiomyocytes increase in size, become anisotropic, lose automaticity, acquire a more 
negative membrane potential and an increase in action potential duration and 
amplitude, polarized gap junctions concentrated at cell ends, improved calcium 
handling with increased calcium stores and development of T-tubules, increased force 
of contraction due to presence of more myofibrils and alignment, increased fatty acid 
utilisation and mitochondrial content (Karbassi et al., 2020). Expression of GLUTs 
especially GLUT1 and GLUT4 is highly flexible during cardiac development and therefore 
we chose a more mature model to overcome this limitation.  
 
5.3.2 Investigation of GLUT4 dispersal in adult cardiomyocytes has 
several challenges 
The biggest advantage of using isolated adult cardiomyocytes as a model for cardiac 
research is the similarity of morphology and behaviour they share with cardiomyocytes 
of intact cardiac tissue (Peter et al., 2016). Adult cardiomyocytes are large and rod 
shaped (~150 µm in length), binucleated and have well organized sarcomeres 
throughout their cell bodies (Louch et al., 2011). In our study adult cardiomyocytes 
were successfully isolated from New Zealand white rabbits and maintained in culture for 
up to 48 h. As any experimental system the culture of adult cardiomyocytes has some 
significant limitations (Peter et al. 2016). Reproducible isolation of high-quality 
cardiomyocytes is the most important factor for successful experimentation with these 
cells. Single cardiomyocytes have been isolated for over 40 years but up to this date no 
single universal method has been developed (Peter et al., 2016; Powell and Twist, 
1976). In general isolation protocols include retrograde perfusion of the isolated heart 
with a Langendorff apparatus but details such as apparatus of choice, enzymes and 
dissociation methods differ widely within the scientific community (Louch et al., 2011). 
Isolation of cardiomyocytes remains challenging and even laboratories that perform 
routine isolations suddenly and unpredictably experience difficulties. This can be due to 




solutions, lots of chemicals (especially enzymes), air bubbles in the perfusate and detail 
in handling the hearts (Louch et al., 2011). In our study we repeatedly observed huge 
discrepancies in cell viability and insulin-stimulated Akt phosphorylation between 
different batches of isolated cardiomyocytes. Isolating cardiomyocytes from rabbit 
hearts is relatively costly compared to smaller animal models and cells from each 
isolation were used by multiple investigators. Protocols for isolation typically need to be 
optimised for the type of experiment that is planned but in reality this is not affordable 
from a financial or ethical point of view because cells are shared to reduce numbers of 
animals needed. 
 
Long-term culture of these cells results in morphological, electrical and mechanical 
alterations revoking one of their key advantages (Banyasz et al., 2008). Progressive 
reduction in cell size, T-tubule density, systolic shortening and membrane currents was 
observed from the first day of maintenance in culture (Banyasz et al., 2008). Adult 
cardiomyocytes isolated from rats showed spontaneous upregulation of GLUT1 and 
downregulation of GLUT4 after two days in primary culture (Montessuit et al., 2004). In 
line with this result we also observed a significant reduction in GLUT4 protein 
expression in rabbit adult cardiomyocytes at the same time point. To circumvent the 
limitation of dedifferentiation investigators frequently perform their analysis within 24 
h of isolation (Peter et al., 2016). Treatment with IGF-1 has also been observed to 
restore GLUT4 protein and mRNA levels during prolonged culture periods (Montessuit et 
al., 2004).  
 
Generally imaging techniques are limited in thick tissue and the long and flat 
morphology of adult cardiomyocytes makes them well-suited for experiments aimed at 
visualizing cell structure and localization of intracellular molecules. In this study several 
substrates were used to attach cardiomyocytes to glass coverslips and no optimal 
substrate was identified. Generally adult cardiomyocytes are cultured on laminin-
coated coverslips but we experienced that cells did not attach well (Louch et al., 2011). 
Further experiments were carried out using poly-d-lysine as a substrate because we 
observed that the cells stuck down well on coated coverslips. However, it remained 
challenging to image cardiomyocytes in TIRF mode. Unlike immortalised cell lines and 
NRVM, adult cardiomyocytes do not proliferate in culture and tightly attach to the 
substrate via focal adhesions. During our dSTORM imaging experiments we frequently 
observed that cardiomyocytes only formed contact with the glass coverslip in very small 
areas and therefore it was impossible to illuminate bigger parts of their plasma 
membrane in TIRF mode. This limitation could have been possibly resolved by changing 




a plane of light to optically section tissues and view them with subcellular resolution 
(Santi, 2011). It is not within the scope of this study to try this novel technique but 
obtaining serial sections of HA-stained adult cardiomyocytes allowing three-dimensional 
reconstructions might be well suited to elucidate the plasma membrane distribution of 
GLUT4 in this cardiac model. Highly inclined and laminated optical sheet (HILO) imaging 
uses an incredibly thin highly inclined beam of light that is directed through the sample 
(Tokunaga et al., 2008). Unlike TIRF this technique is not limited to 200 nm from the 
glass surface of the coverslip. HILO allows deeper sample penetration and is another 
method that should be explored to image the plasma membrane of cardiomyocytes 
hovering above the glass coverslips.  
 
In this study we have used rabbit cardiomyocytes because they are available through a 
collaboration and they share physiology and electrophysiology that is most closely 
related to that of human cardiomyocytes. However different sources of adult 
cardiomyocytes should be explored. The current standard of adult cardiomyocytes are 
adult rat ventricular myocytes due to high cell yields, ease of isolation and cost-
effectiveness (Peter et al., 2016). Furthermore, cardiomyocytes can be prepared from 
adult mice. Cell yields are generally lower and isolation is more difficult due to the 
small size of the hearts. However a big variety of transgenic mouse models are available 
that allow the study of different pathologies or offer models with fluorescently-tagged 
proteins (Peter et al., 2016). A transgenic mouse model in which HA-GLUT4-GFP is 
expressed in cardiac and skeletal muscle under the control of the MCK promoter is 
commercially available and has been characterised in the literature (Fazakerley et al., 
2009; Lizunov et al., 2012). In the model HA-GLUT4-GFP was observed to translocate to 
the plasma membrane and T-tubules of skeletal (Lizunov et al., 2012) and cardiac 
muscle (Fazakerley et al., 2009) in response to insulin similarly to endogenous GLUT4. 
Adult cardiomyocytes need to be virally transduced to express fluorescently labelled 
proteins and another limitation of our study was that cells had to be cultured for 
several days to express the GFP-tagged GLUT4 protein which led to a significant 
decrease in cell viability and dedifferentiation. Establishing the transgenic HA-GLUT4-
GFP mouse model in our lab would give the opportunity to isolate cells and image them. 
Efforts towards this goal were hampered by the Covid-19 outbreak. 
 
5.3.3 The promise of human induced pluripotent stem cell-
derived cardiomyocytes 
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) are the most 




(Peter et al., 2016). In recent years several advances have been made to direct 
differentiation of iPSCs into cardiac lineages and a number of protocols exist to 
generate cardiomyocytes with improved cell yields (Burridge et al., 2011, 2012, 2014; 
Josowitz et al., 2011; Zwi et al., 2009). Cardiomyocyte differentiation of iPSC is 
associated with high costs, a high amount of required resources, technical challenges 
and time consumption and requires trained staff. An attempt was made to generate 
cardiomyocytes from iPSC in a the lab of our collaborator Nikolaj Gadegaard (University 
of Glasgow) but was abandoned due to high time consumption, low cell yields and 
difficulty of quality control (data not shown). In recent years iPSC-CM have become 
commercially available from a number of companies that specialise in cardiomyocyte 
generation and ensure quality control (Peter et al., 2016). IPSC-CM exhibit 
cardiomyocyte specific gene and protein expression and general function and were 
commercially obtained from two sources to study insulin-stimulated GLUT4 dispersal. It 
was observed that iPSC-CM obtained from NCardia showed a significant increase in HA-
GLUT4 localization density and dispersal in response to insulin treatment. However, 
experiments included a relatively small amount of cells and investigation of more 
samples is required to validate the observed effect. Unfortunately, NCardia experienced 
problems with their quality control and the cells were withdrawn from the market in 
the middle of this study. Similar experiments were carried out using iPSC-CM produced 
by CDI but these yielded conflicting results. CDI iPSC-CM showed a similar fold increase 
in HA-GLUT4 plasma membrane localization density but the overall GLUT4 density per 
μm2 observed was much lower compared to cells obtained from NCardia. CDI iPSC-CM 
did not exhibit insulin-stimulated GLUT4 dispersal assessed by dSTORM. This indicates 
differences between the two iPSC-CM lines that were commercially obtained. One 
possible explanation for this is the huge variety of differentiation and purification 
protocols that are employed by different companies and laboratories resulting in 
problems with consistency. We observed morphological differences between cells 
obtained from NCardia and CDI. In general cells had a circular shape but it was observed 
that cells from CDI were smaller with typical diameters of ~ 30 µm and that NCardia 
cells were much bigger and more spread out. Cells from both sources were 
spontaneously beating but the frequency of spontaneous beating and the size of beating 
clusters of cells varied. These variations in iPSC-CM cultures have been previously 
reported in the literature (Karbassi et al., 2020). 
 
One widely accepted major limitation of iPSC-CM is that protocols generate immature 
cardiomyocytes at embryonic or early foetal stages (Karbassi et al., 2020). Previous 
studies carried out in our laboratory assessed the capacity of iPSC-CM to act as a novel 




general observation was that iPSC-CM obtained from both NCardia and CDI expressed 
insulin signalling intermediates and trafficking proteins but lacked significant expression 
of GLUT4 protein (Bowman et al., 2019). Furthermore it was discovered that iPSC-CM 
did not exhibit insulin-stimulated glucose uptake (Bowman et al., 2019). It was observed 
that iPSC-CM had high levels of GLUT1 protein expression. Consistent with the current 
literature taken together these results indicate that iPSC-CM are metabolically 
immature. Several interventions were explored to increase the low endogenous levels of 
GLUT4 protein in these cells in our laboratory. Treatment with thyroid hormone tri-
iodothyronine (T3) and maturation medium conditioning with low glucose were not 
successful and had no or limited impact on GLUT4 expression (Bowman et al., 2019). 
The observed differences in insulin-stimulated GLUT4 dispersal observed in this study 
might be attributed to different levels of maturation of the cells. NCardia iPSC-CM 
showed higher levels of GFP fluorescence intensity following transduction with Ad-HA-
GLUT4-GFP compared to CDI iPSC-CM. Transduction efficiency was higher in NCardia 
iPSC-CM and similar to that observed in highly proliferative and immature NRVM and 
therefore it might be that these cells can be classed as more immature. CDI iPSC-CM 
appeared dim after transduction with Ad-HA-GLUT4-GFP and this resulted in lower 
quality dSTORM image raw data quality which made it harder to investigate GLUT4 
spatial dynamics in these cells. Human iPSC-CM provide the opportunity to capture the 
heterogeneity of the human population that arises from gender, ethnicity and patient-
specific gene modifications and have been successfully used to model genetic cardiac 
disorders (Itzhaki et al., 2011; Josowitz et al., 2011; Matsa et al., 2011; Moretti et al., 
2010). The cells can be directly derived from patients and have been used to 
successfully model diabetic cardiomyopathy and study drug-gene interactions and 
evaluate potency of candidate drugs in reversing aberrant phenotypes (Bellin et al., 
2012; Drawnel et al., 2014; Granéli et al., 2019; Takahashi and Yamanaka, 2013). 
 
5.3.4 Conclusions and future directions 
To our knowledge this was the first study that investigated insulin-stimulated GLUT4 
dispersal in a variety of in vitro models of cardiac muscle tissue. It was observed that 
insulin did not stimulate GLUT4 dispersal in NRVM and CDI iPSC-CM. Insulin did have an 
effect an GLUT4 plasma membrane distribution in NCardia iPSC-CM. This study was 
unable to study GLUT4 translocation or dispersal in adult cardiomyocytes due to a 
number of experimental limitations. Therefore, it can be concluded that this study shed 
some light on the mechanisms of GLUT4 dispersal that exist in cardiac tissues but more 
studies are needed to explore more cell culture models and also experimental 
techniques. Cardiac cell culture models differ vastly in their individual stage of 




combination of experimental systems can solve the nature of cardiac GLUT4 dispersal in 
the future. In the future it would be highly desirable to expose different in vitro models 
to drug treatments and investigate models of cardiac disease which was not within the 

































6. Plasma membrane GLUT4 dispersal in health and 
disease 
6.1 Introduction  
6.1.1 Skeletal muscle glucose uptake 
In vivo, skeletal muscle is the primary tissue in which the vast majority (about 90 %) of 
insulin-stimulated glucose uptake occurs (Kraegen et al., 1993). Similarly to adipocytes 
skeletal muscle fibres express both GLUT1 and GLUT4 transporter isoforms with a higher 
abundance of GLUT4 (Marette et al., 1992). GLUT4 is the main isoform facilitating 
insulin-dependent glucose transport in skeletal muscle (Hansen et al., 1995). Although 
GLUT4 trafficking has been extensively studied in adipose tissue far less is known about 
GLUT4 trafficking in skeletal muscle (Mueckler, 2001). This may be due to the more 
complex tissue architecture, lack of appropriate cell culture models closely reflecting 
the anatomy and physiology of striated muscle fibres and difficulty of performing 
traditional experimental techniques on skeletal muscle tissues compared to adipocytes. 
Analysis of single muscle fibres from the vastus lateralis of eight male subjects has 
shown that GLUT4 protein content was highest in muscle fibres expressing myosin heavy 
chain (MHC) 1 compared to fibres expressing MHC IIA and MHC IIX (Daugaard et al., 
2000). Another study found that mRNA concentrations of GLUT4 were highest in human 
muscle samples compared to mRNA concentrations of other GLUT isoforms (Stuart et 
al., 2006). Human muscle homogenates predominantly expressed GLUT4 protein and 
showed lower expression of GLUT5 and GLUT12 isoforms. Immunostaining experiments 
showed that GLUT4 and GLUT12 were predominantly expressed in type I oxidative fibres 
whereas GLUT5 was most abundant in type II white fibres (Stuart et al., 2006).  
 
Contrary to adipocytes, skeletal muscle fibres contain two anatomically distinct plasma 
membrane domains: the sarcolemma (plasma membrane) and transverse tubules (t-
tubules) which are invaginations of the plasma membrane that penetrate deep into the 
centre of the muscle fibre. GLUT1 is restricted to the surface of the muscle cells and 
does not respond to insulin stimulation in contrast to adipocytes (Marette et al., 1992). 
GLUT4 is localised to both the sarcolemma and the interior of the fibres. Insulin 
stimulation results in translocation of GLUT4 to both the sarcolemma and the t-tubules 
but the majority of insulin-stimulated glucose transport occurs across t-tubules (Wang 
et al., 1996). Electron microscopy experiments of human muscle revealed no GLUT4 
immunogold labelling on the sarcolemma and specific GLUT4 labelling within the t-
tubules and possibly the sarcoplasmic tubules (Friedman et al., 1991). Using 




reported that 90 % of GLUT4 is present in the t-tubules after insulin stimulation (Wang 
et al., 1996).  
 
GLUT4 trafficking in muscle tissue is more complex because contraction is a major 
physiological stimulus of GLUT4 translocation independent of insulin. Observations of 
changes in arteriovenous glucose in equine masseter muscle during chewing indicated 
the existence of contraction-induced skeletal muscle glucose uptake more than 120 
years ago (Richter and Hargreaves, 2013). In the 1950s quantitative physiological studies 
using rats and dogs confirmed that contractions stimulate muscle glucose uptake 
(Goldstein et al., 1953; Huycke and Kruhoffer, 1955). Several studies confirmed that 
contraction-induced glucose uptake is primarily due to translocation of GLUT4 from 
intracellular stores to the sarcolemma and t-tubules. Recently, immunofluorescence 
microscopy was used to quantify net GLUT4 translocation to the PM in human vastus 
lateralis biopsies from ten human subjects following glucose ingestion for the first time 
(Bradley et al., 2015). Moreover, It has been reported that electrical stimulation or a 3 
h swim exercise had no effect on glucose uptake in muscle in GLUT4-deficient mice 
highlighting the fundamental importance of GLUT4 in exercise-induced glucose uptake 
(Ryder et al., 1999; Zisman et al., 2000).  
 
6.1.2 Insulin resistance  
6.1.2.1 Theories of peripheral insulin resistance 
Insulin resistance is the inability of the body’s cells to respond appropriately to insulin 
as a stimulus to increase glucose transport across cell surface membranes in target 
tissues to reduce blood sugar levels (Samuel and Shulman, 2016). Many causes have 
been proposed to lead to the development of insulin resistance and the underlying 
molecular mechanisms are not completely elucidated. Skeletal muscle accounts for the 
majority of glucose disposal after a meal in healthy individuals. Therefore skeletal 
muscle is the major glucose sink of the body and has to play an important role in the 
pathogenesis of insulin resistance which has been extensively studied (Abdul-Ghani and 
DeFronzo, 2010). Insulin resistance has been identified as a key defect in T2DM and is 
heavily associated with obesity and metabolic syndrome in which insulin-stimulated 
glucose transport into skeletal muscle is significantly impaired (DeFronzo, 2004; 
DeFronzo et al., 1985; Mitrakou et al., 1990). Under normal conditions insulin secretion 
after a meal suppresses lipolysis resulting in a decrease in plasma free fatty acids (FFA) 
levels and drop in the rate of lipid oxidation. It has been proposed that chronic 
overfeeding leads to increased FFA availability and onset of obesity. Different studies 




muscle insulin resistance in human subjects (Erdmann et al., 2008; Lemay et al., 2010; 
Schrauwen, 2007; Wedick et al., 2009). Muscle biopsies have revealed an accumulation 
of triglycerides in skeletal muscle cells and that these deposits negatively impact insulin 
sensitivity (Pan et al., 1997; Phillips et al., 1996). 
 
One defect that has been proposed is that levels of GLUT4 may be reduced in insulin-
resistant individuals. One study investigated the insulin resistance of aging in 
relationship to GLUT4 protein content in vastus lateralis muscle in men and women 
(Houmard et al., 1995). With increasing age insulin sensitivity was observed to decrease 
significantly and this was associated with a decrease in skeletal muscle GLUT4 protein 
concentration (Houmard et al., 1995). However, there is evidence that GLUT4 content 
and levels of mRNA are not changed in individuals with obesity, impaired glucose 
tolerance, non-insulin-dependent diabetes or gestational diabetes (Garvey et al., 1992). 
Another study reported no change in GLUT4 gene and protein expression in vastus 
lateralis muscle of subjects with insulin-dependent diabetes mellitus compared to 
healthy controls in the same year (Kahn et al., 1992). A study comparing gene and 
protein expression of muscle biopsies isolated from T2DM patients, T2DM first-degree 
relatives and healthy controls showed that T2DM patients and their relatives had an 
impairment in insulin-stimulated total-body glucose disposal indicating insulin resistance 
(Eriksson et al., 1992). The observed skeletal muscle insulin resistance was not 
associated with a defect GLUT4 gene expression (Eriksson et al., 1992). A study using a 
novel photoaffinity labelling agent has found that GLUT4 cell surface levels in skeletal 
muscle of nine T2DM patients were only 10% of those observed in nine healthy controls 
(Ryder et al., 2000). Glucose transport activity in T2DM skeletal muscle samples was 
approximately 50% of that in healthy controls. This study highlights that a reduction in 
GLUT4 translocation majorly contributes to the impairment of glucose transport 
observed in T2DM subjects (Ryder et al., 2000). As outlined in section 1.5.5 there is 
strong evidence for the impairment of molecular pathways of insulin signalling for 
instance reduced insulin receptor phosphorylation, decreased IRS-1 tyrosine 
phosphorylation and decreased PI3-kinase activation (Björnholm et al., 1997; Cusi et 
al., 2000; Dresner et al., 1999; Isakoff et al., 1995; Kim et al., 1999). Furthermore, in 
skeletal muscle of T2DM subjects reduced insulin-stimulated Akt kinase activity (Krook 






6.1.2.2 Defects in the adipocyte glucose transport system and cellular insulin 
resistance  
Isolated omental adipocytes obtained during caesarean sections from healthy and 
gestational diabetes patients were used to study defects in the adipocyte glucose 
transport system and insulin resistance at the cellular level (Garvey et al., 1993). It was 
observed that basal and insulin-stimulated glucose transport rates were markedly 
reduced in adipocytes isolated from gestational diabetes patients indicative of cellular 
insulin resistance. Cellular content of GLUT4 was found to be decreased in diabetic 
patients with segregation into two groups. One group suffered severe GLUT4 depletion 
and the other group had GLUT4 levels within the normal range. Insulin stimulated 
GLUT4 translocation from low-density microsomes to the PM in healthy subjects but 
failed to stimulate GLUT4 translocation in diabetic patients indicating abnormalities in 
cellular traffic and targeting of GLUT4 (Garvey et al., 1993). 3T3-L1 adipocytes are the 
model system of choice for investigating regulatory effects on glucose transport at the 
cellular level and researchers have developed experimental approaches to mimic 
adipocyte insulin resistance in culture. Chronic treatment with 500 nM insulin for 24 h 
has been used to mimic insulin resistance and study its consequences. It has been 
reported that chronic insulin treatment of 3T3-L1 adipocytes results in an increase in 
GLUT1 protein expression but had no effect on GLUT4 (Tordjman et al., 1989). Using a 
novel bis-mannose-photolabeling technique cell surface levels of GLUT4 were found to 
be 53 % reduced following chronic insulin stimulation compared to that of acute insulin 
stimulation (Kozka et al., 1991). Furthermore, as a result of chronic insulin treatment a 
6-fold rise of total amount of GLUT1 was reported whereas total amount of GLUT4 
increased by 1.4-fold. Radioactive glucose uptake experiments showed that chronic 
insulin treatment by itself increased glucose transport in 3T3-L1 adipocytes whereas a 
second challenge with insulin resulted in a blunted response (Kozka et al., 1991). It was 
observed that binding of insulin tracer was not altered after chronic insulin treatment 
of the cells. Therefore it was proposed that the downregulation of cell surface GLUT4 in 
3T3-L1 cells was not due to resistance at the insulin receptor level or depleted GLUT4 
pool but rather dependent on a defect existing in the signalling pathway (Kozka et al., 
1991). Another study using iodixanol gradient centrifugation to separate intracellular 
GLUT4 compartments into recycling endosomes and GSVs reported that an acute insulin 
stimulus reduced GLUT4 content in the GSV but not in the endosomal compartment 
(Maier and Gould, 2000). Chronic insulin treatment resulted in a decreased in GLUT4 
content by 40 % and blunted the GLUT4 translocation response to a second acute insulin 
challenge. This study also reported that GLUT4 was selectively diminished from the GSV 




resistance (Maier and Gould, 2000). There is only one study currently assessing the 
effect of chronic insulin treatment on PM GLUT4 dispersal and whether this affects 
cellular insulin resistance in adipocytes needs to be validated.  
6.1.3 Transferrin receptor trafficking 
6.1.3.1 The transferrin receptor and glucose metabolism 
The Transferrin receptor (TfR) is a membrane protein that facilitates iron uptake in 
cells and is widely expressed throughout the body (Mayle et al., 2012). Iron-loaded 
transferrin binds to the TfR which imports iron by internalizing through clathrin-
mediated endocytosis and intracellular trafficking pathways. The endocytosed 
transferrin-iron complexes are sorted into early, late and recycling endosomes. 
Acidification by proton pumps lowers the pH of the endosomes to 5 to release the iron 
from the transferrin and leaves apo-transferrin bound to the TfR (Bomford and Munro, 
1985). Cargo can return directly from the early endosomes to the PM via a fast route or 
delivered to perinuclear recycling endosomes via a slow route before being returned to 
the cell surface (Mayle et al., 2012). Due to its continuous recycling pathway between 
the PM and endosomes TfR has become a widely recognised marker for endosomal 
compartments (Kobayashi and Fukuda, 2013). In 1986 it was discovered that insulin 
stimulated translocation of TfR from intracellular stores to the PM in isolated rat 
adipocytes (Davis et al., 1986). Analysing the rate of uptake of diferric 125I-transferrin a 
3-fold increase in the amount of cell surface TfR was found following insulin 
stimulation. This was associated with a concomitant decrease of TfR within intracellular 
membranes indicating insulin-mediated redistribution of the TfR similar to that 
observed in GLUT4 (Davis et al., 1986). Furthermore, it was reported that contraction 
stimulated translocation of TfR from intracellular compartments to the PM but not to 
the t-tubules in perfused hindlimb rat muscle (Lemieux et al., 2000). It was reported 
that the effect of insulin and contraction on TfR translocation was not additive and the 
same as recorded for the effect of contraction by itself (Lemieux et al., 2000). 
Contraction was observed to reduce TfR content in purified GLUT4 vesicles whereas 
insulin did not affect TfR content and only reduced GLUT4 content in these vesicles. 
This led to the conclusion that contraction stimulates GLUT4 translocation from two 
distinct intracellular GLUT4 pools in skeletal muscle defined by the presence of TfR 
(Lemieux et al., 2000). In 3T3-L1 adipocytes a vesicular fraction from intracellular 
membranes was identified that contained >90 % GLUT4 and 40 % TfR using 
immunoadsorption (Livingstone et al., 1996). Another vesicle fraction containing 50 % 
TfR and 40 % GLUT4 was identified similarly indicating that significant amounts of both 
TfR and GLUT4 reside in distinct internal compartments (Livingstone et al., 1996). A 




resulted in the identification of a TfR-negative/GLUT4-positive, TfR-positive/GLUT4-
negative and TfR-positve/GLUT4-positive compartment (Livingstone et al., 1996). 
Another study showed that GLUT4 is equally distributed between TfR-containing 
endosomes and a TfR-negative specialised compartments in the basal state in 3T3-L1 
adipocytes using a fluorescent quenching assay (Zeigerer et al., 2002). It was proposed 
that the equal distribution of GLUT4 indicates that the rate of transport from 
endosomes and the specialised compartment must be similar. Insulin stimulation 
resulted in GLUT4 translocation from both pools and trafficking of GLUT4 from 
endosomes was regulated by Rab11 (Zeigerer et al., 2002). Taken together these studies 
highlight that GLUT4 trafficking overlaps with TfR trafficking and the general endocytic 
recycling pathway. 
 
6.1.3.2 The role of the transferrin receptor in insulin resistance  
Recently the association between insulin resistance and disturbances of iron 
homeostasis has become a popular research topic. Skeletal muscle is not only the major 
tissue for glucose disposal but also for iron utilization and storage and several studies 
described a growing link between insulin resistance and iron dysregulation. A study 
using human skeletal muscle myoblasts (HSMM) from Lonza and skeletal muscle biopsies 
as model systems found that palmitate treatment induced a state of insulin resistance 
in HSMM and increased intracellular iron levels (Cui et al., 2019). Knock-down of TfR1 
resulted in protection of HSMM from excess iron-induced insulin resistance indicating 
that TfR is important for maintenance of insulin sensitivity in these cells. Furthermore, 
it was observed that palmitate treatment induced overexpression of TfR1 at the protein 
and mRNA level in HSMM and this result corresponded with results obtained from muscle 
biopsies of diabetic patients (Cui et al., 2019). In this model intracellular iron 
accumulation was induced by excess FFA availability and modulated by upregulation of 
TfR and increased TfR internalization indicating a critical role of TfR in the 
development of insulin resistance (Cui et al., 2019). Simple incubation of 3T3-L1 
adipocytes with transferrin has been observed to result in decreased rates of insulin-
stimulated glucose uptake indicating that transferrin alone induced insulin resistance of 
glucose uptake in adipocytes (Green et al., 2006). A study investigating serum soluble 
TfR in men with normal glucose tolerance, impaired glucose tolerance and T2DM 
reported that insulin sensitivity predicted circulating TfR in normal glucose tolerance 
and non-obese subjects (Fernández-Real et al., 2007). Another cross-sectional study 
found an independent and positive association between circulating TfR and insulin 
resistance in men and postmenopausal women (Suárez-Ortegón et al., 2016). In a 




including 1,277 men and women transferrin was found to be predictive of the onset of 
hyperglycaemia within 3 years (Fumeron et al., 2006). A retrospective longitudinal study 
including 30,000 Koreans found that serum transferrin levels were elevated in T2DM 
subjects compared to controls (Kim et al., 2020). Furthermore, transferrin levels helped 
to predict future incident of T2DM in healthy subjects in this population (Kim et al., 
2020). Assessment of gene expression, genotype, and insulin sensitivity of adipose tissue 
in 256 nondiabetic African Americans revealed that 30 iron homeostasis genes were 
correlated with insulin sensitivity (McClain et al., 2018). Findings were successfully 
replicated in two European cohorts independently. Knock-down of transferrin in vitro in 
SGBS cells changed gene expression related to glucose transport, mitochondrial function 
and chemokine activity (McClain et al., 2018). The study indicates that genetic 
regulation of transferrin expression in adipocytes plays in important role in regulating 
insulin sensitivity (McClain et al., 2018). A meta-analysis including 46 observational 
studies investigating the association of iron metabolism and development of T2DM 
concluded that results were extremely heterogenous across studies (Orban et al., 2013). 
However, clinically elevated transferrin saturation was found to be highly correlated 
with an increased risk of T2DM with current evidence hinting at a causal effect (Orban 
et al., 2014). Recently a bifunctional proinsulin-transferrin fusion protein containing 
two functional moieties of insulin and transferrin was designed to serve as a liver-
targeted prodrug for treatment of type I diabetes in mice (Liu et al., 2020). The fusion 
protein activated both the IR and TfR and attenuated insulin resistance in palmitate-
treated HepG2 cells and non-obese diabetic mice (Liu et al., 2020). This study highlights 
the therapeutic potential of the investigation of the role of the TfR in the development 
of T2DM and insulin resistance. Taken together these studies highlight a close link 
between iron and glucose metabolism. Elevated TfR levels have been associated with 
decreased insulin sensitivity and onset of metabolic disease.   
 
6.1.4 Hypothesis and research aims 
The aim of this chapter was to investigate different aspects of GLUT4 trafficking and 
dispersal in several cell culture models of health and disease. Firstly, we aimed to 
characterise the effect of chronic insulin treatment on surface GLUT4 spatial patterning 
at the single molecule level in adipocytes using dSTORM. We hypothesised that chronic 
insulin treatment would result in a state of cellular insulin resistance and attenuation of 
insulin-stimulated GLUT4 dispersal could be an underlying cause in adipocytes.  
Subsequently we aimed to investigate whether the mechanism of insulin-stimulated 
dispersal is specific to GLUT4. We aimed to produce a novel plasmid vector with a pCDH 
backbone and CMV promoter for the production of a lentivirus to express a GFP-tagged 




patterning of TfR on the cell surface. Given the emerging role of the TfR in insulin 
resistance these baseline studies are a valuable contribution. 
Finally, we aimed to characterise GLUT4 dispersal in a cell culture model of human 
skeletal muscle for the first time. We also aimed to investigate the expression of 
several proteins involved in the GLUT4 trafficking cascade to gain insights into 
underlying molecular processes. There is a gap in our understanding of the mechanisms 
that contribute to peripheral and cellular insulin resistance and the experiments 






























6.2.1 Insulin resistance reorganises plasma membrane GLUT4 
clustering  
As a starting point we assessed whether chronic insulin treatment with 500 nM for 24 h 
resulted in an insulin resistant phenotype in 3T3-L1 adipocytes as previously reported in 
the literature. Insulin resistance is characterised by impaired glucose uptake and 
therefore a radioactive glucose uptake assay was conducted to confirm this. Insulin 
stimulation resulted in a 4.5-fold increase of glucose uptake in control cells and this was 
significantly reduced to a 1.2-fold increase in the chronic insulin treatment group 
(Figure 6.1). This data is in good agreement with other studies (Kozka et al., 1991; 
Maier and Gould, 2000). After establishing that we can induce insulin resistance 
experimentally in 3T3-L1 adipocytes we adapted the same protocol for all future 
experiments.  
                
Figure 6.1 Insulin-stimulated deoxyglucose uptake in control and chronic insulin-
treated 3T3-L1 adipocytes.  
2-deoxyglucose uptake was measured as described (section 2.4.1). 3T3-L1 adipocytes 
were differentiated and either left untreated (control) or treated with 500 nM insulin on 
Day 10 for 24 h (chronic insulin). On Day 11 cells were incubated in serum-free medium 
for 2 h prior to experiments. Cells were washed with KRP and either left untreated or 
treated with 100 nM insulin for 20 min followed by a 5 min uptake of 2-deoxyglucose at 
37°C. Basal glucose uptake rates were typically of the order of 600 counts per min/well. 
The data displayed represent fold changes of insulin stimulation from one experiment 
conducted in triplicate. p<0.0001 indicated by *, ns=not significant; determined by one-
way ANOVA. 
 
Subsequently we carried out STORM imaging experiments for 3T3-L1 adipocytes under 
control and chronic insulin treated basal and insulin-stimulated conditions. Ripley’s L-
function analysis was carried out to quantify changes in GLUT4 dispersal in the PM. 




basal and insulin-stimulated cells from three independently performed experiments. 
The observed L(r) peaked at similar clustering values for GLUT4 on the PM of untreated 
control and chronic insulin treated cells. This indicates that there was no significant 
difference in GLUT4 clustering on the plasma membrane in the absence of insulin 
stimulation. Insulin stimulation shifted L(r) to lower values indicating GLUT4 dispersal. 
Furthermore, chronic insulin treatment was observed to attenuate the observed insulin-
stimulated GLUT4 dispersal in 3T3-L1 adipocytes significantly (Figure 6.2). 
 
 
Figure 6.2 Ripley's K-function analysis of the effect of chronic insulin treatment on 
GLUT4 clustering in basal and insulin-stimulated 3T3-L1 adipocytes. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. 3T3-L1 adipocytes were 
differentiated and either left untreated (control) or treated with 500 nM insulin on Day 
10 for 24 h (chronic insulin). On Day 11 cells were serum-starved for 2 h prior to the 
experiment and stimulated with 100 nM insulin for 20 min or left untreated. Cells were 
fixed and stained for surface HA and dSTORM images acquired. GLUT4 molecule 
coordinates were obtained using ThunderSTORM and the obtained localization data was 
subjected to Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 200 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are mean ± SD (N=3). The experiment was performed independently 3 times for 
control basal (N=31 cells) and insulin-stimulated (N=30 cells), and chronic insulin basal 




We also assessed localization density of GLUT4 molecules in control and chronic insulin 
treated experimental groups (Figure 6.3). The localisation density of GLUT4 molecules 
significantly increased by 2.6-fold from 152 localisations per μm2 in the basal state to 
402 per μm2 after insulin stimulation. Furthermore, chronic insulin treatment slightly 
elevated the localisation density of GLUT4 molecules by 48 % to 220 per μm2. Insulin 





















stimulation of chronically insulin-treated cells resulted in a measured GLUT4 
localization density of 268 molecules per μm2 which is 34 % less than the density 
observed for control insulin-stimulated cells. This shows that more GLUT4 molecules 
were present in the plasma membrane of 3T3-L1 adipocytes following insulin 
stimulation and that this effect was blunted following chronic insulin treatment. 
Therefore, insulin-stimulated GLUT4 translocation occurs in chronic insulin-treated 3T3-
L1 adipocytes but the observed effect is attenuated compared to that observed in the 
control group.  
 
Figure 6.3 Localisation density in control and chronic insulin treated basal and 
insulin-stimulated 3T3-L1 adipocytes determined by dSTORM imaging. 
3T3-L1 adipocytes were incubated in serum-free medium for 2 h prior to the experiment 
and stimulated with 100 nM insulin for 20 min or left untreated. Cells were fixed and 
stained for surface HA and dSTORM images acquired on a Zeiss Elyra PS.1 (described in 
section 2.3). Reconstructions of raw images were calculated using the ImageJ plugin 
ThunderSTORM. Localisation density was determined using the ImageJ plugin 
LocFileVisualizer (see 2.4.10). Control basal: 152 ± 86 (n = 31), control insulin: 402 ± 
268 (n = 30), chronic insulin basal 220 ± 158 (n = 17) and chronic insulin +insulin 268 ± 
195 (n = 29). Mean ± SD. p <0.0001; determined by one-way ANOVA. 
 
 
High-throughput flowcytometry experiments have shown that 3T3-L1 adipocytes present 
as a very heterogenous cell population in culture (Figure 4.10). Our imaging 
experiments support the existence of significant morphological heterogeneity regarding 
cell shapes and sizes. Here we investigated how morphological heterogeneity affects 
metabolic heterogeneity in adipocytes and whether there is a relationship between cell 




insulin-stimulated 3T3-L1 adipocytes and GLUT4 molecule localization density per μm2 
over a range of cell sizes. In both basal and insulin-stimulated cells cell area was 
significantly negatively correlated with GLUT4 molecule density indicating that bigger 
cells have a lower GLUT4 molecule density and are less insulin sensitive.  
 
 
Figure 6.4 GLUT4 localisation density as a function of cell area for basal and insulin-
treated 3T3-L1 adipocytes determined by dSTORM imaging. 
3T3-L1 adipocytes were serum-starved and stimulated with 100 nM insulin for 20 min or 
left untreated. Cells were fixed, stained for anti-HA and dSTORM images acquired 
(described in section 2.3). Reconstructions were calculated using ThunderSTORM. 
Localisation density was determined using LocFileVisualizer (see 2.4.10). ROIs were 
drawn around each cell to determine cell area and GLUT4 molecule localization density. 
Basal cells (N=72) Pearson r=-0.5 with p<0.0001; Insulin=stimulated cells (N=66) Pearson 
r=-0.4 with p=0.0011, correlation analysis with Graphpad Prism. 
 
 
Segmentation of data according to mean cell area allowed further comparison of the 
effect of insulin stimulation on small and big cells (Figure 6.5). It was observed that 
insulin stimulation resulted in a significant increase in GLUT4 molecule density in cells 
with areas above and below 7,500 μm2. However, figure 6.5 shows that the increase in 
GLUT4 molecule density was higher in small cells with areas below 7,500 μm2 following 
insulin stimulation.  






























Figure 6.5 Comparison of GLUT4 localisation density in small and bigger basal and 
insulin-stimulated 3T3-L1 adipocytes determined by dSTORM imaging. 
3T3-L1 adipocytes were serum-starved and stimulated with 100 nM insulin for 20 min or 
left untreated. Cells were fixed, stained for anti-HA and dSTORM images acquired 
(described in section 2.3). Reconstructions were calculated using ThunderSTORM. 
Localisation density was determined using LocFileVisualizer (see 2.4.10). ROIs were 
drawn around each cell to determine cell area and GLUT4 molecule localization density. 
The mean GLUT4 localization density comparing basal and insulin-stimulated adipocytes 
with areas below or above the mean cell area of ~7,500 μm2. Mean ± SEM. Basal vs 





6.2.2 Generation of a novel pCDH-TfR-GFP lentiviral vector to 
investigate the specificity of GLUT4 dispersal 
To assess whether insulin-stimulated plasma membrane dispersal is specific to GLUT4 
we decided to investigate dispersal of TfR in a similar manner. The performance of 
imaging experiments requires a fluorescent tag to visualise the protein of interest. 
Therefore we decided to develop a lentivirus capable of expressing a GFP-tagged 
version of the TfR in a variety of cell culture models. To achieve this goal the TfR-GFP 
sequence from a plasmid that was gifted to our lab was subcloned into a pCDH vector 





Figure 6.6 Generation of a novel pCDH-CMV-MCS-EF1-TfR-GFP DNA plasmid. 
Representative restriction enzyme digests of plasmid vectors. (A) Cutting the pEGFP-N1-
Flag-TfR-GFP with both Nhe1 and Not1 restriction enzymes resulted in excision of the 
TfR-GFP gene fragment with the size 4000 bp. Kas1 was used to break the vector apart 
further to distinguish the vector backbone clearly from the TfR-GFP fragment. (B) 
Cutting the original pCDH-CMV-MCS-EF1-HA-GLUT4-GFP with both Nhe1 and Not1 
restriction enzymes resulted in excision of the GLUT4-GFP gene fragment with the size 
5000 bp. The TfR-GFP gene sequence was ligated into the open pCDH backbone to 
generate a novel pCDH-CMV-MCS-EF1-TfR-GFP plasmid and successful ligation was 
assessed by comparing the sizes of fragments after digestion. The pCDH backbone of the 
novel pCDH-CMV-MCS-EF1-TfR-GFP plasmid was similar to that found in the original 
pCDH-CMV-MCS-EF1-HA-GLUT4-GFP plasmid but the newly inserted TfR-GFP gene 
fragment was smaller compared to the HA-GLUT4-GFP sequence found in the original 
plasmid. pCDH GLUT4 = pCDH-CMV-MCS-EF1-HA-GLUT4-GFP; pEGFP TfR = pEGFP-N1-
Flag-TfR-GFP; pCDH TfR = pEGFP-N1-Flag-TfR-GFP; DD = double digest with Nhe1 and 
Not1 restriction enzymes.  
 
 
Next, we confirmed whether the newly developed plasmid was capable of inducing cells 
to produce GFP-tagged TfR protein. The novel pCDH-CMV-MCS-EF1-TfR-GFP plasmid was 
amplified in Stbl 3 competent E. coli and used to transfect HeLa cells. Figure 6.7 shows 
that transfected HeLa cells contained clearly detectable levels of TfR-GFP protein at 
120 kDa. Our intention was to generate recombinant lentivirus to allow expression of 
TfR-GFP in 3T3-L1 adipocytes. However, as a result of the lockdown, insufficient time 




virus. We have previously shown that GLUT4 translocates and disperses in response to 
insulin stimulation in HeLa cells which are easily transfected with DNA (Morris et al., 
2020; Figure 4.18). Therefore, we transfected HeLa cells again with pCDH-CMV-MCS-
EF1-TfR-GFP plasmid DNA and carried out dSTORM experiments to investigate the 




Figure 6.7 Transfection of HeLa cells with pCDH-CMV-MCS-EF1-TfR-GFP plasmid.  
HeLa cells were plated into wells of a 12-well plate and maintained until 70% 
confluence. Cells were transfected according to the manufacturer’s protocol, as 
described in methods section 2.6.2. Final volumes of Lipofectamine 2000 and DNA 
added per well are indicated. 48 h later lysates were generated and 35 μL of each 
sample was subjected to SDS-PAGE and immunoblotting in order to assess the expression 




We performed Ripley’s K-function analysis of dSTORM images of untreated and insulin-
stimulated HeLa cells expressing TfR-GFP. Data from three independent experiments 
are shown in figure 6.8. Insulin stimulation for 20 min did not affect the L(r) function 
indicating that there was no difference in clustering of TfR-GFP molecules in the PM (p= 
0.0683; determined by two-tailed Student’s t-test). TfR expression has been linked to 
insulin sensitivity and the development of T2DM. Here we report that insulin did not 
stimulate TfR dispersal in HeLa cells as observed in GLUT4. Therefore, in HeLa cells TfR 



















Figure 6.8 Ripley's K-function analysis of TfR-GFP clustering in basal and insulin-
stimulated HeLa cells. 
Representative plot of Ripley’s K function analysis of the clustering abilities of TfR-GFP 
molecules in the PM of HA-GLUT4-GFP HeLa cells. Cells were transfected with TfR-GFP 
as previously described. Cells were serum-starved for 2 h prior to the experiment and 
stimulated with 1 μM insulin for 20 min or left untreated. Cells were fixed, 
permeabilised and stained for GFP and dSTORM images acquired. GLUT4 molecule 
coordinates were obtained using ThunderSTORM and the obtained localization data was 
subjected to Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 
nm, step radius 10 nm, and maximum radius 200 nm. L(r)-r (y-axis) represents the 
clustering ability and r (x-axis) represents the radial scales of clustering. The presented 
data are mean ± SD (N=3). The experiment was performed independently 3 times for 
basal (N=16 cells) and insulin-stimulated (N=16 cells) conditions. p = 0.0683; determined 
by two-tailed Student’s t-test. 
 
 
6.2.3 GLUT4 dispersal in primary human skeletal muscle cells 
from healthy and diabetic donors 
Cryopreserved CloneticsTM Human Skeletal Muscle Myoblasts (HSMM) were commercially 
obtained from Lonza. The cells were isolated from the upper arm or leg muscle tissue 
from normal donors and donors diagnosed with T2DM allowing for comparisons between 
healthy and diseased tissue. Firstly, we confirmed the ability of healthy and T2DM HSMM 
to differentiate into multinucleated myotubes in cell culture. Bright field images show 
that HSMM from both sources demonstrated robust morphological differentiation into 
myotubes 5 days after initiation of differentiation according to the supplier’s 





Figure 6.9 Bright field images of undifferentiated and differentiated HSMM derived 
from healthy and T2DM donors.  
Representative confocal images of HSMM. The upper panel shows cells derived from a 
healthy donor whereas the lower panel shows cells derived from a T2DM donor. Images 
on the right show myoblasts and images on the left show myotubes 5 days after 
initiation of differentiation. Scale bars=100 μm.  
 
 
Desmin is an abundant class-III intermediate filament protein known to regulate 
sarcomere architecture in human muscle. Staining for desmin is frequently used to 
confirm skeletal muscle differentiation and therefore was used to characterise the 
differentiation process of HSMM further in this study. Confocal images show that 
undifferentiated healthy and T2DM myoblasts did not express desmin but differentiated 





Figure 6.10 Confocal images HSMM stained for DAPI and desmin. 
Representative confocal images of undifferentiated and differentiated HSMM derived 
from healthy and T2DM donors. Images on the right show DAPI-stained cell nuclei and 
images on the left show anti-desmin staining. Displayed are grayscale images with 





In the following immunofluorescence staining of GLUT4 was used to assess basal state 
GLUT4 localization in HSMM. Confocal images show that both undifferentiated and 
differentiated cells showed weak GLUT4-positive staining (Figure 6.11). However, the 
staining intensity was too low to gain reliable insights into intracellular GLUT4 
localization.  
 
HSMM were differentiated into myotubes and infected with Ad-HA-GLUT4-GFP to 
perform imaging experiments. The expression of GFP-tagged GLUT4 protein following 
adenoviral transduction was confirmed by epifluorescence microscopy 48 h post-
transduction prior to each imaging experiment. Numerous differentiated HSMM 
expressed GFP indicating a high transduction efficiency (data not shown). 
Morphologically there were no differences between HSMM from a healthy or T2DM 
donor. To observe the molecular distribution and quantify the spatial patterning of 
GLUT4 within the PM HA-staining was carried out and dSTORM images acquired. As 
previously described myotubes were screened in TIRF mode (Figure 6.12 A and D). 
Representative TIRF images show selectively excited diffraction-limited GLUT4-GFP in 
the PM (Figure 6.12 A and D). Reconstructed dSTORM images show clearly visible single 
GLUT4 molecules as well as clusters withing the PM (Figure 6.12 B and E). The 
magnifications of the reconstructed images as seen in figure 6.12 for a (C) basal and (F) 







Figure 6.11 Confocal images HSMM stained for DAPI and endogenous GLUT4. 
Representative confocal images of undifferentiated and differentiated HSMM derived 
from healthy and T2DM donors. Images on the right show DAPI-stained cell nuclei and 
images on the left show anti-GLUT4 staining. Displayed are grayscale images with 






Figure 6.12 TIRF and STORM images of surface GLUT4 in basal and insulin-stimulated 
HSMM from a healthy donor. 
HSMM transduced with Ad-HA-GLUT4-GFP were incubated in serum-free medium for 4 h 
and stimulated with 1 μM insulin for 20 min or left untreated. Cells were fixed and 
stained for surface HA and dSTORM images acquired. Reconstructions were created 
using the ImageJ plugin ThunderSTORM. (A) Representative fluorescence TIRF image of 
a HSMM. (B) Representative scatterplot of a basal cell showing localisations of single 
GLUT4 molecules. (C) Magnified section of image B. (D) Representative TIRF image of an 
insulin-stimulated cell. (E) Representative scatterplot of an insulin-stimulated cell 
showing localisations of single GLUT4 molecules. (F) Magnified section of image D. Scale 
bars = 10 μm (A, B, D, E) and 1 μm (C and F). This experiment was repeated 3 times 
with similar results.  
 
 
Ripley’s L-function analysis was carried out to quantify changes in GLUT4 dispersal in 
the PM of basal and insulin-stimulated HSMM from healthy and T2DM donors. Figure 6.13 
shows the averaged L(r) functions for basal and insulin-stimulated cells from three 
independently performed experiments. The observed L(r) peaked at similar clustering 
values for GLUT4 on the PM of untreated and insulin-stimulated cells derived from 
healthy (A) and T2DM (B) donors. This indicates that there was no significant difference 









Figure 6.13 Ripley's K-function analysis of GLUT4 clustering in basal and insulin-
stimulated HSMM. 
Ripley’s K function analysis of the clustering abilities of GLUT4 molecules in the PM of 
differentiated HSMM from (A) healthy and (B) T2DM donors. Cells were serum-starved 
and stimulated with 1 μM insulin for 20 min or left untreated. Cells were fixed, stained 
for surface HA and dSTORM images acquired. Molecules were localized using 
ThunderSTORM and the obtained data was subjected to Ripley’s K-function analysis 
using SR Tesseler with the minimum radius 10 nm, step radius 10 nm, and maximum 
radius 200 nm. The presented data are mean ± SD and experiments were performed 
independently 3 times for healthy basal (N=36 cells) and insulin-stimulated (N=31 cells), 
and T2DM basal (32 cells) and insulin-treated (31 cells) conditions. (A) p =0.18; (B) p= 





Subsequently, several proteins involved in GLUT4 trafficking were investigated and 
compared in healthy and diseased HSMM. As a starting point we assessed GLUT protein 
expression and insulin sensitivity of differentiated myotubes by western 
immunoblotting. Differentiated myotubes from each source showed a high insulin-
stimulated phosphorylation of Akt, indicating a robust insulin response (Figure 6.14). 
 
 
Figure 6.14 Insulin sensitivity in differentiated healthy and T2DM HSMM.  
HSMM were differentiated as previously described and protein expression was assessed 
by western immunoblotting. Differentiated myotubes from (A) healthy and (B) T2DM 
donors were treated with or without 1 μM insulin for 20 min as indicated. Blots were 
incubated with anti-Akt or anti-phospho Akt (p-Akt). Blots were visualised with a LI-COR 





Furthermore, it was observed that differentiated (myotubes) and undifferentiated 
(myoblasts) HSMM from both healthy and T2DM donors had a relatively low endogenous 
expression of GLUT4 protein compared to 3T3-L1 adipocytes (Figure 6.15 A). GLUT1 
protein expression was higher in both myoblasts and myotubes from healthy and T2DM 
donors with no striking differences between groups (Figure 6.15 B). We also assessed 
endogenous expression of GLUT8 and GLUT12 protein in HSMM but did not detect any 










Figure 6.15 Endogenous GLUT protein expression in differentiated and 
undifferentiated HSMM.  
3T3-L1 adipocytes and HSMM were differentiated as previously described and protein 
expression was assessed by western immunoblotting. (A) 20 μL of sample were loaded. 
Blots were incubated with anti–GLUT4 and anti-GAPDH (as a loading control) as labelled. 
(B) 20 μg of sample were loaded. Blots were incubated with anti-GLUT1 and anti-GAPDH 
as labelled. Blots were visualised with a LI-COR Odyssey-SA system; data from a typical 
experiment is shown. 
 
 
Clathrins are cytoplasmic proteins that play important roles in endocytosis. The two 
clathrin heavy chains CHC17 and CHC22 are found in humans with CHC17 being known to 
be ubiquitously expressed and CHC22 being enriched in skeletal muscle. In this study we 
assessed CHC17 protein expression in HSMM (Figure 6.16 A/B). It can be observed that 
CHC17 protein expression was higher in myotubes compared to myoblasts of healthy and 
T2DM HSMM (Figure 6.16 B). Moreover, CHC17 protein expression was reduced in both 
myoblasts and myotubes derived from T2DM donors compared to those from healthy 
donors. Investigation of CHC22 in HSMM was hampered by the non-specificity of 
commercially available antibodies (data not shown). Furthermore, we investigated 
expression of Rab proteins 8, 10 and 14 with limited success. The antibodies used 






Figure 6.16 Endogenous CHC17 and sortilin protein expression in differentiated and 
undifferentiated HSMM.  
3T3-L1 adipocytes and HSMM were differentiated as previously described and protein 
expression was assessed by western immunoblotting. (A) 20 μL of sample were loaded 
and blots were incubated with anti-CHC17, anti–sortilin and anti-GAPDH as labelled. 
Blots were visualised with a LI-COR Odyssey-SA system. Quantification of (B) CHC17 and 
(C) sortilin immunoblots performed via densitometry, expressed as fold change of 
protein ratio from healthy myoblasts. Data from 3 independently conducted 
experiments are shown. * indicating p<0.05. (B) p= 0.0037 (C) p= 0.0393; determined by 
one-way ANOVA.  
 
 
Sortilin is widely abundant on cell surfaces and the endoplasmic reticulum-Golgi 
apparatus where it acts as a sorting receptor for a variety of intracellular proteins 
between endosomes, lysosomes, the trans-Golgi network, secretory granules and the 
PM. Its molecular function enables sortilin to participate in GLUT4 translocation from 
intracellular stores to the PM in response to insulin. Here we investigated endogenous 




expression of sortilin at an expected size of 100 kDa in both myoblasts and myotubes 
derived from healthy and T2DM donors. Again it can be observed that sortilin expression 
was reduced in both myoblasts and myotubes derived from T2DM donors (Figure 6.16 C).  
 
6.3 Discussion 
6.3.1 Insulin resistance reorganises GLUT4 clustering  
Cellular insulin resistance is strongly associated with defects in the adipocyte glucose 
transport system and in this study we investigated the effect of insulin resistance on 
GLUT4 dispersal. It was observed that chronic insulin treatment induced a state of 
insulin resistance in 3T3-L1 adipocytes (Figure 6.1) and this treatment resulted in 
attenuated insulin-stimulated GLUT4 dispersal in the PM (Figure 6.2). Up to date there 
is only one report of induced cellular insulin resistance resulting in the reorganization of 
GLUT4 clustering in adipocytes (Gao et al., 2017). In this study 3T3-L1 adipocytes were 
treated with 100 nM insulin overnight and this treatment resulted in inhibition of the 
phosphorylation of Akt assessed by western immunoblotting indicating the inability of 
the adipocytes to appropriately respond to insulin stimuli. STORM was used to 
investigate GLUT4 clustering dynamics and it was reported that insulin resistance 
resulted in enhanced GLUT4 clustering under both basal and insulin stimulated 
conditions (Gao et al., 2017). Ripley’s K function analysis revealed that insulin 
stimulated GLUT4 dispersal moderately in insulin-resistant cells and that the effect was 
not as large as observed in control 3T3-L1 cells (Gao et al., 2017). Insulin resistance did 
not change cluster properties for instance number of molecules per cluster, 
clusters/μm2 and molecules/μm2 (in this study Ripley’s K function analysis was chosen to 
quantify GLUT4 clustering  as lined out in Chapter 1). However, there was an increase in 
the total amount of molecules found in large GLUT4 clusters in insulin-resistant cells. In 
line with this study we report that insulin resistance affected the spatial distribution of 
GLUT4 in the PM of 3T3-L1 adipocytes. Ripley’s K function analysis of three 
independently conducted experiments revealed that chronic insulin treatment with 500 
nM for 24 h resulted in a shift of L(r) towards peaking at higher clustering values for 
both basal and insulin-stimulated cells (Figure 6.2). This result is similar to the accounts 
of the previous study (Gao et al., 2017). In addition, we analysed localization density of 
GLUT4 molecules and found that chronic insulin treatment affected translocation of 
GLUT4 from intracellular stores to the PM. In control cells insulin stimulation resulted in 
a higher density of GLUT4 molecules in the PM and this effect was reduced by 34 % 
following chronic insulin treatment indicating a reduction in GLUT4 translocation 
(Figure 6.3). Our results suggest that insulin resistance affects intracellular GLUT4 




A negative correlation between adipocyte cell area and GLUT4 molecule density was 
observed in both basal and insulin-stimulated cells indicating that more GLUT4 
translocated to the PM following insulin stimulation in small cells compared to large 
cells (Figure 6.4). Therefore, small 3T3-L1 adipocytes were identified to be more insulin 
sensitive (Figure 6.5). Adipose tissue expands by increasing cell size (hypertrophy) and 
cell number (hyperplasia) and consequently contains cells of various sizes in vivo and in 
vitro. Over the years numerous studies have investigated the relationship between cell 
size and pathological states such as insulin resistance and T2DM (Acosta et al., 2016; 
Bernstein et al., 1975; Haller et al., 1979; Laforest et al., 2015; McLaughlin et al., 2007; 
Stenkula and Erlanson-Albertsson, 2018; Verboven et al., 2018; Weyer et al., 2000). In 
isolated human adipose tissues metabolism of glucose to carbon dioxide and 
triglycerides was observed to be closely related to cell numbers but not cell size (Salans 
et al., 1968). In contrast, insulin sensitivity was discovered to be dependent on adipose 
cell size. The larger the cells composing the adipose tissue the less insulin responsive it 
was (Salans et al., 1968). Weight loss accompanied by a reduction in adipocyte cell size 
was found to restore insulin responsiveness (Salans et al., 1968). Several studies have 
indicated that adipocyte size serves as a predictor of metabolic disease and diabetes 
independent of body mass index (Haller et al., 1979; Laforest et al., 2015; Weyer et al., 
2000). A study including 280 Pima Indians with normal, impaired or diabetic glucose 
tolerance found that subcutaneous abdominal adipocyte size was higher in subjects with 
impaired or diabetic glucose tolerance (Weyer et al., 2000). Of 108 control subjects 
that were followed up for a decade 33 subjects developed diabetes with subcutaneous 
abdominal adipocyte size being an independent predictor of disease onset (Weyer et 
al., 2000). Interestingly it has been reported that even non-obese individuals with T2DM 
have adipocytes of increased size compared to healthy controls (Acosta et al., 2016). 
Furthermore, 166 healthy individuals with genetic predisposition for T2DM, but not for 
obesity, have been reported to display adipose tissue hypertrophy and reduced insulin 
sensitivity (Arner et al., 2011). One study investigated insulin responsiveness in small 
and large populations of adipocytes obtained from the same individual to eliminate 
biological variation as a confounding variable (Franck et al., 2007). Small and large 
primary human fat cells from the same volunteer were found to have similar amounts of 
IR, IRS-1 and GLUT4 protein and similar activation of proteins involved in the insulin 
signalling cascade (Franck et al., 2007). However, confocal images showed that insulin 
stimulation resulted in reduced GLUT4 translocation to the PM in large cells compared 
to small cells (Franck et al., 2007). This result is in line with the reduced GLUT4 
localization density in large 3T3-L1 cells reported in this study. Recently a study 
reported that C57BL6/J mice that were fed a high-fat diet for 2 weeks leading to 




(Hansson et al., 2019). In hypertrophic adipocytes the insulin response was impaired and 
filamentous actin was significantly increased. This mechanism could significantly 
contribute to the deteriorating adipocyte function observed in T2DM (Hansson et al., 
2019). Taken together these results suggest that adipocyte size is an important feature 
and even predictor of T2DM. Impaired cellular function of hypertrophic adipocytes is an 
understudied aspect of adipose tissue biology and further studies are warranted to 
establish a knowledge basis that could fuel the development of novel therapeutic 
strategies. 
 
6.3.2 Is plasma membrane dispersal specific to GLUT4?  
Super resolution microscopy has not only revealed the existence of GLUT4 dispersal but 
also advanced our understanding of GLUT1 spatial organization and function (Yan et al., 
2018). GLUT1 is responsible for constitutive basal glucose uptake that sustains 
respiration in all mammalian cells. STORM showed that GLUT1 was organised within 
clusters in the PM of cultured HeLa cells (Yan et al., 2018). GLUT1 formed clusters of up 
to 25 molecules but the majority of GLUT1 clusters contained 2-4 molecules and were 
small in size. Dual-colour STORM experiments using anti-cholera toxin subunit B staining 
to visualise lipid rafts were performed to investigate the interactions between GLUT1 
clusters and these membrane microdomains. It was observed that 35 % of GLUT1 
clusters were colocalised with lipid rafts and disruptions of lipid rafts with MβCD 
attenuated GLUT1 clustering (Yan et al., 2018). Glucose uptake experiments showed 
that MβCD treatment of HeLa cells resulted in increased rates of uptake and activation 
of GLUT1. This study supports that GLUT1 similar to many membrane proteins forms 
aggregates and clustering dynamics are associated with its activation and function.  
 
GLUT1 is constitutively expressed and does not translocate in response to insulin. 
However, apart from GLUT4 insulin recruits transmembrane proteins such as TfR and 
the insulin-responsive amino peptidase (IRAP) to the PM of fat and muscle cells. GLUT4 
and IRAP have been identified to colocalise and cycle through similar endocytic 
pathways (Bryant et al., 2002). Several studies have observed colocalization of GLUT4, 
IRAP and the endosomal marker TfR (Chen et al., 2012; Lim et al., 2001; Livingstone et 
al., 1996; Watson et al., 2008). TIRF microscopy revealed that in fibroblasts the 
majority of GLUT4 and IRAP colocalises with TfR in the endosomal system (Lampson et 
al., 2001). In contrast in the highly insulin-responsive 3T3-L1 adipocytes it was found 
that only 30-40 % of GLUT4 is located in endosomal compartments with TfR under basal 
conditions (Martin et al., 1996). In this study we aimed to produce a lentivirus to 
express TfR-GFP to perform imaging experiments in 3T3-L1 adipocytes. Our aim was to 




in related transmembrane proteins such as TfR. HeLa cells have comparable GLUT4 
trafficking and dispersal mechanisms to those observed in adipocytes (Morris et al., 
2020). Taken together with the evidence that GLUT4 and TfR colocalise in several cell 
types that show small insulin responses we decided to overexpress TfR-GFP in HeLa cells 
and use dSTORM to investigate clustering dynamics of TfR similarly to GLUT4. Here we 
report for the first time that insulin did not stimulate the reorganisation of TfR in the 
PM of HeLa cells (Figure 6.6). Chemical ablation of endosomes did not block insulin-
stimulated GLUT4 translocation in adipocytes (Martin et al., 1998) indicating that even 
though insulin has a small effect on general endosomal recycling by stimulating 
translocation of TfR endosomes are not the main insulin-responsive vesicles (IRV) 
(Bryant et al., 2002). Recently, using TIRFM it was reported that GLUT4 and the TfR are 
packaged into distinct intracellular vesicles budding from the endosomal recycling 
compartment in CHO cells (Lampson et al., 2001; Lim et al., 2001). It was proposed that 
in fibroblasts GLUT4 is located in slowly recycling vesicles and TfR in rapidly recycling 
vesicles that directly fuse with the PM even in the absence of insulin (Lampson et al., 
2001). In insulin responsive tissues this is not the case and taken together these findings 
indicate the segregation of GLUT4 from recycling endosomes during insulin-stimulated 
trafficking (Bryant et al., 2002). The finding that insulin stimulation did not result in 
dispersal of TfR in HeLa cells might be an indication that the insulin-stimulated GLUT4 
dispersal we previously observed in these cells (see figure 4.18) originated from 
separate IRV and not endosomal compartments. Our finding also supports that HeLa 
cells have similar GLUT4 trafficking and dispersal mechanisms as observed in 
adipocytes. Further studies are needed to confirm whether insulin stimulation affects 
TfR distribution in highly insulin-responsive cells and to confirm that insulin-stimulated 
dispersal is specific to GLUT4 from IRV.  
 
6.3.3 GLUT4 dispersal in primary human skeletal muscle cells 
from healthy and diabetic donors 
In recent years human skeletal muscle myoblasts have become commercially available 
(Owens et al., 2013). Myoblasts are mononucleate precursors of skeletal muscle that 
fuse during development to form multinucleated myotubes that mature into muscle 
fibres (Zammit et al., 2006). This process can be partly mimicked in vitro by 
propagating skeletal muscle myoblasts in culture and chemically inducing them to fuse 
and differentiate into myotubes (Wasserman and Halseth, 1998). One study aimed to 
characterise myotube formation and differentiation of a variety of cells from different 
commercial vendors (Owens et al., 2013). HSMM purchased from Lonza Bioscience were 




robust myotube formation in cell culture (Owens et al., 2013), therefore we adopted 
this model for use. HSMM from both healthy and T2DM donors developed into myotubes 
5 days after initiation of differentiation (Figure 6.7). Myotubes stained desmin-positive 
and myoblasts desmin-negative (Figure 6.8) but levels of GLUT1 and GLUT4 were found 
to be too low to accurately quantitate (Figure 6.9). In foetuses GLUT1 is majorly 
expressed in the PM of myoblasts and myotubes but the total amount is higher in 
myoblasts compared to myotubes and decreases markedly during postnatal life. GLUT4 
expression follows an opposing trend with levels being low during early development 
and levels peaking progressively during postnatal life (Castelló et al., 1993). In our 
hands, HSMM were highly insulin sensitive but expressed low levels of GLUT4 (Figure 
6.12/13). This result could be explained by the state of differentiation of skeletal 
muscle myotubes that lies between undifferentiated myoblasts and fully mature muscle 
fibres. 
 
In this study we observed that sortilin protein expression was lower in differentiated 
HSMM derived from diabetic donors. It has been largely documented that sortilin 
colocalises with GLUT4 in differentiated myotubes and adipocytes and several studies 
reported that sortilin is crucial for insulin-mediated glucose metabolism (Ariga et al., 
2008, 2017; Morris et al., 1998; Shi and Kandror, 2005). Induction of sortilin on day 2 of 
3T3-L1 adipocyte differentiation was reported to result in the formation of IRV (Shi and 
Kandror, 2005). Furthermore, overexpression of sortilin was observed to increase the 
formation of IRV and insulin-stimulated glucose transport whereas GLUT4 expression 
before induction of sortilin resulted in GLUT4 degradation. This indicates that sortilin is 
vital for the biogenesis of IRV in adipocytes (Shi and Kandror, 2005). Later the same 
group reported that sortilin interacts with GLUT4 and IRAP in the vesicular lumen of 
adipocytes resulting in IRV biogenesis (Shi and Kandror, 2007). Similarly it was found 
that sortilin expression was upregulated during differentiation of C2C12 skeletal muscle 
myotubes and contributed to the development of the insulin-responsive glucose 
transport system (Ariga et al., 2008, 2017). Co-expression of myc7-tagged GLUT4 and 
sortilin in 3T3-L1 adipocytes has resulted in increased GLUT4 targeting to insulin-
responsive vesicles and maximal levels of insulin responsiveness (Huang et al., 2013). 
These studies indicate that the presence of sortilin is vital for insulin responsiveness in 
adipocytes and skeletal muscle and decreased levels of sortilin might result in insulin 
resistance. Specifically sortilin was found to enable two critical steps in the GLUT4 
sorting pathway namely retrieval of GLUT4 from early endosomes to the trans-Golgi 
network followed by the formation of IRV from trans-Golgi network donor membranes 
(Blondeau et al., 2018). In endosomes the luminal Vps10p domain of sortilin was found 




(Pan et al., 2017). This results in the retrieval of GLUT4 from endosomes. For the 
biogenesis of IRV the sortilin C-terminus interacts with specific clathrin adaptor proteins 
(Li and Kandror, 2005). Defects in the described GLUT4 sorting mechanisms play a role 
in the development of T2DM. In C2C12 myotubes it was observed that palmitate 
treatment decreased sortilin expression which resulted in impairment of GLUT4 
trafficking (Tsuchiya et al., 2010). Sortilin mRNA and protein levels were reported to be 
decreased in adipose and muscle tissues from obese db/db and ob/ob mice (Kaddai et 
al., 2009). Moreover, sortilin mRNA and protein levels were downregulated in tissues of 
morbidly obese T2DM patients (Kaddai et al., 2009). Here, we report a decrease in 
sortilin protein expression in HSMM from a normal weight subject which is in line with 
the current evidence that sortilin is key to regulation of intracellular GLUT4 location 
and defects in GLUT4 sorting contribute to the development of the T2DM phenotype.  
 
Clathrin heavy chains interact at their C-termini to form the clathrin triskelion in the 
cytoplasm that binds adaptor proteins linking it to the PM (Pearse, 1976). The triskelion 
will bind other membrane-bound triskelia to form a clathrin lattice that facilitates 
vesicle formation and is able to capture cargo molecules for transport. The CHC17 and 
CHC22 heavy chains build two clathrin lattices with distinct cellular functions. CHC17 is 
important for receptor-mediated endocytoses at the PM and organelle biogenesis in the 
trans-Golgi network whereas CHC22 plays a key role in intracellular targeting of GLUT4 
and has been observed to accumulate during insulin resistance (Dannhauser et al., 
2017). In this study we have observed CHC17 protein expression in all HSMM but 
unfortunately were not able to detect CHC22 protein in our samples.  
 
6.3.4 Conclusions and future directions 
Here we confirmed that insulin resistance induced by chronic insulin treatment 
attenuated insulin-stimulated GLUT4 dispersal in 3T3-L1 adipocytes. Furthermore, we 
produced a novel plasmid vector to study the spatial patterning of TfR-GFP in the PM of 
HeLa cells. We found that TfR does not disperse in response to insulin stimulation. 
Further studies are needed to investigate whether this effect can also be observed in 
adipocytes and muscle cells. It would be desirable to further investigate the link 
between TfR and insulin resistance.  
 
To our knowledge this was the first study that investigated insulin-stimulated GLUT4 
dispersal in a commercially available model of skeletal muscle. It was observed that 
insulin did not stimulate GLUT4 dispersal in HSMM from healthy and T2DM donors. We 
report that HSMM were highly insulin-sensitive but did not have similar GLUT1 or GLUT4 




not find any significant difference in expression of GLUT or clathrin heavy chain 
proteins between myoblasts and myotubes from healthy and T2DM donors. We did find 
that sortilin protein levels were reduced in T2DM myotubes. It can be concluded that 
this study shed some light on the mechanisms of GLUT4 dispersal in health and disease 
but more studies are needed employing a range of cell culture models and experimental 
techniques. A future aim is to study how HSMM from healthy and T2DM donors compare 































7.1 Summary of key findings 
Firstly, we successfully developed a microscopy-based assay to quantify GLUT4 
clustering within the PM of adipocytes at the single molecule level. To achieve this aim 
we explored a range of sample preparation and image processing methods to perform 
GLUT4 cluster analysis. Automated Ripley’s K function analysis was recognised as a 
valuable tool to summarize spatial dependence of GLUT4 molecules over a range of 
distances and indicate changes in GLUT4 clustering dynamics. It was the fastest and 
most user-friendly cluster analysis approach and thus was used for analysis throughout 
this study.  
 
We measured GLUT4 clustering and insulin-stimulated dispersal with the use of dSTORM 
in a variety of cell culture model systems. This provided us with a tool to assess how 
clustering might underpin key aspects of glucose transport regulation. For the first time 
it was observed that AMPK activation attenuated insulin-stimulated GLUT4 dispersal and 
shifted the molecular distribution of GLUT4 towards a more clustered state in 3T3-L1 
adipocytes. AMPK is activated in response to cellular stress in adipocytes and inhibits 
the effects of insulin. Here we propose that AMPK activation prevents insulin-stimulated 
GLUT4 dispersal in the PM, identifying a new facet of AMPK biology. Furthermore, we 
observed that cholesterol depletion resulted in increased basal glucose transport and 
enhanced GLUT4 clustering. This finding seems contradictory but could be due to the 
functional role of GLUT4 clustering being linked to insulin action specifically or the 
possibility that GLUT4 clusters are readily endocytosed in the presence of cholesterol. 
In the absence of cholesterol endocytosis is diminished resulting in increased glucose 
transport. Pervious work in our laboratory indicated that the membrane protein EFR3 
plays a role in the regulation of PM GLUT4 (Laidlaw, 2018; Morris, 2020). In this study 
we used spatial point pattern analysis with spatstat to reanalyse existing imaging data 
of control and EFR3 knock down conditions in basal and insulin-stimulated 3T3-L1 
adipocytes and found that EFR3 knock down diminished insulin-stimulated GLUT4 
dispersal. We observed insulin-stimulated GLUT4 dispersal in HeLa cells for the first 
time and argue that experimentally tractable HeLa cells provide a valuable model 
organism to study GLUT4 dynamics and the elucidation of mechanisms that operate in 
human adipose tissues.  
 
To our knowledge this was the first study that investigated GLUT4 dispersal in a variety 
of in vitro models of cardiac muscle tissue. It was observed that insulin did not 




GLUT4 plasma membrane distribution in NCardia iPSC-CM. Cardiac cell culture models 
differ vastly in their individual stage of development and each model has advantages 
and disadvantages. This study employed a combination of experimental model systems 
and insulin-stimulated GLUT4 dispersal was found to be present in some models, but not 
others.  
 
Finally, we investigated insulin-stimulated GLUT4 dispersal in models of health and 
disease. Chronic insulin treatment was observed to induce a state of cellular insulin 
resistance in 3T3-L1 adipocytes and resulted in a more clustered GLUT4 configuration 
for both basal and insulin-stimulated cells. Analysis of GLUT4 molecule localization 
density revealed that chronic insulin treatment also affected translocation of GLUT4 
from intracellular stores to the PM. This indicates that insulin resistance affects 
intracellular GLUT4 trafficking pathways as well as the organization of the transporter 
within the PM in adipocytes. Moreover, we found a negative correlation between 
adipocyte cell area and GLUT4 molecule density in both basal and insulin-stimulated 
cells. 
 
We also report that insulin did not stimulate the reorganisation of TfR in the PM of HeLa 
cells suggesting that insulin-stimulated GLUT4 dispersal originated from separate IRV 
and not endosomal compartments in HeLa cells and that this observed effect may be 
specific for GLUT4. 
 
Finally, we investigated insulin-stimulated GLUT4 dispersal in a commercially available 
model of skeletal muscle from healthy and T2DM donors. HSMM were highly insulin-
sensitive but insulin stimulation did not result in GLUT4 dispersal. Sortilin protein levels 
were found to be reduced in HSMM myotubes derived from a T2DM donor.  
 
7.2 Current limitations and future directions 
7.2.1 Super resolution microscopy as a tool to quantify membrane 
protein clustering dynamics 
Super resolution microscopy has become a valuable research tool for cell biologists to 
investigate the nanoscale organization of biological structures and processes (Gormal et 
al., 2020). SMLM techniques produce super-resolved images from precise localization of 
single fluorophores across thousands of data-acquisition frames (Godin et al., 2014). 
The prolonged image acquisition times result in considerable photo-bleaching of 
fluorophores and toxicity for live cells making SMLM particularly powerful for fixed cell 




dynamic molecular reorganisation of membrane proteins in response to several stimuli 
live cell imaging is advantageous. But imaging live cells is a challenge for all current 
super resolution microscopy techniques. One limitation of the current study using 
dSTORM to investigate GLUT4 clustering in the PM is that information was obtained 
exclusively on spatial dynamics and temporal dynamics were disregarded. Current SMLM 
techniques achieve high resolution at the expense of acquisition time but fast imaging 
acquisition rates with large fields of view are required to image membrane receptors 
that can move up to 1 μm2/s (Godin et al., 2014). Moreover dSTORM experiments 
require the use of reducing/oxidizing buffers which are toxic for cells making this 
technique not suitable for live cell imaging (Jones et al., 2011). PALM is better suited 
for super resolution live cell imaging and has been used to monitor mobility states of 
single proteins by single-particle tracking (sptPALM) (Manley et al., 2008). This method 
can create spatially resolved maps of single molecule trajectories in the PM and provide 
insight into spatial and temporal dynamics simultaneously. It has been successfully 
employed to observe that lateral diffusion of syntaxin1A and its organisation in 
nanoclusters regulate neurotransmitter release in nerve terminals (Bademosi et al., 
2017) and that Munc18 controls syntaxin-1A engagement into SNARE complex assembly 
(Kasula et al., 2016). Single molecule imaging of GLUT4 diffusion in the PM was 
achieved using TIRF/FPALM imaging of GLUT4-EOS (Lizunov et al., 2013). However it will 
be of considerable interest to investigate GLUT4 dynamics in the PM using sptPALM.  
 
It has been suggested that subtle changes in conformational states of proteins promote 
transient confinement in functionally essential clusters within the PM (Gormal et al., 
2020). Even the sptPALM technique is not suited to investigate changes in mobility and 
clustering associated with possible activity-dependent conformational changes due to 
the requirement for genetic overexpression of fluorescently labelled proteins. Recently 
one group coupled anti-GFP nanobodies to single-molecule imaging-amenable tags to 
study endogenous proteins in discrete conformational states at high resolution in various 
living cells (Gormal et al., 2020). Single-particle tracking of conformation-specific 
nanobodies revealed that the activated β2-adrenoreceptor is organised into stationary 
nanoclusters in live neurosecretory cells and selectively targeted for endocytosis 
(Gormal et al., 2020). This study highlights the importance to investigate highly 
transient changes in the dynamic nanoscale organization of endogenous proteins which 
has recently become possible. Quantum dot technology was used for the analysis of 
intracellular GLUT4 dynamics at the single molecule level in 3T3-L1 adipocytes (Fujita 
et al., 2010; Hatakeyama and Kanzaki, 2011) and L6 cells in the past (Qu et al., 2010) 




Universal point accumulation imaging in the nanoscale topography (uPAINT) is a novel 
super resolution microscopy method that relies on the stochastic binding of specific 
ligands coupled to fluorescent dyes to a target molecule instead of stochastic photo 
switching of fluorophores (Giannone et al., 2010; Sharonov and Hochstrasser, 2006). 
Low concentrations of fluorescently labelled ligands that start to fluoresce upon binding 
to an object of interest are diffused in a solution surrounding the specimen. Fast 
molecule diffusion by Brownian motion results in constant flux of ligands at the 
proximity of the specimen and stochastic binding of ligands to their targets on the cell 
surface (Giannone et al., 2010). Fluorophores are excited selectively with a HILO beam 
and imaged. By combining single-molecule detection with ligand-induced receptor 
activation, uPAINT currently is the technique that allows investigation of activated 
functional receptors and their interactions at the membrane of living cells in real-time 
at high resolution (Godin et al., 2014). Future investigations of GLUT4 membrane 
dynamics should take advantage of this recently developed technology. Real time 
imaging and tracking of diffusing fluorescent ligands has the big advantage that single 
emitters are imaged at low density upon labelling their biomolecular targets (Giannone 
et al., 2010). dSTORM relies on the stochastic switching of fluorophores that can result 
in bias of quantitative analysis because fluorescently labelled molecules can be 
observed more than once. Antibody linkage error is also avoided using uPAINT making it 
the most superior super resolution technique for quantitative imaging (Giannone et al., 
2010). The Gould lab is presently developing modified versions of GLUT4 suitable to 
analysis using PAINT and SPT. 
 
The biggest limitation of this study is that specific quantification of cluster descriptors 
was not possible with the current experimental setup (discussed in detail in chapter 1). 
The use of a commercial HA-tag antibody increased the apparent size of visualised 
structures and photo switching itself introduced a bias and therefore it is not 
scientifically accurate to quantify GLUT4 cluster sizes. However it is generally desirable 
to make estimates regarding GLUT4 cluster size, cluster radius and percentage and 
number of molecules in clusters. Bayesian cluster analysis provided some information of 
GLUT4 cluster parameters in 3T3-L1 adipocytes and iPSC-CM. But as previously 
mentioned for the correct interpretation of SMLM data several sample preparation 
limitations need to be considered. Nevertheless, Ripley’s L function analysis provides 
accurate information on the radial scales of clustering across a variety of distances and 
can serve to compare GLUT4 clustering between several cell types. We have established 
that spatial analysis of point pattern data using spatstat with appropriate controls and 
corrections is comparable to the automated fast Ripley’s L function that was carried out 




of proteins in the PM and it was shown that cluster size can be estimated reliably using 
this method (Ruan et al., 2019). Figure 7.1 provides a summary of Ripley’s L function 
analysis of all cell types included in this study that were presented in the previous 
chapters.  























Figure 7.1 Summary of Ripley's K-function analysis of GLUT4 clustering in a range 
basal and insulin-stimulated cell types. 
Representative plot of Ripley’s K function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP expressing cells. Cells were serum-starved for 2 h 
prior to experiments and stimulated with insulin or left untreated. Cells were fixed and 
stained for surface HA and dSTORM images acquired. GLUT4 molecule coordinates were 
obtained using ThunderSTORM and the obtained localization data was subjected to 
Ripley’s K-function analysis using SR Tesseler with the minimum radius 10 nm, step 
radius 10 nm, and maximum radius 400 nm. L(r)-r (y-axis) represents the clustering 




The amplitude of L(r)-r can be influenced by varying particle density and needs to be 
normalised for the comparison of data from several imaging experiments. However the 
peak of L(r)-r has been shown to correspond to the diameter of the cluster and the 




investigated in this study. This result is an estimate of GLUT4 cluster size and in line 
with previously published accounts for adipocytes (Gao et al., 2017). To obtain a full 
understanding of the spectrum of mobility behaviours of GLUT4 in the PM over time 
several imaging approaches should be combined as each approach has its own inherent 
advantages and drawbacks. 
 
7.2.2 Insulin-stimulated plasma membrane GLUT4 dispersal in 
adipocytes 
The phenomenon of insulin-stimulated GLUT4 dispersal was firstly recognised in 
adipocytes and all current studies have employed this cell type as model organism (Gao 
et al., 2017; Lizunov et al., 2013a; Stenkula et al., 2010). Therefore GLUT4 clustering 
dynamics are best elucidated in adipocytes even though studies are scarce. Currently 
the most significant caveat seems to be to directly link the structural information of 
imaging studies regarding GLUT4 clustering dynamics with functional assays such as 
glucose uptake. It is of foremost interest to establish how structural changes in GLUT4 
clustering directly affect the functional status of the transporter. Studies investigating 
GLUT4 dispersal in response to insulin stimulation have employed diffraction-limited 
live cell TIRF imaging (Stenkula et al., 2010), single molecule tracking of GLUT4-EOS in 
live cells using PALM (Lizunov et al., 2013a) and dSTORM in fixed cells (Gao et al., 
2017). Recently highly responsive, single fluorescent protein-based glucose sensors of 
wide dynamic range have been developed for real-time glucose detection in vitro and in 
vivo (Hu et al., 2018a). Furthermore, glucose transporter activity was successfully 
imaged in HEK293 cells (Keller et al., 2019). HEK293 cells were co-transfected with the 
cytoplasmic single wavelength iGlucoSnFR glucose sensor and GLUT1 and exposed to 
buffers alternating between 0 and 20 mM glucose. Cytochalasin B was added to the 
buffers to decrease GLUT1 transport activity in a dose dependent manner and 
fluorescence changes were recorded to quantify magnitudes of glucose transport 
relative to baseline (Keller et al., 2019). Future studies of insulin-stimulated GLUT4 
dispersal should optimise experimental protocols to use a glucose sensor to measure 
functional glucose transport activity at the same time as structural changes in PM 
GLUT4 clusters in response to various stimuli.  
 
Currently overexpression and knock down of signalling molecules and treatments with 
pharmacological mimetics and inhibitors are the most appropriate way to elucidate 
underlying mechanisms of GLUT4 dispersal. In this study we have for instance 
manipulated the activation of AMPK and presence of cholesterol in 3T3-L1 adipocytes. It 




shifting GLUT4 towards a more clustered distribution. Simultaneously AMPK activation 
decreased insulin-stimulated glucose transport in adipocytes as previously reported (Salt 
et al., 2000). AMPK plays an important role in whole body energy homeostasis and is 
activated when energy is low. In response to AMPK activation metabolic pathways are 
activated that produce ATP and diminish its consumption. It was hypothesised that 
AMPK activation reduced insulin-stimulated glucose transport in adipocytes to inhibit 
triacylglycerol synthesis to diminish ATP consumption. However, the underlying 
molecular processes have not been determined. Here we present attenuation of insulin-
stimulated GLUT4 dispersal as a possible molecular mechanism. If GLUT4 clusters are 
the main site for endocytosis and recycling of GLUT4 AMPK activation might attenuate 
insulin-stimulated dispersal so GLUT4 is readily recycled which inhibits increased 
glucose transport and triacylglycerol synthesis. AMPK and insulin regulate a variety of 
metabolic processes with numerous complex pathways and further studies are needed 
to confirm how AMPK activation influences insulin signalling. This conclusion is, of 
course, tempered by an unknown effect of AMPK on (for example) insulin receptor 
clustering and signalling. Nevertheless, the observed changes in GLUT4 clustering are 
consistent with published work on transport rates and make a novel contribution to this 
field. 
 
The current kinetic model of GLUT4 recycling suggests that GLUT4 endocytosis occurs at 
GLUT4 clusters in the PM (Stenkula et al., 2010). GLUT4 clusters in adipocytes were 
observed to be elongated with a diameter of 90-170 nm in the basal state and this was 
not affected by insulin stimulation (Lizunov et al., 2013a). The shape of GLUT4 clusters 
indicates that they are not maintained by cross-linking. Destruction of lipid raft domains 
with cholesterol was observed to not alter GLUT4 cluster shape or size (Lizunov et al., 
2013a). Contrary to this finding another study reported that cholesterol depletion had a 
significant effect on GLUT4 clustering dynamics (Gao et al., 2017). In line with this 
result in this study it was also observed that cholesterol depletion affected the extent 
of GLUT4 clustering. Further studies need to address the role of lipid rafts in PM protein 
clusters which are generally debated in the scientific community (Pike, 2009). In recent 
years novel imaging techniques have revealed that mechanisms responsible for PM 
organization and compartmentalisation are much more complex than originally 
expected (Krapf, 2018). In fibroblasts single particle tracking was used to study the 
characteristics of transient confinement zones detected within the lateral long-term 
trajectories of different membrane molecules (Dietrich et al., 2002). Lipid analogues 
were found to spend less time in transient confinement zones compared to a 
glycosylphosphatidylinositol-anchored protein (Thy-1) and a glycosphingolipid (GM1). 




Thy-1 indicating that the observed temporary confinement was related to the presence 
of lipid rafts (Dietrich et al., 2002). Particle mobility within the observed transient 
confinement zones was markedly reduced. This study provides experimental evidence 
for presence of putative lipid microdomains within particle trajectories that depend 
strongly on the presence of cholesterol (Dietrich et al., 2002). Single particle tracking 
has further revolutionized our understanding of PM organization and resulted in the 
creation of the ‘picket fence’ model of membrane compartmentalisation (Kusumi et al., 
2014). According to the ‘picket fence’ model membranes are partitioned into domains 
and regions are separated from each other by molecular fences and pickets. Several 
studies have confirmed that the actin cytoskeleton introduces barriers (fences) to the 
diffusion of membrane proteins creating compartments approximately ∼40–300 nm in 
diameter (Andrade et al., 2015; Andrews et al., 2008; Fujiwara et al., 2002, 2016). 
Within these compartments dynamic transmembrane protein complexes bound to the 
actin membrane-skeleton fence exist that have been termed ‘pickets’ (Kusumi et al., 
2014). GLUT4 clusters in the adipocyte PM could be confined within the described 
molecular picket fence. However it was found that disruption of actin structures did not 
result in a change in GLUT4 cluster features (Lizunov et al., 2013a). This indicates that 
GLUT4 clusters are confined in PM regions independently of the presence of the actin 
skeleton. Nevertheless in the basal state it is still plausible that GLUT4 clusters are 
confined by specific protein structures. Recently it has been discussed that current 
studies into factors influencing the dynamic exchange between protein monomers, 
nanoscale protein clusters, and microscale higher-order structures in the PM have been 
too fragmented (van Deventer et al., 2020). Intrinsic and extrinsic factors that regulate 
the dynamic PM organization probably act together and therefore it is hard to 
determine specific key organisers (van Deventer et al., 2020). GLUT4 clustering within 
the PM of adipocytes and other cell types is probably dependent on a variety of extrinsic 
and intrinsic factors acting jointly which should be considered in future research.  
 
7.2.3 Plasma membrane GLUT4 dispersal in cardiac muscle 
In this study the investigation of insulin-stimulated GLUT4 dispersal in the myocardium 
was hampered by the availability of suitable cell culture models. We obtained a HA-
GLUT4-GFP transgenic mouse that overexpresses an HA-tagged human GLUT4-EGFP 
fusion protein under the control of a muscle creatinine kinase promoter. In homozygous 
animals HA-GLUT4-GFP is expressed in cardiac and skeletal muscle and this strain has 
been used to visualise GLUT4 translocation in response to insulin previously (Fazakerley 
et al., 2009; Lizunov et al., 2012). In cardiomyocytes of this animal model it was 
observed that insulin, contraction and hypoxia resulted in translocation of GLUT4 from 




Furthermore, HA-tagged GLUT4 was observed to colocalise with clathrin during early 
stages of internalization indicating GLUT4 endocytosis via a clathrin-mediated route 
(Fazakerley et al., 2009). The HA-GLUT4-GFP transgenic mouse was also used to study 
GLUT4 trafficking in skeletal muscle. Insulin stimulation was found to result in 
translocation of HA-GLUT4-GFP to the sarcolemma and T-tubules comparable to 
endogenous GLUT4 (Lizunov et al., 2012). Using TIRFM it was observed that 10% of 
intracellular GLUT4-containing vesicles were mobile and a majority of vesicles remained 
tethered at the PM or T-tubules and insulin stimulation resulted in exocytosis from 
these pre-tethered vesicles specifically (Lizunov et al., 2012). These studies show the 
utility of the HA-GLUT4-GFP transgenic mouse model in the study of GLUT4 trafficking 
in muscle tissues but currently studies are limited. In this study we aimed to isolate 
cardiomyocytes and muscle tissues from the transgenic animals to study GLUT4 dispersal 
in response to insulin using dSTORM. Unfortunately the shipment of HA-GLUT4-GFP 
transgenic animals was postponed due to the Covid-19 pandemic. It was not within the 
timeline of this study to establish a breeding transgenic mouse colony and optimise 
procedures effectively to image HA-GLUT4-GFP cardiomyocytes. However, the work has 
been started and is currently ongoing in our laboratory. Establishing a colony of the 
transgenic animal model opens many opportunities for the study of GLUT4 dispersal in 
muscle tissues. GLUT4 translocation has been observed in response to insulin, 
contraction and hypoxia and it would be desirable to investigate GLUT4 dispersal in 
these contexts as well. Furthermore, cardiomyocytes rely on fatty acids as well as 
glucose as an energy source. It has been observed that the fatty acid receptor CD36 
translocates to the PM from intracellular stores in response to insulin stimulation and 
contraction similarly to GLUT4 in cardiomyocytes (Steinbusch et al., 2011). It would be 
interesting to investigate the clustering dynamics of CD36 alongside GLUT4 in the PM of 
these cells.  
 
7.2.4 Plasma membrane GLUT4 dispersal in skeletal muscle 
GLUT4 trafficking is less well studied in skeletal muscle tissues due to the more complex 
tissue architecture and a variety of stimuli that influence this process. In this study the 
commercially available HSMM from healthy and T2DM donors were used to study PM 
GLUT4 dynamics and it was observed that PM GLUT4 clustering was not affected by 
insulin stimulation. This could be due to a variety of reasons. Insulin-stimulated GLUT4 
dispersal has previously only been described in the literature in adipose tissues of 
murine origin (Gao et al., 2017; Stenkula et al., 2010). Recent studies have identified 
more species-specific distinctions in GLUT4 trafficking for instance the importance of 
CHC22 in humans but not rodents (Gould et al., 2020). We observed GLUT4 




derived from cervical cancer and do not behave like normal human cells. Future studies 
need to address whether species-specific differences affect insulin-stimulated GLUT4 
dispersal. Furthermore, it is known that the magnitude of GLUT4 translocation is 
significantly smaller in muscle tissues compared to adipocytes. Insulin-stimulated GLUT4 
dispersal might also be less pronounced in muscle tissues and the chosen analysis 
method not sufficient to study the differences. Another complexity in skeletal muscle 
GLUT4 translocation from intracellular stores is that GLUT4 localises to two distinct 
regions the sarcolemma and T-tubules. Future studies should address whether GLUT4 
dispersal is a mechanism present in the sarcolemma or also the T-tubules. GLUT4 
translocation has been observed to be stimulated by treatment with exercise mimetics 
in skeletal muscle. A straightforward next experiment is to administer exercise 
mimetics to HSMM and observe GLUT4 translocation and GLUT4 trafficking machinery 
protein expression. HSMM myotubes are less developed than mature muscle fibres. 
Studying GLUT4 trafficking and dispersal in skeletal muscle from HA-GLUT4-GFP 
transgenic animals has the advantage to be able to investigate more mature muscle 
fibres.  
 
The light-sensitive ion channel channelrhodopsin-2 can be genetically expressed in 
excitable cells such as cardiomyocytes and skeletal muscle cells to control contractile 
function using light with high spatial and temporal precision (Bruegmann et al., 2015). 
Optogenetic stimulation is non-invasive and a valuable experimental tool to mimic 
muscle contractions in the laboratory (Ganji et al., 2021). This technology could also 




Overall, this thesis has detailed several novel findings regarding the regulation of GLUT4 
clustering in adipose and muscle tissues. With dSTORM we established an experimental 
setup to quantify GLUT4 clustering and dispersal in the PM in response to insulin 
stimulation. We managed to describe several molecular mechanisms behind the 
observed GLUT4 clustering dynamics for instance the influence of AMPK, cholesterol and 
EFR3 in adipocytes. Furthermore we have characterised GLUT4 clustering in several cell 
culture models of skeletal and cardiac muscle for the first time. Axiogenesis iPSC-CM 
showed significant GLUT4 dispersal in response to insulin stimulation. Apart from that 
we successfully investigated how T2DM affects GLUT4 dynamics in the plasma 
membrane in several model organisms. Cellular states of insulin resistance resulted in 




trafficking associated with T2DM. Furthermore, we observed that TfR did not disperse in 
the PM following insulin stimulation indicating that GLUT4 clusters may not be derived 






































8.1 Nanobody optimisation staining 
Firstly we optimised sample preparation steps for the performance of super resolution 
microscopy experiments. As lined out in section 3.2.1 two commercially available anti-
GFP VHH / nanobodies were used for immunostaining from Chromotek and Nanotag. It 
was observed that the Chromotek GFP-boost nanobody co-localized well with the GFP 
signal in the HA-GLUT4-GFP 3T3-L1 adipocytes at a concentration of 1:800 (Figure 8.1). 
Because the Atto-647N dye was not bright enough for dSTORM experiments we used 
another nanobody obtained from Nanotag. According to manufacturer’s instructions the 
recommended dilution for their product was 1:500 but our experiments showed that the 
anti-GFP nanobody at a concentration of 1:250 co-localized poorly with GLUT4-GFP in 
3T3-L1 cells (Figure 8.1). At a concentration of 1:50 the nanobody co-localized well with 
the GFP signal but dSTORM imaging experiments required a dilution of 1:10 to yield 





Supplemental Figure 8.1 Colocalization of HA-GLUT4-GFP with anti-GFP nanobody 
immunostaining in 3T3-L1 adipocytes. 
Representative confocal images of 3T3-L1 adipocytes expressing HA-GLUT4-GFP. Images 
on the right show GLUT4-GFP and images on the left show anti-GFP staining with two 
different commercially available nanobodies. Cells were serum-starved and stimulated 




8.2 Bayesian cluster analysis of GLUT4 distribution in the 
plasma membrane of induced pluripotent stem cell-
derived cardiomyocytes  
Similarly to adipocytes we applied Bayesian cluster analysis to quantify GLUT4 clusters 
in basal iPSC-CM (NCardia) and dispersal of the transporter in response to insulin (see 
section 3.2.3). Four 3 x 3 μm sized ROIs were chosen as previously described and the 
percentage of molecules in clusters, the number of clusters per ROI, the mean number 
of molecules per cluster, and the mean radius of clusters was determined for basal and 
insulin-stimulated cells. The majority of the ROIs chosen for basal cells showed that 30-
40 % of molecules were found in clusters whereas after insulin-stimulation the majority 
of the ROIs showed that 20 % of molecules were found in clusters indicating that GLUT4 
molecules were less clustered and more dispersed after insulin-stimulation (Figure 8.2). 
In basal and insulin-stimulated iPSC-CM the frequency distribution for the number of 
clusters per ROI was observed to be relatively similar with a minimal shift of insulin-
stimulated cells towards the left indicating that more ROIs contained fewer clusters 
compared to basal cells (Figure 8.2 B). The average number of molecules per cluster 
was slightly reduced after insulin stimulation suggesting that GLUT4 clusters decreased 
in size (Figure 8.2 C). This result was supported by the analysis of the mean cluster 





Supplemental Figure 8.2 Bayesian Cluster Analysis of GLUT4 molecules in the PM of 
basal and insulin stimulated iPSC-CM. 
HA-GLUT4-GFP iPSC-CM (NCardia) were serum-starved for 2 h prior to the experiment 
and stimulated with 1 µM insulin for 20 min or left untreated. Cells were fixed and 
stained for surface HA and dSTORM images acquired on a Zeiss Elyra PS.1 (see section 
2.3). Reconstructions were calculated using the ImageJ plugin ThunderSTORM and 
molecule coordinates were subjected to Bayesian cluster analysis. Basal cells: black, 
n = 8; Insulin stimulated: white, n = 9. 4 ROIs of 3x3 µm size per cell were analysed. (A) 
Percentage of molecules in clusters. (B) Number of clusters per ROI. (C) Mean number of 
molecules per cluster. (D) Mean radius of clusters. The bar graphs shown here are 












8.3 Optimisation of parameters for hierarchical density-
based spatial clustering of applications with noise 
In section 3.2.6 HDBSCAN was used to identify clusters of GLUT4 in dSTORM images of 
3T3-L1 adipocytes. As a starting point the two parameters minimum clusters and 
minimum samples were manipulated to observe how clustering changed in response 
(Figure 8.3). A minimum cluster size of 5 and minimum samples of 30 were chosen 
arbitrarily to get a good visualization of GLUT4 clustering in 3T3-L1 adipocytes. 
 
Supplemental Figure 8.3 Optimisation of hierarchical density-based spatial 
clustering of applications with noise analysis for 3T3-L1 adipocytes.  
Cells were fixed and stained for surface HA. DSTORM images were acquired (see section 
2.3) and reconstructions calculated using ThunderSTORM. ROI of 8μm x 8μm were 
selected and GLUT4 molecule coordinates processed using an HDBSCAN script written in 
house with Marie Cutiongco in Python. (A) GLUT4 molecule coordinates of a 3T3-L1 
adipocyte. Image scale 51.2 μm. The red square highlights a representative ROI. (B) 
Coloured clusters identified in the cell. (C) Coloured clusters and grey non-clustered 
GLUT4 molecules in the cell. Colourful clusters identified in the chosen ROI by HDBSCAN 
min_cluster_size=5 and (D) min_samples=10, (E) min_samples=20, (F) min_samples=30. 
Colourful clusters identified in the chosen ROI by HDBSCAN min_samples=30 and (G) 
min_cluster_size =10, (H) min_cluster_size =20, (I) min_cluster_size =50. Image scales 




8.4 Spatial analysis using spatstat 
In section 3.2.7 we explored spatial summary function to quantify GLUT4 molecule 
distribution in the PM using spastat. Up to this point we only considered measuring 
dependence between points using the concept of correlation. Ripley’s K and L functions 
define and measure covariance in a point process with clustered patterns showing 
positive covariance, independently placed points showing zero variance and dispersed 
points showing negative covariance (Baddeley et al., 2016). Summary functions 
measuring spatial correlations are the most popular tools for assessing dependence but 
not the only ones that are available. Additional information about spatial point patterns 
can be obtained by the investigation of spacings between points. A duality exists 
between counting points in a given area and measuring shortest distances between 
points and each method provides information that is complementary to the other. 
Generally, an unmitigated analysis of spatial point pattern data should include the study 
of both correlation and spacings. Valuable information about the spatial arrangement of 
points is disclosed in the nearest-neighbour distances but simply taking the average of 
these distances leads to information loss. The G-function provides information about the 
cumulative distribution of the nearest-neighbour distances and is therefore called the 
‘nearest-neighbour distance distribution function’. G(r) is the probability of reaching 
another cluster of points from any point with distance r. The nearest neighbour distance 
(di) is written as  
di = d(xi, x \ xi) 
which is the shortest distance (d) from xi to the points x \ xi consisting of all points of x 
except xi. The nearest-neighbour distance distribution function is  
G(r) = P {d(u, X \ u) ≤ r | X has a point at u} 
defined for all distances r ≥ 0, where u is an arbitrary reference location. P is the 
probability and X the point process. Values obtained for G(r) are probabilities between 
0 and 1. The empty space function F(r) provides a summary of the cumulative 
distribution of the empty-space distances between points in a sample. The empty space 
function is 
F(r) = P {d(u, X) ≤ r} 
defined for all distances r ≥ 0. Similarly to G(r) the values of F(r) are probabilities 
between 0 and 1 indicating the chance that there will be a point of X lying within 
distance r of this location for any fixed reference location (u). The interpretation of 
deviations in F is opposite to each of the previously described summary functions. If a 
pattern is random G(r) and F(r) have a similar probability distribution. However, for 
clustered or dispersed spatial patterns G(r) and F(r) tend to respond in opposite 




can be useful in assessing departures from complete spatial randomness further. The J-
function compares G(r) and F(r) and is  





defined for all r ≥ 0 such that F(r) < 1 (Baddeley et al., 2016). If the empirical J(r) is 
bigger than 1 a pattern is dispersed and if J(r) is smaller than 1 a pattern is clustered.  
G(r) was calculated as described for the example 3T3-L1 adipocyte data set and it was 
observed that the empirical curve lies above the theoretical curve for a completely 
random pattern for both basal and insulin-stimulated cells (Figure 8.4). This indicates 
that the nearest neighbour distances are shorter than expected for a random pattern 
which is consistent with clustering. G(r) lies closer to the theoretical curve for insulin-
treated cells indicating that nearest neighbour distances are bigger compared to basal 
cells indicating that GLUT4 is less clustered after insulin stimulation. For both basal and 
insulin-stimulated 3T3-L1 adipocytes the empty-space function F(r) lies below the 
theoretical curve suggesting the empty-space distances are larger than expected from a 
completely random pattern and this is indicative of clustered patterns (Figure 8.5). 
Again F(r) lies closer to the theoretical curve for insulin-stimulated 3T3-L1 adipocytes 
indicating smaller empty-space distances compared to basal cells indicating that GLUT4 






Supplemental Figure 8.4 G function of GLUT4 molecule dispersal in 3T3-L1 
adipocytes using spatstat in R. 
Representative plot of nearest neighbour distance function analysis of the clustering 
abilities of GLUT4 molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were 
stimulated with 100 nM insulin (panel B) for 20 min or left untreated (panel A) before 
fixation and staining for surface HA. DSTORM images were acquired (see section 3.4) 
and reconstructions calculated using ThunderSTORM. GLUT4 coordinates were subjected 
to G function analysis using spatstat. The presented data are means (solid black lines). 
The grey shading indicates the global upper and lower envelopes which stand for the 
most extreme deviation from the theoretical L function at any distance r. The reference 
function is displayed as red line. The experiment was performed under basal (N=8 cells) 








Supplemental Figure 8.5 F function of GLUT4 molecule dispersal in 3T3-L1 
adipocytes using spatstat in R. 
Representative plot of empty-space function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were stimulated with 
100 nM insulin (panel B) for 20 min or left untreated (panel A) before fixation and 
staining for surface HA. DSTORM images were acquired (see section 3.4) and 
reconstructions calculated using ThunderSTORM. GLUT4 coordinates were subjected to 
F function analysis using spatstat. The presented data are means (solid black lines). The 
grey shading indicates the global upper and lower envelopes. The reference function is 
displayed as red line. The experiment was performed under basal (N=8 cells) and 




Furthermore, we investigated J(r) for basal and insulin-stimulated cells (Figure 8.6). 
Again, the function indicates that both basal and insulin-stimulated cells show a 
clustered pattern of GLUT4 molecules. J(r) comes down from the value 1 quicker than 
the empirical curve for insulin-stimulated cells indicating a lower degree of clustering of 
GLUT4 molecules. One advantage of J(r) is that the function is completely insensitive to 
edge effects and time can be saved for calculation of the uncorrected version. Each 
function does not completely characterise a point process and therefore it is important 






Supplemental Figure 8.6 J function of GLUT4 molecule dispersal in 3T3-L1 
adipocytes using spatstat in R. 
Representative plot of inhomogeneous J function analysis of the clustering abilities of 
GLUT4 molecules in HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were stimulated with 100 
nM insulin (panel B) for 20 min or left untreated (panel A) before fixation and staining 
for surface HA. DSTORM images were acquired (see section 2.3) and reconstructions 
calculated using ThunderSTORM. GLUT4 coordinates were subjected to inhomogeneous J 
function analysis using spatstat. The presented data are means (solid black lines). The 
grey shading indicates the global upper and lower envelopes. The function is displayed 
as centred (red line). The experiment was performed once for basal (N=8 cells) and 
insulin-stimulated (N=9 cells) conditions. 
 
In section 3.2.5 tessellation was described as a method to segment data. We have used 
SR Tesseler to segment GLUT4 clustering data and performed spatial statistics on the 
identified clusters. Figure 8.7 shows the centred inhomogenous L function analysis for 
clusters found in basal and insulin-stimulated 3T3-L1 adipocytes. It can be observed that 
the function shows inhibition at small distances for basal and insulin-stimulated cells. 
The curve than sweeps up for both conditions reaches greater values for insulin-
stimulated cells indicating a higher degree of clustering. At distances above 3000 nm 





We also looked at summary statistics of the characteristics of the clusters that were 
previously identified through tessellation and object segmentation with SR Tesseler 
(Figure 8.8). The results show that insulin-stimulation led to an increase in cluster area, 
numbers of clusters per cell and cluster diameter (Figure 8.8 A-C). The density of 
clusters per nm2 was observed to be reduced after insulin stimulation in 3T3-L1 
adipocytes (Figure 8.8 D). Due to GLUT4 translocation from intracellular stores to the 
PM we expected to find an increase in overall GLUT4 density and clusters. Identification 
of clusters through tessellation indicates that insulin stimulation resulted in increase of 
cluster diameter and area and overall clusters present in the PM. However, the cluster 
density was higher in basal cells indicative of GLUT4 dispersal after insulin stimulation. 
We also investigate cluster diameter in relation to local density (Figure 8.9). The 
density distribution plot shows a summary of all identified clusters within the sample 
and a shift in the cluster characteristics between basal and insulin-stimulated cells 
indicative of a change in GLUT4 clustering dynamics. Clusters identified after insulin 









Supplemental Figure 8.7 Ripley's L function of GLUT4 clusters previously identified 
by tesselation in 3T3-L1 adipocytes. 
Representative plot of Ripley’s inhomogeneous L function analysis of the clustering 
abilities of GLUT4 molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were 
stimulated with 100 nM insulin (panel B) for 20 min or left untreated (panel A) before 
fixation and staining for surface HA. DSTORM images were acquired (see section 2.3) 
and reconstructions calculated using ThunderSTORM. GLUT4 coordinates were subjected 
to tesselation with SR Tesseler to identify clusters. Spatial analysis of clusters for (A) 
basal and (B) insulin-stimulated cells was performed using Ripley’s inhomogeneous L 
function analysis. The presented data are means (solid black lines). The grey shading 
indicates the global upper and lower envelopes. The function is displayed as centred 
(red line). The experiment was performed for basal (N=8 cells) and insulin-stimulated 











Supplemental Figure 8.8 GLUT4 clusters identified by tessellation in 3T3-L1 
adipocytes summary statistics. 
Representative plot of different cluster characteristics after cluster identification 
through tessellation. 3T3-L1 adipocytes were stimulated with 100 nM insulin for 20 min 
or left untreated before fixation and staining for surface HA. Reconstructions of dSTORM 
images were calculated using ThunderSTORM. GLUT4 coordinates were subjected to 
Tesselation with SR Tesseler to identify clusters with density factor 1.8. Analysis of 
identified clusters through tessellation was performed using spatstat in R. (A) Cluster 
areas, (B) number of clusters per cell, (C) cluster diameter and (D) cluster density from 







Supplemental Figure 8.9 GLUT4 clusters identified with Tesselation in 3T3-L1 
adipocytes. 
Representative plot of cluster diameter against local density (log values) for 3T3-L1 
adipocytes. Cells were stimulated with 100 nM insulin for 20 min or left untreated 
before fixation and staining for surface HA. DSTORM images were acquired (see section 
3.4) and reconstructions calculated using ThunderSTORM. GLUT4 coordinates were 
subjected to Tesselation with SR Tesseler to identify clusters. Spatial analysis of 
clusters was performed using spatstat in R. 
 
Next, we investigated the spatial relationships of GLUT4 clusters previously identified 
through HDBSCAN (Figure 8.10). The L function shows inhibition at all distances for 
basal and insulin-stimulated cells with a different curve progression as previously 
observed. We observed that identification of clusters with HDBSCAN changes the 
summary functions generated with spatstat significantly and the results are difficult to 






Supplemental Figure 8.10 Ripley's L function of GLUT4 clusters previously identified 
with HDBSCAN in 3T3-L1 adipocytes using spatstat in R. 
Representative plot of Ripley’s inhomogeneous L function analysis of the clustering 
abilities of GLUT4 molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes. Cells were 
stimulated with 100 nM insulin (panel B) for 20 min or left untreated (panel A) before 
fixation and staining for surface HA. DSTORM images were acquired (see section 3.4) 
and reconstructions calculated using ThunderSTORM. GLUT4 coordinates were subjected 
to HDBSCAN analysis to identify clusters. Spatial analysis of clusters was performed for 
(A) basal and (B) insulin-stimulated cells using Ripley’s inhomogeneous L function 
analysis. The presented data are means (solid black lines). The grey shading indicates 
the global upper and lower envelopes which stand for the most extreme deviation from 
the theoretical L function at any distance r. The function is displayed as centred (red 








Supplemental Figure 8.11 HDBSCAN ROI Ripley's L-function of GLUT4 molecule 
dispersal in 3T3-L1 adipocytes using spatstat in R. 
Representative plot of Ripley’s L function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes, stained for surface HA and 
dSTORM images acquired as described. GLUT4 molecule coordinates were obtained using 
ThunderSTORM and subjected to Ripley’s L-function analysis using SR Tesseler with the 
minimum radius 10 nm, step radius 10 nm, and maximum radius 400 nm. L(r)-r (y-axis) 
represents the clustering ability and r (x-axis) represents the radial scales of clustering. 
The presented data are means. The experiment was performed once basal (panel A; N=8 
cells) and insulin-stimulated (panel B; N=9 cells) conditions.  
 
Lastly, we calculated L(r)-r for ROI chosen from raw localization data sets (Figure 8.12). 
The L function is higher after insulin stimulation in contrast to L(r)-r calculated for the 
localizations without choosing ROI (Figure 3.16). The results are discussed alongside the 











Supplemental Figure 8.12 ROI localizations Ripley's L-function of GLUT4 molecule 
dispersal in 3T3-L1 adipocytes using spatstat in R. 
Representative plot of Ripley’s L function analysis of the clustering abilities of GLUT4 
molecules in the PM of HA-GLUT4-GFP 3T3-L1 adipocytes stained for surface HA and 
dSTORM images acquired. GLUT4 molecule coordinates were obtained using 
ThunderSTORM and subjected to Ripley’s L-function analysis using SR Tesseler with the 
minimum radius 10 nm, step radius 10 nm, and maximum radius 400 nm. L(r)-r (y-axis) 
represents the clustering ability and r (x-axis) represents the radial scales of clustering. 
The presented data are means. The experiment was performed once basal (panel A; N=8 
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